Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23408.Triglycerides in VLDL,AGRP,Agouti-related protein,40058,0.309241063340404,0.00460196217411763,0.300221217479134,0.318260909201675,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCL27,C-C motif chemokine 27,39868,0.277629633672064,0.00567531161653208,0.266506022903661,0.288753244440466,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCN1,CCN family member 1,39758,0.404944920852487,0.00669677594045149,0.391819240009202,0.418070601695772,0
NMR metabolomics,X23408.Triglycerides in VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.108196167953812,0.00267806175696292,0.102947166910165,0.11344516899746,0
NMR metabolomics,X23408.Triglycerides in VLDL,CES1,Liver carboxylesterase 1,39854,0.321214966993451,0.00732703421374093,0.306853979934518,0.335575954052383,0
NMR metabolomics,X23408.Triglycerides in VLDL,F7,Coagulation factor VII,39899,0.12827407465227,0.00273143011075809,0.122920471635184,0.133627677669355,0
NMR metabolomics,X23408.Triglycerides in VLDL,FURIN,Furin,39913,0.132526314636293,0.00312707843808043,0.126397240897656,0.138655388374931,0
NMR metabolomics,X23408.Triglycerides in VLDL,GCG,Pro-glucagon,39477,0.542833277628286,0.0111356302436704,0.521007442350692,0.564659112905879,0
NMR metabolomics,X23408.Triglycerides in VLDL,GHR,Growth hormone receptor,37124,0.1110914246711,0.00264253589425364,0.105912054318363,0.116270795023837,0
NMR metabolomics,X23408.Triglycerides in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.305391702118318,0.00701521423973773,0.291641882208432,0.319141522028204,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF9,Protein turtle homolog A,37437,0.331289294586811,0.00753351878281056,0.316523597772503,0.34605499140112,0
NMR metabolomics,X23408.Triglycerides in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0862790651057534,0.00200266888036941,0.0823538341002293,0.0902042961112774,0
NMR metabolomics,X23408.Triglycerides in VLDL,LDLR,Low-density lipoprotein receptor,39882,0.432893394739874,0.00380204788153058,0.425441380892074,0.440345408587673,0
NMR metabolomics,X23408.Triglycerides in VLDL,LPL,Lipoprotein lipase,39868,-0.190608226954489,0.00434881155050158,-0.199131897593472,-0.182084556315506,0
NMR metabolomics,X23408.Triglycerides in VLDL,MFGE8,Lactadherin,39858,0.265839438924121,0.00370918057589628,0.258569444995365,0.273109432852878,0
NMR metabolomics,X23408.Triglycerides in VLDL,NPY,Pro-neuropeptide Y,40030,0.39413320956536,0.00565617064241832,0.38304711510622,0.4052193040245,0
NMR metabolomics,X23408.Triglycerides in VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.164653881673621,0.00367252074649579,0.157455741010489,0.171852022336752,0
NMR metabolomics,X23408.Triglycerides in VLDL,PROC,Vitamin K-dependent protein C,39908,0.0956839479408956,0.00239120463223073,0.0909971868617234,0.100370709020068,0
NMR metabolomics,X23408.Triglycerides in VLDL,PTH,Parathyroid hormone,37039,0.319517766178405,0.00728006596932523,0.305248836878527,0.333786695478282,0
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.199752190440571,0.00431471485878983,0.191295349317343,0.208209031563799,0
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.137890881415875,0.00299191063460442,0.132026736572051,0.1437550262597,0
NMR metabolomics,X23408.Triglycerides in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.158127190478632,0.00394605256820103,0.150392927444958,0.165861453512306,0
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS15,Enteropeptidase,39788,0.325960300101331,0.00827200416538176,0.309747171937183,0.342173428265479,0
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.192755539105426,0.00491580310736715,0.183120565014986,0.202390513195865,1.11253692925377e-308
NMR metabolomics,X23408.Triglycerides in VLDL,INHBC,Inhibin beta C chain,39858,0.151210603008203,0.00385737946009026,0.143650139266427,0.15877106674998,1.11253692925386e-308
NMR metabolomics,X23408.Triglycerides in VLDL,GPR37,Prosaposin receptor GPR37,39585,0.231934390268964,0.0059862283309231,0.220201382740355,0.243667397797573,1.1125419013834e-308
NMR metabolomics,X23408.Triglycerides in VLDL,CCL23,C-C motif chemokine 23,39931,0.145372323215015,0.00383777609457979,0.137850282069639,0.152894364360392,7.98773148515857e-301
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.289397262169283,0.00770914125534578,0.274287345308806,0.304507179029761,2.3298444998344e-295
NMR metabolomics,X23408.Triglycerides in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.293241322221918,0.0078960678444883,0.277765029246721,0.308717615197115,1.87381184267611e-289
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.500943993636505,0.0135061470674957,0.474471945384213,0.527416041888796,9.50973041476902e-289
NMR metabolomics,X23408.Triglycerides in VLDL,CPM,Carboxypeptidase M,39955,0.118814171434215,0.00322076592910687,0.112501470213165,0.125126872655264,4.70797779721838e-286
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.104547749346825,0.00285051973063806,0.0989607306747746,0.110134768018876,7.67293769214485e-283
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.296186297058063,0.00811142608981928,0.280287901922017,0.312084692194109,2.04514873674637e-280
NMR metabolomics,X23408.Triglycerides in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.225600347960865,0.00621728702857376,0.213414465384861,0.23778623053687,4.48019110901809e-277
NMR metabolomics,X23408.Triglycerides in VLDL,APCS,Serum amyloid P-component,37333,0.11713844189611,0.00324793361128676,0.110772492017988,0.123504391774232,5.39401039817654e-272
NMR metabolomics,X23408.Triglycerides in VLDL,TTR,Transthyretin,37309,0.0844686089217923,0.00234892885267361,0.079864708370552,0.0890725094730325,1.7909506151152e-270
NMR metabolomics,X23408.Triglycerides in VLDL,NRP1,Neuropilin-1,39949,-0.0926399267052031,0.00259471704895009,-0.0977255721211453,-0.0875542812892609,9.57549394309634e-269
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.096871504108166,0.00272636403272223,0.0915278306040305,0.102215177612302,3.71735058568739e-266
NMR metabolomics,X23408.Triglycerides in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.263646991396136,0.00743738709391908,0.249069712692055,0.278224270100218,5.31734610870053e-265
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.112176752763872,0.00317933353830872,0.105945259028787,0.118408246498957,8.81056484935966e-263
NMR metabolomics,X23408.Triglycerides in VLDL,ADIPOQ,Adiponectin,37453,-0.218567946876682,0.00617507108478615,-0.230671086202862,-0.206464807550501,1.38438934999282e-262
NMR metabolomics,X23408.Triglycerides in VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0919001246652562,0.00264005334382922,0.0867256201113509,0.0970746292191615,4.40195869611974e-256
NMR metabolomics,X23408.Triglycerides in VLDL,DSG2,Desmoglein-2,39858,-0.0869644038861404,0.00250708996073312,-0.0918783002091773,-0.0820505075631035,2.89202111913771e-254
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA1,Glutathione S-transferase A1,39841,0.276230397167498,0.00797171448023619,0.260605836786235,0.291854957548761,9.46816410503794e-254
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.344518363938302,0.00999497888934279,0.32492820531519,0.364108522561414,3.56093545425939e-251
NMR metabolomics,X23408.Triglycerides in VLDL,ACY1,Aminoacylase-1,39868,0.197626444894915,0.0058020809049581,0.186254366321198,0.208998523468633,1.46895642453237e-245
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.391268737151662,0.0115611204991331,-0.413928533329963,-0.368608940973362,1.23180098049925e-242
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.241478964618955,0.00722774135824615,0.227312591556793,0.255645337681118,9.83445803192443e-237
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.060467891882198,0.00181618795967955,0.0569081634812261,0.0640276202831699,4.85830631289892e-235
NMR metabolomics,X23408.Triglycerides in VLDL,C9,Complement component C9,37445,-0.166181656447809,0.00497817206649459,-0.175938873698138,-0.156424439197479,6.72631406960313e-235
NMR metabolomics,X23408.Triglycerides in VLDL,F9,Coagulation factor IX,39908,0.0565776990520252,0.00171213609270379,0.0532219123103258,0.0599334857937246,9.90304155891598e-232
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA3,Glutathione S-transferase A3,39477,0.236952207342916,0.00720288718460805,0.222834548461084,0.251069866224748,1.53593522688363e-229
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0931261547443044,0.00284590261489318,0.0875481856191138,0.0987041238694951,2.13104667632596e-227
NMR metabolomics,X23408.Triglycerides in VLDL,BCHE,Cholinesterase,37208,0.0850320758278025,0.0025923897644563,0.0799509918894681,0.0901131597661368,5.19615442469572e-227
NMR metabolomics,X23408.Triglycerides in VLDL,GUSB,Beta-glucuronidase,39919,0.179972325121288,0.00553710340137216,0.169119602454599,0.190825047787978,1.69805193852877e-224
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.0782955693460999,0.0024032739848896,0.0735851523357162,0.0830059863564835,4.04825750057517e-224
NMR metabolomics,X23408.Triglycerides in VLDL,CRIP2,Cysteine-rich protein 2,39749,0.109411528009442,0.00338587866658364,0.102775205822938,0.116047850195946,6.3164242251641e-222
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA4,Kallistatin,37241,0.0713170908268277,0.00220144458312997,0.067002259443893,0.0756319222097624,1.02886965038187e-221
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0967522623507442,0.00299421117499837,0.0908836084477474,0.102620916253741,1.15661403934122e-220
NMR metabolomics,X23408.Triglycerides in VLDL,RBP5,Retinol-binding protein 5,39788,0.169843325389143,0.00527432411720591,0.159505650119419,0.180181000658867,1.81983902046135e-220
NMR metabolomics,X23408.Triglycerides in VLDL,AFM,Afamin,37453,0.0573669580060619,0.00178626301305379,0.0538658825004764,0.0608680335116473,3.40783715800335e-218
NMR metabolomics,X23408.Triglycerides in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.178954908249762,0.00558587901106778,0.168006585388069,0.189903231111455,3.58152499019336e-218
NMR metabolomics,X23408.Triglycerides in VLDL,CFI,Complement factor I,37453,0.0603215797840734,0.00187951258867467,0.0566377351102711,0.0640054244578758,6.45032014383137e-218
NMR metabolomics,X23408.Triglycerides in VLDL,PLAT,Tissue-type plasminogen activator,40002,0.149269549187642,0.00468526092773668,0.140086437769278,0.158452660606006,4.51711998773568e-216
NMR metabolomics,X23408.Triglycerides in VLDL,GRP,Gastrin-releasing peptide,37043,0.156372415528712,0.00490672021371106,0.146755243909838,0.165989587147586,9.01040610200002e-215
NMR metabolomics,X23408.Triglycerides in VLDL,UPB1,Beta-ureidopropionase,37437,0.276264252367701,0.00867393279274304,0.259263344093924,0.293265160641477,9.47837641677689e-215
NMR metabolomics,X23408.Triglycerides in VLDL,SERPIND1,Heparin cofactor 2,37424,0.0844246507502665,0.00265308427980662,0.0792246055618455,0.0896246959386875,2.25138275619193e-214
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.186065308715261,0.00586764400328647,-0.197565890961702,-0.174564726468819,3.87659378217613e-214
NMR metabolomics,X23408.Triglycerides in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0929375198218597,0.00293381277716201,0.0871872467786222,0.0986877928650972,1.07814179497778e-213
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0574663570710825,0.00181756421999091,0.0539039311999003,0.0610287829422646,1.11469035194022e-212
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.169242017034672,0.00534579470912625,0.158764259404785,0.17971977466456,2.70109471728102e-212
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN3,Contactin-3,39858,0.0968086098092758,0.00308773245663892,0.0907566541942636,0.102860565424288,1.84402288378842e-209
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.0925977849582334,0.00297161808391243,0.086773413513765,0.0984221564027017,5.3605455460657e-207
NMR metabolomics,X23408.Triglycerides in VLDL,KYNU,Kynureninase,40058,0.133858929898388,0.00429924043176748,0.125432418652124,0.142285441144653,9.39662818879361e-207
NMR metabolomics,X23408.Triglycerides in VLDL,CFH,Complement factor H,36763,0.0692533834968061,0.00221768964677776,0.0649067117891217,0.0736000552044905,1.9388214890677e-206
NMR metabolomics,X23408.Triglycerides in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.24706976491998,0.00796726136197182,0.231453932650515,0.262685597189445,5.02975527348908e-204
NMR metabolomics,X23408.Triglycerides in VLDL,AMBP,Protein AMBP,40003,0.0564175693908779,0.00182842806573232,0.0528338503820426,0.0600012883997133,3.5501931811632e-203
NMR metabolomics,X23408.Triglycerides in VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.148708284082381,0.00483105508185741,0.13923941612194,0.158177152042821,4.69127842444949e-202
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.151461206737742,0.00495240417046438,0.141754494563632,0.161167918911853,9.66969825522887e-200
NMR metabolomics,X23408.Triglycerides in VLDL,CCL16,C-C motif chemokine 16,40052,0.150706864199045,0.00493566867483438,0.14103295359637,0.16038077480172,3.87338562988348e-199
NMR metabolomics,X23408.Triglycerides in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.318286159524551,0.0104221729076036,0.297858700625648,0.338713618423454,5.29148487411033e-199
NMR metabolomics,X23408.Triglycerides in VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.081133151397323,0.0026657829804418,-0.0863580860389889,-0.075908216755657,7.44700284259569e-198
NMR metabolomics,X23408.Triglycerides in VLDL,AGR3,Anterior gradient protein 3,39464,0.169657234135012,0.00558277633403242,0.158714992520309,0.180599475749716,4.00412158279932e-197
NMR metabolomics,X23408.Triglycerides in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.324838272053116,0.0107375144847994,0.303792743662909,0.345883800443322,1.49787796626896e-195
NMR metabolomics,X23408.Triglycerides in VLDL,F10,Coagulation factor X,37445,0.0757854085082319,0.00250560178894525,0.0708744290018992,0.0806963880145646,1.52097704061441e-194
NMR metabolomics,X23408.Triglycerides in VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0790842638483734,0.00262628758345719,0.0739367401847973,0.0842317875119495,8.14138227550727e-194
NMR metabolomics,X23408.Triglycerides in VLDL,ELN,Elastin,37437,0.095772696299486,0.00317629302040511,0.089547161979492,0.10199823061948,2.20168552406567e-193
NMR metabolomics,X23408.Triglycerides in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0849367322283507,0.00284987200551091,0.0793509830975493,0.090522481359152,5.52031674644333e-190
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0950501326360235,0.00322163721898485,-0.101364541585234,-0.0887357236868132,2.13393048430715e-186
NMR metabolomics,X23408.Triglycerides in VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0839467235215234,0.00284781124475852,-0.0895284335612501,-0.0783650134817967,4.81906933523975e-185
NMR metabolomics,X23408.Triglycerides in VLDL,SNCA,Alpha-synuclein,37124,0.323776740161699,0.0109884606861571,0.302239357216831,0.345314123106567,6.80667308891984e-185
NMR metabolomics,X23408.Triglycerides in VLDL,PLTP,Phospholipid transfer protein,39976,-0.0998581755653554,0.00340731075247027,-0.106536504640197,-0.0931798464905136,5.46554411737026e-184
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR2,Cadherin-related family member 2,39788,0.200973327918955,0.00691397570798122,0.187421935531312,0.214524720306598,4.73895820040813e-181
NMR metabolomics,X23408.Triglycerides in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.128097312197554,0.00441072861403264,0.11945228411405,0.136742340281058,1.02685294286021e-180
NMR metabolomics,X23408.Triglycerides in VLDL,MME,Neprilysin,39788,0.216079328580847,0.00745794135949578,0.201461763516235,0.230696893645459,6.45534549649627e-180
NMR metabolomics,X23408.Triglycerides in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.171626506151534,0.00592461827501878,0.160014254332497,0.183238757970571,9.02447565542164e-180
NMR metabolomics,X23408.Triglycerides in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.203520864085209,0.00703113922312124,0.189739831207892,0.217301896962527,1.40850385494203e-179
NMR metabolomics,X23408.Triglycerides in VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0673160046939768,0.00232101311355405,0.0627668189914108,0.0718651903965427,1.67494251299859e-179
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0582009886921581,0.00201161437754545,0.054258224512169,0.0621437528721472,1.72136357315128e-179
NMR metabolomics,X23408.Triglycerides in VLDL,CFP,Properdin,37453,0.0632955498942549,0.00219406956402643,0.0589951735487631,0.0675959262397467,1.13014727789116e-177
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0589104694677208,0.00204749057217249,0.0548973879462627,0.0629235509891789,1.49260004162193e-177
NMR metabolomics,X23408.Triglycerides in VLDL,SHBG,Sex hormone-binding globulin,37445,-0.140819656855268,0.00488671866890226,-0.150397625446316,-0.13124168826422,2.69245011388509e-177
NMR metabolomics,X23408.Triglycerides in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.183728823242383,0.00641933998750963,0.171146916866864,0.196310729617902,1.2124486733734e-175
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.067955212303936,0.0023816709851382,0.0632871371730652,0.0726232874348069,1.0282721040155e-174
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.187511977339626,0.00657726748783833,0.174620533063463,0.200403421615789,1.1870115394677e-173
NMR metabolomics,X23408.Triglycerides in VLDL,ENO3,Beta-enolase,37043,0.163047567933799,0.00572773168354615,0.151821213834048,0.174273922033549,4.95055382955254e-173
NMR metabolomics,X23408.Triglycerides in VLDL,SOST,Sclerostin,39846,0.103056779515509,0.00363500558591276,0.0959321685671196,0.110181390463898,1.46159902765921e-172
NMR metabolomics,X23408.Triglycerides in VLDL,NPPC,C-type natriuretic peptide,39866,0.123055130542221,0.00434207701226873,0.114544659598174,0.131565601486268,1.94694021291628e-172
NMR metabolomics,X23408.Triglycerides in VLDL,HEG1,Protein HEG homolog 1,37124,0.0729504750810724,0.00257180891758187,0.0679097296026119,0.0779912205595328,6.90813827434612e-172
NMR metabolomics,X23408.Triglycerides in VLDL,FGF21,Fibroblast growth factor 21,40011,0.320232909690485,0.0113276106350892,0.29803079284571,0.34243502653526,1.18494314244854e-171
NMR metabolomics,X23408.Triglycerides in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.231097835023633,0.00817082013871056,0.21508302755176,0.247112642495506,6.57906301726219e-171
NMR metabolomics,X23408.Triglycerides in VLDL,P4HB,Protein disulfide-isomerase,39776,0.103937444935119,0.00369698216530045,0.0966913598911303,0.111183529979108,9.00670784650757e-170
NMR metabolomics,X23408.Triglycerides in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.172245520209476,0.00612879533999415,0.160233081343088,0.184257959075865,5.67935250091836e-169
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS1,Protein MTSS 1,37382,0.293605723440379,0.0104803651860219,0.273064207675776,0.314147239204982,6.37847047800139e-168
NMR metabolomics,X23408.Triglycerides in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.132138807599576,0.00472765529660903,0.122872603218222,0.14140501198093,7.02776683544579e-168
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.191404424003775,0.00684791246925095,0.177982515564044,0.204826332443507,7.3753856797264e-168
NMR metabolomics,X23408.Triglycerides in VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.153657998011612,0.00550528877775211,0.142867632007218,0.164448364016006,9.7467040168949e-167
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0731952387513011,0.00263133236860087,0.0680378273088434,0.0783526501937588,2.31176911976008e-166
NMR metabolomics,X23408.Triglycerides in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.144314281411289,0.00519108907806013,0.134139746818291,0.154488816004287,4.33350431512595e-166
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS8,Prostasin,39805,0.106005388439898,0.0038139874418938,0.0985299730537863,0.11348080382601,4.55702977081943e-166
NMR metabolomics,X23408.Triglycerides in VLDL,SORT1,Sortilin,39846,0.0984674979132112,0.00354684808905312,0.091515675658667,0.105419320167755,1.03797473350043e-165
NMR metabolomics,X23408.Triglycerides in VLDL,SCLY,Selenocysteine lyase,39984,0.129840857264468,0.00467948250012302,0.120669071564227,0.139012642964709,1.43867136862959e-165
NMR metabolomics,X23408.Triglycerides in VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0744495618841394,0.00268381990329902,0.0691892748736733,0.0797098488946054,8.62445210236383e-165
NMR metabolomics,X23408.Triglycerides in VLDL,GLA,Alpha-galactosidase A,37088,0.0995084917424944,0.00359100300801839,0.0924701258467784,0.10654685763821,2.45361180458791e-164
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.154664538432736,0.00559891388843674,0.1436906672114,0.165638409654072,3.66230469202487e-164
NMR metabolomics,X23408.Triglycerides in VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.326647582970713,0.0118287006106634,0.303463329773813,0.349831836167613,5.2517826073951e-164
NMR metabolomics,X23408.Triglycerides in VLDL,STAB2,Stabilin-2,37437,0.0735542357135904,0.00266422132497494,0.0683323619166395,0.0787761095105412,2.75022286038371e-163
NMR metabolomics,X23408.Triglycerides in VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0680176835390141,0.00247123720957621,0.0631740586082447,0.0728613084697834,5.88369269662816e-163
NMR metabolomics,X23408.Triglycerides in VLDL,NUMB,Protein numb homolog,37056,0.221577091234112,0.00804111218254233,0.205816511356329,0.237337671111895,1.44907388127034e-162
NMR metabolomics,X23408.Triglycerides in VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.197926170173019,0.0072038439229994,0.18380663608394,0.212045704262098,1.11971561590497e-161
NMR metabolomics,X23408.Triglycerides in VLDL,MVK,Mevalonate kinase,39587,0.205840999158154,0.00753135189425904,0.191079549445407,0.220602448870902,1.00288338436957e-160
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.14494647952944,0.00529948084000765,0.134559497083025,0.155333461975855,2.34954249964991e-160
NMR metabolomics,X23408.Triglycerides in VLDL,PPY,Pancreatic prohormone,39826,0.259652921646676,0.00952970666042099,0.240974696592251,0.278331146701101,8.04107217031412e-160
NMR metabolomics,X23408.Triglycerides in VLDL,F11R,Junctional adhesion molecule A,39858,0.146428668581076,0.00538877020253462,0.135866678984109,0.156990658178044,5.40007206078194e-159
NMR metabolomics,X23408.Triglycerides in VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0659115406209579,0.00243059733778263,0.0611475698389039,0.0706755114030119,2.22277292335284e-158
NMR metabolomics,X23408.Triglycerides in VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.128824801564514,0.00475070197093807,0.119513425701476,0.138136177427553,2.65248386760686e-158
NMR metabolomics,X23408.Triglycerides in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.363995474015197,0.0134006459518027,0.337730207949664,0.390260740080731,3.05543500564385e-158
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.0942581563998973,0.00349042719103022,-0.101099393694317,-0.087416919105478,4.23256270417941e-157
NMR metabolomics,X23408.Triglycerides in VLDL,EEF1D,Elongation factor 1-delta,37437,0.234342448083569,0.00868467596467519,0.217320483192806,0.251364412974332,2.94494793257138e-156
NMR metabolomics,X23408.Triglycerides in VLDL,DTYMK,Thymidylate kinase,37437,0.176081387579449,0.00653390563784371,0.163274932529276,0.188887842629623,7.14293698922811e-156
NMR metabolomics,X23408.Triglycerides in VLDL,NOMO1,Nodal modulator 1,39858,0.0607081862463664,0.00226088179212022,0.0562768579338108,0.0651395145589221,2.20301526369139e-155
NMR metabolomics,X23408.Triglycerides in VLDL,ATRN,"Attractin, Isoform 2",37453,0.0416890533225749,0.00154963521972753,0.0386517682919089,0.0447263383532408,2.31634333455408e-155
NMR metabolomics,X23408.Triglycerides in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.055344046029584,0.002056851500493,0.0513126170886177,0.0593754749705502,2.57030784860604e-155
NMR metabolomics,X23408.Triglycerides in VLDL,KHK,Ketohexokinase,37043,0.165743734400762,0.00616138352357378,0.153667422694558,0.177820046106967,3.23265582950376e-155
NMR metabolomics,X23408.Triglycerides in VLDL,IL16,Pro-interleukin-16,40058,0.105196764867577,0.00392257986269269,0.0975085083366993,0.112885021398455,4.71868224015686e-155
NMR metabolomics,X23408.Triglycerides in VLDL,MYH9,Myosin-9,37437,0.284751921985723,0.010603495266675,0.26396907126304,0.305534772708406,7.97482094066055e-155
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.231891304423597,0.00869813601013017,0.214842957843742,0.248939651003452,2.92840161063827e-153
NMR metabolomics,X23408.Triglycerides in VLDL,PYY,Peptide YY,37021,0.234688873441983,0.00878641064465005,0.217467508578469,0.251910238305497,4.13282433493057e-153
NMR metabolomics,X23408.Triglycerides in VLDL,GH1,Somatotropin,39846,-0.458199386492875,0.0171978071270782,-0.491907088461948,-0.424491684523801,4.66358109026399e-153
NMR metabolomics,X23408.Triglycerides in VLDL,DPY30,Protein dpy-30 homolog,39979,0.149976858686211,0.00564430083693731,0.138914029045814,0.161039688326608,2.72105471890884e-152
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0844998222325598,0.00318132265546909,0.0782644298278404,0.0907352146372792,3.64749994433637e-152
NMR metabolomics,X23408.Triglycerides in VLDL,MLN,Promotilin,39866,0.22530856653398,0.00848818138097953,0.20867173102726,0.2419454020407,5.78512087548012e-152
NMR metabolomics,X23408.Triglycerides in VLDL,SORD,Sorbitol dehydrogenase,39963,0.173171483438234,0.00652806482366156,0.160376476383857,0.18596649049261,8.43877525081992e-152
NMR metabolomics,X23408.Triglycerides in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0988296148378117,0.00372562056924343,0.0915273985220946,0.106131831153529,9.19041451506506e-152
NMR metabolomics,X23408.Triglycerides in VLDL,CKB,Creatine kinase B-type,37437,-0.146969290930157,0.00553951547082705,-0.157826741252978,-0.136111840607336,2.94753519574414e-151
NMR metabolomics,X23408.Triglycerides in VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.304363728447964,0.011499501101436,0.28182470628915,0.326902750606779,1.89004499075724e-150
NMR metabolomics,X23408.Triglycerides in VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.214463450601236,0.00812865166714549,0.19853129333363,0.230395607868841,3.83295597659524e-150
NMR metabolomics,X23408.Triglycerides in VLDL,SYAP1,Synapse-associated protein 1,37124,0.144802156085936,0.00547929581264145,0.134062736293158,0.155541575878713,4.94050606114286e-150
NMR metabolomics,X23408.Triglycerides in VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.284956411309194,0.010855617005474,0.263679401978465,0.306233420639923,1.03046641016752e-148
NMR metabolomics,X23408.Triglycerides in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.200123815498516,0.00761604168227233,0.185196373801262,0.215051257195769,1.84945633154947e-148
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3F,Semaphorin-3F,39868,0.0637467922128713,0.0024335406175489,0.0589770526024755,0.0685165318232672,3.93268430800274e-148
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.108747037379731,0.00415553882567128,0.100602181281415,0.116891893478047,7.81050864201782e-148
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0729726215070895,0.00279013891064457,0.0675039492422261,0.0784412937719528,3.82001370968751e-147
NMR metabolomics,X23408.Triglycerides in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0559354866343511,0.00215433870978027,0.0517129827631818,0.0601579905055205,1.26826452377822e-145
NMR metabolomics,X23408.Triglycerides in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.129659164909928,0.00498925529468577,0.119880224532344,0.139438105287512,2.47158949695422e-145
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0949821791944837,0.00366523066814934,-0.102166031304056,-0.087798327084911,4.3132829392797e-145
NMR metabolomics,X23408.Triglycerides in VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0802703977432415,0.00310485135344089,0.0741848890904974,0.0863559063959857,1.87640495035492e-144
NMR metabolomics,X23408.Triglycerides in VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.168169633815255,0.00651495639831413,0.15540031927456,0.180938948355951,5.71217117958181e-144
NMR metabolomics,X23408.Triglycerides in VLDL,KLKB1,Plasma kallikrein,37187,0.0615689987460051,0.00238156180186647,0.0569011376143468,0.0662368598776634,7.7990109138465e-144
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.105468182209721,0.00409471359900427,0.0974425435556729,0.11349382086377,2.03665535284519e-143
NMR metabolomics,X23408.Triglycerides in VLDL,CCL22,C-C motif chemokine 22,39686,0.123387748705046,0.00480783368915209,0.113964394674308,0.132811102735784,2.37628654952584e-142
NMR metabolomics,X23408.Triglycerides in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.16688664421302,0.00651511076551304,0.154117027112614,0.179656261313425,2.89222962866757e-141
NMR metabolomics,X23408.Triglycerides in VLDL,FYB1,FYN-binding protein 1,39836,0.222945123601181,0.00876586206502403,0.205764033953734,0.240126213248628,6.46979514259071e-140
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0628881693887277,0.00247318026972019,0.0580407360600761,0.0677356027173793,2.2660723366988e-139
NMR metabolomics,X23408.Triglycerides in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.11866408273706,0.00467429398034318,0.109502466535588,0.127825698938533,7.15244225749207e-139
NMR metabolomics,X23408.Triglycerides in VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0770591524911634,0.00304340466942367,0.071094079339093,0.0830242256432338,4.20200563555331e-138
NMR metabolomics,X23408.Triglycerides in VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0669403745590992,0.00265621864992141,0.0617341860052532,0.0721465631129451,1.82745198892196e-137
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.128744574560526,0.00511093483605329,0.118727142281862,0.138762006839191,2.44929226101936e-137
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.141733071976467,0.0056368634105861,-0.152781324261216,-0.130684819691718,7.68476302247457e-137
NMR metabolomics,X23408.Triglycerides in VLDL,DKK1,Dickkopf-related protein 1,40009,0.143243245316132,0.00570556419006812,0.132060339503599,0.154426151128666,1.7546686572892e-136
NMR metabolomics,X23408.Triglycerides in VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.262839875964605,0.0104566217989497,0.242344897238664,0.283334854690547,2.61836706492175e-136
NMR metabolomics,X23408.Triglycerides in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.113747229283111,0.00452749764317421,0.10487333390249,0.122621124663733,4.093790944235e-136
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.13726647149389,0.00547850783008597,0.126528596146922,0.148004346840859,2.18274990077018e-135
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0828316741972516,0.00332723536490196,0.0763102928820438,0.0893530555124595,2.92659262485492e-134
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0320981446251755,0.00128768533703366,0.0295742813645896,0.0346220078857615,4.28003602714721e-134
NMR metabolomics,X23408.Triglycerides in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0472750993088943,0.00190293360362191,0.0435453494457954,0.0510048491719933,1.04855057271707e-133
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4R,Reticulon-4 receptor,40030,0.0783184686374999,0.00316685722313665,0.0721114284801521,0.0845255087948477,1.43763161345681e-132
NMR metabolomics,X23408.Triglycerides in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.211492037032049,0.00855705822674825,0.194720202907623,0.228263871156476,2.29830403897622e-132
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.200422395145129,0.0081108920283814,0.184525046769502,0.216319743520757,8.08141710951133e-132
NMR metabolomics,X23408.Triglycerides in VLDL,FN1,Fibronectin,37453,0.0626518372172472,0.00254431557374476,0.0576649786927074,0.0676386957417869,5.05362281905505e-131
NMR metabolomics,X23408.Triglycerides in VLDL,FCN2,Ficolin-2,39810,0.0950886523914424,0.00387053260474519,0.0875024084861419,0.102674896296743,7.54655256011017e-131
NMR metabolomics,X23408.Triglycerides in VLDL,LEP,Leptin,39868,0.158981029566313,0.00647721578782845,0.146285686622169,0.171676372510457,1.26646180250942e-130
NMR metabolomics,X23408.Triglycerides in VLDL,CEP20,Centrosomal protein 20,39477,0.172737738168713,0.00706361478436002,0.158893053191368,0.186582423146059,1.21864132676057e-129
NMR metabolomics,X23408.Triglycerides in VLDL,BTD,Biotinidase,37453,0.0480296854482071,0.00196155910873457,0.0441850295950873,0.0518743413013269,1.32738797566108e-129
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR5,Cadherin-related family member 5,39868,0.0905912610873167,0.00370801744897439,0.0833235468873269,0.0978589752873065,1.85227032634239e-129
NMR metabolomics,X23408.Triglycerides in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0692123586678771,0.00283012158401507,0.0636653203632076,0.0747593969725466,2.76418572914321e-129
NMR metabolomics,X23408.Triglycerides in VLDL,CTSD,Cathepsin D,38721,0.0915361163010397,0.00374955089120787,0.0841869965542723,0.0988852360478071,4.32387277651047e-129
NMR metabolomics,X23408.Triglycerides in VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.189378685678988,0.00776627620105523,0.17415678432492,0.204600587033057,5.68322553903306e-129
NMR metabolomics,X23408.Triglycerides in VLDL,AGRN,Agrin,39931,0.075875451456518,0.00311932609655847,0.0697615723072634,0.0819893306057726,2.24722031499936e-128
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0959173033076542,0.0039387851367988,0.0881972844395286,0.10363732217578,3.11841331027706e-128
NMR metabolomics,X23408.Triglycerides in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.168392592465817,0.0069271472031609,0.154815383947622,0.181969800984012,3.15926160917266e-128
NMR metabolomics,X23408.Triglycerides in VLDL,CTSO,Cathepsin O,40058,0.0695369494370688,0.00286248929086912,0.0639264704269653,0.0751474284471723,4.55723941870074e-128
NMR metabolomics,X23408.Triglycerides in VLDL,DCXR,L-xylulose reductase,39913,0.124692212708974,0.00515253972035099,0.114593234857087,0.134791190560862,4.15278434100565e-127
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0909555630154681,0.00376628926765759,0.0835736360508593,0.098337489980077,1.35835532839315e-126
NMR metabolomics,X23408.Triglycerides in VLDL,HJV,Hemojuvelin,37411,0.102424656717264,0.00424242868375062,0.094109496497113,0.110739816937415,4.00925461982443e-126
NMR metabolomics,X23408.Triglycerides in VLDL,CCL17,C-C motif chemokine 17,39836,0.207364861528937,0.00863051107876891,0.19044905981455,0.224280663243324,2.41048583607256e-125
NMR metabolomics,X23408.Triglycerides in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.118497778358777,0.00493593652271996,0.108823342774246,0.128172213943308,4.26291159863746e-125
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.188376495940986,0.00784295266719692,0.17300430871328,0.203748683168692,7.25857498064035e-125
NMR metabolomics,X23408.Triglycerides in VLDL,FUOM,Fucose mutarotase,37124,0.14572575452678,0.00607495139638705,0.133818849789861,0.157632659263699,1.63444229992489e-124
NMR metabolomics,X23408.Triglycerides in VLDL,EHBP1,EH domain-binding protein 1,37437,0.171442644077111,0.00718345817344926,0.157363066057151,0.185522222097072,2.34025837497004e-123
NMR metabolomics,X23408.Triglycerides in VLDL,TXLNA,Alpha-taxilin,39749,0.203178219581785,0.0085345556904619,0.186450490428479,0.21990594873509,4.05203849360517e-123
NMR metabolomics,X23408.Triglycerides in VLDL,TJAP1,Tight junction-associated protein 1,39913,0.188942848356647,0.007946978189788,0.173366771104663,0.204518925608632,7.89176371284145e-123
NMR metabolomics,X23408.Triglycerides in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.207108351222834,0.0087240991656506,0.190009116858159,0.224207585587509,1.97657541483835e-122
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.218119625542518,0.00922270233918902,0.200043128957707,0.236196122127328,1.35652943307459e-121
NMR metabolomics,X23408.Triglycerides in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.123333582356858,0.00522318401591604,0.113096141685663,0.133571023028053,3.81755533598656e-121
NMR metabolomics,X23408.Triglycerides in VLDL,CLUL1,Clusterin-like protein 1,39840,-0.102112914466237,0.00432702539663093,-0.110593884243634,-0.0936319446888404,4.61813700966126e-121
NMR metabolomics,X23408.Triglycerides in VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.106451665700514,0.00450457907101005,0.0976226907213346,0.115280640679694,5.05205257214007e-121
NMR metabolomics,X23408.Triglycerides in VLDL,HGF,Hepatocyte growth factor,40058,0.0766906159610075,0.00325160169122239,0.0703174766462116,0.0830637552758033,5.88928439171485e-121
NMR metabolomics,X23408.Triglycerides in VLDL,EZR,Ezrin,40009,0.0542459824474074,0.00230100297892137,0.0497360166087215,0.0587559482860932,7.60024872506397e-121
NMR metabolomics,X23408.Triglycerides in VLDL,NPL,N-acetylneuraminate lyase,37437,0.099240863016462,0.00421207539170602,0.0909851952487182,0.107496530784206,2.47456956273851e-120
NMR metabolomics,X23408.Triglycerides in VLDL,THOP1,Thimet oligopeptidase,39798,0.0682782620526133,0.00291308738240115,0.062568610783107,0.0739879133221195,1.80383981372179e-119
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0879531150413181,0.00375458181000243,0.0805941346937133,0.0953120953889228,2.25193963806276e-119
NMR metabolomics,X23408.Triglycerides in VLDL,NUCB2,Nucleobindin-2,39995,0.0839826271784676,0.00358951288248411,0.0769471819287987,0.0910180724281364,4.40441469272378e-119
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE4,Ribonuclease 4,37051,0.058181755043921,0.00248664577642189,0.0533079293221341,0.0630555807657078,1.1582641408196e-118
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.158724558180531,0.00679590071313999,0.145404592782777,0.172044523578286,1.2834127853066e-118
NMR metabolomics,X23408.Triglycerides in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.218025363472226,0.00933734100577605,0.199724175100905,0.236326551843547,1.34733715928371e-118
NMR metabolomics,X23408.Triglycerides in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.218734895369885,0.00935769278338731,0.200393817514446,0.237075973225324,1.67709654890595e-118
NMR metabolomics,X23408.Triglycerides in VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0617169499635769,0.00264328045001086,0.0565361202815556,0.0668977796455982,3.16587797347604e-118
NMR metabolomics,X23408.Triglycerides in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.177680393715473,0.00762825221087171,0.162729019382165,0.192631768048782,5.36679289407277e-118
NMR metabolomics,X23408.Triglycerides in VLDL,CD2AP,CD2-associated protein,39868,0.141157462727945,0.006066580444025,0.129266965057656,0.153047960398234,8.35605824246199e-118
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0967582294432121,0.00415975932363245,0.0886051011688925,0.104911357717532,9.90283316044838e-118
NMR metabolomics,X23408.Triglycerides in VLDL,ARF6,ADP-ribosylation factor 6,37382,0.236012678237386,0.0101869365947449,0.216046282511686,0.255979073963086,1.74497148829732e-116
NMR metabolomics,X23408.Triglycerides in VLDL,CD63,CD63 antigen,39720,0.11399782704513,0.00493040327657822,0.104334236623036,0.123661417467223,2.35064509757697e-116
NMR metabolomics,X23408.Triglycerides in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0811878171399482,0.00352361633661298,0.0742815291201868,0.0880941051597097,1.36458546206376e-115
NMR metabolomics,X23408.Triglycerides in VLDL,SELP,P-selectin,39931,0.126537702391947,0.00549368875576131,0.115770072430655,0.137305332353239,1.59551233465853e-115
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN1,Perilipin-1,39489,0.0764210358611123,0.00331823999605419,0.0699172854688461,0.0829247862533785,1.90833776098746e-115
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0848355744979214,0.00368687107900777,0.0776093071830661,0.0920618418127766,2.5982102557087e-115
NMR metabolomics,X23408.Triglycerides in VLDL,NT5E,5'-nucleotidase,39913,0.121881147544487,0.005297183566219,0.111498667754698,0.132263627334276,2.77740124018523e-115
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS2,Protein MTSS 2,37368,0.220037877456772,0.00955327735400022,0.201313453842932,0.238762301070613,3.5796754999678e-115
NMR metabolomics,X23408.Triglycerides in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0617219534666087,0.00268637792559104,0.0564566527324503,0.0669872542007671,5.84504458065649e-115
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.181215189874775,0.00788906767214128,0.165752617237378,0.196677762512172,6.35776754434009e-115
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.24955521505581,0.0108510252363722,0.228287205592521,0.2708232245191,8.26841442235895e-115
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.139194291102474,0.00606718672892488,-0.151085977091167,-0.127302605113781,1.26430655942942e-114
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.21504624190843,0.00940085297434257,0.196620570078719,0.233471913738142,5.48372132491894e-114
NMR metabolomics,X23408.Triglycerides in VLDL,FETUB,Fetuin-B,39908,0.0735117352726851,0.00322382823248989,0.0671930319370049,0.0798304386083653,2.70898902611992e-113
NMR metabolomics,X23408.Triglycerides in VLDL,BECN1,Beclin-1,37043,0.13203724253409,0.00580341522618028,0.120662548690777,0.143411936377403,1.99342280995817e-112
NMR metabolomics,X23408.Triglycerides in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.179787052414204,0.00792574959704495,0.164252583203996,0.195321521624412,8.53437182625819e-112
NMR metabolomics,X23408.Triglycerides in VLDL,CES3,Carboxylesterase 3,39788,0.149219626480932,0.00659010992894493,0.1363030110202,0.162136241941664,9.44259871612863e-112
NMR metabolomics,X23408.Triglycerides in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.115932815189617,0.00512138707564711,0.105894896521348,0.125970733857885,1.08716052743353e-111
NMR metabolomics,X23408.Triglycerides in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.230532220518717,0.0101898984877993,0.21056001948263,0.250504421554803,1.41728630244934e-111
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0443354026699443,0.0019631872051396,0.0404875557478706,0.0481832495920179,3.49270407086786e-111
NMR metabolomics,X23408.Triglycerides in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.179725035108922,0.00795860657592888,0.164126166220101,0.195323903997742,3.85253269011578e-111
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN1,Dynactin subunit 1,40030,0.140591311977399,0.0062333283712188,0.12837398836981,0.152808635584988,6.16547570016912e-111
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNA4,Plexin-A4,39866,0.175111985197088,0.00778480357954081,0.159853770181188,0.190370200212988,2.41955547507858e-110
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.119767651839398,0.0053271847824617,0.109326369665773,0.130208934013023,3.09082185845457e-110
NMR metabolomics,X23408.Triglycerides in VLDL,AXIN1,Axin-1,39866,0.205655440686752,0.00914930242449126,0.187722807934749,0.223588073438754,3.45874632493776e-110
NMR metabolomics,X23408.Triglycerides in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.144883541374094,0.00644772555941083,0.132245999277648,0.157521083470539,4.45586851225951e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CCL5,C-C motif chemokine 5,39931,0.217154876870514,0.00967555692419945,0.198190785299084,0.236118968441945,7.16062310162131e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.13741360420198,0.00612544314531843,0.125407735637156,0.149419472766804,1.00314331070437e-109
NMR metabolomics,X23408.Triglycerides in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.233697565767727,0.0104057594492605,0.213302277247177,0.254092854288278,1.05826807194372e-109
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0801623488733629,0.00356968597089019,0.0731657643704181,0.0871589333763076,1.21031388325555e-109
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.156564119161851,0.0069746167414554,0.142893870348599,0.170234367975104,1.50349443413185e-109
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.141562261855858,0.00631948076369102,0.129176079559023,0.153948444152692,1.81623347626264e-109
NMR metabolomics,X23408.Triglycerides in VLDL,CCN2,CCN family member 2,39880,0.125430908053444,0.00560649417239362,0.114442179475552,0.136419636631335,3.41676072251574e-109
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0837334848528114,0.00374650038749349,-0.0910766256122987,-0.0763903440933242,5.60423916463178e-109
NMR metabolomics,X23408.Triglycerides in VLDL,CPB2,Carboxypeptidase B2,37424,0.0482972842408194,0.00216485557376734,0.0440541673162354,0.0525404011654034,2.61211953530203e-108
NMR metabolomics,X23408.Triglycerides in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.222400248545496,0.0100002122706236,0.202799832495074,0.242000664595919,6.25667071715298e-108
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.242762736177908,0.0109243085595893,0.221351091401113,0.264174380954703,9.00417447774086e-108
NMR metabolomics,X23408.Triglycerides in VLDL,DAB2,Disabled homolog 2,40030,0.237109426091083,0.0106977233013413,0.216141888420454,0.258076963761712,2.97624816501071e-107
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.232357237973587,0.0104685379666606,0.211838903558932,0.252875572388241,3.09410337060452e-107
NMR metabolomics,X23408.Triglycerides in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.151304499779663,0.0068187629741496,0.13793972435033,0.164669275208996,3.45681775061753e-107
NMR metabolomics,X23408.Triglycerides in VLDL,OXT,Oxytocin-neurophysin 1,40009,0.293899766264097,0.0133000998232382,0.26783157061055,0.319967961917644,1.26235342483108e-106
NMR metabolomics,X23408.Triglycerides in VLDL,MUC13,Mucin-13,39489,0.107434997639319,0.00486099972963024,0.0979074381692435,0.116962557109394,1.30805435230375e-106
NMR metabolomics,X23408.Triglycerides in VLDL,TCTN3,Tectonic-3,37437,0.0625904732080857,0.00283012464097588,0.057043428911773,0.0681375175043984,1.67405505649697e-106
NMR metabolomics,X23408.Triglycerides in VLDL,KAZN,Kazrin,37382,0.220922607019134,0.00999229431417956,0.201337710163342,0.240507503874926,1.95713394861476e-106
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0829495273197102,0.00376552605478866,-0.0903299583870959,-0.0755690962523244,5.72415705917002e-106
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0496348104588848,0.0022537724687987,0.0452174164200394,0.0540522044977303,6.46453344835277e-106
NMR metabolomics,X23408.Triglycerides in VLDL,CREG1,Protein CREG1,39660,0.0792109624353195,0.00360866059567845,0.0721379876677897,0.0862839372028492,3.20099854941298e-105
NMR metabolomics,X23408.Triglycerides in VLDL,CST3,Cystatin-C,39897,0.0558188917190894,0.00254759185519566,0.0508256116829059,0.0608121717552729,7.09895959905116e-105
NMR metabolomics,X23408.Triglycerides in VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.12911314385608,0.00588470618447787,0.117579119734504,0.140647167977657,7.99421449643771e-105
NMR metabolomics,X23408.Triglycerides in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.115045523850108,0.00525256635753336,0.104750493789342,0.125340553910873,8.96102065759465e-105
NMR metabolomics,X23408.Triglycerides in VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0847875735868597,0.00387918948110721,0.0771843622038896,0.0923907849698299,2.2288907411226e-104
NMR metabolomics,X23408.Triglycerides in VLDL,STC1,Stanniocalcin-1,40009,0.0878637576980603,0.00402417384398107,0.0799763769638575,0.0957511384322632,3.52914839216282e-104
NMR metabolomics,X23408.Triglycerides in VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.2696758901597,0.0123734037316194,0.245424018845726,0.293927761473674,8.07458696297281e-104
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.264188879825604,0.0121212418259935,0.240431245846656,0.287946513804551,8.1178553487137e-104
NMR metabolomics,X23408.Triglycerides in VLDL,ERBIN,Erbin,39788,0.214480986395914,0.00984801272889185,0.195178881447286,0.233783091344542,1.18524794850736e-103
NMR metabolomics,X23408.Triglycerides in VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.179636025745497,0.00825417439746242,0.163457843926471,0.195814207564523,3.04405709254768e-103
NMR metabolomics,X23408.Triglycerides in VLDL,CD6,T-cell differentiation antigen CD6,40040,0.109033986512162,0.00503109515083702,0.0991730400165216,0.118894933007803,1.08302558718584e-102
NMR metabolomics,X23408.Triglycerides in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.100865184922701,0.00465874477761651,0.0917340451585727,0.109996324686829,1.69316451718584e-102
NMR metabolomics,X23408.Triglycerides in VLDL,CDH2,Cadherin-2,39868,0.0728436766928232,0.00336806940586532,0.0662422606573272,0.0794450927283193,2.85425848568816e-102
NMR metabolomics,X23408.Triglycerides in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.155074826712255,0.00716028210414221,0.141040673788136,0.169108979636374,3.08636721331295e-102
NMR metabolomics,X23408.Triglycerides in VLDL,PAXX,Protein PAXX,37124,0.0952799089306573,0.00441496950250148,0.0866265687057544,0.10393324915556,1.49451728807767e-101
NMR metabolomics,X23408.Triglycerides in VLDL,F13B,Coagulation factor XIII B chain,37380,0.0527742578254679,0.00244769454403709,0.0479767765191552,0.0575717391317806,2.12071703878288e-101
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.179291475710141,0.00835042805197506,0.16292463672827,0.195658314692013,7.66586434858645e-101
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINH1,Serpin H1,37169,0.264763512672547,0.0123299417442544,0.240596826853808,0.288930198491286,1.39808344998177e-100
NMR metabolomics,X23408.Triglycerides in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.126663010371675,0.0059114981895548,0.115076473920148,0.138249546823203,2.09325093746746e-100
NMR metabolomics,X23408.Triglycerides in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.101452923054137,0.00473545988834924,0.0921714216729727,0.110734424435302,2.20893677184089e-100
NMR metabolomics,X23408.Triglycerides in VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.181292576368768,0.00847148983826069,0.164688456285777,0.197896696451759,5.97556964517241e-100
NMR metabolomics,X23408.Triglycerides in VLDL,BCR,Breakpoint cluster region protein,39866,0.188283712095147,0.00882627404013503,0.170984214976482,0.205583209213812,1.38414070468894e-99
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.153330699985213,0.00718782274621992,0.139242567402622,0.167418832567804,2.72513986715976e-99
NMR metabolomics,X23408.Triglycerides in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0589631630993087,0.00278079297236506,0.0535128088734732,0.0644135173251442,1.91606293153304e-98
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.13778999936229,0.00649890877112265,0.12505213817089,0.150527860553691,1.98468355949631e-98
NMR metabolomics,X23408.Triglycerides in VLDL,SELE,E-selectin,40052,0.101212931865256,0.00478204190421539,0.091840129732994,0.110585733997518,4.24548156879465e-98
NMR metabolomics,X23408.Triglycerides in VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.121168666380229,0.00571776579922059,0.109961845413757,0.132375487346702,4.4654895385921e-98
NMR metabolomics,X23408.Triglycerides in VLDL,PGF,Placenta growth factor,40058,0.0522508179125917,0.00247013158382139,0.0474093600083018,0.0570922758168816,5.45053045646248e-98
NMR metabolomics,X23408.Triglycerides in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.21895922293641,0.0103486156729354,0.198675936217456,0.239242509655363,8.7021270316091e-98
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.13007610708029,0.00616389011798482,0.117994882449039,0.14215733171154,2.7273427450952e-97
NMR metabolomics,X23408.Triglycerides in VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.136449112756357,0.00646724815485668,0.123773306372838,0.149124919139876,3.31502498448342e-97
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R9B,Neurabin-2,40058,0.191386146189723,0.00909597241529192,0.17355804025575,0.209214252123695,5.4957274997223e-97
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.190969480730117,0.00909196298895985,0.173149233271756,0.208789728188479,1.19400381212044e-96
NMR metabolomics,X23408.Triglycerides in VLDL,CMIP,C-Maf-inducing protein,37368,0.167640915671002,0.00797106442115962,0.152017629405529,0.183264201936475,1.19545579040761e-96
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.114966295676143,0.00547578236223812,0.104233762246156,0.12569882910613,1.40915811553584e-96
NMR metabolomics,X23408.Triglycerides in VLDL,S100A4,Protein S100-A4,39913,0.114534604972832,0.00546101212192802,0.103831021213853,0.12523818873181,2.25529196720577e-96
NMR metabolomics,X23408.Triglycerides in VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.127323545134793,0.00607186313973698,0.115422693380909,0.139224396888678,2.45407474979275e-96
NMR metabolomics,X23408.Triglycerides in VLDL,CCL13,C-C motif chemokine 13,40024,0.138539772509514,0.00660927125077784,0.125585600857989,0.151493944161038,2.8092872118462e-96
NMR metabolomics,X23408.Triglycerides in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0885549676236492,0.00422588435059994,0.0802722342964733,0.0968377009508251,3.31905260351457e-96
NMR metabolomics,X23408.Triglycerides in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.169801459474597,0.00811048494700691,0.153904908978464,0.185698009970731,4.92602606111325e-96
NMR metabolomics,X23408.Triglycerides in VLDL,BACH1,Transcription regulator protein BACH1,39866,0.148963087725057,0.00712235765718945,0.135003266716966,0.162922908733148,7.48426774414833e-96
NMR metabolomics,X23408.Triglycerides in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0666622793182087,0.00318789280286109,0.060414009424601,0.0729105492118164,8.00698740852814e-96
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.108193853753014,0.00517648063382867,-0.118339755795318,-0.0980479517107098,1.03311006410019e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.208495301729061,0.00998169538803502,0.188931178768512,0.22805942468961,1.30042029021436e-95
NMR metabolomics,X23408.Triglycerides in VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.152168155805708,0.00728744638612229,0.137884760888908,0.166451550722507,1.44662699945905e-95
NMR metabolomics,X23408.Triglycerides in VLDL,SLA2,Src-like-adapter 2,37411,0.21157759508532,0.0101294619633695,0.191723849637116,0.231431340533524,2.20675667724857e-95
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.171718810139795,0.0082320503786329,0.155583991397675,0.187853628881916,2.27260751354772e-95
NMR metabolomics,X23408.Triglycerides in VLDL,RTBDN,Retbindin,39788,0.058684225785881,0.0028133122703338,0.0531701337360268,0.0641983178357352,2.34626904474519e-95
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD5,Programmed cell death protein 5,40009,0.116221887203261,0.00557279506905293,0.105299208867918,0.127144565538605,2.45963697934722e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA5,Integrin alpha-5,39858,0.0496902186162136,0.0023834930436631,0.0450185722506339,0.0543618649817932,2.94760141009015e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ISM1,Isthmin-1,39866,0.0797461643568954,0.00383087815606089,0.072237643171016,0.0872546855427747,5.5237585778282e-95
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0835756060426013,0.00402027792216117,0.0756958613151654,0.0914553507700372,1.02884161890851e-94
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.140649432492277,0.00676640238291331,0.127387283821767,0.153911581162787,1.07299679052108e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.168992482024242,0.00812591074334948,0.153065696967277,0.184919267081207,1.38106477329865e-94
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0581497591875701,0.00280312941368605,0.0526556255367454,0.0636438928383947,2.55607396216366e-94
NMR metabolomics,X23408.Triglycerides in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0518429438333978,0.00249942542669292,0.0469440699970797,0.0567418176697159,4.57327367003022e-94
NMR metabolomics,X23408.Triglycerides in VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.273411751476781,0.0132113982139832,0.247517410977374,0.299306091976189,6.56848553025679e-94
NMR metabolomics,X23408.Triglycerides in VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.132822446389865,0.00642028081680342,0.12023869598893,0.1454061967908,7.31088026754374e-94
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.205253549322898,0.00991185619967135,0.185826311171542,0.224680787474254,9.07462605178927e-94
NMR metabolomics,X23408.Triglycerides in VLDL,SRPK2,SRSF protein kinase 2,39866,0.167078323668396,0.00808117505309257,0.151239220564334,0.182917426772457,9.73104884292471e-94
NMR metabolomics,X23408.Triglycerides in VLDL,ANG,Angiogenin,39843,0.0670299946072475,0.00324536946283065,0.0606690704600994,0.0733909187543956,1.49124300015474e-93
NMR metabolomics,X23408.Triglycerides in VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0867188596785946,0.00419426625245223,0.0784980978237882,0.094939621533401,1.73654248734008e-93
NMR metabolomics,X23408.Triglycerides in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0797450792540195,0.0038598935363048,0.0721796879228621,0.0873104705851769,2.18717780346187e-93
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.114947847938104,0.00557790363557894,0.104015156812369,0.125880539063838,3.85332666106872e-93
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.196755508519195,0.00957386410152625,0.177990734880204,0.215520282158187,1.13606278567522e-92
NMR metabolomics,X23408.Triglycerides in VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.182001756338917,0.00885600334349371,0.164643989785669,0.199359522892165,1.17511620547781e-92
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0530906904028694,0.00258474389672955,0.0480245923652795,0.0581567884404594,1.4362904791303e-92
NMR metabolomics,X23408.Triglycerides in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.128047946373804,0.00623275237954282,0.1158317517099,0.140264141037708,1.44242429840918e-92
NMR metabolomics,X23408.Triglycerides in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.139566314992953,0.00681021454226699,0.12621829449011,0.152914335495796,3.9056055794246e-92
NMR metabolomics,X23408.Triglycerides in VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.209124945236978,0.0102105981984432,0.189112172768029,0.229137717705927,4.73277868592809e-92
NMR metabolomics,X23408.Triglycerides in VLDL,FABP5,Fatty acid-binding protein 5,39972,0.134165607489244,0.00655758772189369,0.121312735554333,0.147018479424156,7.23598626054736e-92
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0444665666224199,0.00217454542146177,0.0402044575963549,0.048728675648485,9.58455556594823e-92
NMR metabolomics,X23408.Triglycerides in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0838286914378381,0.00410369598840363,0.075785447300567,0.0918719355751092,1.36222986711326e-91
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0729726648964323,0.00358155710069785,0.0659528129790645,0.0799925168138,3.91008542793029e-91
NMR metabolomics,X23408.Triglycerides in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.149712750704417,0.00734480151369328,0.135316939737578,0.164108561671256,5.36124136914593e-91
NMR metabolomics,X23408.Triglycerides in VLDL,MINK1,Misshapen-like kinase 1,37388,0.181968139579616,0.0089388852291668,0.164447924530449,0.199488354628783,9.1791602676702e-91
NMR metabolomics,X23408.Triglycerides in VLDL,DOK2,Docking protein 2,39868,0.239754659241777,0.0117956302176068,0.216635224015267,0.262874094468286,1.06018055384581e-90
NMR metabolomics,X23408.Triglycerides in VLDL,AAMDC,Mth938 domain-containing protein,37043,0.104665676197243,0.00514587468868594,0.0945797618074188,0.114751590587068,1.39717298246331e-90
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0382332510453793,0.0018855585377128,0.0345375563114622,0.0419289457792963,2.810611457822e-90
NMR metabolomics,X23408.Triglycerides in VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.119275849205285,0.00589878947977552,0.107714221824925,0.130837476585645,9.10441023277801e-90
NMR metabolomics,X23408.Triglycerides in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.124484175616142,0.00615739937726781,0.112415672836697,0.136552678395587,1.43653400750592e-89
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO1,Forkhead box protein O1,39866,0.166643738068731,0.00826814477280771,0.150438174314028,0.182849301823434,3.11193614927109e-89
NMR metabolomics,X23408.Triglycerides in VLDL,EGLN1,Egl nine homolog 1,39866,0.103316596832517,0.00513012672377118,0.0932615484539255,0.113371645211109,4.24159228495908e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PXN,Paxillin,39489,0.0999793577299014,0.00497473461748466,0.0902288778796314,0.109729837580171,1.02388673898004e-88
NMR metabolomics,X23408.Triglycerides in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.182262378538501,0.00909764328254249,0.164430997704718,0.200093759372285,3.40753932376217e-88
NMR metabolomics,X23408.Triglycerides in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.186879303420564,0.00933186316218567,0.168588851622681,0.205169755218448,4.09584687314056e-88
NMR metabolomics,X23408.Triglycerides in VLDL,TPD52L2,Tumor protein D54,37124,0.210678475082424,0.0105116532888994,0.190075634636181,0.231281315528667,4.70767815586366e-88
NMR metabolomics,X23408.Triglycerides in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.22064331981265,0.0110176038176068,0.199048816330141,0.24223782329516,6.09209915989982e-88
NMR metabolomics,X23408.Triglycerides in VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.153393917243075,0.00766125468405505,0.138377858062327,0.168409976423823,7.10414848170142e-88
NMR metabolomics,X23408.Triglycerides in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.103280474736241,0.00516004974584782,0.0931667772343796,0.113394172238103,7.88479904911809e-88
NMR metabolomics,X23408.Triglycerides in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0974736539046541,0.00489856784091656,0.0878724609364576,0.107074846872851,7.94793809703456e-87
NMR metabolomics,X23408.Triglycerides in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.132879802071642,0.006681150993759,0.119784746123874,0.145974858019409,8.81013734154191e-87
NMR metabolomics,X23408.Triglycerides in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.148289207813684,0.00745707032244954,0.133673349981683,0.162905065645685,9.30023495444231e-87
NMR metabolomics,X23408.Triglycerides in VLDL,USO1,General vesicular transport factor p115,39788,0.171254948189818,0.00862248095962385,0.154354885508956,0.188155010870681,9.81910850123288e-87
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.206943911888509,0.0104212017410782,0.186518356475996,0.227369467301022,1.60091038172979e-86
NMR metabolomics,X23408.Triglycerides in VLDL,SEC31A,Protein transport protein Sec31A,37043,0.147143215628317,0.00742095755286446,0.132598138824702,0.161688292431931,3.0640427790125e-86
NMR metabolomics,X23408.Triglycerides in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0518222461020987,0.00261959735942095,0.0466878352776336,0.0569566569265638,4.74507656868216e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.218308161525248,0.0110308561692211,0.196687683433575,0.239928639616922,5.83722063868591e-86
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.172841687225149,0.00873421746883172,0.155722620986239,0.189960753464059,6.05427674530076e-86
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0672551942525823,0.00340453851063608,0.0605822987717356,0.073928089733429,7.79208516833368e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CEP43,Centrosomal protein 43,39476,0.132961395159045,0.00673272670798717,0.11976525081139,0.1461575395067,9.17453332938258e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.137879513254023,0.00698280180843519,0.12419322170949,0.151565804798556,1.3914468991833e-85
NMR metabolomics,X23408.Triglycerides in VLDL,HEXIM1,Protein HEXIM1,39866,0.154885720273775,0.00785438087836367,0.139491133752183,0.170280306795368,1.51218524488166e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0986568751629237,0.00500743519874294,0.0888423021733876,0.10847144815246,2.11020079203802e-85
NMR metabolomics,X23408.Triglycerides in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.095677362631596,0.00486275291222952,0.0861463669236261,0.105208358339566,3.73925556989325e-85
NMR metabolomics,X23408.Triglycerides in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.132554725504159,0.00674364231222546,0.119337186572197,0.145772264436121,8.33197227234163e-85
NMR metabolomics,X23408.Triglycerides in VLDL,PENK,Proenkephalin-A,37124,0.0551142786665368,0.00280644510594456,0.0496136462588854,0.0606149110741881,1.15165499115768e-84
NMR metabolomics,X23408.Triglycerides in VLDL,SIAE,Sialate O-acetylesterase,39875,0.0889325035953194,0.00454180925683002,0.0800305574519325,0.0978344497387062,2.18125098465514e-84
NMR metabolomics,X23408.Triglycerides in VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.137899013303771,0.00705629974745061,0.124068665798768,0.151729360808774,4.72088540021457e-84
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1A,Meprin A subunit alpha,37382,0.134759099283455,0.00689332136110736,0.121248189415684,0.148270009151225,6.01419285548298e-84
NMR metabolomics,X23408.Triglycerides in VLDL,VNN1,Pantetheinase,37445,0.136132237329656,0.00697800617229759,0.122455345231953,0.149809129427359,1.28418768163133e-83
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0524095349199047,0.00269265379510156,0.0471319334815056,0.0576871363583037,2.06528555323409e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MMP10,Stromelysin-2,39857,-0.109859055403812,0.00564992861684087,-0.12093291549282,-0.0987851953148039,2.97041710402738e-83
NMR metabolomics,X23408.Triglycerides in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.211849838634413,0.0108973324883334,0.190491066957279,0.233208610311546,3.18966052096322e-83
NMR metabolomics,X23408.Triglycerides in VLDL,DAG1,Dystroglycan,39931,0.090805297181778,0.00467169438383319,0.081648776189465,0.0999618181740911,3.35947994524905e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.209527394047748,0.0107811775707189,0.188396286009139,0.230658502086357,3.64908853475531e-83
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH2,Neutral ceramidase,39749,0.097926509219936,0.00504102498665671,0.0880461002460888,0.107806918193783,4.28014053952374e-83
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0500612446657805,0.00257845726818506,0.0450074684201378,0.0551150209114232,5.20815070709061e-83
NMR metabolomics,X23408.Triglycerides in VLDL,GOLM2,Protein GOLM2,40009,0.0413476442581639,0.00213158769287638,0.0371697323801262,0.0455255561362016,7.08282801935973e-83
NMR metabolomics,X23408.Triglycerides in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.1254530246927,0.00648434842782928,0.112743701774154,0.138162347611245,1.98295254356881e-82
NMR metabolomics,X23408.Triglycerides in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.142697353565971,0.00737946933945177,0.128233593660646,0.157161113471297,2.29936603088008e-82
NMR metabolomics,X23408.Triglycerides in VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0399440450623925,0.00206772208671375,0.0358913097724336,0.0439967803523515,3.19311189941348e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB3,Plexin-B3,39812,0.0885437162066283,0.0045863702795988,0.0795544304586147,0.097533001954642,4.14024629051175e-82
NMR metabolomics,X23408.Triglycerides in VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.142730217812144,0.00739317811026948,0.128239588716016,0.157220846908272,6.07614748123921e-82
NMR metabolomics,X23408.Triglycerides in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.11391813435378,0.00590990566317413,0.102334719253959,0.125501549453601,7.27720422346299e-82
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.111172041333251,0.00577500930138111,0.0998530231025439,0.122491059563958,1.14785512027007e-81
NMR metabolomics,X23408.Triglycerides in VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.063144592257209,0.00328046232446034,-0.0695742984131512,-0.0567148861012667,1.21059171582835e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.189677484926049,0.00986756085697401,0.170337065646379,0.209017904205718,2.91101384189901e-81
NMR metabolomics,X23408.Triglycerides in VLDL,OGFR,Opioid growth factor receptor,39788,0.06031489527256,0.00314312507210906,0.0541543701312263,0.0664754204138938,3.72912808874832e-81
NMR metabolomics,X23408.Triglycerides in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.103472186369822,0.0053937160830149,0.0929005028471126,0.114043869892531,4.00450278715425e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CNST,Consortin,39868,0.198947373026634,0.0104006969307638,0.178562007042337,0.219332739010931,1.16467918600821e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SCG2,Secretogranin-2,39949,0.0572926396583756,0.00299608125202021,0.051420320404416,0.0631649589123353,1.28396812901308e-80
NMR metabolomics,X23408.Triglycerides in VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.167046552592556,0.00873493973822806,0.149926070705629,0.184167034479483,1.81746044247538e-80
NMR metabolomics,X23408.Triglycerides in VLDL,BID,BH3-interacting domain death agonist,39866,0.121644389873918,0.00636772371983551,0.10916365138304,0.134125128364795,1.86103055685466e-80
NMR metabolomics,X23408.Triglycerides in VLDL,IDUA,Alpha-L-iduronidase,40030,0.0843467581936416,0.0044178074577862,0.0756878555763807,0.0930056608109026,2.23300097524665e-80
NMR metabolomics,X23408.Triglycerides in VLDL,DNMBP,Dynamin-binding protein,39749,0.113797218004555,0.00597119704341713,0.102093671799457,0.125500764209652,4.43154046163809e-80
NMR metabolomics,X23408.Triglycerides in VLDL,FKBPL,FK506-binding protein-like,37382,0.10939995988993,0.00573853214017918,0.0981524368951791,0.120647482884681,5.60099717253965e-80
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0562817955584624,0.00295264656508456,0.0504946082908966,0.0620689828260281,5.87559583439747e-80
NMR metabolomics,X23408.Triglycerides in VLDL,EREG,Proepiregulin,39713,0.146402022884962,0.00768831269485603,0.131332930003044,0.161471115766879,5.95058431843194e-80
NMR metabolomics,X23408.Triglycerides in VLDL,NIT2,Omega-amidase NIT2,37377,0.138530946943839,0.00727006280132669,0.124281623853239,0.15278027003444,6.64239064550964e-80
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX2,Heme oxygenase 2,39489,0.0866825207989474,0.00455566974883872,0.0777534080912235,0.0956116335066713,8.06715161918003e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.132487310116171,0.00696648335816173,0.118833002734174,0.146141617498168,1.31190603481419e-79
NMR metabolomics,X23408.Triglycerides in VLDL,COCH,Cochlin,37437,0.0837726479205575,0.00440790906704554,0.0751331461491482,0.0924121496919668,1.66209899959794e-79
NMR metabolomics,X23408.Triglycerides in VLDL,DLK1,Protein delta homolog 1,40052,0.101809270914926,0.00536981020601299,0.0912844429111407,0.112334098918712,2.65848097963342e-79
NMR metabolomics,X23408.Triglycerides in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.114560555472025,0.00603844897524192,0.102725195480551,0.126395915463499,3.10414322293396e-79
NMR metabolomics,X23408.Triglycerides in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.142505227362854,0.00751524574290419,0.127775345706761,0.157235109018946,3.89075510781102e-79
NMR metabolomics,X23408.Triglycerides in VLDL,AMN,Protein amnionless,39587,0.0866833793728617,0.00459157734590028,0.0776838877748971,0.0956828709708262,1.26022546694108e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.189126120374091,0.0100246413808773,0.169477823267572,0.208774417480611,1.52719308568717e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SH2B3,SH2B adapter protein 3,39477,0.178988442651653,0.00949427678340663,0.160379660156176,0.19759722514713,2.08749111821376e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0437566712418914,0.00232159620728718,0.0392063426756085,0.0483069998081743,2.16763105853975e-78
NMR metabolomics,X23408.Triglycerides in VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0670563423501889,0.00355882426687822,0.0600810467871076,0.0740316379132702,2.42993462797794e-78
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.119521229042838,0.00633942609848632,0.107095953889805,0.131946504195871,2.74710304110946e-78
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.156472895526859,0.00831341312853289,0.140178605794934,0.172767185258783,3.49646857452563e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CD36,Platelet glycoprotein 4,37056,0.0830606949883413,0.00440924480385727,0.0744185751727811,0.0917028148039016,3.90373636310929e-78
NMR metabolomics,X23408.Triglycerides in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.16505072750582,0.00876405705449087,0.147873175679018,0.182228279332622,4.05986738699986e-78
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0589895429931243,0.00313696720287651,0.0528410872754864,0.0651379987107623,4.82208573706092e-78
NMR metabolomics,X23408.Triglycerides in VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.114487628329838,0.006083145119722,0.102564663895183,0.126410592764493,5.07812353013248e-78
NMR metabolomics,X23408.Triglycerides in VLDL,QDPR,Dihydropteridine reductase,39790,0.07869668181797,0.0041887304401475,0.0704867701552809,0.0869065934806591,6.60968913660469e-78
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS9,Galectin-9,39859,0.0569551803009843,0.00303378858741473,0.0510089546696514,0.0629014059323172,8.50073541985565e-78
NMR metabolomics,X23408.Triglycerides in VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.152876864321385,0.0081444739588098,0.136913695362117,0.168840033280652,9.05834487814593e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0910767704734342,0.00485409634445356,0.0815627416383053,0.100590799308563,1.03612147757847e-77
NMR metabolomics,X23408.Triglycerides in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.138600512427149,0.0073868781651428,0.124122231223469,0.153078793630829,1.45161753198145e-77
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0975550762798297,0.00520498591847749,0.0873533038796138,0.107756848680046,1.52365128979371e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.102029025655797,0.00544915293566983,0.0913486859018837,0.112709365409709,2.12258525468735e-77
NMR metabolomics,X23408.Triglycerides in VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.153792317353803,0.00822122159409552,0.137678723029376,0.16990591167823,3.03887763762706e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.107692982015931,0.00575258245259624,0.0964179204088422,0.118968043623019,3.163496588025e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CES2,Cocaine esterase,39788,0.0973271302470311,0.00520861250155452,0.0871182497439843,0.107536010750078,4.30491665182912e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0810073784652853,0.00433202539089333,-0.0894981482314362,-0.0725166086991343,4.63593310423316e-77
NMR metabolomics,X23408.Triglycerides in VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0307903784872879,0.0016469635259894,0.0275623299763487,0.0340184269982271,4.99162208681615e-77
NMR metabolomics,X23408.Triglycerides in VLDL,METAP2,Methionine aminopeptidase 2,40011,0.103863422920678,0.00556206337673588,0.0929617787022759,0.114765067139081,5.25326922226102e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.15632039102816,0.0083737368198875,0.139907866861181,0.17273291519514,5.89068003461029e-77
NMR metabolomics,X23408.Triglycerides in VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.136503550957678,0.00731551110967146,0.122165149182722,0.150841952732635,7.14494731042359e-77
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.154087781975709,0.00825405694606949,0.137909830361413,0.170265733590005,8.80770055530128e-77
NMR metabolomics,X23408.Triglycerides in VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0422698541538232,0.00226873041753956,0.0378231425354456,0.0467165657722007,1.17392215498302e-76
NMR metabolomics,X23408.Triglycerides in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.130638134689473,0.00701742322432786,0.116883985169791,0.144392284209156,2.13731538189979e-76
NMR metabolomics,X23408.Triglycerides in VLDL,SNCG,Gamma-synuclein,39749,0.116191691523763,0.00625892737014508,0.103924193878278,0.128459189169247,3.9968207688299e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.184358666431984,0.00993275545091975,0.164890465748181,0.203826867115786,4.14965736908418e-76
NMR metabolomics,X23408.Triglycerides in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.114021576942229,0.00614569455184878,0.101976015620606,0.126067138263853,5.04766569312538e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0586886948479886,0.00316743586092901,0.0524805205605677,0.0648968691354094,7.39749816077786e-76
NMR metabolomics,X23408.Triglycerides in VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.098896246353306,0.00534727785053855,0.0884155817662504,0.109376910940362,1.92754210325192e-75
NMR metabolomics,X23408.Triglycerides in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.10161677107014,0.00550240613878941,0.090832055038113,0.112401487102167,3.16104232025475e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CCL11,Eotaxin,40058,0.0678318268963926,0.00367743190931447,0.0606240603541362,0.075039593438649,3.33915303649172e-75
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0498515130514736,0.00270559677718536,0.0445485433681903,0.0551544827347569,4.90591662029446e-75
NMR metabolomics,X23408.Triglycerides in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.102105392127887,0.00554249864575454,0.0912420947822077,0.112968689473565,5.12298202815089e-75
NMR metabolomics,X23408.Triglycerides in VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.10560051358131,0.00574216834248755,0.0943458636300342,0.116855163532585,9.31416437038714e-75
NMR metabolomics,X23408.Triglycerides in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.17968244138504,0.00977819180961538,0.160517185438194,0.198847697331886,1.20028543317761e-74
NMR metabolomics,X23408.Triglycerides in VLDL,MTDH,Protein LYRIC,37056,0.164035238058514,0.0089324372467634,0.146527661054858,0.181542815062171,2.14938538095406e-74
NMR metabolomics,X23408.Triglycerides in VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.170170450806308,0.00930074122880256,0.151940997997855,0.188399903614761,6.86545463570544e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0983135434274836,0.00538264879188675,0.0877635517953856,0.108863535059582,8.83818008593518e-74
NMR metabolomics,X23408.Triglycerides in VLDL,BRAP,BRCA1-associated protein,37249,0.194427263155513,0.0106349671576455,0.173582727526528,0.215271798784498,9.08829666176121e-74
NMR metabolomics,X23408.Triglycerides in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.141652326957014,0.00775269892394695,0.126457037066078,0.15684761684795,1.0709053716351e-73
NMR metabolomics,X23408.Triglycerides in VLDL,ARSB,Arylsulfatase B,39788,0.0970896952022545,0.00531998970009515,0.086662515390068,0.107516875014441,1.16471872305956e-73
NMR metabolomics,X23408.Triglycerides in VLDL,C19orf12,Protein C19orf12,39489,0.114230193448997,0.00626191949548937,0.101956831237837,0.126503555660156,1.38720017594361e-73
NMR metabolomics,X23408.Triglycerides in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0349775320084053,0.00191684341808654,0.0312205189089557,0.038734545107855,1.64673704356138e-73
NMR metabolomics,X23408.Triglycerides in VLDL,MYDGF,Myeloid-derived growth factor,37437,0.178354197232173,0.00977531419532017,0.159194581409345,0.197513813055,1.69757799611146e-73
NMR metabolomics,X23408.Triglycerides in VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.171908184175838,0.00942658760852279,0.153432072463134,0.190384295888543,2.10515046680976e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.186913296023692,0.0102502616013512,0.166822783285044,0.20700380876234,2.12685163781406e-73
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.155656860183313,0.00854011880423801,0.138918227327007,0.17239549303962,2.5152339037246e-73
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS8,Galectin-8,40009,0.107079021948247,0.00589812971201356,0.0955186877126999,0.118639356183793,6.2521526790802e-73
NMR metabolomics,X23408.Triglycerides in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0957499001976763,0.00527681516151176,0.0854073424811132,0.106092457914239,7.4958351913029e-73
NMR metabolomics,X23408.Triglycerides in VLDL,STAMBP,STAM-binding protein,39713,0.112605657724575,0.00620813403601238,0.10043771501399,0.124773600435159,8.62742873132221e-73
NMR metabolomics,X23408.Triglycerides in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0784201055856454,0.00432573344989416,0.0699416680238529,0.086898543147438,1.01685689219509e-72
NMR metabolomics,X23408.Triglycerides in VLDL,VSNL1,Visinin-like protein 1,37388,0.0660997325328673,0.00364469608975752,0.0589561281969426,0.0732433368687921,1.20193192486501e-72
NMR metabolomics,X23408.Triglycerides in VLDL,THPO,Thrombopoietin,39585,0.0665704044690339,0.00367586517590438,0.0593657087242613,0.0737751002138065,1.44692623635763e-72
NMR metabolomics,X23408.Triglycerides in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.164414367103913,0.00907886478391714,0.146619792127435,0.18220894208039,1.46138931772384e-72
NMR metabolomics,X23408.Triglycerides in VLDL,MITD1,MIT domain-containing protein 1,39749,0.169533687370839,0.00936738597823069,0.151173610853507,0.187893763888171,1.75562223003347e-72
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0886557965905656,0.00490140100356537,0.0790490506235775,0.0982625425575537,2.1754819396923e-72
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.164532287994976,0.00913461708210312,0.146628438514054,0.182436137475898,8.03543237513194e-72
NMR metabolomics,X23408.Triglycerides in VLDL,PALM2,Paralemmin-2,37388,0.0658241425694203,0.00365168187350279,0.0586668460973548,0.0729814390414858,8.45444199869082e-72
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD1,COMM domain-containing protein 1,37043,0.10788600733154,0.00598682351557622,0.0961518332410105,0.119620181422069,9.7274662659361e-72
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR,GMP reductase 1,40058,0.0860719850778273,0.00478345601625463,0.0766964112859682,0.0954475588696863,1.0886503864401e-71
NMR metabolomics,X23408.Triglycerides in VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0462811370135526,0.00257248063579292,0.0412390749673984,0.0513231990597067,1.55099613073039e-71
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0657621063027282,0.00365929237920206,0.0585898932394922,0.0729343193659643,1.63864733492838e-71
NMR metabolomics,X23408.Triglycerides in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0875543219120274,0.00487600170311479,0.0779973585739224,0.0971112852501324,2.88188632327127e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0674307042648516,0.00375545505545041,0.0600700123561688,0.0747913961735344,3.02956707713949e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D23,TBC1 domain family member 23,39788,0.155519889524398,0.00867068612031334,0.138525344728583,0.172514434320212,3.08203613898691e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0908926670720218,0.00507009459216309,0.0809552816713821,0.100830052472661,3.59149896886778e-71
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0891834071524011,0.00497810907569722,0.0794263133640346,0.0989405009407677,4.44481394957074e-71
NMR metabolomics,X23408.Triglycerides in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.184472760768751,0.0102961145070686,0.164292376334897,0.204653145202606,5.74024915313076e-71
NMR metabolomics,X23408.Triglycerides in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0820024989081825,0.00457692073158427,0.0730317342742773,0.0909732635420877,5.78481180614451e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0506014288702562,0.00282817628322168,0.0450582033551417,0.0561446543853707,6.67236670020307e-71
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0839063285162393,0.00469014405350162,0.0747136461713761,0.0930990108611024,7.11688506970339e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0607268518246815,0.0033958615448941,0.0540709631966891,0.067382740452674,7.85134741646042e-71
NMR metabolomics,X23408.Triglycerides in VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.130803284549323,0.00731156372177298,0.116472619654648,0.145133949443998,9.1886031661351e-71
NMR metabolomics,X23408.Triglycerides in VLDL,WASHC3,WASH complex subunit 3,37388,0.130811128226539,0.0073176801632545,0.11646847510656,0.145153781346518,1.1755927540741e-70
NMR metabolomics,X23408.Triglycerides in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0478682845334317,0.00267812625342431,0.0426191570767201,0.0531174119901434,1.2682486291654e-70
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.223089395604855,0.0124951401747932,0.198598920862261,0.24757987034745,1.29098418494658e-70
NMR metabolomics,X23408.Triglycerides in VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.141334915633714,0.00791933711474208,0.12581301488882,0.156856816378609,1.94791747261829e-70
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0631224368747449,0.00353716391035481,0.0561895956104495,0.0700552781390403,2.00652626566686e-70
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.117517187132357,0.00661111150102101,0.104559408590355,0.130474965674358,5.06177370854817e-70
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.128670934043962,0.00724583240672508,0.114469102526781,0.142872765561143,7.00134999495698e-70
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS2,Trypsin-2,39931,0.0878646442397291,0.00494866597575534,0.0781652589272486,0.0975640295522096,7.29504600264966e-70
NMR metabolomics,X23408.Triglycerides in VLDL,SNX15,Sorting nexin-15,37124,0.0923868268718566,0.00520518883983267,0.0821846567457845,0.102588996997929,1.119595299835e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.205107580605628,0.0115589981819972,0.182451944168914,0.227763217042343,1.1664601422548e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TBCC,Tubulin-specific chaperone C,39749,0.138988427122288,0.00783973686305238,0.123622542870705,0.15435431137387,1.17890636644863e-69
NMR metabolomics,X23408.Triglycerides in VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.111033038567966,0.00626902271459495,0.0987457540473604,0.123320323088573,1.55621669461215e-69
NMR metabolomics,X23408.Triglycerides in VLDL,OCLN,Occludin,37411,0.0734387949090416,0.0041436456734486,0.0653172493890823,0.0815603404290009,1.68563555464069e-69
NMR metabolomics,X23408.Triglycerides in VLDL,DDHD2,Phospholipase DDHD2,37411,0.114108288593736,0.00644255589870196,0.10148087903228,0.126735698155192,2.0613441169143e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.209623583979959,0.0118586151497948,0.186380698286361,0.232866469673556,3.01395490688337e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.199167248759425,0.0112694863401073,0.177079055532815,0.221255441986036,3.09111497595616e-69
NMR metabolomics,X23408.Triglycerides in VLDL,LEFTY2,Left-right determination factor 2,40011,0.0909127459636662,0.00514470136188861,0.0808291312943645,0.100996360632968,3.13494666495087e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0442493590889807,0.00250503257773369,0.0393394952366227,0.0491592229413387,3.5228840088552e-69
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS1,Galectin-1,39868,0.0570994998788059,0.00323311125745556,0.050762601814193,0.0634363979434188,3.79886581935407e-69
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.187390710059783,0.0106165704628597,0.166582231952578,0.208199188166988,4.49933321870059e-69
NMR metabolomics,X23408.Triglycerides in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.123115655103285,0.0069703149597663,0.109453837782144,0.136777472424427,4.99048629846331e-69
NMR metabolomics,X23408.Triglycerides in VLDL,FAM13A,Protein FAM13A,37382,0.115478103958184,0.00654324311510567,0.102653347452577,0.128302860463791,6.18874220889017e-69
NMR metabolomics,X23408.Triglycerides in VLDL,ELOA,Elongin-A,39788,0.0867285450106059,0.00492301909429523,0.0770794275857873,0.0963776624354246,8.20126845809743e-69
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.151641083677974,0.00860503893850243,0.134775207358509,0.168506959997439,9.7178626678337e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CRKL,Crk-like protein,39881,0.181579017114897,0.0103237178100189,0.16134453020726,0.201813504022534,1.33019343322623e-68
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GLB2,Endophilin-B2,37388,0.112416441861791,0.00639040955383553,0.0998912391362738,0.124941644587309,1.65644972493067e-68
NMR metabolomics,X23408.Triglycerides in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0977149867992877,0.00555959083460929,0.0868181887634535,0.108611784835122,2.26891388294602e-68
NMR metabolomics,X23408.Triglycerides in VLDL,OGA,Protein O-GlcNAcase,37382,0.120770051160101,0.00687452228847308,0.107295987474694,0.134244114845508,2.49260185157024e-68
NMR metabolomics,X23408.Triglycerides in VLDL,FUS,RNA-binding protein FUS,39455,0.0664273778217612,0.00378790622948718,0.0590030816119664,0.0738516740315561,3.38992521034864e-68
NMR metabolomics,X23408.Triglycerides in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0451299822136394,0.00257393612566884,0.0400850674073285,0.0501748970199503,3.44524342697748e-68
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINC1,Antithrombin-III,37424,0.0246589938705955,0.00140562296958584,0.0219039728502072,0.0274140148909837,3.7915771678045e-68
NMR metabolomics,X23408.Triglycerides in VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0723904177125408,0.00413183978851408,0.0642920117270532,0.0804888236980284,5.92795392554307e-68
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0528321342991099,0.00302280904360419,0.0469074285736457,0.0587568400245741,1.2216147073693e-67
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0677380239372981,0.00388066475741926,0.0601319210127563,0.0753441268618398,1.30514191053247e-67
NMR metabolomics,X23408.Triglycerides in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0783218239060941,0.00449366595408534,0.0695142386360868,0.0871294091761013,2.07053877562352e-67
NMR metabolomics,X23408.Triglycerides in VLDL,AMOT,Angiomotin,37124,0.0695543361208077,0.00399252318724942,0.0617289906737989,0.0773796815678166,3.18869447637956e-67
NMR metabolomics,X23408.Triglycerides in VLDL,SDC4,Syndecan-4,39868,0.07617222416005,0.00437678031369019,0.0675937347452172,0.0847507135748827,3.21279921691859e-67
NMR metabolomics,X23408.Triglycerides in VLDL,OPHN1,Oligophrenin-1,37388,0.181570075712651,0.0104299885416629,0.161127298170991,0.20201285325431,3.83154171520223e-67
NMR metabolomics,X23408.Triglycerides in VLDL,TALDO1,Transaldolase,37415,0.0751692995083876,0.00432070708028837,0.0667007136310224,0.0836378853857528,4.60896022986225e-67
NMR metabolomics,X23408.Triglycerides in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.153185920528265,0.00880525200908514,0.135927626590459,0.170444214466072,4.84914610520817e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.140680247782323,0.00809463813675582,0.124814757034282,0.156545738530364,6.30399132273244e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.057644406697085,0.00332055603808471,0.051136116862439,0.0641526965317311,6.97736888865734e-67
NMR metabolomics,X23408.Triglycerides in VLDL,CTSZ,Cathepsin Z,39865,0.0518828674272516,0.00299002700352326,0.0460224145003461,0.0577433203541572,7.78947286293728e-67
NMR metabolomics,X23408.Triglycerides in VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.132226481791247,0.00761299528476796,0.117305011033102,0.147147952549393,7.89452314519536e-67
NMR metabolomics,X23408.Triglycerides in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0493699314521833,0.0028458605253321,0.0437920448225323,0.0549478180818342,8.3372595404381e-67
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.145216430689737,0.00837274338845568,0.128805853648363,0.16162700773111,9.28792949570139e-67
NMR metabolomics,X23408.Triglycerides in VLDL,DBNL,Drebrin-like protein,39931,0.155444090040513,0.0089781783909747,0.137846860394202,0.173041319686823,1.49255302231634e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.124711438635916,0.00721189069345225,0.11057613287675,0.138846744395082,2.16937682703119e-66
NMR metabolomics,X23408.Triglycerides in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.246236375935572,0.0142495704934724,0.218307217768366,0.274165534102778,3.39976480290608e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.119640463985318,0.00693027028890983,0.106057134219055,0.133223793751581,3.46666855941656e-66
NMR metabolomics,X23408.Triglycerides in VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0833686796256471,0.00482470771947126,0.0739122524954834,0.0928251067558107,3.58231503226218e-66
NMR metabolomics,X23408.Triglycerides in VLDL,GTPBP2,GTP-binding protein 2,37039,0.13497194352872,0.00781519063682586,0.119654169880541,0.150289717176898,4.18640212266315e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0888223425352614,0.00514413784903915,0.0787398323511447,0.0989048527193781,4.27832559784359e-66
NMR metabolomics,X23408.Triglycerides in VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.15267636767321,0.00885455459202176,0.135321440672847,0.170031294673572,6.6958917849267e-66
NMR metabolomics,X23408.Triglycerides in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0578433460499718,0.00335880832416563,0.0512600817346071,0.0644266103653364,7.19423972292975e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CCL7,C-C motif chemokine 7,39866,0.0968212438077774,0.00562362432608533,0.0857989401286502,0.107843547486905,7.76793844822805e-66
NMR metabolomics,X23408.Triglycerides in VLDL,C3,Complement C3,36816,0.0766723405092807,0.00445588039421167,0.0679388149366258,0.0854058660819355,1.25939946077152e-65
NMR metabolomics,X23408.Triglycerides in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.120344684270623,0.00701303368950265,0.106599138239198,0.134090230302048,2.02217012088315e-65
NMR metabolomics,X23408.Triglycerides in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.129622717675792,0.00755294699070543,0.11481894157401,0.144426493777575,2.03811450128726e-65
NMR metabolomics,X23408.Triglycerides in VLDL,APOC1,Apolipoprotein C-I,37424,0.0620401299401552,0.00361675902089484,0.0549512822592013,0.0691289776211091,2.8831468223288e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0545606540562903,0.00318100788835411,0.0483258785951162,0.0607954295174643,3.1701879028689e-65
NMR metabolomics,X23408.Triglycerides in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0966671742512084,0.00563941180262494,0.0856139271180636,0.107720421384353,3.66496696995668e-65
NMR metabolomics,X23408.Triglycerides in VLDL,PLG,Plasminogen,37162,0.0374529012152972,0.00218714302294057,0.0331661008903337,0.0417397015402607,4.87533864999101e-65
NMR metabolomics,X23408.Triglycerides in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.103290645562107,0.006037255836615,0.091457624122342,0.115123667001873,6.4063096732009e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.128332013787266,0.00750476113599621,0.113622681960713,0.143041345613819,7.09362824245617e-65
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.136786343150631,0.00800334847764163,0.121099780134453,0.152472906166808,8.52194851740731e-65
NMR metabolomics,X23408.Triglycerides in VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0905193134991197,0.00529632791870466,0.0801385107784586,0.100900116219781,8.61758345405246e-65
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.136317715870762,0.00805416685481531,0.120531548835324,0.1521038829062,1.05160499990205e-63
NMR metabolomics,X23408.Triglycerides in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.151279373403042,0.00893879247979604,0.133759340142642,0.168799406663442,1.10726265864913e-63
NMR metabolomics,X23408.Triglycerides in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0791934038955272,0.0046761021163458,0.0700282437474895,0.088358564043565,1.11159422757222e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.074053167027662,0.00437589707238667,0.0654764087657841,0.0826299252895399,1.12490344982798e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CPB1,Carboxypeptidase B,40052,0.0937002903903738,0.00554308557094462,0.0828358426713223,0.104564738109425,1.47444029453751e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FGF19,Fibroblast growth factor 19,39931,0.124663406821061,0.00738608769302262,0.110186674942737,0.139140138699385,2.28929280074653e-63
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.118589942072188,0.00702388555694453,0.104823126380577,0.132356757763799,2.73471183308691e-63
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.131436473363255,0.00779429462938495,0.11615965588966,0.146713290836849,2.95114317735354e-63
NMR metabolomics,X23408.Triglycerides in VLDL,PPBP,Platelet basic protein,37371,0.138547602644239,0.00821491602327512,0.12244636723862,0.154648838049858,3.57771183717602e-63
NMR metabolomics,X23408.Triglycerides in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0919886779198701,0.00546911012551273,0.0812692220738652,0.102708133765875,6.08423957703042e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.111497018757359,0.00662822849272927,0.0985056909116099,0.124488346603109,7.66648623446829e-63
NMR metabolomics,X23408.Triglycerides in VLDL,MAX,Protein max,39489,0.171147649519809,0.0101854620324524,0.151184143936202,0.191111155103416,8.23465594721952e-63
NMR metabolomics,X23408.Triglycerides in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.140415845954266,0.00835591404001013,0.124038254435846,0.156793437472686,1.01254447510548e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CCL4,C-C motif chemokine 4,39882,0.101042176768393,0.00601856181365836,0.0892457956136223,0.112838557923163,1.01873899809861e-62
NMR metabolomics,X23408.Triglycerides in VLDL,GLB1,Beta-galactosidase,39749,0.0682848340401023,0.00406958719273754,0.0603084431423367,0.0762612249378678,1.1969282836727e-62
NMR metabolomics,X23408.Triglycerides in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.110534503341493,0.0065820222426928,0.0976337397458155,0.123435266937171,1.20872198135839e-62
NMR metabolomics,X23408.Triglycerides in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.137850608557358,0.00821796080802851,0.121743405373622,0.153957811741094,1.32805542764188e-62
NMR metabolomics,X23408.Triglycerides in VLDL,F2,Prothrombin,37453,0.02380426381806,0.00141917544636432,0.0210226799431859,0.026585847692934,1.62501051521432e-62
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.127173815313389,0.00759073853339753,0.112295967787929,0.142051662838848,1.82426634312583e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT1,Angiopoietin-1,39794,0.136438867823797,0.00814388714702355,0.12047684901563,0.152400886631963,1.82648121257051e-62
NMR metabolomics,X23408.Triglycerides in VLDL,IST1,IST1 homolog,37287,0.161832518676382,0.00965264517525883,0.142913334132875,0.18075170321989,1.87750720633449e-62
NMR metabolomics,X23408.Triglycerides in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.11815738797826,0.00706962841311365,0.104300916288558,0.132013859667963,3.52392217192072e-62
NMR metabolomics,X23408.Triglycerides in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.101258149507517,0.0060650675683673,0.089370617073517,0.113145681941517,5.89049973873151e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CD69,Early activation antigen CD69,39785,0.141560360213555,0.00848581283511105,0.124928167056737,0.158192553370372,5.94417600019239e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA11,Annexin A11,39829,0.107583899859298,0.00645292575085675,0.0949361653876187,0.120231634330977,6.97153169551938e-62
NMR metabolomics,X23408.Triglycerides in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0900208748766456,0.00540478840385527,0.0794274896050893,0.100614260148202,9.00113676141929e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0948255831397249,0.00569338734501363,0.0836665439434982,0.105984622335952,9.43148507885922e-62
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.125727566244586,0.00754623566529274,0.110936944340612,0.14051818814856,1.03454461875116e-61
NMR metabolomics,X23408.Triglycerides in VLDL,YJU2,Splicing factor YJU2,37368,0.052270256290381,0.00314013803664131,0.0461155857385641,0.058424926842198,1.33106934651341e-61
NMR metabolomics,X23408.Triglycerides in VLDL,GPC5,Glypican-5,39749,0.0897663485904156,0.0053981214940524,0.0791860304620729,0.100346666718758,1.41949212337878e-61
NMR metabolomics,X23408.Triglycerides in VLDL,C1S,Complement C1s subcomponent,37453,0.0336720984808427,0.00202353696029878,0.029705966038657,0.0376382309230283,1.44685018897327e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.037212717547444,0.00224361396511771,0.0328152341758133,0.0416102009190747,2.81822102725768e-61
NMR metabolomics,X23408.Triglycerides in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.108748051149938,0.00655361918639663,0.0959029575446009,0.121593144755276,3.11369395958283e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY4,Protein canopy homolog 4,39788,0.120972951520528,0.00729610628730541,0.10667258319741,0.135273319843647,3.14302240741389e-61
NMR metabolomics,X23408.Triglycerides in VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.149431063689008,0.00901274256488728,0.131766088261829,0.167096039116187,3.2171738352888e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CASC3,Protein CASC3,37039,0.0671940258947638,0.00405473758924935,0.059246740219835,0.0751413115696925,4.62185972898912e-61
NMR metabolomics,X23408.Triglycerides in VLDL,RBKS,Ribokinase,39504,0.079190816265491,0.00478347519332441,0.0698152048865751,0.0885664276444068,4.86201824594289e-61
NMR metabolomics,X23408.Triglycerides in VLDL,TWF2,Twinfilin-2,37437,0.135276028124964,0.00817727158176631,0.119248575824702,0.151303480425226,7.09104142258126e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0599131240551186,0.00362953439278511,0.0527992366452598,0.0670270114649774,1.06362474127667e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SPARC,SPARC,39913,0.112380170216066,0.00680912162060084,0.0990342918396881,0.125726048592443,1.07914981437198e-60
NMR metabolomics,X23408.Triglycerides in VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0520661520890565,0.00315496615669451,-0.0582498857561777,-0.0458824184219353,1.10329950709604e-60
NMR metabolomics,X23408.Triglycerides in VLDL,DOK1,Docking protein 1,37388,0.219051438359758,0.0132709676404802,0.193040341784416,0.245062534935099,1.29751816460487e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.126709301884582,0.00769057336392253,0.111635778091294,0.14178282567787,1.73424044686776e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SPART,Spartin,37124,0.124413532140553,0.00755135249820666,0.109612881244068,0.139214183037038,2.18212506508608e-60
NMR metabolomics,X23408.Triglycerides in VLDL,PF4,Platelet factor 4,37385,0.153728768354123,0.00933619488929908,0.135429826371097,0.172027710337149,2.49019820989537e-60
NMR metabolomics,X23408.Triglycerides in VLDL,RWDD1,RWD domain-containing protein 1,40009,0.10123093524116,0.00616665806729806,0.0891442854292559,0.113317585053064,4.51515375587499e-60
NMR metabolomics,X23408.Triglycerides in VLDL,NIT1,Deaminated glutathione amidase,37043,0.0748510011721272,0.0045604049419509,0.0659126074859035,0.083789394858351,6.03931817159373e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0973412729210805,0.00594436572972236,0.0856903160908247,0.108992229751336,8.77802441253699e-60
NMR metabolomics,X23408.Triglycerides in VLDL,EGF,Pro-epidermal growth factor,39808,0.163838749440235,0.0100117562711162,0.144215707148848,0.183461791731623,1.0485092767815e-59
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2,Microtubule-associated protein 2,37388,0.0728678804896566,0.00445298429681545,0.0641400312678983,0.0815957297114149,1.29450069454038e-59
NMR metabolomics,X23408.Triglycerides in VLDL,KLK10,Kallikrein-10,39856,0.0621881809460802,0.00380403625297379,0.0547322698902516,0.0696440920019088,1.36825173457669e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ICA1,Islet cell autoantigen 1,39587,0.126690193304605,0.00774978003312456,0.11150062443968,0.141879762169529,1.40237463732075e-59
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.124524426809076,0.007622843358864,0.109583653825703,0.13946519979245,1.70873969189809e-59
NMR metabolomics,X23408.Triglycerides in VLDL,DTNB,Dystrobrevin beta,37348,0.0694981721816226,0.00425255534199314,0.0611631637113161,0.0778331806519292,1.82634533141496e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CD226,CD226 antigen,37056,0.0662733531322475,0.00405644523565292,0.0583227204703678,0.0742239857941273,2.03338776868551e-59
NMR metabolomics,X23408.Triglycerides in VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.102017854874218,0.00625796151220783,0.0897522503102906,0.114283459438145,2.87097501855239e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CPA1,Carboxypeptidase A1,40052,0.0930143696294501,0.00571184153731843,0.081819160216306,0.104209579042594,3.75389784276175e-59
NMR metabolomics,X23408.Triglycerides in VLDL,RFC4,Replication factor C subunit 4,37368,0.0336371630062351,0.00206724080639306,0.0295853710257047,0.0376889549867656,5.71236172283203e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0520958014279202,0.00320564034332117,0.0458127463550108,0.0583788565008297,6.47742054588451e-59
NMR metabolomics,X23408.Triglycerides in VLDL,RILPL2,RILP-like protein 2,37437,0.155338870992558,0.00955287975857008,0.136615226665761,0.174062515319355,6.72335478894182e-59
NMR metabolomics,X23408.Triglycerides in VLDL,IL18,Interleukin-18,39795,0.0714416155919624,0.00439856178789817,0.062820434487682,0.0800627966962428,7.55003742200132e-59
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.111397122304372,0.00686195333014846,0.097947693777281,0.124846550831463,8.54455586066024e-59
NMR metabolomics,X23408.Triglycerides in VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0586306435169415,0.0036125973881207,0.0515499526362249,0.0657113343976581,9.18757870218453e-59
NMR metabolomics,X23408.Triglycerides in VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0531574078140271,0.00328464712774269,0.0467194994436515,0.0595953161844028,1.90946050934187e-58
NMR metabolomics,X23408.Triglycerides in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0684897099142757,0.00423184831780085,0.0601952872113861,0.0767841326171654,2.34422629143341e-58
NMR metabolomics,X23408.Triglycerides in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0415452625545916,0.00257016582235781,0.0365077375427703,0.0465827875664129,2.60296006223792e-58
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.163545922384668,0.0101230243170246,0.1437047947233,0.183387050046036,2.98402246820223e-58
NMR metabolomics,X23408.Triglycerides in VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0943506551407419,0.00583852359603661,0.0829071488925102,0.105794161388974,3.37517851720982e-58
NMR metabolomics,X23408.Triglycerides in VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.097141929892216,0.00601535961536283,0.0853518250461048,0.108932034738327,3.41404363973078e-58
NMR metabolomics,X23408.Triglycerides in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0852309486421806,0.00527852753814895,0.0748850346674086,0.0955768626169525,3.46841846672891e-58
NMR metabolomics,X23408.Triglycerides in VLDL,LPP,Lipoma-preferred partner,37021,0.104867228247466,0.00649348619487588,0.0921399953055096,0.117594461189423,4.13166916449089e-58
NMR metabolomics,X23408.Triglycerides in VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.121376973277259,0.00752246983549046,0.106632932399698,0.13612101415482,4.1426948830981e-58
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0777597060521823,0.00481664631165883,0.068319079281331,0.0872003328230336,4.45675100660961e-58
NMR metabolomics,X23408.Triglycerides in VLDL,SPRY2,Protein sprouty homolog 2,39587,0.144351600870655,0.00895151172219314,0.126806637895157,0.161896563846154,4.89528915014126e-58
NMR metabolomics,X23408.Triglycerides in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.150180989728195,0.00931572429646176,0.13192217010713,0.16843980934926,5.18008348767227e-58
NMR metabolomics,X23408.Triglycerides in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0957004196345082,0.00594072181021559,0.0840566048864856,0.107344234382531,6.25257363207037e-58
NMR metabolomics,X23408.Triglycerides in VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.121547229712468,0.00755931546489782,0.106730971401269,0.136363488023668,1.01265909972467e-57
NMR metabolomics,X23408.Triglycerides in VLDL,HPSE,Heparanase,37306,0.146474121371149,0.0091038469490988,0.128630581350915,0.164317661391383,1.04831159954433e-57
NMR metabolomics,X23408.Triglycerides in VLDL,PKD2,Polycystin-2,37021,0.0924085519443475,0.00576428297638461,0.0811105573106337,0.103706546578061,2.6943973772121e-57
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0738085032320544,0.00461518209255807,0.0647627463306406,0.0828542601334682,4.78745160383331e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CETN3,Centrin-3,37382,0.122218073791964,0.00764234737996962,0.107239072927224,0.137197074656705,4.82448826401944e-57
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.136674688757347,0.0085622405082295,0.119892697361217,0.153456680153476,6.44346254561786e-57
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.118891138301597,0.00745350883514027,-0.133500015618472,-0.104282260984722,7.66209472487911e-57
NMR metabolomics,X23408.Triglycerides in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0905195059588141,0.00567152830615344,0.0794033104787533,0.101635701438875,8.20420877847716e-57
NMR metabolomics,X23408.Triglycerides in VLDL,RRAS,Ras-related protein R-Ras,37039,0.20319580355406,0.0127439966458971,0.178217570128102,0.228174036980018,1.05495236420581e-56
NMR metabolomics,X23408.Triglycerides in VLDL,HNMT,Histamine N-methyltransferase,39669,0.0711736610417857,0.0044676989144198,0.0624169711695229,0.0799303509140485,1.07102367101414e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ST13,Hsc70-interacting protein,37124,0.085249969486959,0.00535154952111475,0.0747609324255741,0.0957390065483439,1.31388610715693e-56
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.118616441375704,0.00744792592318437,0.104018506566263,0.133214376185146,1.40609190063344e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0448158231163309,0.00282098431568687,0.0392866938575846,0.0503449523750771,2.09880529280726e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0406773650961278,0.00255925129125657,0.035661232565265,0.0456934976269907,2.23798646795326e-56
NMR metabolomics,X23408.Triglycerides in VLDL,F12,Coagulation factor XII,37453,0.0636656289103903,0.00401111595282952,0.0558038416428445,0.0715274161779362,3.15120171806601e-56
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.085525286310119,0.00539971124377018,0.0749418522723294,0.0961087203479085,4.55211706884144e-56
NMR metabolomics,X23408.Triglycerides in VLDL,RBM17,Splicing factor 45,37411,0.117383787911657,0.00741235170704863,0.102855578565841,0.131911997257472,5.55561449555908e-56
NMR metabolomics,X23408.Triglycerides in VLDL,MGLL,Monoglyceride lipase,39908,0.133546688551258,0.00844003911802428,0.117004211879931,0.150089165222586,5.72117541095859e-56
NMR metabolomics,X23408.Triglycerides in VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.196255107693265,0.0124122809874732,0.171927036957818,0.220583178428712,6.87854007567075e-56
NMR metabolomics,X23408.Triglycerides in VLDL,CETN2,Centrin-2,39489,0.103522450185238,0.00655021139425165,0.0906840358525046,0.116360864517971,7.8450660839988e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ESYT2,Extended synaptotagmin-2,37388,0.126020157948494,0.00797001282838772,0.110398932804854,0.141641383092134,8.15113886700463e-56
NMR metabolomics,X23408.Triglycerides in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.117392876903754,0.00743228266223472,0.102825602885774,0.131960150921734,9.0988766107891e-56
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.130625464731133,0.00826834932663683,0.114419500050924,0.146831429411341,1.00818698089466e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.129957931284914,0.00824646777887554,0.113794854438318,0.14612100813151,1.58932817114763e-55
NMR metabolomics,X23408.Triglycerides in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0907153368192431,0.00575838636219302,0.0794288995493448,0.102001774089141,1.72291660410956e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0426173487848205,0.00270851331351619,0.0373086626903288,0.0479260348793122,2.26890584727132e-55
NMR metabolomics,X23408.Triglycerides in VLDL,APP,Amyloid-beta precursor protein,39829,0.101253818903581,0.00643764226668365,0.088636040060881,0.113871597746281,2.5132764252102e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0527554824505415,0.00335815346477036,-0.0593374632414914,-0.0461735016595916,3.35523548661978e-55
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6AP2,Renin receptor,39477,0.0617969102484443,0.00393859928122936,0.0540772556572347,0.0695165648396538,4.65540743677706e-55
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.108175337946147,0.00690341991271892,0.0946446349172175,0.121706040975076,6.21263788668592e-55
NMR metabolomics,X23408.Triglycerides in VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0743624647567397,0.00474892403070294,0.065054573656562,0.0836703558569175,9.00701620749632e-55
NMR metabolomics,X23408.Triglycerides in VLDL,DLG4,Disks large homolog 4,37388,0.108612817689783,0.00693956396794051,0.0950112723126191,0.122214363066946,9.83285856452021e-55
NMR metabolomics,X23408.Triglycerides in VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.127310332420348,0.00814343581629328,0.111349198220413,0.143271466620283,1.09251698716848e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE2,Glia-derived nexin,37437,0.0977812791130121,0.0062514930044434,0.0855283528243031,0.110034205401721,1.14243750115254e-54
NMR metabolomics,X23408.Triglycerides in VLDL,JAM3,Junctional adhesion molecule C,37124,0.0766384202580144,0.00490033837812555,0.0670337570368883,0.0862430834791404,1.20605293318886e-54
NMR metabolomics,X23408.Triglycerides in VLDL,NUDC,Nuclear migration protein nudC,40058,0.0971761718827119,0.0062197926891785,0.0849853782119221,0.109366965553502,1.2572491967983e-54
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0492370398982158,0.00315638986013794,0.0430505157723455,0.0554235640240862,1.85624074636377e-54
NMR metabolomics,X23408.Triglycerides in VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0339119412004855,0.00217618113272177,0.0296466261803509,0.0381772562206202,2.86356362292634e-54
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR2,GMP reductase 2,37124,0.101157848915574,0.00649190831061909,0.0884337086267604,0.113881989204387,2.91196298273646e-54
NMR metabolomics,X23408.Triglycerides in VLDL,STX8,Syntaxin-8,39866,0.073361769948076,0.00471452743835556,0.0641212961688991,0.0826022437272529,3.35347724188264e-54
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN3,Ataxin-3,37388,0.0923477379837186,0.00593498197631797,0.0807151733101354,0.103980302657302,4.01125119285774e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.129657049459692,0.00833753099017505,0.113315488718949,0.145998610200435,4.69588856410708e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0446219119459338,0.00287654044877551,0.0389838926663338,0.0502599312255338,7.12651540066831e-54
NMR metabolomics,X23408.Triglycerides in VLDL,NEXN,Nexilin,37445,0.103357855886413,0.00666199226590709,0.090300351045235,0.116415360727591,8.00216813871507e-54
NMR metabolomics,X23408.Triglycerides in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.138922363388792,0.0089607069231944,-0.156485348958253,-0.121359377819331,8.08519380306769e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.043154227886149,0.0027873809510522,0.0376909612220867,0.0486174945502114,1.11256693497659e-53
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.101515266497627,0.00655632630589509,0.0886648669380722,0.114365666057181,1.32938188702617e-53
NMR metabolomics,X23408.Triglycerides in VLDL,COMT,Catechol O-methyltransferase,39403,0.126966970818999,0.00822544889139151,0.110845090991872,0.143088850646126,2.33683581017288e-53
NMR metabolomics,X23408.Triglycerides in VLDL,UBXN1,UBX domain-containing protein 1,37124,0.103712773325589,0.00672395948635847,0.0905338127323268,0.116891733918852,3.25039471239906e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0687157197651801,0.00445732692601936,0.0599793589901821,0.077452080540178,3.59712725066047e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0855532976977104,0.00555538445501766,0.0746647441658757,0.096441851229545,3.95623696378501e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FOXJ3,Forkhead box protein J3,37056,0.066964063578651,0.00434641263606455,0.0584450948119645,0.0754830323453375,4.27196729743834e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3C,Protein FAM3C,39846,0.0430353702768259,0.00279842211289191,0.0375504629355578,0.048520277618094,5.47019731193316e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.139518071472653,0.00906846945068512,0.12174387134931,0.157292271595996,5.7861120001215e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CCL18,C-C motif chemokine 18,39715,0.104939764642069,0.00682707791757886,0.0915586919236141,0.118320837360523,6.15947025830372e-53
NMR metabolomics,X23408.Triglycerides in VLDL,APOA2,Apolipoprotein A-II,37445,-0.0708871167076338,0.00460984235291262,-0.0799224077193426,-0.0618518256959251,6.47943872285814e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TP53,Cellular tumor antigen p53,39477,0.0656278291087427,0.00427096321474999,0.0572567412078327,0.0739989170096527,6.74092442777396e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CPA2,Carboxypeptidase A2,39933,0.0957591017051297,0.00623265478035937,0.0835430983356254,0.107975105074634,6.77247935977846e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0533422593097655,0.00346997336636569,0.0465411115116887,0.0601434071078422,7.01083908980149e-53
NMR metabolomics,X23408.Triglycerides in VLDL,MSTN,Growth/differentiation factor 8,39585,0.0769868205006514,0.00501396345073456,0.0671594521372116,0.0868141888640911,7.98758679063589e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.14464568655648,0.00942036042732651,0.12618178011892,0.16310959299404,9.43628744747649e-53
NMR metabolomics,X23408.Triglycerides in VLDL,IMPACT,Protein IMPACT,37388,0.0822994849222118,0.00536184966614286,0.0717902595765718,0.0928087102678518,9.98773645816244e-53
NMR metabolomics,X23408.Triglycerides in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.124466863850626,0.00810970062135481,0.108571850632771,0.140361877068481,1.01733722372687e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0587544250606501,0.00383193785931497,0.0512438268563927,0.0662650232649074,1.10975065865464e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.113707544008253,0.00742002716249667,0.09916429076976,0.128250797246747,1.23895623602876e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.112266442699836,0.0073286254107578,0.0979023368947506,0.126630548504921,1.57159764254302e-52
NMR metabolomics,X23408.Triglycerides in VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.187769732827315,0.0122622279541038,0.163735766037271,0.211803699617358,1.76286465698138e-52
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4D,Semaphorin-4D,40009,0.0443059138553515,0.00289585953979078,0.0386300291573616,0.0499817985533414,1.79104671382222e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CASP10,Caspase-10,39489,0.105715291181911,0.00691327147115348,0.0921652790984505,0.119265303265372,2.08196317885208e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.11834191002576,0.00773400589897846,0.103183258463762,0.133500561587757,2.10858419253703e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ATOX1,Copper transport protein ATOX1,39913,0.107596893183675,0.00703750353552426,0.0938033862540473,0.121390400113302,2.11575453600912e-52
NMR metabolomics,X23408.Triglycerides in VLDL,KITLG,Kit ligand,39868,-0.0547485204081937,0.00358270191313969,-0.0617706161579475,-0.0477264246584399,2.38357507653343e-52
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.144922095803374,0.00949086661512414,0.126319997237731,0.163524194369018,3.31812083432639e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MMP7,Matrilysin,39563,0.072952589584492,0.00478085775543468,0.0635821083838401,0.082323070785144,3.38042975178334e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TMED8,Protein TMED8,37382,0.152957030195888,0.0100238101401104,0.133310362321272,0.172603698070504,3.87508724607823e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.037620772242639,0.00246845389118107,-0.0424589418693538,-0.0327826026159241,4.39183904146126e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0902629972994134,0.00592302352800866,0.0786538711845164,0.10187212341431,4.51450074648034e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.144964554809054,0.00951401963868406,0.126317076317234,0.163612033300875,4.75985486400674e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CASP7,Caspase-7,37388,0.124499117806114,0.00816984481365825,0.108486221971344,0.140512013640884,5.27471738051189e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GHRL,Appetite-regulating hormone,39868,0.112944726176763,0.00741786270239721,0.0984057152800641,0.127483737073461,5.49384245633547e-52
NMR metabolomics,X23408.Triglycerides in VLDL,KLK13,Kallikrein-13,39490,0.0620007667628465,0.00407968344974188,0.0540045872013524,0.0699969463243405,8.62166513844232e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CRADD,Death domain-containing protein CRADD,39713,0.112189849340196,0.00738288751108091,0.0977193898184776,0.126660308861915,8.71622732593963e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CTSS,Cathepsin S,36543,0.0359179171340635,0.00236261511037817,0.0312871915177223,0.0405486427504047,9.70366188416152e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0583457682405087,0.00384279030780616,0.0508138992372087,0.0658776372438088,1.06290180147461e-51
NMR metabolomics,X23408.Triglycerides in VLDL,GZMA,Granzyme A,40058,0.0496087492151085,0.00326830035687577,0.043202880515632,0.056014617914585,1.10859340475244e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0757782081098588,0.00499298185499962,0.0659919636740595,0.085564452545658,1.15063948515323e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0958145610025991,0.00631116656518286,0.0834446745348407,0.108184447470358,1.26677901088628e-51
NMR metabolomics,X23408.Triglycerides in VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.0993639052172242,0.00655306224241612,0.0865199032220886,0.11220790721236,1.40532582238509e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0828304330454329,0.00546409375845204,0.0721208092788669,0.0935400568119989,1.53614152295956e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0731017740305261,0.00482317599994238,0.0636483490706391,0.0825551989904132,1.57660628009202e-51
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0684021455601576,0.00452400729516791,0.0595350912616284,0.0772691998586867,3.13091964292154e-51
NMR metabolomics,X23408.Triglycerides in VLDL,FMNL1,Formin-like protein 1,39489,0.0889996277104146,0.00589662844960697,0.077442235949185,0.100557019471644,4.10767303341699e-51
NMR metabolomics,X23408.Triglycerides in VLDL,EHD3,EH domain-containing protein 3,37043,0.172052824976429,0.0113933694133393,0.149721820926284,0.194383829026574,4.25590979798715e-51
NMR metabolomics,X23408.Triglycerides in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0822926051125648,0.00546462090536576,0.0715819481380479,0.0930032620870816,6.73428233052588e-51
NMR metabolomics,X23408.Triglycerides in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0653989011943818,0.00434655290080961,0.056879657508795,0.0739181448799687,9.44637481254919e-51
NMR metabolomics,X23408.Triglycerides in VLDL,KIFBP,KIF-binding protein,39788,0.120393816000178,0.0080186910842718,0.104677181475006,0.136110450525351,1.31642334335925e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0838372865775838,0.0055856088350572,0.0728894932608717,0.0947850798942959,1.43259641366792e-50
NMR metabolomics,X23408.Triglycerides in VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.16438501129029,0.0109558795865233,0.142911487300704,0.185858535279875,1.78535684630333e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3B,Protein FAM3B,39788,0.0519839139453919,0.00346763652423008,0.0451873463579009,0.0587804815328828,1.85226321986395e-50
NMR metabolomics,X23408.Triglycerides in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0432116048416988,0.00288155868752237,0.0375637498141549,0.0488594598692426,2.00043978253227e-50
NMR metabolomics,X23408.Triglycerides in VLDL,BIN2,Bridging integrator 2,39858,0.130006814927943,0.00867911021886951,0.112995758898959,0.147017870956927,2.20208871710726e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ADD1,Alpha-adducin,37124,0.100182202488343,0.00668550570478011,0.0870786113069741,0.113285793669712,2.37565254525539e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CCL8,C-C motif chemokine 8,40003,0.0873775079344987,0.00583652928179721,0.0759379105421762,0.0988171053268213,2.47987606547952e-50
NMR metabolomics,X23408.Triglycerides in VLDL,TADA3,Transcriptional adapter 3,37368,0.0574812422020256,0.0038379672184315,0.0499588264538999,0.0650036579501513,2.62870653625529e-50
NMR metabolomics,X23408.Triglycerides in VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.158923226187941,0.0106292511843455,0.138089893866624,0.179756558509258,3.33068472171771e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.123829395881048,0.00828008573790862,0.107600427834747,0.140058363927348,3.62429882906302e-50
NMR metabolomics,X23408.Triglycerides in VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.0775372582822354,0.00518663715490932,0.0673714494586132,0.0877030671058577,4.09095583294878e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0556241301640994,0.00372198322490569,0.0483290430432842,0.0629192172849145,4.22835385866941e-50
NMR metabolomics,X23408.Triglycerides in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.112214394398072,0.00751440645498231,0.097486157746307,0.126942631049838,4.35608579405988e-50
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0593268394221137,0.00397378558395539,0.0515382196775612,0.0671154591666663,4.5838936580414e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.0463343329827766,0.00310257249190407,0.0402532908986446,0.0524153750669086,5.05796917664281e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0694169994795529,0.00465360493103891,0.0602959338147166,0.0785380651443891,6.37513415943031e-50
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0737282717848556,0.00494336700928597,0.0640392724466551,0.0834172711230561,6.60775979676496e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0453883174881903,0.00304892810449065,0.0394124184033886,0.051364216572992,8.69773377742282e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0459402254760198,0.00308651597762389,0.039890654159877,0.0519897967921626,8.93067624407391e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0407967115993475,0.00274207150437917,0.0354222514507643,0.0461711717479307,9.88363682036795e-50
NMR metabolomics,X23408.Triglycerides in VLDL,TBCB,Tubulin-folding cofactor B,39749,0.145716409041559,0.00980090538324037,0.126506634490408,0.16492618359271,1.15301039500927e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CD22,B-cell receptor CD22,40058,0.0576591608914487,0.00387862157452387,0.0500570626053819,0.0652612591775154,1.16619252867099e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0542880807629292,0.0036509451070649,0.047132228353082,0.0614439331727764,1.28116292513325e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0536187993849678,0.00361371661970405,0.0465359148103479,0.0607016839595878,1.80894616916958e-49
NMR metabolomics,X23408.Triglycerides in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0432701728978172,0.00291756940670455,0.0375517368606763,0.0489886089349581,1.95697825313207e-49
NMR metabolomics,X23408.Triglycerides in VLDL,DNM3,Dynamin-3,37411,0.0788621066819048,0.00531740537457319,0.0684399921477414,0.0892842212160683,2.25325463509709e-49
NMR metabolomics,X23408.Triglycerides in VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.089600704218535,0.00604163659662182,0.0777590964891562,0.101442311947914,2.26658200145193e-49
NMR metabolomics,X23408.Triglycerides in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.105462673666797,0.00711239440010047,0.0915223806426,0.119402966690994,2.3899304115574e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.137943943875261,0.00931062898697465,0.119695111060791,0.156192776689732,2.46301735228976e-49
NMR metabolomics,X23408.Triglycerides in VLDL,BGLAP,Osteocalcin,37437,0.12417487410217,0.00837769613654229,0.107754589674547,0.140595158529793,2.56130672708731e-49
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0895019675491269,0.00603894902180592,0.0776656274663873,0.101338307631867,2.61031393887398e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0964222641909255,0.00650631672183229,0.0836698834161342,0.109174644965717,2.72300799326433e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.105632333539189,0.00712893713559952,0.0916596167534144,0.119605050324965,2.81571659082816e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.04840973940085,0.00327603890560973,0.0419887031458549,0.0548307756558451,4.31869584882138e-49
NMR metabolomics,X23408.Triglycerides in VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.0994145400473299,0.00672576686779213,0.0862320369864573,0.112597043108202,4.75861875119492e-49
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.039423706260963,0.00266950251896653,0.0341914813237886,0.0446559311981374,4.97821514448917e-49
NMR metabolomics,X23408.Triglycerides in VLDL,STX4,Syntaxin-4,39788,0.0845611513992229,0.00572602862083352,0.0733381353023892,0.0957841674960566,4.98142075503439e-49
NMR metabolomics,X23408.Triglycerides in VLDL,DDT,D-dopachrome decarboxylase,37437,0.0574499918773102,0.00389048311624915,0.0498246449694619,0.0650753387851585,5.74877425276526e-49
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.114056957576003,0.00773577921964887,0.0988948303054908,0.129219084846514,8.21860806972588e-49
NMR metabolomics,X23408.Triglycerides in VLDL,IL7,Interleukin-7,39866,0.0929330281382723,0.006307874711376,0.0805695937039754,0.105296462572569,8.27871727994738e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CTF1,Cardiotrophin-1,39585,0.120937468723243,0.00820905221568513,0.1048477263805,0.137027211065986,8.4673361302189e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CCL3,C-C motif chemokine 3,39866,0.0894420565605581,0.00607269043020546,0.0775395833173554,0.101344529803761,8.81346916441573e-49
NMR metabolomics,X23408.Triglycerides in VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0526541232837297,0.00357621783491754,0.0456447363272913,0.0596635102401681,9.62738472979755e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.125416029314289,0.0085140114877018,0.108728566798394,0.142103491830185,9.75409420933328e-49
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0632314983462351,0.00429726541802401,0.054808858126908,0.0716541385655621,1.09029413987533e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB2,Lysosome membrane protein 2,39486,0.040944372917699,0.00278265887921301,0.0354903615144415,0.0463983843209565,1.10763649541717e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM106A,Transmembrane protein 106A,37368,0.101588380645872,0.00690337636521334,0.0880577629700543,0.115118998321691,1.21507316038894e-48
NMR metabolomics,X23408.Triglycerides in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.14175881176251,0.00964175436049512,0.12286097321594,0.16065665030908,1.5078592793533e-48
NMR metabolomics,X23408.Triglycerides in VLDL,PMVK,Phosphomevalonate kinase,39480,0.157938375300391,0.0107513442966099,0.136865740479036,0.179011010121746,1.57199334842289e-48
NMR metabolomics,X23408.Triglycerides in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0956009861294101,0.00650441755108787,0.0828523277292778,0.108349644529542,1.59651398601198e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB6,Serpin B6,39970,0.0854302396344953,0.00582400687437113,0.0740151861607278,0.0968452931082627,2.10073084651974e-48
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.0829506423903082,0.00565195840531117,0.0718728039158983,0.0940284808647181,2.14932199613813e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CD164,Sialomucin core protein 24,39858,0.0371873279257899,0.00253672265678879,0.0322153515184838,0.0421593043330959,2.40775672922316e-48
NMR metabolomics,X23408.Triglycerides in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0735175494411758,0.00501195269476596,0.0636941221594346,0.0833409767229171,2.46474495561306e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0963057807652377,0.00656728058752854,0.0834339108136818,0.109177650716794,2.55187274458238e-48
NMR metabolomics,X23408.Triglycerides in VLDL,C2,Complement C2,39908,0.033466056996164,0.00228528227798815,0.0289869037313072,0.0379452102610208,3.00583851005399e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0605213124843598,0.00413802045585656,0.052410792390881,0.0686318325778387,3.9066671962967e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CACYBP,Calcyclin-binding protein,37088,0.147163177073569,0.0100628724884139,0.127439946996278,0.166886407150861,4.65595482248194e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.158485207654379,0.0108691221667442,0.13718172820756,0.179788687101197,7.47293940346406e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0897360360639835,0.00615713687342374,0.077668047792073,0.101804024335894,8.22444386470486e-48
NMR metabolomics,X23408.Triglycerides in VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0504701300070013,0.00346375747566113,0.0436811653547055,0.0572590946592971,8.71212300742081e-48
NMR metabolomics,X23408.Triglycerides in VLDL,IMMT,MICOS complex subunit MIC60,37368,0.0619341655782571,0.00425268946504201,0.0535988942267748,0.0702694369297395,1.10082447216913e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.168559988893735,0.0115806393309093,0.145861935805153,0.191258041982317,1.25770393281618e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D5,TBC1 domain family member 5,39866,0.109641271576236,0.0075388785127352,0.0948650696912745,0.124417473461197,1.29329910104042e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CFB,Complement factor B,37220,0.0463278744876277,0.0031989100455135,0.0400580107984212,0.0525977381768341,3.56311391060348e-47
NMR metabolomics,X23408.Triglycerides in VLDL,YWHAQ,14-3-3 protein theta,37124,0.104189788106433,0.00720007715815531,0.0900776368764487,0.118301939336417,4.2405629807194e-47
NMR metabolomics,X23408.Triglycerides in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.146818842965294,0.010146782344253,0.126931149570558,0.16670653636003,4.31101278687378e-47
NMR metabolomics,X23408.Triglycerides in VLDL,UMOD,Uromodulin,40012,-0.0736481041274729,0.00509911456177221,-0.0836423686685464,-0.0636538395863994,5.42126061670786e-47
NMR metabolomics,X23408.Triglycerides in VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0664786457784962,0.00460076994931357,0.0574611366778416,0.0754961548791508,5.63246258839124e-47
NMR metabolomics,X23408.Triglycerides in VLDL,LARP1,La-related protein 1,37368,0.0897397844114119,0.00621368388744477,0.0775609639920202,0.101918604830804,6.26928222196636e-47
NMR metabolomics,X23408.Triglycerides in VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0930301848725452,0.00644549040771326,0.0803970236734272,0.105663346071663,6.28796587526209e-47
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0644193649848555,0.0044611101814812,0.0556755890291523,0.0731631409405586,6.58582366780983e-47
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB1,Heat shock protein beta-1,39617,0.0972227419883448,0.00674143994818178,0.0840095196899085,0.110435964286781,7.515715652965e-47
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0908240617434549,0.0062964372450964,0.078483044743066,0.103165078743844,8.05522905044957e-47
NMR metabolomics,X23408.Triglycerides in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.101986717650891,0.00707255354373385,0.0881245127051728,0.115848922596609,8.57091911265944e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0622544975287415,0.00432056139976041,0.0537861971852111,0.0707227978722719,1.02879836060752e-46
NMR metabolomics,X23408.Triglycerides in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0640404686933052,0.00444811097479133,0.0553221711827142,0.0727587662038962,1.21573976686315e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.094755479089795,0.00658810172223953,0.0818427997142055,0.107668158465384,1.29508308812188e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0656900187951379,0.00457018927346805,0.0567324478191406,0.0746475897711353,1.46882750366384e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0919017602247803,0.00639753176479974,0.0793625979657729,0.104440922483788,1.68496543276312e-46
NMR metabolomics,X23408.Triglycerides in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.131891604646176,0.00917936323894949,0.113900052697835,0.149883156594517,1.80054277362503e-46
NMR metabolomics,X23408.Triglycerides in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.123995386608153,0.00863786166251213,0.107065177749629,0.140925595466677,2.16981636986914e-46
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0451618568696686,0.0031493460189449,0.0389891386725366,0.0513345750668006,2.38894071282384e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.15653547384203,0.0109169202781622,0.135138310096832,0.177932637587228,2.4636898126643e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.139728152029831,0.00974636755335728,0.120625271625251,0.158831032434411,2.50786103067823e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.107555306689867,0.00749889833220686,0.0928574659587412,0.122253147420992,2.58225941914084e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ADM,Pro-adrenomedullin,40030,0.0364623054068834,0.00254663650619545,0.0314708978547403,0.0414537129590265,3.24550253272927e-46
NMR metabolomics,X23408.Triglycerides in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0859101839800633,0.00599951763403002,0.0741511294173645,0.0976692385427621,3.66665931994608e-46
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3,Galectin-3,39901,0.0408334683829913,0.00285411522373725,0.0352394025444663,0.0464275342215163,3.81145329557665e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NID1,Nidogen-1,39892,0.0519841277424264,0.00363404443581645,0.0448614006482261,0.0591068548366267,3.92909907944457e-46
NMR metabolomics,X23408.Triglycerides in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0535431096174898,0.0037405313560926,0.0462116681595483,0.0608745510754313,3.9376159352039e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0701163186949077,0.00490390824264792,0.0605046585393178,0.0797279788504976,4.32611613994661e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NFASC,Neurofascin,40058,0.0383063027014542,0.00267947297114202,0.0330545356780158,0.0435580697248925,4.40659609362508e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.149694570799289,0.0104719001561536,0.129169646493228,0.17021949510535,5.09958484508273e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.039544384587072,0.00276830689180218,0.0341185030791397,0.0449702660950043,5.86821614274807e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CTSL,Cathepsin L1,39868,0.0329952016499295,0.00231134905718687,0.0284649574978433,0.0375254458020158,5.97183606717124e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.058379996654089,0.00408802629321064,0.0503674651193961,0.0663925281887818,6.31755360624533e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.119071202252942,0.00834491961949008,0.102715159798741,0.135427244707142,6.57759108063261e-46
NMR metabolomics,X23408.Triglycerides in VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0760362680127929,0.00533275198892177,0.0655840741145063,0.0864884619110796,7.71361357404182e-46
NMR metabolomics,X23408.Triglycerides in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0652785089717767,0.00457683328057729,0.0563079157418452,0.0742491022017082,8.17559409930673e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CTRB1,Chymotrypsinogen B,39858,0.0736812291547713,0.00517413919277863,0.0635399163369251,0.0838225419726174,9.8040907759072e-46
NMR metabolomics,X23408.Triglycerides in VLDL,F2R,Proteinase-activated receptor 1,39908,0.0804839160486875,0.00565279978336834,0.0694044284732856,0.0915634036240895,1.01223980241272e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0331272837625259,0.00232642303006516,0.0285674946235982,0.0376870729014536,1.10941220642794e-45
NMR metabolomics,X23408.Triglycerides in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0683949702847929,0.00480853816773463,0.058970235476033,0.0778197050935527,1.44363399590889e-45
NMR metabolomics,X23408.Triglycerides in VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0814263544428433,0.00574389738151951,0.0701683155750651,0.0926843933106215,2.41004011707198e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CCL2,C-C motif chemokine 2,39720,0.0708704836518469,0.00500025431475199,0.061069985194933,0.0806709821087608,2.53204671848424e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0570911915616326,0.00402673482661147,0.0491987913014742,0.0649835918217911,2.68337551347522e-45
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.137492012368718,0.00970377917324352,0.11847260518916,0.156511419548275,3.00533032386625e-45
NMR metabolomics,X23408.Triglycerides in VLDL,THTPA,Thiamine-triphosphatase,37345,0.121229843284835,0.00856455868253176,0.104443308267073,0.138016378302597,3.67035922394139e-45
NMR metabolomics,X23408.Triglycerides in VLDL,MENT,Protein MENT,37124,-0.0304947764592854,0.00215560702631303,-0.0347197662308589,-0.0262697866877119,4.16238059002721e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0842924278856915,0.00596107089024243,0.0726087289408163,0.0959761268305666,4.46491377551872e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.122243823968423,0.00866952004794545,0.10525156467445,0.139236083262396,7.02276805072249e-45
NMR metabolomics,X23408.Triglycerides in VLDL,APOM,Apolipoprotein M,39908,0.0362844275103115,0.00257554537753589,0.0312363585703411,0.0413324964502818,8.31735664995648e-45
NMR metabolomics,X23408.Triglycerides in VLDL,FGF23,Fibroblast growth factor 23,40008,0.0795412989932952,0.00565113771144373,0.0684650690788655,0.090617528907725,9.90753700296379e-45
NMR metabolomics,X23408.Triglycerides in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.101460602125657,0.0072077035424375,0.08733350318248,0.115587701068835,9.9099981151464e-45
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0877809763216293,0.0062325712970357,0.0755651365794393,0.0999968160638192,9.96875849850897e-45
NMR metabolomics,X23408.Triglycerides in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0641947585764977,0.00456324751706615,0.055250793443048,0.0731387237099473,1.23453786887672e-44
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.129113123897692,0.00918541541492319,0.111109709684442,0.147116538110941,1.30367289788637e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CERT,Ceramide transfer protein,39489,0.0838896512066237,0.00596832427981121,0.0721917356181937,0.0955875667950536,1.32628931493512e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PTGR1,Prostaglandin reductase 1,37437,0.108515639801452,0.00772237154473986,0.0933797915737619,0.123651488029142,1.533440753494e-44
NMR metabolomics,X23408.Triglycerides in VLDL,POSTN,Periostin,37437,-0.0506397651701959,0.00360415765269768,-0.0577039141694834,-0.0435756161709085,1.57100452633541e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SPON2,Spondin-2,39775,-0.0455871259573403,0.00324631101115728,-0.0519498955392085,-0.039224356375472,1.57375086154434e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MESD,LRP chaperone MESD,39858,0.166040145467086,0.0118243385250755,0.142864441957938,0.189215848976234,1.58004244582357e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH9,Protocadherin-9,37382,0.0451948552369319,0.0032230435700498,0.0388776898396343,0.0515120206342295,2.32417203190779e-44
NMR metabolomics,X23408.Triglycerides in VLDL,WDR46,WD repeat-containing protein 46,37368,0.0489460601623431,0.00349801902240868,0.0420899428784221,0.0558021774462641,3.52226308431254e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0606477599139786,0.00434600904163755,0.052129582192369,0.0691659376355882,6.03371737987495e-44
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0711866549242713,0.00510854920224732,0.0611738984878666,0.0811994113606761,7.12660942341121e-44
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0920274472809946,0.0066073719754503,0.079076998209112,0.104977896352877,7.83078822616833e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PVR,Poliovirus receptor,40009,0.0501253740597131,0.00360209282311973,0.0430652721263985,0.0571854759930278,9.11004188488204e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.138147007964832,0.00993669368805905,0.118671088336236,0.157622927593428,1.23903686392455e-43
NMR metabolomics,X23408.Triglycerides in VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.0741717823438211,0.00533589776377171,0.0637134227268286,0.0846301419608137,1.25556461644174e-43
NMR metabolomics,X23408.Triglycerides in VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0917238210334249,0.00660580907016436,0.0787764352559027,0.104671206810947,1.39327961528746e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.042010271030312,0.00302580460405314,0.0360796940063678,0.0479408480542561,1.40760208766342e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0774672758005615,0.00558287876562444,0.0665248334199376,0.0884097181811854,1.58556302816814e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL1,Growth-regulated alpha protein,39839,0.127471603318834,0.00918676229003279,0.10946554923037,0.145477657407298,1.59303185663598e-43
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.133965978130263,0.00965353101280534,0.115045057345165,0.152886898915362,1.72223124453625e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0529436871261382,0.00381742314200503,0.0454615377678083,0.060425836484468,1.76847245942319e-43
NMR metabolomics,X23408.Triglycerides in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0873484504727019,0.00629643635861451,0.0750074352098175,0.0996894657355864,1.87514271221317e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TREH,Trehalase,37437,0.101305548426867,0.00730915603208984,0.0869796026039711,0.115631494249763,2.18228340097411e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.124100975476236,0.0089657799784161,0.10652804671854,0.141673904233931,2.53947369456083e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.122514339651922,0.00884564320633302,0.105176878967509,0.139851800336334,2.54700831287581e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0536645035695894,0.00387565622577607,0.0460682173670683,0.0612607897721105,2.62776996047164e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.12417813468338,0.00897642370526168,0.106584344221067,0.141771925145693,3.19320065534832e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.126896825094771,0.00917908523004001,0.108905818043893,0.144887832145649,3.2194681911397e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0555629853977852,0.00401966353510407,0.0476844448689813,0.0634415259265892,3.30310811105162e-43
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO3,Forkhead box protein O3,39477,0.130599803107781,0.0094573245544639,0.112063446981032,0.149136159234531,4.01022081604991e-43
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0563078427644187,0.00407629717710137,0.0483183002973001,0.0642973852315374,4.14963484798973e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0807078830552349,0.00584685738946058,0.0692480425718922,0.0921677235385776,4.33898918996057e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.132269640580282,0.00957878631625728,0.113495219400418,0.151044061760146,4.42112008747943e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CIAPIN1,Anamorsin,39913,0.0842868696667479,0.00611220133703558,0.0723069550461582,0.0962667842873376,5.15355217206856e-43
NMR metabolomics,X23408.Triglycerides in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0263871702237238,0.00191436348916148,-0.0301393226624804,-0.0226350177849673,5.63143294079536e-43
NMR metabolomics,X23408.Triglycerides in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.109344690607562,0.00793686967284746,0.0937884260487811,0.124900955166343,6.17905540423892e-43
NMR metabolomics,X23408.Triglycerides in VLDL,APOD,Apolipoprotein D,36780,-0.0580257916122799,0.00421492313278875,-0.0662870409525458,-0.0497645422720139,8.09926857133782e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0890405517075378,0.00647051758464319,0.0763583372416371,0.101722766173438,8.65456419031692e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0596068655840302,0.00433706110103031,0.0511062258260108,0.0681075053420496,9.86279560720831e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CALCA,Calcitonin,39713,0.0810068330076364,0.00590159399800588,0.0694397087715449,0.092573957243728,1.23909724179439e-42
NMR metabolomics,X23408.Triglycerides in VLDL,MICALL2,MICAL-like protein 2,37039,0.090564203685439,0.00659791016869244,0.0776322997548018,0.103496107616076,1.38836246411921e-42
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0715301407859271,0.00521363720621357,0.0613114118617485,0.0817488697101057,1.48838957897329e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0814483863677653,0.00594112693388391,0.0698037775773529,0.0930929951581778,1.74809631472349e-42
NMR metabolomics,X23408.Triglycerides in VLDL,APOF,Apolipoprotein F,37445,-0.0343946709089739,0.00251054562694523,-0.0393153403377866,-0.0294740014801613,1.94115189593684e-42
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0423135856348313,0.00309372019695693,0.0362498940487957,0.0483772772208668,2.39825866219313e-42
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0707738510294538,0.005172339243743,0.0606360661117175,0.0809116359471901,2.48111288652415e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0403148461304713,0.00294869833234742,0.0345353973990704,0.0460942948618723,2.85712409812516e-42
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0814099896144807,0.00596041215083772,0.0697275817988388,0.0930923974301227,3.42066880611285e-42
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.086108654816072,0.00631401193140278,0.0737331914305226,0.0984841182016214,4.53413087272111e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CASP3,Caspase-3,40052,0.117285045001436,0.00861327053169338,0.100403034759317,0.134167055243555,5.42068143324093e-42
NMR metabolomics,X23408.Triglycerides in VLDL,F11,Coagulation factor XI,37249,0.0412701733818039,0.00303238354955753,0.0353267016246712,0.0472136451389367,6.65109440486424e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0863846166962407,0.00635151736035173,0.0739356426699513,0.0988335907225301,6.75428876736096e-42
NMR metabolomics,X23408.Triglycerides in VLDL,LAP3,Cytosol aminopeptidase,39587,0.0640515695986049,0.00471121647651745,0.0548175853046307,0.0732855538925791,7.33714141287047e-42
NMR metabolomics,X23408.Triglycerides in VLDL,SUGT1,Protein SGT1 homolog,39477,0.106765817948497,0.00785285481039144,0.0913742225201301,0.122157413376865,7.34041513982642e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CASP2,Caspase-2,39866,0.0899390244908495,0.00661677549650065,0.0769701445177083,0.102907904463991,7.56611051199553e-42
NMR metabolomics,X23408.Triglycerides in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0450053699704244,0.00331198401142943,0.0385138813080227,0.0514968586328261,8.0849312137677e-42
NMR metabolomics,X23408.Triglycerides in VLDL,EPPK1,Epiplakin,37043,0.0982753834714114,0.00724098821674512,0.0840830465665909,0.112467720376232,1.1166941242478e-41
NMR metabolomics,X23408.Triglycerides in VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.108592201719709,0.00800657518535378,0.0928993143564159,0.124285089083003,1.24096298008045e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SMTN,Smoothelin,37342,0.126599104008493,0.00934697171334943,0.108279039450328,0.144919168566658,1.59788661916321e-41
NMR metabolomics,X23408.Triglycerides in VLDL,GMFG,Glia maturation factor gamma,37437,0.0946192585222828,0.00698999605582171,0.0809188662528722,0.108319650791693,1.77182996684643e-41
NMR metabolomics,X23408.Triglycerides in VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.115864538562797,0.00856546917182493,0.0990762189860198,0.132652858139574,2.01643255182085e-41
NMR metabolomics,X23408.Triglycerides in VLDL,IL12A_IL12B,Interleukin-12,39788,0.096254597493997,0.00712326489277704,0.0822929983041541,0.11021619668384,2.22452301663685e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CCL25,C-C motif chemokine 25,40058,0.0651623673750931,0.00482560382749455,0.0557041838732037,0.0746205508769824,2.49678014497627e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0595184917945606,0.0044082336421019,0.0508783538560409,0.0681586297330803,2.56817499096439e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRD2,Protein ZNRD2,37382,0.0889693278014398,0.00658879329317184,0.076055292946823,0.101883362656057,2.77454295619688e-41
NMR metabolomics,X23408.Triglycerides in VLDL,DBI,Acyl-CoA-binding protein,39793,0.104525049363234,0.00774741942089237,0.0893401072982847,0.119709991428183,2.95277391928201e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.146654014324829,0.0108839159005664,0.125321539159719,0.167986489489939,3.74458283198123e-41
NMR metabolomics,X23408.Triglycerides in VLDL,RP2,Protein XRP2,39788,0.0543966119523479,0.00403906884619361,0.0464800370138085,0.0623131868908874,4.07263576769364e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CCL15,C-C motif chemokine 15,40052,0.056509165754956,0.00419752215441255,0.0482820223323074,0.0647363091776046,4.32439288330081e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB9,Serpin B9,39749,0.0434389132092953,0.00323758275007236,0.0370932510191535,0.0497845753994372,8.01113584462804e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CD244,Natural killer cell receptor 2B4,40058,0.034681995177486,0.0025858721596878,0.0296136857444979,0.0397503046104741,8.47825144915759e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.104604841001572,0.00779802993710712,0.0893207023248419,0.119888979678302,9.22397697814333e-41
NMR metabolomics,X23408.Triglycerides in VLDL,NBN,Nibrin,39587,0.0668699995182657,0.00499056932861,0.0570884836341901,0.0766515154023413,1.02108751018444e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ARSA,Arylsulfatase A,39858,0.0582678103383437,0.00435746410089667,0.0497271807005862,0.0668084399761011,1.45621937989889e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF6,SLAM family member 6,39477,0.0488422736210336,0.00365682346178903,0.0416748996359271,0.0560096476061401,1.81056249579789e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0761092752980315,0.00570268729380507,0.0649320082021736,0.0872865423938895,2.0748163452652e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.155892147432362,0.0116840709713937,0.13299136832843,0.178792926536293,2.1549422917666e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA3,Annexin A3,39985,0.0902220657029379,0.00676389334092578,0.0769648347547233,0.103479296651152,2.25375340117807e-40
NMR metabolomics,X23408.Triglycerides in VLDL,TMSB10,Thymosin beta-10,39858,0.0998390193195973,0.00748686733486813,0.0851647593432557,0.114513279295939,2.37184123489433e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0738414441231711,0.00553600377545669,0.062990876723276,0.0846920115230663,2.52574681028526e-40
NMR metabolomics,X23408.Triglycerides in VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0687250346616551,0.00515632564914887,0.0586186363893233,0.0788314329339868,2.58795305186093e-40
NMR metabolomics,X23408.Triglycerides in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.049197940409479,0.00369479364925604,0.0419561448569372,0.0564397359620208,3.087781571823e-40
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN2,Nectin-2,39846,0.036341369487775,0.00273147984309624,0.0309876689953064,0.0416950699802436,3.55751409932077e-40
NMR metabolomics,X23408.Triglycerides in VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0621269990183966,0.00467530347972474,0.0529634041981361,0.0712905938386571,4.81225249728554e-40
NMR metabolomics,X23408.Triglycerides in VLDL,NRGN,Neurogranin,37445,0.118098361301782,0.00889775633966103,0.100658758876046,0.135537963727517,5.90039462956529e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.0467411079579833,0.00352338067682568,0.039835281831405,0.0536469340845616,5.96013871664693e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PARK7,Parkinson disease protein 7,39858,0.0674388515458495,0.00508388798694288,0.0574744310914414,0.0774032720002575,5.98794043258341e-40
NMR metabolomics,X23408.Triglycerides in VLDL,GBP1,Guanylate-binding protein 1,37376,0.0818115626265678,0.00616821786536936,0.0697218556104439,0.0939012696426918,6.69932271145977e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB1,Beta-crystallin B1,37437,0.0856836429969548,0.00646061652255169,0.0730208346127534,0.0983464513811561,6.76609766370214e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0258558603636525,0.00195170861814538,-0.0296812092552175,-0.0220305114720876,7.51623379412225e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0738651614319722,0.00557287244163037,0.0629423314463767,0.0847879914175677,7.64522715313611e-40
NMR metabolomics,X23408.Triglycerides in VLDL,TTF2,Transcription termination factor 2,37039,0.0632658682806356,0.00477399031395684,0.0539088472652802,0.072622889295991,7.87721792208628e-40
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA4,Ephrin-A4,39720,0.0355034228274813,0.00268074630200188,0.0302491600755576,0.040757685579405,7.96818990147208e-40
NMR metabolomics,X23408.Triglycerides in VLDL,HEPH,Hephaestin,37437,0.0338525936005566,0.00255513279404489,0.0288445333242286,0.0388606538768846,8.09190431684967e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0637145035574372,0.00481408353717717,-0.0731501072903045,-0.05427889982457,8.91209478535321e-40
NMR metabolomics,X23408.Triglycerides in VLDL,GDF2,Growth/differentiation factor 2,39868,0.0452210175049017,0.00341765160795411,0.0385224203533117,0.0519196146564918,9.32157181601542e-40
NMR metabolomics,X23408.Triglycerides in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0559492766604997,0.00422606477746838,0.0476661896966617,0.0642323636243377,9.35785189004599e-40
NMR metabolomics,X23408.Triglycerides in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.163058393837472,0.0123346915268198,0.138882398444905,0.187234389230039,1.19145270237509e-39
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0813223848174349,0.0061551040554171,0.0692583808688174,0.0933863887660524,1.20341013560012e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ASS1,Argininosuccinate synthase,37021,0.102465175227844,0.00775650706936694,0.087262421371885,0.117667929083803,1.3680699007e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0428933058149604,0.00324947419930093,0.0365243363843305,0.0492622752455902,1.41596667060656e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GP5,Platelet glycoprotein V,37124,0.0463596395393645,0.0035128357715364,0.0394744814271532,0.0532447976515759,1.6151640591638e-39
NMR metabolomics,X23408.Triglycerides in VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0583570068035645,0.00442572477347859,0.0496825862475465,0.0670314273595826,1.69331777857925e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.07776002084053,0.00589765229273269,0.0662006223467739,0.0893194193342861,1.72179082663261e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0837803735580265,0.00635954890194856,0.0713156577102073,0.0962450894058457,2.0113011593264e-39
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.046626579124325,0.00353787918383553,0.0396923359240073,0.0535608223246426,2.0519916856252e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0735396929506308,0.005589702292825,0.0625838764566938,0.0844955094445678,2.51421691015035e-39
NMR metabolomics,X23408.Triglycerides in VLDL,BLMH,Bleomycin hydrolase,40052,0.0407018824340415,0.00309891665373039,0.0346280057927299,0.0467757590753531,3.3254857325998e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0863172552690766,0.00657581415576861,0.0734286595237702,0.0992058510143831,3.69473166815237e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0381731650162575,0.0029094670208682,0.0324706096553559,0.0438757203771592,4.00978159256599e-39
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.112309909870295,0.00856751650678217,0.0955175775170019,0.129102242223588,5.07292755820308e-39
NMR metabolomics,X23408.Triglycerides in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0510965186491891,0.00390583774103096,0.0434410766767684,0.0587519606216097,7.17175307058272e-39
NMR metabolomics,X23408.Triglycerides in VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0968191223686865,0.00741116051408356,0.0822932477610827,0.11134499697629,8.45550389518146e-39
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB6,Heat shock protein beta-6,40030,0.0474031869019321,0.00363027847818448,0.0402878410846905,0.0545185327191737,9.01876640025365e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0978722621543956,0.00749378490857184,0.0831844437335948,0.112560080575196,9.63446502777256e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CD83,CD83 antigen,39866,0.0414772270290592,0.00317817823450599,0.0352479976894275,0.047706456368691,9.93549507796824e-39
NMR metabolomics,X23408.Triglycerides in VLDL,DCTD,Deoxycytidylate deaminase,37124,0.121357964998031,0.00929890706808539,0.103132107144583,0.139583822851478,1.08862651020515e-38
NMR metabolomics,X23408.Triglycerides in VLDL,GP6,Platelet glycoprotein VI,39836,0.111992852439359,0.00859834498298722,0.0951400962727038,0.128845608606014,1.38794924704655e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.093490400575387,0.00719325914364093,0.0793916126538508,0.107589188496923,2.15728688399086e-38
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.0986102748779131,0.0075891218668736,0.0837355960188408,0.113484953736985,2.25378030885862e-38
NMR metabolomics,X23408.Triglycerides in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.111302256640674,0.00856781622696397,0.0945093368358246,0.128095176445523,2.36624913706888e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.07646018881142,0.00589139626499291,0.0649130521320339,0.0880073254908061,2.77868448555025e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.105078517435058,0.00810965609098908,0.089183591496719,0.120973443373396,3.32473112005838e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0965637718599757,0.00745000385699359,0.0819617643002682,0.111165779419683,3.41131990742975e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SDHB,Succinate dehydrogenase,37382,0.0882562834104288,0.00681010460902241,0.0749084783767449,0.101604088444113,3.49877460454276e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ING1,Inhibitor of growth protein 1,39453,0.0564749647878571,0.00436463647443891,0.0479202772979568,0.0650296522777573,4.2469804315922e-38
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0377712930287361,0.00292415539723651,0.0320399484501525,0.0435026376073196,6.0350086561189e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.0972391275467432,0.00754198143325328,0.0824568439375667,0.11202141115592,7.57197207845746e-38
NMR metabolomics,X23408.Triglycerides in VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0451074901714674,0.00350226191560926,0.0382430568168733,0.0519719235260616,9.02893762509809e-38
NMR metabolomics,X23408.Triglycerides in VLDL,MDK,Midkine,39843,0.063086328707794,0.00490137071838741,0.0534796420997547,0.0726930153158333,1.00704899506587e-37
NMR metabolomics,X23408.Triglycerides in VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0568013812210158,0.00441468767103582,0.0481485933857856,0.065454169056246,1.15589235289144e-37
NMR metabolomics,X23408.Triglycerides in VLDL,GET3,ATPase GET3,37437,0.0699038656917035,0.0054371192808826,0.0592471119011736,0.0805606194822334,1.30562595101584e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CALB2,Calretinin,39489,0.0362956594411933,0.00282819507562082,0.0307523970929765,0.0418389217894101,1.6462092566716e-37
NMR metabolomics,X23408.Triglycerides in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0725680098446471,0.00565593440666633,0.0614823784075811,0.0836536412817132,1.71710637305747e-37
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0875688609862875,0.00682808672678064,0.0741858110017975,0.100951910970778,1.99477717798287e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0864010202716687,0.0067403544595432,0.0731899255309641,0.0996121150123734,2.16240630850569e-37
NMR metabolomics,X23408.Triglycerides in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.044747984985701,0.00349659295844335,0.037894662787152,0.05160130718425,2.56404843933225e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TGFA,Protransforming growth factor alpha,39866,0.0568846463402957,0.00444578891366324,0.0481709000695158,0.0655983926110756,2.65754785460475e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0292523265015997,0.00228948679265402,0.0247649323879979,0.0337397206152016,3.35605014591197e-37
NMR metabolomics,X23408.Triglycerides in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.061167749820185,0.00478678594572098,0.0517856493665719,0.0705498502737982,3.54490956509719e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0351206198210446,0.00275402905314021,0.0297227228768898,0.0405185167651994,4.58162697624945e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CCN4,CCN family member 4,40030,0.0494525530647224,0.00388096150544696,0.0418458685140464,0.0570592376153985,5.18121372118384e-37
NMR metabolomics,X23408.Triglycerides in VLDL,XCL1,Lymphotactin,40030,0.0676331949564709,0.00531300217037251,0.0572197107025407,0.078046679210401,6.07887268316791e-37
NMR metabolomics,X23408.Triglycerides in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0549293791010209,0.00432038342107837,-0.0633973306063345,-0.0464614275957073,7.42521035909744e-37
NMR metabolomics,X23408.Triglycerides in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0476097476486049,0.00374301232259827,0.0402734434963123,0.0549460518008975,7.47147779139666e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH7,Protocadherin-7,37382,0.0414301922407049,0.00326080833757234,0.0350390078990631,0.0478213765823467,8.9423792595895e-37
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0591519520248673,0.00465834006047076,0.0500216055063446,0.06828229854339,9.9380375126012e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CTSE,Cathepsin E,37124,0.0650948782183177,0.00513073652329571,0.0550386346326582,0.0751511218039773,1.13654901906638e-36
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0557071088811187,0.00439859193323884,0.0470858686919706,0.0643283490702668,1.51248042732794e-36
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.121535491161645,0.00961382324552138,0.102692397600423,0.140378584722867,1.99697112162749e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0742717682036459,0.00588027314088394,-0.0857971035597784,-0.0627464328475134,2.32307268542151e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0579159671521054,0.00458934459838746,0.048920851739266,0.0669110825649448,2.67230162860118e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FCN1,Ficolin-1,37430,0.0688272997717349,0.00546200441847722,0.0581217711115195,0.0795328284319502,3.32031397949389e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0786307530355254,0.00624481724335054,0.0663909112385584,0.0908705948324925,3.52984995161474e-36
NMR metabolomics,X23408.Triglycerides in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0473512792661212,0.0037611533568893,-0.0547231398456242,-0.0399794186866182,3.57637665976475e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CCL26,C-C motif chemokine 26,39866,0.10429738831359,0.0082915763920743,0.0880458985851243,0.120548878042056,4.09742015287847e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.12515813478525,0.00994770266042129,0.105660637570825,0.144655631999676,4.24538978069173e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0332194080571575,0.0026436670435666,0.0280378206517669,0.038400995462548,4.80428045435706e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.14907012179292,0.0118764752297892,0.125792230342534,0.172348013243307,5.74560434368597e-36
NMR metabolomics,X23408.Triglycerides in VLDL,TSNAX,Translin-associated protein X,37021,0.047808470078246,0.00380808391940954,0.0403446255962033,0.0552723145602887,6.03575782153084e-36
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0451120806595266,0.003594261743156,0.0380673276429408,0.0521568336761123,6.26893380947675e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.10723130965697,0.00854858487336854,0.0904760833051679,0.123986536008773,6.33730306926239e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0678537965351803,0.0054146536182416,0.0572410754434268,0.0784665176269339,7.98108861166237e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DBN1,Drebrin,37056,0.0637662822464677,0.00509214901319546,0.0537856701806046,0.0737468943123308,8.98392532047724e-36
NMR metabolomics,X23408.Triglycerides in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0653365440635007,0.00522378296482575,0.0550979294524423,0.0755751586745592,9.99589319357645e-36
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.105754854171905,0.00845163237880124,0.0891896547094543,0.122320053634355,9.99994526073931e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CCL14,C-C motif chemokine 14,39843,0.0470837611828732,0.0037684476089841,0.0396976038692643,0.054469918496482,1.17829811424396e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TBCA,Tubulin-specific chaperone A,37124,0.104751174034016,0.00840011341132683,0.0882869517478157,0.121215396320217,1.71603362172433e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0660768798224452,0.00530340855917404,0.0556821990464641,0.0764715605984263,1.83430952047678e-35
NMR metabolomics,X23408.Triglycerides in VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0638438577775283,0.00513631592482994,0.0537766785648616,0.0739110369901949,2.63531534951139e-35
NMR metabolomics,X23408.Triglycerides in VLDL,LEPR,Leptin receptor,39868,-0.0372254862882169,0.00299507007536471,-0.0430958236359317,-0.031355148940502,2.64944501784992e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FGF2,Fibroblast growth factor 2,39866,0.0802801251704261,0.00646055541556613,0.0676174365559165,0.0929428137849357,2.74051293835142e-35
NMR metabolomics,X23408.Triglycerides in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0861806889366098,0.00693478391785466,0.0725885124576146,0.0997728654156049,2.88912742427414e-35
NMR metabolomics,X23408.Triglycerides in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0487974747280656,0.00392860859244252,0.0410974018868783,0.056497547569253,3.12613480278102e-35
NMR metabolomics,X23408.Triglycerides in VLDL,C1R,Complement C1r subcomponent,37453,0.0233088497768312,0.00187755375604734,0.0196288444149784,0.026988855138684,3.38382551049574e-35
NMR metabolomics,X23408.Triglycerides in VLDL,RAB10,Ras-related protein Rab-10,37437,0.0645455973252705,0.0052002007275189,0.0543532038993335,0.0747379907512076,3.48494936096593e-35
NMR metabolomics,X23408.Triglycerides in VLDL,OPLAH,5-oxoprolinase,37043,0.0836349526074509,0.00674063981578758,0.0704232985685072,0.0968466066463945,3.73543258567446e-35
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0370302642546777,0.00298736417060615,-0.0428854980290658,-0.0311750304802897,3.98299370114e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.13163641162885,0.0106189179010527,0.110823332542787,0.152449490714913,4.33708781142839e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CD40LG,CD40 ligand,40058,0.0933673882051204,0.00753845347194613,0.078592019400106,0.108142757010135,4.51433716133661e-35
NMR metabolomics,X23408.Triglycerides in VLDL,NGRN,Neugrin,37388,0.0256634422348554,0.00207111782643348,0.0216040512950458,0.0297228331746651,4.52469142739464e-35
NMR metabolomics,X23408.Triglycerides in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0360610742715223,0.00291220087875994,-0.0417689879938918,-0.0303531605491528,4.68412918516998e-35
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0340321244623509,0.00275040857718334,0.0286413236510716,0.0394229252736302,5.67607822763213e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.052130317180629,0.0042158579806849,0.0438672355384866,0.0603933988227714,5.86971988754719e-35
NMR metabolomics,X23408.Triglycerides in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.103719531136845,0.00839237369785765,0.0872704786890436,0.120168583584646,6.81034269101107e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0373712811680329,0.00302479303198933,0.0314426868253338,0.043299875510732,7.05897477249243e-35
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0910358904331252,0.00736999228027148,0.0765907055637931,0.105481075302457,7.3032036020155e-35
NMR metabolomics,X23408.Triglycerides in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0810185172550361,0.00656289248036214,0.0681552479935263,0.0938817865165459,7.53945055962028e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAL,Integrin alpha-L,37056,0.0512892180239073,0.00415380122193535,0.043147767628914,0.0594306684189006,7.8198366600787e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CD46,Membrane cofactor protein,39777,0.0338469340090565,0.00274742565780485,0.0284619797197589,0.039231888298354,1.02379983762761e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0706187794019595,0.00574563308439695,0.0593573385565415,0.0818802202473775,1.46502762189247e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0809441087297219,0.00658295583381822,0.0680415152954382,0.0938467021640056,1.47251033420728e-34
NMR metabolomics,X23408.Triglycerides in VLDL,IL32,Interleukin-32,39866,-0.0509870312501388,0.00415011675359683,-0.0591212600871886,-0.0428528024130891,1.54713487386878e-34
NMR metabolomics,X23408.Triglycerides in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0778686149868326,0.00634254993618038,0.065437217111919,0.0903000128617461,1.72787938495945e-34
NMR metabolomics,X23408.Triglycerides in VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0497280045508261,0.00405289222465767,0.0417843357904971,0.0576716733111551,1.8929466148564e-34
NMR metabolomics,X23408.Triglycerides in VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0774904927001739,0.00632286939541883,0.065097668685153,0.0898833167151948,2.38496427912833e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0713792335049831,0.00582510708067603,0.0599620236268581,0.0827964433831081,2.46844267631704e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DMD,Dystrophin,37043,0.0616354610982641,0.00503444583662307,0.0517679472584829,0.0715029749380453,2.81963089327325e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0700628463349989,0.00572961918940069,-0.0812928999462243,-0.0588327927237735,3.11326735649275e-34
NMR metabolomics,X23408.Triglycerides in VLDL,KLF4,Krueppel-like factor 4,36991,0.0468458200899041,0.00383119144261687,0.039336684862375,0.0543549553174331,3.40151140666096e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0588298938634803,0.00481679074168419,0.0493889840097793,0.0682708037171813,3.73651091981664e-34
NMR metabolomics,X23408.Triglycerides in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0837265739801137,0.00685926696132353,0.0702824107359196,0.0971707372243078,4.38922032774712e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0840329321134611,0.00690669746458512,0.0704958050828742,0.0975700591440479,7.01847427051378e-34
NMR metabolomics,X23408.Triglycerides in VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.0466076111395926,0.003832886127954,0.0390951543288028,0.0541200679503825,7.18890621714686e-34
NMR metabolomics,X23408.Triglycerides in VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0398340860270177,0.00329077700080341,0.033384163105443,0.0462840089485924,1.40583549395115e-33
NMR metabolomics,X23408.Triglycerides in VLDL,NADK,NAD kinase,39868,0.0626045987702619,0.00517507817933586,0.0524614455387636,0.0727477520017602,1.5283188731957e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0511831582046412,0.00422905479470547,0.0428942108070185,0.0594721056022639,1.53815514750609e-33
NMR metabolomics,X23408.Triglycerides in VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.0351118783240927,0.00290604913831191,0.0294160220130014,0.040807734635184,1.84244407942746e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0525007469402241,0.00434584587516229,0.043982889024906,0.0610186048555421,1.87133661834708e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0868193299874726,0.0071847522296693,0.0727372156173208,0.100901444357624,1.9241279746867e-33
NMR metabolomics,X23408.Triglycerides in VLDL,FADD,FAS-associated death domain protein,39868,0.0899807178612548,0.00745413982808983,0.0753706037981988,0.104590831924311,2.09306078924564e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.105821739190717,0.008764048785421,0.088644203571292,0.122999274810142,2.15935504029736e-33
NMR metabolomics,X23408.Triglycerides in VLDL,BLNK,B-cell linker protein,37056,0.045877564503873,0.00380182158279833,0.0384259942015882,0.0533291348061577,2.35647744720227e-33
NMR metabolomics,X23408.Triglycerides in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.141123670384853,0.011714746673295,0.118162766905195,0.164084573864512,2.81316619926095e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0430137210000224,0.00356948981776529,0.0360175209572024,0.0500099210428423,2.88888991120163e-33
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0511392010649343,0.00425001562361371,0.0428091704426514,0.0594692316872172,3.53456837940549e-33
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.058490689621056,0.00486319526480633,0.0489588269020356,0.0680225523400764,3.54112238621091e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CCL19,C-C motif chemokine 19,40009,0.134859949490325,0.0112164847261956,0.112875639426982,0.156844259553668,3.7105788766414e-33
NMR metabolomics,X23408.Triglycerides in VLDL,APOE,Apolipoprotein E,37453,0.0846164353002091,0.00704180548454383,0.0708144965505032,0.098418374049915,4.29199397389588e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0620442343505131,0.00517601980336578,0.0518992355359161,0.07218923316511,5.80941461190029e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CCL24,C-C motif chemokine 24,39908,0.0956414862056023,0.00799157096791279,0.0799780071084932,0.111304965302711,7.23178837712202e-33
NMR metabolomics,X23408.Triglycerides in VLDL,LGMN,Legumain,39931,0.0416507733449634,0.00348155433595874,0.0348269268464843,0.0484746198434425,7.62988303052053e-33
NMR metabolomics,X23408.Triglycerides in VLDL,NID2,Nidogen-2,39858,0.0842890343966153,0.00704881722523083,0.0704733526351629,0.0981047161580677,8.14702063925086e-33
NMR metabolomics,X23408.Triglycerides in VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0728797092764878,0.00609425614684748,0.0609349672286668,0.0848244513243089,8.55403288542137e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0556716866724388,0.00465923132859873,0.0465395932683853,0.0648037800764923,9.64015376688642e-33
NMR metabolomics,X23408.Triglycerides in VLDL,UNC79,Protein unc-79 homolog,36962,0.0655086370653773,0.00548677291505277,0.0547545621518739,0.0762627119788807,1.09001710961388e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA6,Integrin alpha-6,39866,0.0613525863453936,0.00514391789404993,0.0512705072730558,0.0714346654177315,1.17430496253042e-32
NMR metabolomics,X23408.Triglycerides in VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0604557003549465,0.0050729709593858,0.0505126772745503,0.0703987234353426,1.31761910731678e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0365668123226447,0.00307316384822733,0.0305434111801191,0.0425902134651703,1.65097288493587e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0418062521792137,0.00351741582276898,0.0349121171665865,0.0487003871918409,1.92057428348346e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CA13,Carbonic anhydrase 13,39657,0.121565702515399,0.010231348389658,0.101512259671669,0.141619145359129,2.02522275825325e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.069197191216912,0.00582204974811004,0.0577859737106163,0.0806084087232077,2.06422809078229e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DPT,Dermatopontin,40052,0.030814028747102,0.00259827857124996,0.0257214027474521,0.0359066547467519,2.6171572361319e-32
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0462900912837408,0.00390424770148941,0.0386377657888216,0.0539424167786601,2.73228530314665e-32
NMR metabolomics,X23408.Triglycerides in VLDL,S100P,Protein S100-P,39585,0.0604924251794477,0.00510813061578602,0.0504804891725071,0.0705043611863884,3.23010809659855e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.079419835586706,0.00670873380323799,0.0662707173323596,0.0925689538410525,3.35983492379035e-32
NMR metabolomics,X23408.Triglycerides in VLDL,FST,Follistatin,39908,0.0589795030704459,0.00498661630382994,0.0492057351149392,0.0687532710259526,3.82405674841556e-32
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0595711638387244,0.00504733600401295,0.049678385270859,0.0694639424065898,5.1551367234551e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0773083238660913,0.00654847614136645,0.064473310629013,0.0901433371031695,5.29630816523825e-32
NMR metabolomics,X23408.Triglycerides in VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0247534422728084,0.00210242936880057,0.0206326807099593,0.0288742038356575,7.22652895750869e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MMP1,Interstitial collagenase,39314,0.104676135674044,0.0088960536670134,0.0872398704866982,0.122112400861391,7.93323768121803e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0265656752358959,0.00225887294510461,0.0221382842634909,0.030993066208301,8.43333337492606e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN4,Cerebellin-4,40030,0.0353343788090883,0.00300598893202317,0.0294426405023229,0.0412261171158537,9.00058051079173e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.055596576615003,0.00472859096389645,0.0463285383257659,0.06486461490424,9.22456332805428e-32
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0947336812330316,0.00806380087008475,0.0789286315276655,0.110538730938398,9.75966682391642e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0483569409470194,0.00412046911281156,0.0402808214859088,0.0564330604081301,1.13023708080945e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PSAP,Prosaposin,37347,0.0319171428454144,0.00271867222319808,0.0265885452879461,0.0372457404028826,1.13374270607444e-31
NMR metabolomics,X23408.Triglycerides in VLDL,AFP,Alpha-fetoprotein,39699,0.0768064587113566,0.00655191644662012,0.0639647024759812,0.089648214946732,1.31644843765649e-31
NMR metabolomics,X23408.Triglycerides in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0550312239519631,0.00469499773213815,0.0458290283969723,0.0642334195069539,1.34522010064561e-31
NMR metabolomics,X23408.Triglycerides in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.100763556971621,0.00859969155482491,0.0839081615241647,0.117618952419078,1.40921603052111e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0545315607106267,0.00465296110613846,0.0454117569425953,0.0636513644786581,1.4348886004941e-31
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0502197665013134,0.00428705022934387,0.0418171480517995,0.0586223849508274,1.45948762667194e-31
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0605364580999583,0.00516669231562879,0.0504097411613259,0.0706631750385908,1.50083817038434e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TNF,Tumor necrosis factor,39555,0.0431744696916112,0.00368660084040117,0.0359487320444249,0.0504002073387975,1.51123096837474e-31
NMR metabolomics,X23408.Triglycerides in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0793069198478214,0.00677534739337406,0.0660272389568083,0.0925866007388346,1.6133410432955e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0821126949218097,0.00701688553085489,0.0683595992813341,0.0958657905622853,1.67843227284994e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ACYP1,Acylphosphatase-1,37073,0.0747154284331313,0.00638570201242258,0.062199452488783,0.0872314043774795,1.81281687469132e-31
NMR metabolomics,X23408.Triglycerides in VLDL,KLB,Beta-klotho,39489,-0.0835321142581576,0.00714381718637158,-0.0975339959434459,-0.0695302325728693,1.87304508890388e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ACRBP,Acrosin-binding protein,37368,0.0436359683517356,0.00373120609739981,0.0363228044008319,0.0509491323026392,1.91924263333347e-31
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0563798191979873,0.0048251466562995,0.0469225317516403,0.0658371066443344,2.15996912658303e-31
NMR metabolomics,X23408.Triglycerides in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.135902154542763,0.0116391108659917,0.113089497245419,0.158714811840106,2.25626687660769e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0526458342931218,0.00451108401796315,0.043804109617914,0.0614875589683296,2.42521745157326e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BTC,Probetacellulin,39477,0.0837985570110825,0.00718102767253514,0.0697237427729136,0.0978733712492514,2.46387063459404e-31
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0468989732194915,0.00401975499536706,0.0390202534285721,0.054777693010411,2.51006277674169e-31
NMR metabolomics,X23408.Triglycerides in VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.0991102966143948,0.00849607868110695,0.0824579823994252,0.115762610829364,2.72760726489973e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0313196640059389,0.00268509339832989,0.0260568809452123,0.0365824470666655,2.76572725270573e-31
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA9,Serpin A9,39715,0.081996070678621,0.00703986376107874,0.0681979377069067,0.0957942036503353,3.17059363044617e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH1,Acid ceramidase,37340,0.0535219729872008,0.0045946423898473,0.0445164739031001,0.0625274720713015,3.28407066705893e-31
NMR metabolomics,X23408.Triglycerides in VLDL,APLP1,Amyloid-like protein 1,39868,-0.0576888365007999,0.00496538187635705,-0.0674209849784597,-0.0479566880231401,4.43829435886052e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA2,Annexin A2,36879,0.0787370945912051,0.00677628896549394,0.065455568218837,0.0920186209635733,4.66815292385428e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0297647979737762,0.00256519325779607,0.0247370191884959,0.0347925767590565,5.26961845935869e-31
NMR metabolomics,X23408.Triglycerides in VLDL,GAST,Gastrin,37388,0.130955509389067,0.0112842163663724,0.108838445310977,0.153072573467157,5.43731629106493e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BGN,Biglycan,39448,-0.134120256551092,0.0115740221068253,-0.15680533988047,-0.111435173221715,6.34404484389947e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0568329440165065,0.00490732190710116,0.0472145930785882,0.0664512949544248,6.85714550169339e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0618267677133635,0.00533770304738291,0.051364869740493,0.072288665686234,7.0873869694271e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ABHD14B,Protein ABHD14B,39687,0.0645474123544929,0.00557687801285513,0.0536167314492968,0.075478093259689,7.42073159044374e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS27,Serine protease 27,39818,0.0450916379948819,0.00389627927254504,0.0374549306206936,0.0527283453690702,7.49928912466004e-31
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN2,Dynactin subunit 2,39788,0.106035018154687,0.00918645174887715,0.0880295727268879,0.124040463582486,1.06652550810946e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ENAH,Protein enabled homolog,39587,0.0536303101396818,0.00465505417304606,0.0445064039605115,0.0627542163188521,1.37377581360076e-30
NMR metabolomics,X23408.Triglycerides in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0808550281800599,0.00705262655335916,0.067031880135476,0.0946781762246438,2.61102130221935e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CSTB,Cystatin-B,39619,0.0471627048456189,0.00411529287929441,0.0390967308022019,0.055228678889036,2.75065499504148e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CA14,Carbonic anhydrase 14,40030,-0.0390022199402403,0.00340397955211824,-0.045674019862392,-0.0323304200180885,2.81154198203819e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.0352593437683317,0.00308758997621519,0.0292076674149499,0.0413110201217135,4.5725539574716e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0306205650304361,0.00268162185046477,0.0253645862035252,0.0358765438573471,4.6262168144214e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TF,Serotransferrin,37453,0.0241852708409987,0.00212178730587763,0.0200265677214785,0.0283439739605189,5.81619942575594e-30
NMR metabolomics,X23408.Triglycerides in VLDL,COLEC12,Collectin-12,39862,0.0274199495401796,0.00240881696003951,0.0226986682985022,0.032141230781857,6.61146361542974e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN9,Septin-9,39788,0.0312325997098908,0.00274404132840956,0.0258542787062081,0.0366109207135736,6.70970834366977e-30
NMR metabolomics,X23408.Triglycerides in VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0663096078378005,0.00582376864276635,0.0548950212979784,0.0777241943776225,6.71139283730995e-30
NMR metabolomics,X23408.Triglycerides in VLDL,FEN1,Flap endonuclease 1,39477,0.0688369239144487,0.00605193655816965,0.0569751282604362,0.0806987195684612,7.35465484842101e-30
NMR metabolomics,X23408.Triglycerides in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0520012965604364,0.0045751986636987,0.043033907179587,0.0609686859412859,8.09610256933036e-30
NMR metabolomics,X23408.Triglycerides in VLDL,C4BPB,C4b-binding protein beta chain,39913,0.043654529869719,0.00384578566472408,0.0361167899668598,0.0511922697725782,9.49135962318098e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0305766886398057,0.00269601357557418,0.0252925020316803,0.0358608752479311,1.06022697464489e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CTSF,Cathepsin F,39913,0.0444423429801275,0.00392189270984872,0.036755433268824,0.052129252691431,1.18268112281408e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0620096854246349,0.00547392851909604,0.0512807855272067,0.0727385853220631,1.24158423675782e-29
NMR metabolomics,X23408.Triglycerides in VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0364138999556913,0.00321555804192405,0.0301114061935201,0.0427163937178624,1.2897493544078e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SNX9,Sorting nexin-9,39868,0.0760992482960232,0.00672592048356268,0.0629164441482404,0.0892820524438061,1.44341188198694e-29
NMR metabolomics,X23408.Triglycerides in VLDL,MATN2,Matrilin-2,39885,0.0326015930273451,0.00288597629681727,0.0269450794855833,0.038258106569107,1.76396699542982e-29
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0359991707273899,0.00318929669042483,0.0297481492141572,0.0422501922406225,1.95448852008195e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0265537703660425,0.0023545474060567,0.0219388574501714,0.0311686832819137,2.18475950225476e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CLTA,Clathrin light chain A,39585,0.0508912768830006,0.00451583868476698,0.0420402330608573,0.0597423207051439,2.40492538014934e-29
NMR metabolomics,X23408.Triglycerides in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0958694761549447,0.00851331161216354,0.0791833853951042,0.112555566914785,2.75585585868404e-29
NMR metabolomics,X23408.Triglycerides in VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0348904454183309,0.00310473503869001,0.0288051647424985,0.0409757260941633,3.4099462141133e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CORO1A,Coronin-1A,39520,0.0974896373348055,0.00867526946250615,0.0804861091882935,0.114493165481318,3.44523350771374e-29
NMR metabolomics,X23408.Triglycerides in VLDL,KIF22,Kinesin-like protein KIF22,37021,0.132503590032906,0.0117865811074032,0.109401891062396,0.155605289003416,3.44806879416693e-29
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.103407511449485,0.00920477916887796,0.0853661442784841,0.121448878620486,3.57282567694235e-29
NMR metabolomics,X23408.Triglycerides in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.041641786646543,0.00372034034060318,0.0343499195789607,0.0489336537141252,5.68650724701365e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA2,Integrin alpha-2,37124,0.0365866627555766,0.00327128645874571,0.030174941296435,0.0429983842147182,6.56408108195177e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0825573450977615,0.00739052816962248,0.0680719098853014,0.0970427803102216,7.62263507081828e-29
NMR metabolomics,X23408.Triglycerides in VLDL,RNASET2,Ribonuclease T2,39974,0.0274849333796897,0.00247099786386894,0.0226417775665066,0.0323280891928728,1.23251543360283e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX,Glutaredoxin-1,39771,0.0605063013471033,0.00544043615620092,0.0498430464809495,0.0711695562132571,1.25595521530073e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CD84,SLAM family member 5,39866,0.0335570805284955,0.00302199285280319,0.0276339745370012,0.0394801865199897,1.52010957275219e-28
NMR metabolomics,X23408.Triglycerides in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.115108872946078,0.0103683258527494,0.0947869542746893,0.135430791617467,1.62934420171712e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SCRN1,Secernin-1,39866,0.0605583279930929,0.00545725160872041,0.0498621148400009,0.0712545411461849,1.65090900512453e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ARFIP1,Arfaptin-1,37411,0.0746509052090753,0.00673407259151392,0.061452122929708,0.0878496874884426,1.95362030603185e-28
NMR metabolomics,X23408.Triglycerides in VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0667429902469839,0.00602090822685129,-0.0785439703716125,-0.0549420101223554,1.95979001637875e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PPL,Periplakin,37056,0.0345783069145239,0.00312184196255004,0.0284594966679258,0.040697117161122,2.18174178515494e-28
NMR metabolomics,X23408.Triglycerides in VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0206749748057009,0.00187041413846554,0.0170089630943084,0.0243409865170934,2.77766693182986e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0201976314816301,0.00182834687597725,0.0166140716047147,0.0237811913585455,2.99311817014655e-28
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0946456276749468,0.00857830036675323,0.0778321589561105,0.111459096393783,3.34374225747589e-28
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0300162864394473,0.00272223701573721,0.0246807018886024,0.0353518709902922,3.78743591178265e-28
NMR metabolomics,X23408.Triglycerides in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.105774371109636,0.00960139716546555,0.086955632665324,0.124593109553949,4.01004570732421e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GLO1,Lactoylglutathione lyase,39585,0.0616243138096479,0.00561504653989372,0.0506188225914562,0.0726298050278396,6.37520587104108e-28
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1B,Meprin A subunit beta,39868,0.122568776348936,0.0111755971772577,0.100664605881511,0.144472946816361,6.88012126136067e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CD302,CD302 antigen,39788,0.0307925958000455,0.0028148836032051,0.0252754239377635,0.0363097676623275,9.39604409649853e-28
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0407526936431759,0.00373889754816833,0.033424454448766,0.0480809328375858,1.50599653113873e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0709256573902962,0.00650752982744913,0.0581708989284959,0.0836804158520965,1.52310799668881e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC3B,Tetranectin,37138,0.0223965534695623,0.00205920856679696,0.0183605046786403,0.0264326022604843,1.9515198928707e-27
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_E,,39866,0.0288600585837667,0.00265665839229429,0.0236530081348699,0.0340671090326635,2.14870351357818e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TCOF1,Treacle protein,37437,0.0321699503959995,0.00296180574184011,0.0263648111419929,0.0379750896500061,2.27595296681281e-27
NMR metabolomics,X23408.Triglycerides in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0396197741682217,0.00365065945675194,0.0324644816329879,0.0467750667034555,2.4092702001338e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0307936390827715,0.0028387791134173,0.0252296320204736,0.0363576461450694,2.55992896688723e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0426612496190837,0.00393378198147237,0.0349510369353978,0.0503714623027695,2.75192198290021e-27
NMR metabolomics,X23408.Triglycerides in VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0480274434405962,0.00443145036603,0.0393418007231774,0.056713086158015,2.82502383286311e-27
NMR metabolomics,X23408.Triglycerides in VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0707410609463929,0.00654371127469346,0.0579153868479937,0.083566735044792,3.82260189227446e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ADA,Adenosine deaminase,40058,0.0364465258003758,0.00337272363643133,0.0298359874729704,0.0430570641277812,3.9785228637474e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ENO2,Gamma-enolase,40009,0.0693586237006072,0.00642403325444147,0.0567675185219019,0.0819497288793125,4.41270027254475e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DKK4,Dickkopf-related protein 4,39718,0.0474522921261447,0.00439754469423349,0.038833104525447,0.0560714797268423,4.73211641094867e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0622218263673803,0.00576775275401129,0.0509170309695182,0.0735266217652424,5.05659366738493e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0405849324245232,0.00376483935164006,0.0332058472953087,0.0479640175537377,5.30615440907299e-27
NMR metabolomics,X23408.Triglycerides in VLDL,STX16,Syntaxin-16,39477,0.0609533224706654,0.00565655663076921,0.0498664714743577,0.072040173466973,5.57867218879527e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0624294681562957,0.00579963604803996,0.0510621815021374,0.073796754810454,6.29306200370115e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1F,Protein phosphatase 1F,37437,0.0557671906789564,0.00518040943765377,0.045613588181155,0.0659207931767578,6.46618611608291e-27
NMR metabolomics,X23408.Triglycerides in VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0609466257449463,0.00567108935627716,0.049831290606643,0.0720619608832495,7.8610489699029e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0698684052648702,0.00650492970037619,0.0571187430521329,0.0826180674776076,8.43482738046026e-27
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0513514813226796,0.00478375811874329,0.0419753154099427,0.0607276472354164,8.68814459234134e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PER3,Period circadian protein homolog 3,37056,0.122694607226471,0.0114321403874745,0.100287612067021,0.145101602385921,9.24401429738252e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.049085664227808,0.00458141621179186,0.040106088452696,0.0580652400029201,1.07841159521668e-26
NMR metabolomics,X23408.Triglycerides in VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0234532605138136,0.00219079048950387,0.019159311154386,0.0277472098732412,1.22723915345868e-26
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2,Brorin,39684,0.0399009434091584,0.00373835011310594,0.0325737771874708,0.0472281096308461,1.66839846911855e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.114390816836136,0.0107234504525479,-0.13540877972313,-0.0933728539491423,1.778477680466e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0611376774758738,0.00573076956510225,0.0499053691282734,0.0723699858234742,1.82280477657692e-26
NMR metabolomics,X23408.Triglycerides in VLDL,XRCC4,DNA repair protein XRCC4,39489,0.038484929625216,0.00360882373357945,0.0314116351074003,0.0455582241430317,1.84723017984456e-26
NMR metabolomics,X23408.Triglycerides in VLDL,VGF,Neurosecretory protein VGF,37411,0.0302941184016723,0.00284342418795622,0.0247210069932781,0.0358672298100665,2.12228705622981e-26
NMR metabolomics,X23408.Triglycerides in VLDL,APOL1,Apolipoprotein L1,37445,0.0634323890170263,0.00596740092988875,0.0517362831944443,0.0751284948396082,2.74658592991734e-26
NMR metabolomics,X23408.Triglycerides in VLDL,AGT,Angiotensinogen,37445,0.023171923503644,0.00218041180795749,0.0188983163600473,0.0274455306472407,2.82067416476647e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MARCO,Macrophage receptor MARCO,39868,0.026989215303892,0.00254442652101132,0.0220021393227098,0.0319762912850742,3.37102355986347e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SLIT2,Slit homolog 2 protein,39489,0.0531516970351799,0.00501091551109101,0.0433303026334415,0.0629730914369183,3.38761029958657e-26
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0566092232406497,0.00533889996391334,0.0461449793113795,0.0670734671699198,3.53595836970684e-26
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0938817245928078,0.0088759378707145,0.0764848863662074,0.111278562819408,4.80735424359591e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0554358951241599,0.0052448382989515,0.0451560120582149,0.0657157781901048,5.01209954090448e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.034092966453459,0.00323205375457085,0.0277581410945001,0.0404277918124178,6.2714030088152e-26
NMR metabolomics,X23408.Triglycerides in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0722382389629478,0.00684958346597078,0.0588130553696451,0.0856634225562505,6.43084708408882e-26
NMR metabolomics,X23408.Triglycerides in VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0480673734298994,0.00455981474641114,0.0391301365269336,0.0570046103328652,6.75769746849053e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0259671369508337,0.00246345125932377,0.0211387724825591,0.0307955014191083,7.03900222394107e-26
NMR metabolomics,X23408.Triglycerides in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0747526119152732,0.00712309489249062,0.0607913459259916,0.0887138779045548,1.11263344591697e-25
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0783232085708605,0.00746553659163197,0.0636907568512618,0.0929556602904591,1.15281449388371e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0914706215247294,0.00871638111318257,0.0743865145428915,0.108554728506567,1.1588866703633e-25
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0344626100402674,0.00328880648234452,0.0280165493348721,0.0409086707456627,1.31519231232479e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0235537546715565,0.00225310106027547,0.0191376765934166,0.0279698327496964,1.70135895271381e-25
NMR metabolomics,X23408.Triglycerides in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0325355334014409,0.00311354080122062,0.0264329934310485,0.0386380733718333,1.83616944109662e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0916721282621828,0.00879233389398299,0.0744391538299761,0.108905102694389,2.34373269318148e-25
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0339350263190621,0.00326372769094,0.0275381200448197,0.0403319325933045,3.056354624078e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CBS,Cystathionine beta-synthase,37043,0.0515942319692644,0.00496299457955462,0.0418667625933374,0.0613217013451915,3.24316884206289e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0973885469616798,0.0093752511264288,0.0790130547538793,0.11576403916948,3.39318536935202e-25
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0409520669289464,0.00394568163849262,0.0332185309175008,0.0486856029403919,3.71681951067042e-25
NMR metabolomics,X23408.Triglycerides in VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0978392419449012,0.00942395145493621,0.0793682970932262,0.116310186796576,3.72320945728146e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.029948671713637,0.00288565781710097,0.0242927823921191,0.0356045610351549,3.72751691589412e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN6,Dynactin subunit 6,39489,0.0714870510765824,0.00689746320345981,0.0579680231978011,0.0850060789553636,4.34768434841755e-25
NMR metabolomics,X23408.Triglycerides in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0563132170270512,0.00543313003977712,0.0456642821490881,0.0669621519050144,4.4663985566936e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SCRIB,Protein scribble homolog,37043,0.0910323770450059,0.00878503013226768,0.0738137179857612,0.108251036104251,4.5965635490055e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0336695579240792,0.00325667378269533,0.0272864773099963,0.040052638538162,5.85663488143864e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0559119401038839,0.00540866587929358,0.0453109549804685,0.0665129252272993,5.947777018573e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0621537713803076,0.00602020998577523,0.0503541598081882,0.0739533829524271,6.81706690156982e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR3,Small proline-rich protein 3,37388,0.0656991989520205,0.00637216301244371,0.0532097594476309,0.0781886384564102,7.81877441139526e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0471600578512396,0.00457502145132209,0.0381930158066483,0.0561270998958309,7.99420201232032e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DENR,Density-regulated protein,37056,0.0578785850877148,0.00562776684681747,0.0468481620679526,0.068909008107477,1.0263757625832e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0352647345536519,0.00343024690461218,0.028541450620612,0.0419880184866918,1.06294941631825e-24
NMR metabolomics,X23408.Triglycerides in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0243051216089555,0.00236670820585374,0.0196663735254821,0.0289438696924288,1.15244830930662e-24
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0349863857396656,0.00340745687454953,0.0283077702655485,0.0416650012137827,1.21876811072171e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CTSB,Cathepsin B,39847,-0.0510556387492213,0.00498333550726813,-0.0608229763434669,-0.0412883011549758,1.48008946382603e-24
NMR metabolomics,X23408.Triglycerides in VLDL,FXN,"Frataxin, mitochondrial",40030,0.0729268281909147,0.0071242350024416,0.0589633275861292,0.0868903287957002,1.6174104247593e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0415896232707063,0.00406323422233814,0.0336256841949236,0.0495535623464891,1.63437704026837e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA4,Annexin A4,39783,0.071720352726511,0.00703813341736073,0.057925611228484,0.0855150942245381,2.60282055013382e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0401115200119381,0.00393701598397818,0.0323949686833408,0.0478280713405353,2.6608420706757e-24
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0296574427660988,0.00291260386724957,0.0239487391862897,0.035366146345908,2.90301634493402e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ELOB,Elongin-B,37021,0.0388876439437729,0.00381960682827232,0.0314012145603591,0.0463740733271866,2.9631168520285e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PTN,Pleiotrophin,39585,0.0497675547171658,0.00489034283775603,0.040182482755164,0.0593526266791677,2.99559538122424e-24
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0272232093265867,0.00267930667515541,0.0219717682432821,0.0324746504098913,3.52313155356695e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0291444229351214,0.00286745254256973,0.0235242159516848,0.0347646299185581,3.52898945315882e-24
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0519870706389482,0.00511632585066175,0.0419590719716512,0.0620150693062452,3.62864073636288e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0410357944222443,0.00404042134290661,0.0331165685901473,0.0489550202543412,3.80637727575168e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0606430660880605,0.00597270722205254,0.0489365599328375,0.0723495722432835,3.92754234024523e-24
NMR metabolomics,X23408.Triglycerides in VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0604071744677735,0.00595339729982429,0.0487385157601179,0.0720758331754291,4.06091525954735e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0351830086290543,0.00347212698063874,0.0283776397470024,0.0419883775111062,4.80601760060828e-24
NMR metabolomics,X23408.Triglycerides in VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0262053425557518,0.00258772964015659,-0.0312772926504588,-0.0211333924610449,4.96354263775358e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SWAP70,Switch-associated protein 70,37382,0.0353419518376038,0.00349236662222079,0.028496913258051,0.0421869904171565,5.49599646575894e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0648736286244129,0.00643040908192018,0.0522700268238493,0.0774772304249764,7.34661414032839e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PALM,Paralemmin-1,37299,0.0278983729655701,0.00276777475365044,0.0224735344484153,0.033323211482725,8.25344340183291e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0473765993567612,0.00470474646974925,0.0381552962760527,0.0565979024374697,9.09603018184746e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB2,Plexin-B2,39984,0.0230717304141636,0.00229211904263148,0.0185791770906059,0.0275642837377213,9.20888836613291e-24
NMR metabolomics,X23408.Triglycerides in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0513304234698047,0.0050981282517649,0.0413380920963455,0.0613227548432639,9.22931985717593e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0376596958716241,0.00374641675604729,0.0303167190297715,0.0450026727134768,1.05469236302891e-23
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0409699383323448,0.00407679091943107,0.0329794281302599,0.0489604485344297,1.11769431712094e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL8,Interleukin-8,39750,0.0643767051079695,0.00641469277875544,0.0518039072616089,0.0769495029543302,1.24736921237927e-23
NMR metabolomics,X23408.Triglycerides in VLDL,DNM1,Dynamin-1,37382,0.111926423703569,0.0111537061092562,0.0900651597294266,0.133787687677711,1.29492043702237e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0355920763777706,0.00355166517116971,0.028630812642278,0.0425533401132632,1.49260589796482e-23
NMR metabolomics,X23408.Triglycerides in VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0471048797811219,0.00471121747263602,0.0378708935347553,0.0563388660274885,1.86854926709069e-23
NMR metabolomics,X23408.Triglycerides in VLDL,BSG,Basigin,40040,0.0188654301806445,0.00188743873906553,0.015166050252076,0.0225648101092129,1.86989212687803e-23
NMR metabolomics,X23408.Triglycerides in VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0846527264444649,0.00846917111482931,0.0680531510593995,0.10125230182953,1.87035249423812e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0653724027217065,0.00654447559420448,0.0525452305570657,0.0781995748863473,2.05305185346941e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0258511415203933,0.00259498230395872,-0.0309373068361524,-0.0207649762046342,2.61420891505707e-23
NMR metabolomics,X23408.Triglycerides in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0245441088557574,0.0024723513477841,-0.0293899174974142,-0.0196983002141005,3.79182373660395e-23
NMR metabolomics,X23408.Triglycerides in VLDL,STX7,Syntaxin-7,37056,0.0477180236388411,0.00480691581560121,0.0382964686402627,0.0571395786374195,3.83085313016244e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0590943180722839,0.00595893729610859,0.0474148009719111,0.0707738351726567,4.21036603197356e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0332395939335784,0.00336288784524561,0.026648333756897,0.0398308541102598,5.67600265440668e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0487655172108377,0.00493396849759605,-0.058436095466126,-0.0390949389555494,5.860137064578e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0349529885436457,0.0035502049092417,0.0279945869215319,0.0419113901657594,8.59394606325648e-23
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.028449758012384,0.00289222061538115,0.022781005606237,0.0341185104185311,9.07800000960758e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO2,Roundabout homolog 2,40009,0.0216890615362648,0.00220794942515493,0.0173614806629611,0.0260166424095685,1.03607304656115e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0527917171771368,0.0053769033789514,0.0422529865543921,0.0633304477998816,1.12060116299764e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LAMB1,Laminin subunit beta-1,37043,0.0290499898356343,0.00296117431338022,0.023246088181409,0.0348538914898595,1.21531688031422e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TPR,Nucleoprotein TPR,37021,0.0449075296741346,0.0045804075920971,0.0359299307936243,0.0538851285546449,1.28994129768477e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0798339343896264,0.00815632241784743,0.0638475424506454,0.0958203263286074,1.51075884350774e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0393026357064922,0.00402079005928943,0.031421887190285,0.0471833842226995,1.71624941219526e-22
NMR metabolomics,X23408.Triglycerides in VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0654080947416084,0.00670254137301521,0.0522711136504986,0.0785450758327182,2.00688657522709e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA1,BolA-like protein 1,36991,0.0520367879574379,0.00534765965330674,0.0415553750369566,0.0625182008779191,2.65146835536091e-22
NMR metabolomics,X23408.Triglycerides in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0601008129555136,0.006184838269857,0.0479785299465939,0.0722230959644334,3.01720381876799e-22
NMR metabolomics,X23408.Triglycerides in VLDL,THBD,Thrombomodulin,39868,0.0255288206793103,0.00264040972256406,0.0203536176230847,0.0307040237355358,4.71431512037876e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0298110957944138,0.00308593423391402,0.0237626646959423,0.0358595268928853,5.09757880979276e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.0451088977677076,0.00470346790795377,0.0358901006681182,0.054327694867297,1.00552930564367e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.057626936384654,0.00600861695347946,0.0458500471558342,0.0694038256134737,1.02495164722639e-21
NMR metabolomics,X23408.Triglycerides in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0617271875065912,0.00644300502925239,0.0490988976492566,0.0743554773639259,1.13120224538408e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RPL14,60S ribosomal protein L14,37043,0.037744259313112,0.00394086025556704,0.0300201732122006,0.0454683454140234,1.16748118685354e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0471585433097523,0.00492862218516511,0.0374984438268287,0.0568186427926759,1.24128395208162e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RGMB,RGM domain family member B,40009,0.0236806289312504,0.00247550074323342,0.0188286474745129,0.0285326103879879,1.2680217106426e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0343285783036764,0.00358896886493853,0.0272941993283969,0.0413629572789559,1.28140600890254e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.031537118778585,0.00330122593396137,0.0250667159480208,0.0380075216091493,1.43713460606519e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0435219187659208,0.00455762483057813,0.0345889740979877,0.052454863433854,1.49588156193731e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0294581098095022,0.00308718782619548,0.023407221670159,0.0355089979488453,1.59738280807308e-21
NMR metabolomics,X23408.Triglycerides in VLDL,VIT,Vitrin,37437,0.0341668307618847,0.0035803344277541,0.0271493752834867,0.0411842862402827,1.62211779571597e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0696898571774315,0.00730491418159443,0.0553722253815065,0.0840074889733566,1.63168445130896e-21
NMR metabolomics,X23408.Triglycerides in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0324735218018325,0.00341076250783044,-0.0391586163171802,-0.0257884272864849,2.01181618515935e-21
NMR metabolomics,X23408.Triglycerides in VLDL,POMC,Pro-opiomelanocortin,37043,0.0658221568190243,0.00691385772299243,0.0522709956819591,0.0793733179560895,2.02290741115609e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0633742195278763,0.00666153719721459,0.0503176066213357,0.0764308324344169,2.10131996254994e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ULBP2,UL16-binding protein 2,39749,0.0337279835755269,0.00354574378020948,0.0267783257663163,0.0406776413847375,2.12741314299948e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CAPG,Macrophage-capping protein,39739,0.0534689662392362,0.0056382106629245,0.0424180733399042,0.0645198591385682,2.80416944206199e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TLR3,Toll-like receptor 3,40058,0.0560447156341761,0.00591656349644241,0.044448251181149,0.0676411800872032,3.10051360413461e-21
NMR metabolomics,X23408.Triglycerides in VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0230641880270448,0.00243451743877534,0.0182925338470451,0.0278358422070445,3.13745479424997e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0705765050662154,0.00746598088850115,0.0559431825247532,0.0852098276076776,3.84061470359203e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CDA,Cytidine deaminase,37422,0.0426909389136994,0.00451698161093468,0.0338376549562674,0.0515442228711313,3.89028667873368e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0524229507660475,0.00554972719168019,0.0415454854703543,0.0633004160617407,4.00661208790026e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0667664062750483,0.00706970600112894,0.0529097825128356,0.080623030037261,4.0844469817945e-21
NMR metabolomics,X23408.Triglycerides in VLDL,HRG,Histidine-rich glycoprotein,37380,0.029027697208262,0.003079266529908,0.0229923348096424,0.0350630596068817,4.90445612273866e-21
NMR metabolomics,X23408.Triglycerides in VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0200481934770658,0.00213346767301116,0.015866596837964,0.0242297901161677,6.5012986713005e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0826944408254675,0.00881662024147624,-0.0999750164987609,-0.065413865152174,7.53150722237474e-21
NMR metabolomics,X23408.Triglycerides in VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0911848054670942,0.00974245120594413,0.0720896011034437,0.110280009830745,9.08506763230972e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0479217467793458,0.00512223525418497,0.0378821656811433,0.0579613278775483,9.63554713021694e-21
NMR metabolomics,X23408.Triglycerides in VLDL,JAM2,Junctional adhesion molecule B,40009,0.0227407338771,0.00243566673782404,0.0179668270709649,0.0275146406832351,1.1219695840226e-20
NMR metabolomics,X23408.Triglycerides in VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0732012591971486,0.00783789595039576,0.0578389831343729,0.0885635352599243,1.12212898365778e-20
NMR metabolomics,X23408.Triglycerides in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0231393152349257,0.00248239118103584,0.0182738285200955,0.028004801949756,1.32378813348576e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0881573662210216,0.00946059674141461,0.0696145966078489,0.106700135834194,1.33229704312495e-20
NMR metabolomics,X23408.Triglycerides in VLDL,STX6,Syntaxin-6,39477,0.0616250792279871,0.00662667141693045,0.0486368032508034,0.0746133552051708,1.59343430297687e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MMP12,Macrophage metalloelastase,39900,0.0453415290919214,0.00487853481576214,0.0357796008530276,0.0549034573308152,1.67161942949354e-20
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.098511977824764,0.0106021838550796,-0.11929225818072,-0.0777316974688079,1.76301456127264e-20
NMR metabolomics,X23408.Triglycerides in VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0668881114124878,0.00720222278053512,0.0527717547626389,0.0810044680623366,1.78156771047615e-20
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0454534776873181,0.00489740327453785,0.0358545672692239,0.0550523881054123,1.93520279231916e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CCL20,C-C motif chemokine 20,40058,0.0756660752375757,0.00817908004040872,0.0596350783583746,0.0916970721167768,2.4917400610818e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0477033126543683,0.00516108112012338,0.0375875936589265,0.0578190316498101,2.75115702307448e-20
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE6,Ribonuclease K6,37386,0.0248379787267572,0.00268907937225494,0.0195673831571375,0.0301085742963769,2.91814241004052e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.03636447600438,0.00396143279017165,0.0286000677356436,0.0441288842731165,4.96161473127362e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PMM2,Phosphomannomutase 2,37021,0.0536628012921142,0.00585883736487001,0.042179480056969,0.0651461225272594,5.98662767762707e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0369939389812619,0.00404633292992921,0.0290631264386006,0.0449247515239231,6.82933644425006e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0299639519624161,0.0032768281419122,0.0235413688042682,0.036386535120564,6.87623535024226e-20
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0502942164503849,0.00550532999744213,0.0395037696553983,0.0610846632453714,7.28587055814782e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.105254965375566,0.0115441328842841,0.0826284649223696,0.127881465828763,8.7482471266918e-20
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0374493531418963,0.00412023665101946,0.0293736893058982,0.0455250169778945,1.13549839626324e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB8,Serpin B8,40058,0.04853091846682,0.00534705323708142,0.0380506941221404,0.0590111428114996,1.25118382551923e-19
NMR metabolomics,X23408.Triglycerides in VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0296081402643732,0.0032699342474216,0.0231990691394268,0.0360172113893195,1.52554955268532e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PAEP,Glycodelin,39749,-0.127313500965475,0.0140647349288972,-0.154880381426113,-0.0997466205048365,1.56405214693481e-19
NMR metabolomics,X23408.Triglycerides in VLDL,C5,Complement C5,37453,0.0134067862386355,0.00148108093204273,0.0105038676118318,0.0163097048654393,1.5917835697567e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CIT,Citron Rho-interacting kinase,37039,0.0398197418690955,0.0044105818132723,0.0311750015150818,0.0484644822231092,1.98411827232366e-19
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0416927330922886,0.00462144573759623,0.0326346994466,0.0507507667379772,2.06631196136161e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0649964859735792,0.00720800674210065,0.0508687927590619,0.0791241791880965,2.1890159700212e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0821187366763026,0.00911737922296856,0.0642486733992843,0.099988799953321,2.35331889059172e-19
NMR metabolomics,X23408.Triglycerides in VLDL,FSHB,Follitropin subunit beta,37043,0.0573960753880199,0.0063754647829053,0.0449001644135256,0.0698919863625143,2.50198596743186e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SMS,Spermine synthase,36991,0.056179420082865,0.00624588120696888,0.043937492917206,0.068421347248524,2.69158778867453e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0442814070686847,0.00492356150961256,0.0346312265098441,0.0539315876275253,2.71180896365774e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0373170555541924,0.00415370360791779,0.0291757964826735,0.0454583146257113,2.89591950821576e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.036852667831849,0.00410210271384771,0.0288125465127074,0.0448927891509905,2.95654386930476e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0273824034999073,0.0030517735793064,0.0214009272844667,0.0333638797153478,3.28242450355967e-19
NMR metabolomics,X23408.Triglycerides in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0325130861537153,0.00362515437429315,0.0254077835801007,0.0396183887273299,3.39922060666922e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0227867882645593,0.00254213084524996,0.0178042118078694,0.0277693647212492,3.54554241124635e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0424708331487162,0.0047444601329353,0.0331716912881631,0.0517699750092694,3.87917021888982e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0563051005191513,0.00629975842846804,0.0439575739993539,0.0686526270389486,4.49705472100289e-19
NMR metabolomics,X23408.Triglycerides in VLDL,KLK6,Kallikrein-6,39889,0.0256657932944439,0.00287261625235738,0.0200354654398235,0.0312961211490644,4.5215895853014e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CDH1,Cadherin-1,39315,0.0349736810154847,0.00391507914750696,0.027300125886371,0.0426472361445983,4.60314092057052e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CASP8,Caspase-8,39984,0.0534421826736582,0.00599030119275171,0.0417011923358648,0.0651831730114515,5.08793894346124e-19
NMR metabolomics,X23408.Triglycerides in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0793940549409376,0.00892312334406879,0.0619047331865628,0.0968833766953124,6.44517400617838e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.0184123112446146,0.00207147794399615,-0.0224724080148471,-0.0143522144743822,6.83735463823106e-19
NMR metabolomics,X23408.Triglycerides in VLDL,OMD,Osteomodulin,39931,-0.0374608901253205,0.00422396260306181,-0.0457398568273217,-0.0291819234233194,8.1681915425851e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.071481135530884,0.00806583747609314,0.0556720940777414,0.0872901769840265,8.65737232896379e-19
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0232486075824655,0.00262409452433529,-0.0283918328501626,-0.0181053823147683,8.85215254097539e-19
NMR metabolomics,X23408.Triglycerides in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0554427453020365,0.00628930228295036,0.0431157128274538,0.0677697777766192,1.31630339676989e-18
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0375658173468108,0.00426443787699813,0.0292075191078944,0.0459241155857271,1.38898146798618e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0402459162194277,0.00457734098165752,0.031274327895379,0.0492175045434765,1.60891339755067e-18
NMR metabolomics,X23408.Triglycerides in VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0312785973231068,0.00356074511680057,0.0242995368941777,0.038257657752036,1.76642201881796e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0975610792768585,0.0111214961026308,0.0757629469157021,0.119359211638015,1.95781373186019e-18
NMR metabolomics,X23408.Triglycerides in VLDL,S100A12,Protein S100-A12,39615,0.0635363039858922,0.00725483247248096,0.0493168323398295,0.0777557756319549,2.19058565372673e-18
NMR metabolomics,X23408.Triglycerides in VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0532336478421791,0.00608455809169314,0.0413079139824605,0.0651593817018976,2.36420072479018e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0619291140893182,0.0070784380528905,0.0480553755056528,0.0758028526729835,2.36520523060966e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0559271681988833,0.00640267167217892,0.0433779317214126,0.068476404676354,2.67463910228348e-18
NMR metabolomics,X23408.Triglycerides in VLDL,C7,Complement component C7,37149,-0.0272631530499147,0.00312150686737852,-0.0333813065099766,-0.0211449995898528,2.74994466365411e-18
NMR metabolomics,X23408.Triglycerides in VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0410149113885038,0.00469730168355775,0.0318082000887306,0.050221622688277,2.80375263856875e-18
NMR metabolomics,X23408.Triglycerides in VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0343599084390021,0.00394235196428859,-0.0420869182890077,-0.0266328985889964,3.17336486703753e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0343871711444275,0.00395395828590994,0.0266374129040441,0.042136929384811,3.80096716043845e-18
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.044605799310293,0.00513322840035827,0.0345446716455908,0.0546669269749952,3.98995077742077e-18
NMR metabolomics,X23408.Triglycerides in VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0493887021041503,0.00569126660020704,0.0382338195677445,0.0605435846405561,4.4970235825275e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0454082852489274,0.00523608261408179,0.035145563325327,0.0556710071725277,4.71542296644101e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CFC1,Cryptic protein,39477,0.0392835063574255,0.00453681185185416,0.0303913551277913,0.0481756575870596,5.2257945132285e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0256717849808237,0.00298257080457705,-0.0315176237577947,-0.0198259462038527,8.26212149143884e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI2,Serpin I2,37382,0.0479493685920182,0.00557529794031575,0.0370217846289994,0.0588769525550371,8.81588500527704e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0299081514230593,0.00348117550876129,0.0230850474258872,0.0367312554202315,9.52440656774849e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0310165862304024,0.00361193013190848,0.0239372031718618,0.038095969288943,9.73690227377958e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CD248,Endosialin,37437,-0.0330521197069835,0.00386301326783811,-0.0406236257119462,-0.0254806137020208,1.29218011462402e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DAPK2,Death-associated protein kinase 2,37056,0.044374988648178,0.00518925204224734,0.0342040546453732,0.0545459226509828,1.34974833679275e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0412401308913245,0.00482575462743181,0.0317816518215581,0.0506986099610908,1.41611307415584e-17
NMR metabolomics,X23408.Triglycerides in VLDL,RBP2,Retinol-binding protein 2,39788,-0.0633435126490995,0.00741560692092551,-0.0778781022141135,-0.0488089230840855,1.43805724168842e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LTA,Lymphotoxin-alpha,39866,0.0327511141677485,0.00383631004340309,0.0252319464826784,0.0402702818528185,1.49787597604766e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0218407737128864,0.00256096845077892,0.0168212755493597,0.0268602718764131,1.61740705703778e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0277646533091887,0.0032683031422962,0.0213587791502881,0.0341705274680893,2.18114841315056e-17
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0432736960572641,0.00509900205246835,0.0332796520344262,0.0532677400801021,2.3511780677582e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0449160868252647,0.00529707873578425,0.0345338125031276,0.0552983611474018,2.45966070458789e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DHPS,Deoxyhypusine synthase,37368,0.0337614133789789,0.00399112231494395,0.0259388136416888,0.041584013116269,2.9684158659248e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GRN,Progranulin,39787,0.0202861071299117,0.00240073411437148,0.0155806682657436,0.0249915459940798,3.16307611351869e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0239188247134154,0.00283029419940779,0.0183714480825761,0.0294662013442546,3.18130865040432e-17
NMR metabolomics,X23408.Triglycerides in VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0235530008709839,0.00279231214593017,-0.029025932677007,-0.0180800690649608,3.59250732728976e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0192193699447647,0.00227901657931484,0.0147524974493076,0.0236862424402218,3.64663536420838e-17
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0350212845329354,0.00415756532936663,0.0268724564873769,0.043170112578494,4.02916907770214e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CDH5,Cadherin-5,40052,-0.0248986464129775,0.00296228522815228,-0.030704725460156,-0.0190925673657991,4.62183543128524e-17
NMR metabolomics,X23408.Triglycerides in VLDL,APOA1,Apolipoprotein A-I,37453,-0.0223469405180057,0.0026597750473122,-0.0275600996107376,-0.0171337814252737,4.82909500281953e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0237430667824684,0.00283435205515871,0.0181877367543574,0.0292983968105795,5.88357908796811e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA11,Integrin alpha-11,39866,-0.027597433549285,0.00330422496498952,-0.0340737144806645,-0.0211211526179056,7.24559346460235e-17
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0356752715848588,0.00427351315112293,0.0272991858086578,0.0440513573610597,7.50477611623366e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR2,Folate receptor beta,40009,-0.0233803767540223,0.0028012937629271,-0.0288709125293594,-0.0178898409786852,7.60900127869896e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0630093337633314,0.00756268104980749,-0.0778321886209541,-0.0481864789057088,8.6147214948055e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0181451712932941,0.00218074253163833,0.013870915931283,0.0224194266553052,9.45093148781061e-17
NMR metabolomics,X23408.Triglycerides in VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0576853053113132,0.00693213698908507,0.0440983168127064,0.0712722938099199,9.53140003638857e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CASP9,Caspase-9,37056,0.0513676914341439,0.00617304647653093,0.0392685203401433,0.0634668625281445,9.55051591858954e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCN3,CCN family member 3,40042,0.0261483278847352,0.00314469718213249,0.0199847214077555,0.0323119343617149,9.89283108560518e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TEK,Angiopoietin-1 receptor,39913,0.0174858588799809,0.00210456303326038,0.0133609153347906,0.0216108024251713,1.04545733907933e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0526339120160111,0.00634653976885995,0.0401946940690456,0.0650731299629766,1.18718934536537e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SCT,Secretin,37039,0.0356623522552554,0.00430138323139176,0.0272316411217275,0.0440930633887832,1.23210697913398e-16
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0529712501980448,0.00638955454771055,0.0404477232845321,0.0654947771115574,1.23861456231081e-16
NMR metabolomics,X23408.Triglycerides in VLDL,KLK7,Kallikrein-7,36818,0.0315174336861333,0.00380571859029834,0.0240582252491485,0.038976642123118,1.33384882266842e-16
NMR metabolomics,X23408.Triglycerides in VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0317886825071702,0.00384770134589161,0.0242471878692226,0.0393301771451177,1.5473935322055e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0377974458130269,0.00457904905301427,0.028822509669119,0.0467723819569349,1.64722636643704e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.067466815254796,0.00819041733860803,0.0514135972711243,0.0835200332384677,1.9223460588208e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0276975089876101,0.00336450200538009,0.0211030850570652,0.0342919329181551,1.97777336207861e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB6,Integrin beta-6,39587,0.0236556694588513,0.00288320072768895,0.018004596032581,0.0293067428851216,2.49001886078685e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CA2,Carbonic anhydrase 2,39821,0.0541122215017792,0.00660151928036603,0.0411732437122618,0.0670511992912967,2.65163102782538e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SBSN,Suprabasin,37420,-0.0271129774517746,0.00330836575061836,-0.0335973743229866,-0.0206285805805626,2.72288672887894e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.019545653673725,0.00238564574176131,-0.0242215193275771,-0.0148697880198728,2.7793899901129e-16
NMR metabolomics,X23408.Triglycerides in VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0382707598939943,0.00467522493566044,0.0291073190200999,0.0474342007678888,2.90709862177962e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD59,CD59 glycoprotein,39173,0.0167885483727523,0.00205375085406972,0.0127631966987756,0.020813900046729,3.19978024821473e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD300A,CMRF35-like molecule 8,37124,0.0230372157801177,0.00281895391266513,0.0175120661112941,0.0285623654489414,3.29947890493844e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SPOCK1,Testican-1,39749,0.0201510054050888,0.0024664642636093,0.0153167354484146,0.0249852753617631,3.31417033173586e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0447475628790441,0.00548779405635753,0.0339914865285834,0.0555036392295049,3.82885603133875e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0176931359896451,0.00217204274013824,0.0134359322189741,0.0219503397603161,4.09313208572768e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL1,Chordin-like protein 1,39908,0.0242562768203695,0.00297853535875109,0.0184183475172174,0.0300942061235217,4.11356549011751e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.041486558780663,0.00509504026559822,-0.0514728377012355,-0.0315002798600905,4.15360399453837e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TXN,Thioredoxin,37289,0.034233361201019,0.0042062032367613,0.0259892028569668,0.0424775195450712,4.34209540842852e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.031623906131715,0.0038979116523102,0.0239839992931869,0.039263812970243,5.29248680228696e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0226403830884247,0.00279103196434276,-0.0281108057385365,-0.0171699604383129,5.34072752766729e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0216462906069975,0.00267010393091389,0.0164128869024063,0.0268796943115887,5.56522728624546e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0196557949520095,0.00242635561607044,0.0149001379445115,0.0244114519595076,5.84157960770986e-16
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0258437176783561,0.00318962025598773,0.0195920619766201,0.032095373380092,5.857738765989e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0579806909161399,0.00716877148271617,0.0439298988100163,0.0720314830222636,6.50966145172929e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GRSF1,G-rich sequence factor 1,36874,0.0634930410867479,0.00787526664571025,0.0480575184611558,0.0789285637123399,8.13583279368945e-16
NMR metabolomics,X23408.Triglycerides in VLDL,XG,Glycoprotein Xg,39985,0.0235304863542728,0.00292128862033306,0.01780476065842,0.0292562120501256,8.51107851277892e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0439964751771198,0.00546903341340551,0.033277169686845,0.0547157806673946,9.3856308619104e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD300E,CMRF35-like molecule 2,39991,0.0300298275829486,0.00373651457497305,0.0227062590160014,0.0373533961498957,9.85082904677995e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0376724082032964,0.00468816391912218,0.0284836069218169,0.0468612094847758,9.9654362748251e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DGCR6,Protein DGCR6,36991,0.0338850936252306,0.00422176527833839,0.0256104336796873,0.0421597535707738,1.0896508223164e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0324266580137045,0.00404032261678073,0.0245076256848142,0.0403456903425947,1.0939578315428e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0256807285143187,0.00320092880115185,-0.0319545489645763,-0.0194069080640611,1.11700814036043e-15
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0395324220222593,0.00492744031196524,0.0298746390108074,0.0491902050337111,1.11724193819588e-15
NMR metabolomics,X23408.Triglycerides in VLDL,BRK1,Protein BRICK1,39489,0.0347040712890338,0.00432934908167831,0.0262185470889444,0.0431895954891233,1.16918058088902e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0295070033588099,0.00369019048228007,0.0222742300135409,0.0367397767040788,1.38812525591303e-15
NMR metabolomics,X23408.Triglycerides in VLDL,PZP,Pregnancy zone protein,37453,0.0428423608056001,0.00536054324309477,0.0323356960491344,0.0533490255620659,1.43217829859194e-15
NMR metabolomics,X23408.Triglycerides in VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0178256945365378,0.0022312173173529,-0.0221988804785495,-0.0134525085945261,1.44912584759881e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO1,Roundabout homolog 1,39885,0.018308475838893,0.0022937164950698,0.0138127915085562,0.0228041601692299,1.53653950942274e-15
NMR metabolomics,X23408.Triglycerides in VLDL,MMP3,Stromelysin-1,39858,-0.0369724996647395,0.00463485919618282,-0.0460568236892579,-0.0278881756402212,1.59951321785628e-15
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0312161691027284,0.00391656039108193,0.0235397107362078,0.038892627469249,1.71286497813333e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0272364879274394,0.00342375562419568,0.0205259269040159,0.033947048950863,1.91111902888375e-15
NMR metabolomics,X23408.Triglycerides in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0206955372463242,0.00261174041244119,0.0155765260379394,0.0258145484547089,2.44891470636063e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0471582870650842,0.00596534922687735,0.0354662025804046,0.0588503715497638,2.87830397046344e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SNX5,Sorting nexin-5,37043,0.0234572702310918,0.00297015614550516,0.0176357641859017,0.029278776276282,3.06604847325089e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0254861474617534,0.00322960349755405,-0.0318161703169594,-0.0191561246065475,3.1834805408588e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0457066461557547,0.00580149182137323,0.0343357221858632,0.0570775701256463,3.52483772363953e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ALCAM,CD166 antigen,40052,0.0147444484146846,0.00188603910396094,0.0110478117709212,0.0184410850584481,5.70988171551018e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0911675742950382,0.0116729648669509,0.0682885631558144,0.114046585434262,6.14320609797002e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0710603653867937,0.00910080070832589,0.053222795998475,0.0888979347751125,6.16132252967521e-15
NMR metabolomics,X23408.Triglycerides in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0317742225662557,0.00407027473664,0.0237964840824413,0.0397519610500701,6.25624032784088e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GC,Vitamin D-binding protein,37453,0.0196229176869313,0.00251843266727084,0.0146867896590805,0.0245590457147822,7.08828984650396e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB2,Lamin-B2,37388,0.0206994708103961,0.00266464339748147,0.0154767697513324,0.0259221718694598,8.53253637458834e-15
NMR metabolomics,X23408.Triglycerides in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0279239343284443,0.00360493843632306,0.0208582549932511,0.0349896136636375,1.01529560731877e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0436749225847207,0.00564195285605472,0.0326166949868534,0.0547331501825879,1.04570415771243e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0407874199481682,0.00527506257733132,-0.0511265425997376,-0.0304482972965988,1.12034132477182e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0454295936756576,0.00588897013171627,0.0338872122174937,0.0569719751338215,1.28732804820843e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0338668348080854,0.00439434588306911,-0.0424797527389008,-0.0252539168772699,1.36413068980848e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0321890003392335,0.00418292774266727,-0.0403875387148613,-0.0239904619636056,1.4929697864555e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0316111611482379,0.00410719232243036,0.0235610641962744,0.0396612581002014,1.49428193349815e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0179753901741458,0.00233938941748973,0.013390186915866,0.0225605934324257,1.63425140787387e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0388360122230974,0.00506229572190942,-0.0487581118380399,-0.028913912608155,1.79586176207607e-14
NMR metabolomics,X23408.Triglycerides in VLDL,OSM,Oncostatin-M,39785,0.0532004293217329,0.00694729246659076,0.0395837360872151,0.0668171225562508,2.00097042997583e-14
NMR metabolomics,X23408.Triglycerides in VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0190209566932338,0.00248504554810246,0.014150267418953,0.0238916459675146,2.07715888462946e-14
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0601813711977517,0.00787014198169142,0.0447558929136365,0.0756068494818669,2.18015219639608e-14
NMR metabolomics,X23408.Triglycerides in VLDL,S100A13,Protein S100-A13,37056,0.0259073740141898,0.00338908402785943,0.0192647693195853,0.0325499787087943,2.24472288836948e-14
NMR metabolomics,X23408.Triglycerides in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0633778563275249,0.00829678061526445,0.0471161663216065,0.0796395463334432,2.31555091454335e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0188672575508231,0.00247023048988999,0.0140256057906388,0.0237089093110075,2.35974663185785e-14
NMR metabolomics,X23408.Triglycerides in VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0271448726886018,0.00356488264854529,0.020157702697453,0.0341320426797506,2.82687965914403e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CST5,Cystatin-D,39559,0.0401040591964188,0.00527350049059782,0.0297679982348471,0.0504401201579905,3.01402405136022e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0347333735890506,0.00456958389077988,0.025776989163122,0.0436897580149791,3.10551648416191e-14
NMR metabolomics,X23408.Triglycerides in VLDL,BAX,Apoptosis regulator BAX,39456,0.0676811054290232,0.00890505775163105,0.0502271922358264,0.0851350186222201,3.12210310314017e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0457102601912822,0.00603034851203239,0.0338907771076987,0.0575297432748657,3.67900255465884e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CX3CL1,Fractalkine,39749,-0.0243396226967737,0.00322458706603245,-0.0306598133461973,-0.0180194320473501,4.6543664833607e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.02661344095207,0.00352547853260586,0.0197035030281625,0.0335233788759775,4.67104053428971e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0242406390867106,0.0032149089535482,0.0179394175377561,0.030541860635665,4.99439231874862e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0324439728536462,0.00430845798987053,0.0239993951934999,0.0408885505137924,5.39186495538711e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.026987341713826,0.00358542085454331,0.0199599168389211,0.0340147665887309,5.47422717860722e-14
NMR metabolomics,X23408.Triglycerides in VLDL,EGFR,Epidermal growth factor receptor,40052,0.0117055525232668,0.00155866050094453,0.00865057794141554,0.0147605271051181,6.22002518364609e-14
NMR metabolomics,X23408.Triglycerides in VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0266503580906498,0.00354835947891359,0.0196955735119792,0.0336051426693204,6.25395571926342e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0474514879731809,0.00633481030347897,0.0350352597783622,0.0598677161679997,7.21206944916348e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CCN5,CCN family member 5,39858,0.0280164227026077,0.00374222025840264,0.0206816709961385,0.0353511744090768,7.43701533428411e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0460625101577503,0.00615592614633825,0.0339968949109274,0.0581281254045733,7.66359704853801e-14
NMR metabolomics,X23408.Triglycerides in VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0420746284201366,0.00562795502656725,-0.0531054202722084,-0.0310438365680648,8.05596669094657e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.041032758239453,0.00549155029196232,0.0302693196672068,0.0517961968116991,8.39773460031305e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0404434320758346,0.00541768352742033,0.0298247723620908,0.0510620917895785,8.74832324644689e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN8,Septin-8,37357,0.0231724236374055,0.0031062493310494,0.0170841749485487,0.0292606723262623,9.18477722165394e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CA9,Carbonic anhydrase 9,40030,-0.0313595239691128,0.00420647534318235,-0.0396042156417502,-0.0231148322964754,9.43714329673883e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0371193922253761,0.00498279883774144,0.0273531065034029,0.0468856779473493,9.85866289681824e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.017571403246923,0.0023603955753922,0.0129450279191543,0.0221977785746917,1.03532362215501e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CPQ,Carboxypeptidase Q,37430,0.0273822001883125,0.00367952496299031,0.0201703312608515,0.0345940691157735,1.05311665468691e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0390937918145273,0.00526478374346478,0.0287748156773363,0.0494127679517183,1.19021045247712e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PVALB,Parvalbumin alpha,39971,0.082300003581383,0.0110963424557128,0.0605511723681859,0.10404883479458,1.25895965334807e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0244151224269391,0.00329588688276272,0.0179551841367242,0.030875060717154,1.36070445179326e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CRYGD,Gamma-crystallin D,37388,0.0694501513289513,0.0093862707264009,0.0510530607052055,0.0878472419526971,1.45165506029992e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NPPB,Natriuretic peptides B,39585,-0.0910571507803839,0.0123103830429096,-0.115185501544487,-0.0669288000162811,1.46567219314703e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MPO,Myeloperoxidase,39858,0.032561842799867,0.00440771293943477,0.0239227254385748,0.0412009601611591,1.57028286823614e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CDH15,Cadherin-15,39973,0.0384934438402781,0.00521397820410427,0.0282740465602337,0.0487128411203224,1.62635039337215e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA12,Serpin A12,39405,0.0845381132849449,0.0114882981256269,0.0620210489587163,0.107055177611174,1.95096749110739e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0272704681341549,0.00370585346295425,0.0200069953467645,0.0345339409215452,1.96511305921274e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CA4,Carbonic anhydrase 4,40052,-0.0167445592574291,0.00227640537454671,-0.0212063137915406,-0.0122828047233175,1.99017145757832e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS1,Nephrin,37056,0.0245538901489562,0.00334024336603699,0.0180070131515238,0.0311007671463887,2.08420675398558e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0249749956293984,0.00340180372263066,0.0183074603330423,0.0316425309257545,2.21296876362724e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0360552603333062,0.00492251912017326,0.0264071228577666,0.0457033978088457,2.53612909920979e-13
NMR metabolomics,X23408.Triglycerides in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0428037856166626,0.0058456915356772,0.0313462302067353,0.0542613410265899,2.55682688197351e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SNX2,Sorting nexin-2,37368,0.0575188081433316,0.00785710663685528,0.0421188791350953,0.072918737151568,2.60798609527992e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0226539782892268,0.00310004825930326,0.0165778837009925,0.0287300728774612,2.84892377083086e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN8,Tetraspanin-8,37382,0.069737165133605,0.00954799053596819,0.0510231036831074,0.0884512265841027,2.95273970149346e-13
NMR metabolomics,X23408.Triglycerides in VLDL,S100A14,Protein S100-A14,37411,0.0362961668740777,0.00497803964701017,0.0265392091659377,0.0460531245822176,3.24096838670523e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0167720812107755,0.00231387568585835,-0.0213072775550578,-0.0122368848664931,4.40661981078939e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0123805146412921,0.00170887816150884,0.00903111344473473,0.0157299158378494,4.52742536590286e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0421398369870851,0.00581661674710594,0.0307392681627575,0.0535404058114128,4.53132403105194e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0255037333051031,0.00352037177321106,0.0186038046296094,0.0324036619805967,4.53687746710158e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0696002461153496,0.00961048775261489,0.0507636901202244,0.0884368021104748,4.66295433033254e-13
NMR metabolomics,X23408.Triglycerides in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0241727095601469,0.00334023855019246,0.0176258420017697,0.0307195771185241,4.80264091949077e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0207610751256917,0.00287068272361754,0.0151345369874013,0.0263876132639821,4.96998090865556e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FGA,Fibrinogen alpha chain,37149,0.0217277257174167,0.00300469438031323,0.0158385247320027,0.0276169267028306,5.04707979107924e-13
NMR metabolomics,X23408.Triglycerides in VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0597670094766422,0.00827418040460901,0.0435496158836085,0.0759844030696759,5.35035164198781e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAM,Integrin alpha-M,39858,-0.0220960967383989,0.00306727450303044,-0.0281079547643385,-0.0160842387124592,6.11573380091283e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0196324991972174,0.00272803069006258,-0.02497943934974,-0.0142855590446947,6.44788255862981e-13
NMR metabolomics,X23408.Triglycerides in VLDL,AHCY,Adenosylhomocysteinase,39868,0.0474044248119581,0.0065894397762561,0.0344891228504962,0.0603197267734201,6.5707480548327e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PKD1,Polycystin-1,37437,0.0183607539419551,0.00255409055515795,0.0133547364538455,0.0233667714300647,6.87969623610603e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0618360051343247,0.00860421718393433,0.0449717394538134,0.078700270814836,6.93014012012569e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NRP2,Neuropilin-2,39858,-0.0199106264753789,0.0027739552594866,-0.0253475787839726,-0.0144736741667852,7.4006061758047e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL17D,Interleukin-17D,39587,0.0235514580775368,0.00329429229020563,0.0170946451887338,0.0300082709663399,9.11436767651632e-13
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0420943340448992,0.00589490452486694,0.03054032117616,0.0536483469136384,9.7648640464301e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0194626361152212,0.00272761125230466,0.014116518060704,0.0248087541697383,1.00601905103983e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0271115852792432,0.00380181398548945,0.0196600298676839,0.0345631406908025,1.03812374508223e-12
NMR metabolomics,X23408.Triglycerides in VLDL,COPB2,Coatomer subunit beta',37021,0.0296951249221503,0.00416710320713557,0.0215276026361646,0.037862647208136,1.08643046669129e-12
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0370263589762608,0.00520128682284274,0.026831836803489,0.0472208811490326,1.14458296013265e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0283353635924279,0.00398915756463424,0.0205166147657448,0.036154112419111,1.27230282905676e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0478050531276807,0.00673289767985086,0.034608573675173,0.0610015325801884,1.30783509680185e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS4,Galectin-4,39862,0.0363374408084085,0.00512756065862813,0.0262874219174973,0.0463874596993196,1.43086804888175e-12
NMR metabolomics,X23408.Triglycerides in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0579181173925247,0.00818202124903045,0.041881355744425,0.0739548790406244,1.51697882221775e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.019377595405843,0.00274065070357638,-0.0247492707848527,-0.0140059200268333,1.60834194749997e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0338160711583167,0.0047822985013672,0.024442766095637,0.0431893762209964,1.61236699873461e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0247192997643457,0.00349997489175908,0.0178593489764979,0.0315792505521935,1.70129582476717e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO3,R-spondin-3,40030,0.0184693518040786,0.00261945496635858,0.0133352200700158,0.0236034835381414,1.85037912704593e-12
NMR metabolomics,X23408.Triglycerides in VLDL,THBS4,Thrombospondin-4,39892,0.0306199437980675,0.00434431367114574,0.0221050890026219,0.0391347985935132,1.88522428391564e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RCOR1,REST corepressor 1,39585,0.0308023788813792,0.00437081224789493,0.0222355868755052,0.0393691708872533,1.90013882986838e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0327463472437101,0.00464705350101236,0.0236381223817259,0.0418545721056944,1.90698566690062e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0167265092546949,0.00237446294438546,-0.0213804566256904,-0.0120725618836994,1.93851156766985e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0292237992418379,0.00415780849911494,-0.0373731039001031,-0.0210744945835726,2.16993491014751e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0159146591552797,0.00226505920847851,0.0114751431066618,0.0203541752038976,2.20780807374034e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD300C,CMRF35-like molecule 6,40009,0.0227160905596673,0.00323429679100566,0.0163768688492962,0.0290553122700384,2.25004026011419e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0532771565693759,0.00759186312425066,0.0383971048458446,0.0681572082929072,2.36634371244903e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD93,Complement component C1q receptor,39238,-0.0209746956158291,0.00299295445683472,-0.0268408863512252,-0.0151085048804331,2.51750762223672e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0286495664831721,0.00408846127419097,0.0206361823857578,0.0366629505805864,2.54222678422847e-12
NMR metabolomics,X23408.Triglycerides in VLDL,IL1B,Interleukin-1 beta,39478,0.0379232498583108,0.00542408091274746,0.0272920512693258,0.0485544484472958,2.82689162796286e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0314298998439174,0.00449896436948684,0.0226119296797232,0.0402478700081116,2.93912912989875e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0190609489095399,0.00272968948986818,0.0137107575093982,0.0244111403096815,3.03161751523542e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0224835546756712,0.0032208961252874,-0.0287965110812345,-0.0161705982701079,3.07786213471231e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0248778897311995,0.00356695676942846,0.0178866544631197,0.0318691249992793,3.21144424509845e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0280348105471479,0.00402001429459651,0.0201555825297387,0.035914038564557,3.23163918371517e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CPE,Carboxypeptidase E,39906,-0.0260822589641919,0.00375085302913638,-0.0334339309012992,-0.0187305870270846,3.69585971960741e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FABP6,Gastrotropin,39564,0.0365476483185249,0.00525827464548587,0.0262414300133725,0.0468538666236772,3.78313025741433e-12
NMR metabolomics,X23408.Triglycerides in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0375096302347256,0.00539851083429369,0.02692854899951,0.0480907114699412,3.87063915516055e-12
NMR metabolomics,X23408.Triglycerides in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0168827410603488,0.00243118554535935,0.0121176173914445,0.0216478647292532,3.97873728370727e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0236394268631941,0.00342074202598321,0.016934772492267,0.0303440812341212,5.04779243567465e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1,Programmed cell death protein 1,39998,0.0274933920747953,0.00397945612872892,0.0196936580624867,0.035293126087104,5.0692303559081e-12
NMR metabolomics,X23408.Triglycerides in VLDL,INSR,Insulin receptor,37056,0.0112109616164317,0.00162310296863127,0.0080296797979144,0.014392243434949,5.17267790171355e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CRH,Corticoliberin,39455,0.0583613760704662,0.00845853804302861,0.0417826415061301,0.0749401106348023,5.41182104485996e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.031700203573027,0.00460679655305633,0.0226708823290366,0.0407295248170174,6.16151940789375e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0789023765985393,0.0114686637094729,0.0564237957279724,0.101380957469106,6.21753182512054e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.035867187890928,0.0052144862694816,0.025646794802744,0.0460875809791119,6.32034758926179e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.026778507268549,0.0039032227148227,0.0191281907474965,0.0344288237896015,7.10787024675042e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CA6,Carbonic anhydrase 6,39817,-0.042386717569789,0.00618548385524757,-0.0545102659260743,-0.0302631692135038,7.51670494217492e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE3,Eosinophil cationic protein,39791,0.0715630381240951,0.0104564291730161,0.0510684369449836,0.0920576393032067,7.9860844780828e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0399788911814035,0.00584091945692313,0.0285306890458342,0.0514270933169729,8.0069144171772e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1A,Protein phosphatase 1A,39477,0.0203242769312974,0.00297049410525656,0.0145021084849945,0.0261464453776002,8.09680881779395e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0303629666632522,0.00444579142699571,0.0216492154663406,0.0390767178601638,8.88828675245524e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0238520894806491,0.00349461679435751,0.0170026405637084,0.0307015383975898,9.08063995635006e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0686763689024524,0.0100740873429474,0.0489311577102755,0.0884215800946292,9.68161046002037e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GPR15L,Protein GPR15L,37382,0.0406968164070696,0.00598360563498391,0.0289689493625012,0.0524246834516381,1.07971173197149e-11
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0376321160399639,0.00554026598705047,0.026773194705345,0.0484910373745828,1.14178442826162e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0395019416771049,0.00581933790136038,0.0280960393904386,0.0509078439637713,1.18405462185133e-11
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA1,Ephrin-A1,39826,0.0173857548806095,0.00256318723908819,0.0123619078919966,0.0224096018692224,1.2195131503037e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN1,Contactin-1,40052,-0.0175671951439672,0.00259027451805962,-0.0226441331993641,-0.0124902570885703,1.22638729549966e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0304883155413103,0.00449886244191381,0.0216705451551592,0.0393060859274613,1.27037884540935e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL3,Follistatin-related protein 3,39803,0.0197359961596503,0.00291434247708337,0.0140238849045669,0.0254481074147337,1.31429971971795e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0349250352356118,0.0051637183908024,0.0248041471896391,0.0450459232815845,1.40280964337833e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CCL21,C-C motif chemokine 21,39931,0.0257129429912586,0.00380565031087328,0.018253868381947,0.0331720176005703,1.4620155447955e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LY75,Lymphocyte antigen 75,39866,0.0253332147074021,0.00375810621874752,0.0179673265186569,0.0326991028961472,1.62727786307854e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0396263863297101,0.00588389056333283,0.0280939608255777,0.0511588118338424,1.71052708271377e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0167890497274915,0.00249330075685617,-0.0216759192109296,-0.0119021802440534,1.72091608513926e-11
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0234081009004001,0.00348964327471762,0.0165684000819536,0.0302478017188466,2.04467402166267e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LXN,Latexin,39682,-0.0435864236514493,0.00650013498139977,-0.0563266882149928,-0.0308461590879057,2.07562755227488e-11
NMR metabolomics,X23408.Triglycerides in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0277228868313446,0.00414063285744939,0.0196072464307438,0.0358385272319454,2.2389818260685e-11
NMR metabolomics,X23408.Triglycerides in VLDL,EDN1,Endothelin-1,37043,0.0183307699061118,0.00274002582232484,0.0129603192943551,0.0237012205178685,2.32182320960436e-11
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0215923913422776,0.00323385548132059,-0.027930748085666,-0.0152540345988892,2.51928224633265e-11
NMR metabolomics,X23408.Triglycerides in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0279388551509203,0.00418904335487486,0.0197283301753656,0.036149380126475,2.65219967324467e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0263224603678902,0.00394819485121956,0.0185839984594998,0.0340609222762805,2.69909734557121e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLU,Clusterin,37453,0.0206491615671682,0.00310496458456349,0.0145634309814238,0.0267348921529127,3.03531780274097e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0231450474247047,0.003488926542544,0.0163067514013185,0.029983343448091,3.39810104178037e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0169379155280261,0.00255563804004448,0.0119288649695389,0.0219469660865132,3.51883362352406e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CD209,CD209 antigen,39885,-0.025002274287585,0.00377921276590171,-0.0324095313087523,-0.0175950172664176,3.81417020664782e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.15397188338689,0.0233016817185756,0.108300587218482,0.199643179555298,4.04789007281393e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0311468838981731,0.00472050478781667,-0.0403990732822938,-0.0218946945140525,4.316137170165e-11
NMR metabolomics,X23408.Triglycerides in VLDL,MET,Hepatocyte growth factor receptor,39879,-0.0124708793691025,0.00189814559868017,-0.0161912447425156,-0.00875051399568933,5.18546812502608e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CTSH,Pro-cathepsin H,39546,0.0461943749396236,0.00703353487317462,0.0324086465882013,0.0599801032910458,5.26936291552549e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN3,Calsyntenin-3,37388,0.0192920153827962,0.00294843782116231,0.0135130772533181,0.0250709535122743,6.24126382458079e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0241184351599073,0.00368988968515916,0.0168862513769954,0.0313506189428193,6.53593541014083e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0162018403863431,0.00248457749382279,0.0113320684984504,0.0210716122742358,7.19486054153611e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CENPF,Centromere protein F,37169,0.0342807231005982,0.0052615167512807,0.023968150268088,0.0445932959331084,7.51206023683728e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LYZL2,Lysozyme-like protein 2,36962,0.022852988084325,0.00351425090090876,0.0159650563185439,0.0297409198501062,8.16194998287236e-11
NMR metabolomics,X23408.Triglycerides in VLDL,S100A11,Protein S100-A11,39703,0.0287118526276592,0.00441928146787741,0.0200500609506195,0.0373736443046989,8.44085016178331e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0339653061765301,0.00522810193458947,0.0237182263847347,0.0442123859683254,8.45465680920053e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0174192587212689,0.00269218088167562,0.0121425841931847,0.0226959332493531,1.00637876470208e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH1,Protocadherin-1,40018,0.0130540573350959,0.00202212226758779,0.00909069769062386,0.017017416979568,1.10846760113916e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CA7,Carbonic anhydrase 7,37169,-0.0211889681674461,0.00328350636393363,-0.027624640640756,-0.0147532956941361,1.13341511075218e-10
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0222380084031527,0.00345393317750973,-0.0290077174310718,-0.0154682993752337,1.24094599410428e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0168137566350788,0.00261919036735082,-0.0219473697550864,-0.0116801435150712,1.41354874931287e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0190325755579489,0.00296901213699913,-0.0248518393464672,-0.0132133117694306,1.50106757832901e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FCRLB,Fc receptor-like B,39477,0.0359649597034322,0.00563059948110098,0.0249289847204743,0.0470009346863902,1.73488429259937e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RALY,RNA-binding protein Raly,37368,0.0303035245845976,0.00474665333069313,0.021000084056439,0.0396069651127561,1.77943980412208e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CAT,Catalase,37252,0.0328501424487591,0.00515018374449037,0.0227557823095579,0.0429445025879602,1.84779768213047e-10
NMR metabolomics,X23408.Triglycerides in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0226870044105929,0.00356278050765979,0.0157039546155797,0.0296700542056061,1.97104504206212e-10
NMR metabolomics,X23408.Triglycerides in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0163203773924478,0.0025733254360975,0.0112766595376967,0.0213640952471989,2.32682195582179e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0261591594822336,0.00413234335572432,0.0180597665050139,0.0342585524594533,2.5109993163717e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0163464034047429,0.00258368428817575,0.0112823821999184,0.0214104246095674,2.56909598020733e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0249584301947425,0.0039482895934241,0.0172197825916313,0.0326970777978538,2.66359927415598e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0246307216127568,0.00389999083113219,0.0169867395837377,0.0322747036417758,2.76243528718697e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SHISA5,Protein shisa-5,37437,0.0140887245293769,0.00223492146584967,0.0097082784563115,0.0184691706024422,2.99224496868051e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM3,Myomesin-3,37124,-0.0575433766364032,0.00913706413531232,-0.0754520223416154,-0.0396347309311911,3.11431990124625e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RAB37,Ras-related protein Rab-37,39587,0.0510255749811586,0.00810737955904381,0.0351351110454328,0.0669160389168845,3.181573768676e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MDM1,Nuclear protein MDM1,37039,0.019177521820927,0.00304999784494784,0.0131995260448292,0.0251555175970248,3.32337475027677e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0279838201456663,0.00445804747202965,0.0192460471004882,0.0367215931908444,3.55667802847368e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0184804109836417,0.00294874452146824,0.0127008717215639,0.0242599502457194,3.77202563852785e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GM2A,Ganglioside GM2 activator,37178,0.0219992884869174,0.00352492111166785,0.0150904431080484,0.0289081338657863,4.47756871035543e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0371346533373281,0.0059527874318401,0.0254671899709215,0.0488021167037347,4.5618191453065e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ENSA,Alpha-endosulfine,37368,0.0319525565464255,0.00512365660754023,0.0219101895956467,0.0419949234972044,4.61451128894959e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0349313167334059,0.00560370449917113,0.0239480559150305,0.0459145775517813,4.67220206894045e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0189897535153378,0.00305584111732731,0.0130003049253763,0.0249792021052993,5.31227194030694e-10
NMR metabolomics,X23408.Triglycerides in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0232222775011993,0.00374686778887118,0.0158784166350118,0.0305661383673868,5.89684844760687e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LUZP2,Leucine zipper protein 2,37368,0.0264032994103911,0.00426211504026992,0.018049553931462,0.0347570448893201,6.00215600925026e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0094346705354441,0.00152375360997288,0.00644811345989726,0.0124212276109909,6.09424183346453e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0233223703144151,0.00377029094999343,0.015932600052428,0.0307121405764022,6.32863324199126e-10
NMR metabolomics,X23408.Triglycerides in VLDL,B2M,Beta-2-microglobulin,37453,0.0185395395577459,0.0030016634327432,0.0126562792295692,0.0244227998859226,6.74394141408163e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0111594652040781,0.00180819909465476,0.00761539497855481,0.0147035354296015,6.95270406262528e-10
NMR metabolomics,X23408.Triglycerides in VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0256006311125238,0.00415089419640416,-0.033736383737476,-0.0174648784875717,7.1406992735828e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ANPEP,Aminopeptidase N,39891,0.0167361141787901,0.00271499424750651,0.0114147254536773,0.0220575029039028,7.2477425550271e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ITM2A,Integral membrane protein 2A,39866,-0.035312391976549,0.00574966907979211,-0.0465817433729415,-0.0240430405801565,8.36039810814199e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0343271982831165,0.00559433131587862,0.0233623089039944,0.0452920876622386,8.65901291998594e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CST1,Cystatin-SN,35640,0.0602823701496005,0.00982735064190372,0.0410207628914692,0.0795439774077318,8.83650248420474e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PGA4,Pepsin A-4,37445,0.0370861899934623,0.00606488924844042,0.0251990070665191,0.0489733729204055,9.92660357748094e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL15,Interleukin-15,39866,0.019283877630111,0.00315712108112809,0.0130959203110999,0.025471834949122,1.03182718895813e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0193114233302447,0.00316764025260929,0.0131028484351305,0.0255199982253589,1.11464136435046e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0167530260963382,0.00274967049611839,0.0113636719239461,0.0221423802687302,1.13605158174413e-09
NMR metabolomics,X23408.Triglycerides in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.041718878364211,0.00684965580201869,0.0282935529922544,0.0551442037361676,1.15578910148138e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0213902524167454,0.00351333031443215,0.0145041250004584,0.0282763798330325,1.16713238114822e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0263230239486972,0.0043271762937598,0.017841758412928,0.0348042894844664,1.20998637774235e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0322546997631736,0.00530229413380777,0.0218622032609104,0.0426471962654369,1.21100140904583e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0122101489977793,0.00201202398868676,0.00826658197995326,0.0161537160156053,1.31960614792483e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0150579356089344,0.00248246744662218,0.0101922994135549,0.0199235718043139,1.3431591483928e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0152717397517738,0.00252196651034672,-0.0202147941120533,-0.0103286853914942,1.43686404288587e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0251315034403958,0.0041704068647168,-0.0333055008952407,-0.0169575059855508,1.71592904976374e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KLK4,Kallikrein-4,40030,-0.0351709059585069,0.00585114404238693,-0.0466391482815852,-0.0237026636354285,1.88407518042739e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CLC,Galectin-10,39841,-0.038893281336046,0.00647758835643472,-0.051589354514658,-0.0261972081574339,1.96337794671411e-09
NMR metabolomics,X23408.Triglycerides in VLDL,EPO,Erythropoietin,39866,0.0450525686489251,0.00750780528678353,0.0303372702868294,0.0597678670110209,2.00625770972257e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0281710879952079,0.00470754905243605,0.0189442918524332,0.0373978841379826,2.23049858415947e-09
NMR metabolomics,X23408.Triglycerides in VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0200867574004012,0.00336513247927648,0.0134910977410193,0.0266824170597831,2.445507824303e-09
NMR metabolomics,X23408.Triglycerides in VLDL,INSL3,Insulin-like 3,37388,0.0420819726948136,0.00706831403290712,0.0282280771903157,0.0559358681993116,2.68792010305397e-09
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX1,Heme oxygenase 1,39691,-0.027588359777029,0.00463720619849964,-0.0366772839260883,-0.0184994356279697,2.74884660812692e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IL34,Interleukin-34,39456,0.0206070667271163,0.00348205708424549,0.0137822348419952,0.0274318986122375,3.32563133209541e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0412726169920694,0.00699980463841309,0.0275529999007798,0.0549922340833591,3.8086400450175e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0129659969361641,0.00220691123631924,0.00864045091297836,0.0172915429593498,4.30672434297212e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CR1,Complement receptor type 1,37420,0.0204018768495006,0.00347573601423271,0.0135894342616045,0.0272143194373967,4.46517717853953e-09
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0238379387344969,0.00406599999500724,0.0158685787442827,0.0318072987247111,4.65862722837149e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GBP4,Guanylate-binding protein 4,39489,0.0278931143388303,0.00475827037646778,0.0185669044009535,0.0372193242767072,4.66459712344345e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0188381079369956,0.003217372610783,0.0125320576198609,0.0251441582541302,4.85897284352855e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PRTG,Protogenin,40030,0.0141462078557447,0.00242114105354512,0.00940077139079628,0.0188916443206932,5.23216115489639e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TNC,Tenascin,39931,-0.026728338918628,0.00457621385941758,-0.0356977180830865,-0.0177589597541696,5.29824433886245e-09
NMR metabolomics,X23408.Triglycerides in VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.0140542142136922,0.00240760401474442,-0.0187731180825913,-0.00933531034479317,5.40266087888868e-09
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.0300469183646963,0.00514822565163847,0.0199563960874849,0.0401374406419077,5.45990368426361e-09
NMR metabolomics,X23408.Triglycerides in VLDL,APOA4,Apolipoprotein A-IV,37453,0.0201193869353847,0.0034512887017074,0.0133548610800382,0.0268839127907312,5.68454192080282e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE1,Ribonuclease pancreatic,37445,0.0127241676275327,0.00218368946778353,0.00844413627067694,0.0170041989843884,5.77419167713331e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0177647403031317,0.00305699127357982,0.0117730374069153,0.0237564431993482,6.34648992887121e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0217318234885661,0.00374837345187899,0.0143850115228832,0.0290786354542489,6.85193988786078e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AZU1,Azurocidin,39344,0.043183052771436,0.00745837180318679,0.0285646440371899,0.0578014615056821,7.18026212080497e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0192748254095234,0.00332890557496729,-0.0257994803364593,-0.0127501704825876,7.18840527621072e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0201537182319756,0.00350379715604613,-0.027021160657826,-0.0132862758061252,8.98346622188702e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CA1,Carbonic anhydrase 1,39531,0.0331523702649735,0.00577443438075011,0.0218344788787033,0.0444702616512438,9.57302101912722e-09
NMR metabolomics,X23408.Triglycerides in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0434213287940297,0.00756271132446672,0.0285984145980749,0.0582442429899844,9.59094280955524e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0216230023640921,0.00376985165073298,0.0142340931286555,0.0290119115995288,9.91480042545544e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH1,Neurexophilin-1,39489,0.0209213196177527,0.00365494518914675,0.0137576270470251,0.0280850121884803,1.05883367388979e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0223108487955452,0.00389732899382692,0.0146720839676445,0.029949613623446,1.0591016719812e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EBI3_IL27,Interleukin-27,40011,-0.0171206237047959,0.00299391922530035,-0.0229887053863845,-0.0112525420232072,1.09391155207992e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0352037041942778,0.00615560676355352,0.0231387149377129,0.0472686934508427,1.09461084297221e-08
NMR metabolomics,X23408.Triglycerides in VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0307633482904296,0.00538132705513896,0.0202159472623573,0.041310749318502,1.10558591681161e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0527249418355546,0.00924921099002989,-0.0708533953760132,-0.034596488295096,1.21576230107438e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN2,Calsyntenin-2,40058,-0.0217994925591951,0.00383149503111644,-0.0293092228201833,-0.0142897622982069,1.29574288034463e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CABP2,Calcium-binding protein 2,37039,0.0364157385727832,0.00641522818473253,0.0238418913307074,0.0489895858148589,1.40416674080704e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0143818071867728,0.00253696062819071,-0.0193542500180266,-0.00940936435551907,1.46720817188259e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0269616520027607,0.00475754315246871,0.0176368674239221,0.0362864365815994,1.48167284459497e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0188559457354391,0.00333964866594157,0.0123102343501937,0.0254016571206846,1.66894405995966e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.013938475444017,0.00247170337021815,0.00909393683838946,0.0187830140496446,1.7368729660977e-08
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.026188446656454,0.00464932989430908,0.0170757600636082,0.0353011332492998,1.81006974792883e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TSHB,Thyrotropin subunit beta,39868,0.0408508852588101,0.0072845567201046,0.0265731540874051,0.0551286164302151,2.08211167770467e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0203467791018953,0.00363145113466862,0.0132291348779448,0.0274644233258458,2.14227903919591e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0383273505245471,0.00684379316068749,0.0249135159295996,0.0517411851194945,2.17582826319298e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CD276,CD276 antigen,39862,-0.0191511697773637,0.00342292366554548,-0.0258601001618328,-0.0124422393928946,2.24270384773854e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0204903416525106,0.00366897138132946,0.0132991577451049,0.0276815255599163,2.37824455885176e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0279961072898685,0.00501716515202599,0.0181624635918975,0.0378297509878394,2.44424621575145e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0139831504983485,0.00250605691966089,0.00907127893581314,0.0188950220608838,2.4548166423461e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IL6,Interleukin-6,39788,0.0383787538113928,0.00688110977184069,0.024891778658585,0.0518657289642005,2.48099546927114e-08
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0185124938282658,0.00332542185832525,0.0119946669859483,0.0250303206705833,2.6413550164144e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0193504399026349,0.00348767493625045,0.012514597027584,0.0261862827776857,2.93224695694769e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CLMP,CXADR-like membrane protein,40030,0.0110489630131712,0.00199187657563967,0.00714488492491744,0.0149530411014249,2.95149187926179e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D17,TBC1 domain family member 17,39489,0.0237443847346492,0.00428153109377956,0.0153525837908413,0.0321361856784572,2.97408494648132e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CST7,Cystatin-F,39882,0.0497685407163368,0.00897842575418448,0.0321708262381352,0.0673662551945384,3.01808707775997e-08
NMR metabolomics,X23408.Triglycerides in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0210924733439976,0.00381608220828118,0.0136129522157664,0.0285719944722287,3.31301349597677e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0174678536681658,0.00316059672252322,0.0112730840920203,0.0236626232443113,3.32214366352507e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CYTL1,Cytokine-like protein 1,37437,0.0123127729828171,0.0022321201963093,0.00793781739805085,0.0166877285675833,3.52788507071144e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS53,Serine protease 53,37388,0.0200381552822715,0.00363754028260777,0.0129085763283603,0.0271677342361827,3.68073988464007e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0139608256310056,0.00253816076749673,0.008986030526712,0.0189356207352992,3.84778151676041e-08
NMR metabolomics,X23408.Triglycerides in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0363770945856642,0.0066196029491223,0.0234026728053845,0.0493515163659439,3.97201315098272e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SYT1,Synaptotagmin-1,37388,0.0198294232981563,0.00361132563299247,0.0127512250574911,0.0269076215388215,4.07104979318287e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.022166271711614,0.00404256770365305,0.014242839012454,0.030089704410774,4.2398952958456e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DSG3,Desmoglein-3,39964,0.0177775066111225,0.0032424424867596,0.0114223193370737,0.0241326938851713,4.25060311409711e-08
NMR metabolomics,X23408.Triglycerides in VLDL,OLFM4,Olfactomedin-4,36654,0.0658785489545909,0.0120164002206963,0.0423264045220261,0.0894306933871556,4.27582828468747e-08
NMR metabolomics,X23408.Triglycerides in VLDL,AMPD3,AMP deaminase 3,37388,0.0378462815622045,0.0069068801159878,0.0243087965348684,0.0513837665895406,4.34147554880414e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CLGN,Calmegin,37039,0.0232766879003513,0.00425695005965328,0.0149330657834309,0.0316203100172717,4.63625009874604e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0160811213191363,0.00294413924683715,0.0103106083953355,0.0218516342429371,4.77548901160844e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LCP1,Plastin-2,37437,0.0249882272269693,0.00457841614609361,0.0160145315806259,0.0339619228733128,4.90440719581896e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.0139025182932308,0.00254864629856121,0.00890717154805079,0.0188978650384107,4.97346356014812e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR1,Cadherin-related family member 1,39489,0.0223661537697959,0.00415732808556117,0.014217790722096,0.0305145168174958,7.55857684711211e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0267767670141745,0.00498457814671242,0.0170069938466182,0.0365465401817308,7.90192244100624e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0232201842285412,0.00432832626492251,-0.0317037037077893,-0.0147366647492931,8.24553207056401e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MBL2,Mannose-binding protein C,37257,-0.0562318185352152,0.0104819930619175,-0.0767765249365735,-0.0356871121338568,8.24726944389311e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN10,Ataxin-10,39489,0.0381323879305467,0.00712296171140836,0.0241713829761863,0.0520933928849071,8.75138883465705e-08
NMR metabolomics,X23408.Triglycerides in VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0357766718146225,0.00668437663920285,0.0226752936017849,0.0488780500274601,8.83068412743085e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0212683104655449,0.00397585675557718,0.0134756312246136,0.0290609897064761,8.94773514245973e-08
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0274311526032318,0.00513694799770405,0.0173627345277318,0.0374995706787317,9.42537655591051e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LPA,Apolipoprotein(a),37186,-0.091524982915511,0.0171547621113657,-0.125148316653788,-0.0579016491772342,9.6973118980057e-08
NMR metabolomics,X23408.Triglycerides in VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0326619140085034,0.00612804685226625,-0.0446728858389452,-0.0206509421780615,9.96095412399388e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0264714358730248,0.00496984366597289,0.0167305422877179,0.0362123294583317,1.01560007208419e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LTB,Lymphotoxin-beta,37368,0.0177285210457195,0.00333279229747261,0.0111962481426732,0.0242607939487658,1.0575971270219e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0186118402019888,0.00350411423004002,0.0117437763111104,0.0254799040928673,1.10537734289847e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CD7,T-cell antigen CD7,37037,0.0220473522492411,0.00417569736718152,0.0138629854095653,0.0302317190889169,1.31293309742172e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0144056305482851,0.00272858607256008,0.00905760184606739,0.0197536592505029,1.31521677267562e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0262414812616813,0.00497448039787277,0.0164914996818507,0.035991462841512,1.34644500312647e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SNX18,Sorting nexin-18,37382,0.0232562654450565,0.0044103350099239,0.0146120088256056,0.0319005220645073,1.36183338757856e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HYAL1,Hyaluronidase-1,39747,0.0116836586114881,0.00221868345295738,0.00733503904369165,0.0160322781792846,1.41220411732165e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DSG4,Desmoglein-4,39725,0.0251119805661624,0.00476982970632372,0.0157631143417679,0.0344608467905569,1.42207218720023e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0146480038436929,0.00278458186207306,0.00919022339402967,0.0201057842933561,1.45629803326021e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0269892452531812,0.00513167261442249,0.0169311669289131,0.0370473235774493,1.46774947266678e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KLK14,Kallikrein-14,40030,-0.0229972784272928,0.00439049866219094,-0.0316026558051871,-0.0143919010493986,1.64392545688397e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN2,Prefoldin subunit 2,39489,0.0284085797140061,0.00543435990613049,0.0177572342979903,0.0390599251300219,1.73949376847934e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0265007155237601,0.005073703464188,0.0165562567339516,0.0364451743135686,1.7814774405872e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA1,Annexin A1,37072,0.0222477468891845,0.00426802588036167,0.0138824161636757,0.0306130776146934,1.88963384228389e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SATB1,DNA-binding protein SATB1,37411,0.0152513561128286,0.00292597538738476,0.00951644435355452,0.0209862678721028,1.89151553889102e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HMBS,Porphobilinogen deaminase,40030,0.0217431156408365,0.00418055151105612,0.0135492346791665,0.0299369966025065,2.00619652060704e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CA12,Carbonic anhydrase 12,39788,-0.0160858377825077,0.00309631320030955,-0.0221546116551144,-0.010017063909901,2.07067625137622e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0135380457736536,0.00260805065739818,0.00842626648515317,0.018649825062154,2.12342975666828e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0158154376546913,0.00306375803402044,-0.0218204034013713,-0.00981047190801119,2.47747880219795e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MUC16,Mucin-16,39788,0.0931862280266082,0.0180816796036195,0.0577461360035139,0.128626320049703,2.58549833164012e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.016378100430151,0.00318393924401874,-0.0226186213484277,-0.0101375795118743,2.72823134179401e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0155563891366954,0.00303116128411637,-0.0214974652535635,-0.00961531301982732,2.89788455451542e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0157515048191505,0.00307545297662693,0.00972361698496171,0.0217793926533393,3.06335612426471e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.0119246670441519,0.00233390518272515,-0.0164991212022932,-0.00735021288601059,3.27058207819896e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0298749434077143,0.00585203983744614,0.0184049453263199,0.0413449414891088,3.34528866153985e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0106652026130589,0.00208938748060215,-0.0147604020750391,-0.00657000315107863,3.35603385069373e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ICOSLG,ICOS ligand,39788,0.00935038750318392,0.00183238557467749,0.00575891177681603,0.0129418632295518,3.38425339477087e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KLK8,Kallikrein-8,39315,0.0172608895278428,0.00338305502926069,0.0106301016704918,0.0238916773851938,3.39776569120806e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CALB1,Calbindin,39788,0.0207437819120152,0.00407307302322423,0.0127605587864957,0.0287270050375347,3.56639618024671e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRC1,Macrophage mannose receptor 1,37445,0.0136646980565465,0.00268612800788089,0.00839988716109992,0.018929508951993,3.68358789228344e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI1,Neuroserpin,37088,0.0152365740508715,0.00300738519690876,0.00934209906493035,0.0211310490368127,4.10905206483371e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.0113084321619925,0.00223462166754885,0.00692857369359672,0.0156882906303882,4.22698162920768e-07
NMR metabolomics,X23408.Triglycerides in VLDL,APOB,Apolipoprotein B-100,37445,0.0111836489737864,0.00221024858156586,0.00685156175391729,0.0155157361936554,4.24942381941728e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0134301217882503,0.00265440492816185,0.00822748812905312,0.0186327554474476,4.24990113216428e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0246156175586917,0.00488123113045844,0.0150484045429932,0.0341828305743903,4.63618874185867e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SDC1,Syndecan-1,39868,0.0194799682433803,0.00386559511978446,0.0119034018086027,0.0270565346781578,4.72283000315705e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0206803371858706,0.00410532106524893,0.0126339078979827,0.0287267664737585,4.77009610029545e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TFF3,Trefoil factor 3,39839,0.0237164708611337,0.00471630430708115,0.0144725144192546,0.0329604273030127,4.99390201994831e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0348891766970959,0.00694436965492327,0.0212782121734463,0.0485001412207455,5.12370661973968e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF7,SLAM family member 7,39866,-0.0281800781715601,0.00561494941547795,-0.0391853790258969,-0.0171747773172233,5.25643831713918e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0298899450364661,0.005973075191282,0.0181827176615534,0.0415971724113789,5.67258398203828e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0193326187542371,0.00386333219492809,0.0117604876521781,0.0269047498562962,5.68382290118897e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0253909110194763,0.00508730049808058,0.0154198020432383,0.0353620199957142,6.06796348017391e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0148165710773009,0.0029781851613684,-0.020653813993583,-0.00897932816101884,6.59251719753921e-07
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0233280221506426,0.00470118908478171,0.0141136915444705,0.0325423527568148,7.04491142650769e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0185000793300954,0.00374536666914843,0.0111591606585644,0.0258409980016263,7.91497222987197e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0128833541505788,0.00261029956079895,0.00776716701141285,0.0179995412897447,8.08592843191184e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GDF15,Growth/differentiation factor 15,40052,0.0203194495956314,0.0041257210834696,0.012233036272031,0.0284058629192318,8.51633263040113e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0117797958149154,0.00240078601271389,0.00707425522999619,0.0164853363998346,9.35603859057453e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0120550527277391,0.00247037688722551,0.00721311402877705,0.0168969914267011,1.07192513465521e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0141047829639427,0.0028916413330372,0.00843716595118979,0.0197723999766956,1.08548497945989e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0341609956721866,0.0070188704613653,0.0204040095679106,0.0479179817764626,1.14568658737048e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.012463360781153,0.00256124486153991,-0.0174834007097712,-0.00744332085253474,1.15127231415254e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0208220780026899,0.00429346032933788,0.0124068957571877,0.0292372602481922,1.24798040168921e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0305592691071181,0.00630450999260846,0.0182024295216055,0.0429161086926307,1.26624807321866e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.013069420309475,0.00269762153643904,-0.0183567585208955,-0.00778208209805445,1.28171188300424e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MATN3,Matrilin-3,39720,-0.0147551144275571,0.00304829415383406,-0.0207297709690718,-0.00878045788604229,1.30765362331736e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0173150011769154,0.00359202639074794,0.0102746294510495,0.0243553729027814,1.44830601642157e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0276535976892943,0.00574998505619709,0.016383626979148,0.0389235683994406,1.53092544461277e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0141389113693131,0.00294257935247135,0.00837145583846927,0.019906366900157,1.56216697722386e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0202552492471697,0.00421924785275387,0.0119855234557722,0.0285249750385673,1.59849297926488e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0132276268437816,0.00276198154209705,0.0078141430212714,0.0186411106662918,1.69248599148069e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR1,Folate receptor alpha,39809,0.0127555672769193,0.00266488751468163,0.00753238774814328,0.0179787468056953,1.71210015969962e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.0166732873355973,0.00348520539874261,0.00984228475406183,0.0235042899171329,1.73632019221192e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EGFLAM,Pikachurin,37382,0.0142865718677107,0.00298961868206417,0.0084269192508649,0.0201462244845565,1.78263480466546e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0205259870106744,0.00430079460539596,0.0120964295840984,0.0289555444372505,1.83815033720378e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0131923312633965,0.00276813423382638,0.00776678816509681,0.0186178743616962,1.9012640916571e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NEFL,Neurofilament light polypeptide,39438,0.0201165795065407,0.00423281413621418,0.0118202637995609,0.0284128952135205,2.02680370310414e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRUNE2,Protein prune homolog 2,37169,0.0131857022692745,0.00278118947608349,0.00773457089615083,0.0186368336423981,2.14838157247225e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0138180881810626,0.00292077210393546,0.00809337485734911,0.0195428015047761,2.25404539041259e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0283247621836161,0.00599173138922729,0.0165809686607307,0.0400685557065016,2.29884083442401e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BLVRB,Flavin reductase,39858,0.0296285544841152,0.00627659835097069,0.0173264217162126,0.0419306872520177,2.37282628984557e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0168432027629073,0.00356989216230631,0.00984621412478692,0.0238401914010277,2.40014306557526e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LIF,Leukemia inhibitory factor,39489,0.0235679839280794,0.00500066415236981,0.0137666821894345,0.0333692856667242,2.46235623627889e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0302524081245772,0.0064229699015348,-0.0428414291315854,-0.017663387117569,2.50137054339469e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0178104228604828,0.00378528779421482,0.0103912587838217,0.0252295869371438,2.55826961707116e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0323122107813017,0.0068678765450921,-0.0457732488096822,-0.0188511727529212,2.5658996017753e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PMS1,PMS1 protein homolog 1,37039,0.0227892415034762,0.00485249106968101,0.0132783590069014,0.032300124000051,2.67458015301706e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOSB,Protein fosB,39489,0.0178276173884044,0.00380405367279784,0.0103716721897206,0.0252835625870882,2.80289803469864e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRL,Prolactin,40009,-0.0344432364676006,0.0073793741231558,-0.048906809748986,-0.0199796631862152,3.07335155231234e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0139573852206282,0.00300279959805621,-0.0198428724328184,-0.00807189800843802,3.38183645759125e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0152906322431545,0.00329473671426518,-0.0217483162031142,-0.00883294828319474,3.50205436251638e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0436475079330528,0.00943322896129536,0.0251583791689139,0.0621366366971917,3.74542559815204e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0637241148044133,0.0137742965251517,0.036726493615116,0.0907217359937107,3.7523206760492e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3D,Protein FAM3D,37382,0.0376331656316471,0.00814198504917958,0.0216748749352551,0.0535914563280391,3.83365974012053e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PSPN,Persephin,39866,0.0423254989240123,0.00916986053860494,0.0243525722683466,0.0602984255796779,3.94779440438501e-06
NMR metabolomics,X23408.Triglycerides in VLDL,C8B,Complement component C8 beta chain,37453,0.0136442738419692,0.00295768675935605,0.0078472077936314,0.0194413398903071,4.00219588135641e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY2,Protein canopy homolog 2,39585,0.0270402159888158,0.00586545321983381,0.0155439276779415,0.0385365042996901,4.05679024836586e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MSLN,Mesothelin,39766,0.0233683324915314,0.00510448614172449,0.0133635396537514,0.0333731253293114,4.73000141727144e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0112136439049839,0.00245157924766635,0.0064085485795578,0.0160187392304099,4.81939428396604e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.015083918848639,0.00330248667941809,0.00861104495697958,0.0215567927402985,4.97411288487296e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.0140867780453014,0.00308490767018961,0.00804035901172978,0.0201331970788731,4.99980349464054e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MILR1,Allergin-1,39587,-0.0219004436886844,0.00481807487144973,-0.0313438704367258,-0.0124570169406429,5.52197359756995e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0147847389073085,0.00325865132638454,0.00839778230759483,0.0211716955070222,5.75441951941355e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0306716964687426,0.00678080670338243,-0.0439620776073722,-0.0173813153301131,6.13171736089096e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PROCR,Endothelial protein C receptor,37021,-0.0161085246806156,0.00356542134930718,-0.0230967505252577,-0.00912029883597351,6.29740195083302e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0249238731974923,0.00552536492407536,0.0140941579463046,0.03575358844868,6.50395777146723e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KLK11,Kallikrein-11,39779,0.0127712451160599,0.00283211297150632,0.0072203036919075,0.0183221865402123,6.54629571866336e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.0148118607671992,0.00328893665830985,-0.0212581766174865,-0.00836554491691188,6.73875121127478e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CASP1,Caspase-1,39489,0.0293048213034448,0.00651172073830965,0.0165418486563579,0.0420677939505317,6.83412453637999e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IFNG,Interferon gamma,39587,0.0500059731781724,0.0111309895356876,0.0281892336882248,0.07182271266812,7.089336383912e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.012351866523369,0.00276146630494174,-0.0177643404810548,-0.00693939256568322,7.76850108750581e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN1,Calsyntenin-1,39489,0.0218932556315268,0.00490348176152543,0.012282431378937,0.0315040798841167,8.06900983323128e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.024637875707882,0.0055208359855058,0.0138170371762907,0.0354587142394734,8.16007530618787e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0218676283178804,0.00491004559853246,0.0122439389447568,0.031491317691004,8.50993234502124e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN3,Perilipin-3,39868,0.01860094058887,0.00417917864341295,0.0104097504477806,0.0267921307299594,8.61045761966375e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAP,Cartilage-associated protein,37039,0.0214516025506244,0.0048201339084942,0.0120041400899758,0.0308990650112731,8.64071879145751e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2,Ataxin-2,36991,0.0483250196994757,0.0108621951156241,0.0270351172728526,0.0696149221260989,8.70135948803595e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CPA4,Carboxypeptidase A4,36868,0.0189134648495696,0.00425675479158552,0.010570225458062,0.0272567042410773,8.93773679551584e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0256124120855882,0.00576517152382942,0.0143126758988826,0.0369121482722939,8.95794991620351e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0164110267467665,0.00369823039795548,-0.0236595583267592,-0.00916249516677372,9.17360042105281e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DCN,Decorin,39585,-0.00938006978941956,0.00211500322474923,-0.0135254761099281,-0.00523466346891107,9.2690552926465e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GPC1,Glypican-1,40030,0.0124831308529964,0.0028210995564451,0.00695377572236402,0.0180124859836288,9.71102262877324e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0168970645637798,0.00382048917265129,0.00940890578538331,0.0243852233421764,9.82336528204393e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0384993288715441,0.00872371769513378,0.0214008421890819,0.0555978155540064,1.0252790154638e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FGF16,Fibroblast growth factor 16,37056,0.0207828180029892,0.00471503333370825,0.011541352668921,0.0300242833370573,1.05261517588185e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CR2,Complement receptor type 2,39931,0.0194313983094255,0.00441035740709317,0.0107870977915229,0.0280756988273281,1.06048859475371e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GZMB,Granzyme B,39866,0.0274706601066099,0.0062361858826791,0.0152477357765589,0.039693584436661,1.06450063720405e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0256356848210265,0.00583460662904275,0.0141998558281027,0.0370715138139502,1.12271429092927e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SNU13,NHP2-like protein 1,37021,0.0264649677633888,0.00603967606620612,0.0146272026736248,0.0383027328531528,1.18585626209824e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0139436779825516,0.00319264987327414,0.00768608423093431,0.0202012717341689,1.26506317050492e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.012473581640676,0.00285680030463192,0.00687425304359745,0.0180729102377546,1.27207281757953e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MUC2,Mucin-2,37437,0.0384340791843844,0.00880225258180972,0.0211816641240373,0.0556864942447314,1.27251198607508e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLASP1,CLIP-associating protein 1,36962,0.0311930785225388,0.00714587037063597,0.0171871725960923,0.0451989844489853,1.27985999607434e-05
NMR metabolomics,X23408.Triglycerides in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0175443906808024,0.00402495821531275,0.00965547257878938,0.0254333087828154,1.31707935051087e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0188853096977298,0.00433289030270179,0.0103928447044343,0.0273777746910253,1.31866621812619e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DSC2,Desmocollin-2,39673,-0.0140439432949551,0.00324282709026586,-0.0203998843918762,-0.00768800219803405,1.49502727823308e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN1,Tetraspanin-1,39585,0.0170004888724076,0.00392928316682058,0.0092990938654393,0.024701883879376,1.52353615138759e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRELP,Prolargin,39862,0.00933281923129549,0.00215836526425133,0.00510242331336289,0.0135632151492281,1.54136595741917e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NEO1,Neogenin,37411,0.00910352389518513,0.00210789524766458,0.00497204920976256,0.0132349985806077,1.58014027806671e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN4,Contactin-4,39858,-0.0100106418471255,0.00232315446550848,-0.0145640245995221,-0.0054572590947289,1.64919170175446e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SPARCL1,SPARC-like protein 1,39871,-0.0113794061055971,0.00264948129987355,-0.0165723894533493,-0.00618642275784498,1.75757220721414e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD1,Leiomodin-1,37411,-0.0146986859374828,0.00343650486641036,-0.0214342354756471,-0.00796313639931845,1.90539241930218e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0158935904511765,0.00372254170385712,0.00859740871161653,0.0231897721907365,1.96998737948588e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0417769000881408,0.00978687842166625,0.022594618381675,0.0609591817946067,1.98022290755877e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CHAD,Chondroadherin,37124,0.020926053467747,0.00492176749701882,0.0112793891735901,0.0305727177619039,2.13572292421795e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CDH3,Cadherin-3,40009,0.0143350749784479,0.0033719748018137,0.00772600436689303,0.0209441455900027,2.13784125355963e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0351078614498581,0.00826258113173354,0.0189132024316604,0.0513025204680559,2.1595281353322e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ACAN,Aggrecan core protein,39730,0.0116217542696831,0.00274145029579238,0.00624851168993001,0.0169949968494361,2.25513628879909e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0434024687002914,0.0102641698501781,0.0232846957939424,0.0635202416066404,2.36523585478798e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0244770049809361,0.00579090977251525,0.0131268218268062,0.035827188135066,2.38590303821862e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0145726824097013,0.00345492961951435,0.00780102035545321,0.0213443444639494,2.47904110210493e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0214843183118857,0.00511185391096005,0.011465084646404,0.0315035519773674,2.65049377014946e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ARTN,Artemin,39587,0.0182737705913494,0.00436164590597384,0.00972494461564063,0.0268225965670581,2.80909131021832e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0171092931590442,0.00408561024670989,0.00910149707549283,0.0251170892425956,2.83299741359317e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NTF4,Neurotrophin-4,39477,0.0162126891760946,0.00387175030952672,0.00862405856942224,0.023801319782767,2.83676166542232e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.0171014896990931,0.00408729173118109,-0.0251125814922081,-0.00909039790597821,2.88151195893245e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0154418187215869,0.00369242967617053,0.00820465655629269,0.0226789808868812,2.90795627679102e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.018771868808133,0.00449679477924116,0.00995815104082038,0.0275855865754457,3.00541203003743e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BCAM,Basal cell adhesion molecule,39858,-0.00955984775502151,0.00229218670053893,-0.0140525336880778,-0.00506716182196521,3.05368564380983e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0135895093215307,0.00325878117983701,0.00720229820905012,0.0199767204340112,3.06056061120509e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PI3,Elafin,39594,0.0214418721123296,0.00515714630251092,0.0113338653594082,0.031549878865251,3.23169203757882e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0113860923337824,0.00273910380264567,-0.016754735786968,-0.00601744888059694,3.24304293996783e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0140931011549142,0.00339279395511363,0.0074432250028915,0.0207429773069369,3.2862790356203e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00966708008301774,0.00233943611962579,0.00508178528855119,0.0142523748774843,3.61084355269527e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.01610533266708,0.00390123321120264,0.00845891557312284,0.0237517497610372,3.67405934994665e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SPON1,Spondin-1,39885,0.0127430934553677,0.00309966687254486,0.00666774638517973,0.0188184405255556,3.95711181529045e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0147305879589617,0.00358848970695021,-0.0217640277845841,-0.00769714813333927,4.06763811768173e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.0070207359832363,0.00171724498861411,0.00365493580555263,0.01038653616092,4.36910596623522e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD55,Complement decay-accelerating factor,39315,0.0101030072988018,0.00247216703576028,0.00525755990871163,0.0149484546888919,4.39760466441682e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0269338352683575,0.00659178801604221,0.0140139307569148,0.0398537397798003,4.4146952310507e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.0083344046887645,0.00204521796793405,-0.0123430319059152,-0.00432577747161377,4.62701922342446e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM2,Myomesin-2,37021,-0.0204794012938673,0.00502678175545225,-0.0303318935345537,-0.0106269090531809,4.64718247660151e-05
NMR metabolomics,X23408.Triglycerides in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0346042354085505,0.00850151331954919,0.0179412693022341,0.051267201514867,4.72144506492011e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0131070307817519,0.00322607821711861,-0.0194301440873043,-0.00678391747619941,4.87611194906184e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00876616274154055,0.00216510042793953,0.00452256590277906,0.013009759580302,5.17129453051835e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MTPN,Myotrophin,39585,0.0127570055729656,0.00315814466756813,0.00656704202453211,0.0189469691213992,5.38428895833694e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.01630878504744,0.00403843340195111,0.0083934555796158,0.0242241145152642,5.4115746182737e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.00996703529348147,0.00246946925131075,0.0051268755609124,0.0148071950260505,5.45995604917895e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0242591185493548,0.00602180617142096,0.0124563784533697,0.0360618586453399,5.64391058034006e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK2,Protein AHNAK2,37043,0.0115362831270646,0.002865619533286,0.00591966884182403,0.0171528974123052,5.71104288580654e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0730678173515834,0.01818080437685,0.0374334407729574,0.108702193930209,5.87256913583471e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0109887247941762,0.00273874481951314,-0.016356664640422,-0.00562078494793046,6.0399991083343e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.031406991930911,0.00783828069011777,0.0160439617782802,0.0467700220835419,6.18053461407444e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0274792420146558,0.0068605591980675,0.0140325459864435,0.0409259380428681,6.22447360352155e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL,Podocalyxin,39788,0.00585353663273877,0.00146194880930889,0.00298811696649336,0.00871895629898419,6.25820086901084e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VWF,von Willebrand factor,40052,-0.0284433870022888,0.00711080348559884,-0.0423805618340625,-0.0145062121705151,6.361740754122e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0111534204476658,0.00280094838929709,0.00566356160464347,0.0166432792906881,6.86906492437416e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.0123953928054234,0.00312799005122347,-0.0185262533058214,-0.00626453230502537,7.4486848863782e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.0103859496877605,0.00262371306734563,0.00524347207576305,0.0155284272997579,7.58084806591336e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.0097529132193788,0.00246437977859713,-0.0145830975854292,-0.00492272885332843,7.60446708836748e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0102685259376944,0.0026083062594994,0.00515624566907555,0.0153808062063132,8.29079329492077e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.00970139577266511,0.00246678767575157,0.00486649192819203,0.0145362996171382,8.4309976119718e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0175816500709114,0.00447278752495007,-0.0263483136198135,-0.00881498652200926,8.50218624823504e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0185039656426902,0.00470916525016138,0.00927400175237394,0.0277339295330065,8.55980842358963e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0130981327587979,0.00333875550875051,0.00655417196164686,0.0196420935559489,8.78035888457517e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CFD,Complement factor D,37453,0.00694050599439814,0.00178150437719447,0.00344875741509698,0.0104322545736993,9.83164589598606e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CCL28,C-C motif chemokine 28,39815,0.0225885313202567,0.00579877036110738,0.0112229414124862,0.0339541212280271,9.84366149850225e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VCAN,Versican core protein,40009,-0.0112098886021199,0.00287816499671353,-0.0168510919956784,-0.00556868520856137,9.86739884878093e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0294607189362028,0.00759169041398915,0.0145810057247841,0.0443404321476216,0.000104604201155579
NMR metabolomics,X23408.Triglycerides in VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0235078379243264,0.00606700281821398,-0.0353991634480258,-0.011616512400627,0.000107275200927148
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP1,Dipeptidase 1,39713,-0.0178573213392831,0.00461100085100429,-0.0268948830072515,-0.00881975967131466,0.000108039846981648
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.0175232150715408,0.00452475489359518,0.0086546954800943,0.0263917346629874,0.000108055783784054
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0148806222813052,0.00385229530762781,0.00733012347835474,0.0224311210842558,0.000112617998710412
NMR metabolomics,X23408.Triglycerides in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0166298110938776,0.004307649949171,0.00818681719350248,0.0250728049942528,0.000113588279410418
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0115459431809844,0.00299085539508149,0.00568386660662463,0.0174080197553441,0.000113641598210455
NMR metabolomics,X23408.Triglycerides in VLDL,RPS10,40S ribosomal protein S10,37021,-0.0161675185015829,0.00418867877075728,-0.0243773288922672,-0.00795770811089866,0.000114015794798219
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0165080149549016,0.00429034986056925,0.00809892922818584,0.0249171006816173,0.000119690843434897
NMR metabolomics,X23408.Triglycerides in VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0157631772052227,0.004098108194483,0.00773088514403603,0.0237954692664094,0.000120404132238155
NMR metabolomics,X23408.Triglycerides in VLDL,SDK2,Protein sidekick-2,37124,0.0139051456812067,0.00362829814366579,0.00679368131962178,0.0210166100427917,0.00012747682389534
NMR metabolomics,X23408.Triglycerides in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0161753331223412,0.00423873292647931,0.00786741658644179,0.0244832496582407,0.000136208856381416
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0134935316647211,0.00353916454035298,0.00655676916562921,0.0204302941638129,0.000138120257659177
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.021367334483774,0.00562971416329174,0.0103330947237222,0.0324015742438258,0.000147928873084041
NMR metabolomics,X23408.Triglycerides in VLDL,BOC,Brother of CDO,39585,-0.00863755999730098,0.00228046000833453,-0.0131072616136367,-0.00416785838096529,0.000152651607669467
NMR metabolomics,X23408.Triglycerides in VLDL,GZMH,Granzyme H,39585,0.0277442827156002,0.00733177291681143,0.0133740077986498,0.0421145576325506,0.000154827841212981
NMR metabolomics,X23408.Triglycerides in VLDL,MMP9,Matrix metalloproteinase-9,39843,0.0222946660641101,0.0058982945665039,0.0107340087137624,0.0338553234144577,0.000157493475674382
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH12,Protocadherin-12,37411,0.00932407994856773,0.0024694063128081,0.00448404357546386,0.0141641163216716,0.000160151181716436
NMR metabolomics,X23408.Triglycerides in VLDL,DLL4,Delta-like protein 4,37043,0.0317284713537304,0.0084080987594883,0.0152485977851333,0.0482083449223275,0.000161638897778311
NMR metabolomics,X23408.Triglycerides in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00992332916066511,0.0026453487617198,0.0047384455876943,0.0151082127336359,0.000176699288269007
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0108196879360351,0.00288829977559804,0.00515862037586299,0.0164807554962073,0.000180278042375791
NMR metabolomics,X23408.Triglycerides in VLDL,NTF3,Neurotrophin-3,39866,0.0122657931617019,0.00327661261202389,0.0058436324421351,0.0186879538812688,0.000182155258581897
NMR metabolomics,X23408.Triglycerides in VLDL,RAB44,Ras-related protein Rab-44,37368,0.0154244892061301,0.00412216606742172,0.00734504371398351,0.0235039346982766,0.000183433627011421
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0198250098732931,0.00530025151218439,-0.0302135028371745,-0.00943651690941172,0.000184377230242076
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0132844442685928,0.00355262873278853,0.00632129195232726,0.0202475965848583,0.000185274881559503
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0112152826760199,0.00300095019952595,-0.0170971450670908,-0.00533342028494905,0.000186835519264108
NMR metabolomics,X23408.Triglycerides in VLDL,SPP1,Osteopontin,40012,-0.0163518205903299,0.00438000789934443,-0.024936636073045,-0.00776700510761481,0.000189646758960277
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0125000711921301,0.00335151924566365,0.00593109347062933,0.0190690489136308,0.000192393018232789
NMR metabolomics,X23408.Triglycerides in VLDL,ECM1,Extracellular matrix protein 1,37106,0.0131688542427748,0.00353225605404354,0.00624563237684948,0.0200920761087002,0.000193677868059746
NMR metabolomics,X23408.Triglycerides in VLDL,EXTL1,Exostosin-like 1,37021,0.0173536883092006,0.00465899190632909,0.00822206417279558,0.0264853124456056,0.000196307534813268
NMR metabolomics,X23408.Triglycerides in VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00991988060807422,0.00267412338578075,0.00467859877194394,0.0151611624442045,0.000208430925014014
NMR metabolomics,X23408.Triglycerides in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0158034202725759,0.00427256800330167,0.00742918698610462,0.0241776535590472,0.000217483649192522
NMR metabolomics,X23408.Triglycerides in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0132514665350869,0.00358281078745841,-0.0202737756785054,-0.00622915739166845,0.00021765293130852
NMR metabolomics,X23408.Triglycerides in VLDL,CDH6,Cadherin-6,39868,-0.013685131600852,0.00370230501962878,-0.0209416494393244,-0.00642861376237961,0.000219423932339464
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G1B,Phospholipase A2,40031,-0.014691925225969,0.00397598781058523,-0.0224848613347161,-0.00689898911722197,0.000220470127662229
NMR metabolomics,X23408.Triglycerides in VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0168278193001521,0.00455418503710279,0.00790161662743064,0.0257540219728736,0.00022059933850605
NMR metabolomics,X23408.Triglycerides in VLDL,CLSPN,Claspin,39453,0.012390615358861,0.00335545764349246,0.00581391837761574,0.0189673123401062,0.000222664538504856
NMR metabolomics,X23408.Triglycerides in VLDL,MMP8,Neutrophil collagenase,39985,0.0257412180328348,0.0069759996158091,0.012068258785849,0.0394141772798206,0.000225019923098147
NMR metabolomics,X23408.Triglycerides in VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0394641590979813,0.0107010954770974,0.0184900119628704,0.0604383062330922,0.000227054164613852
NMR metabolomics,X23408.Triglycerides in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0148808815544277,0.00405152957997547,-0.0228218795311797,-0.00693988357767581,0.000240759392458188
NMR metabolomics,X23408.Triglycerides in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.013063542282996,0.00355731145026417,0.00609121184047828,0.0200358727255138,0.000241320686257809
NMR metabolomics,X23408.Triglycerides in VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0166246460472507,0.00452706184504262,0.0077516048309672,0.0254976872635343,0.000241346604322865
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN2,Alpha-actinin-2,37021,-0.0211413196371664,0.00576394905917311,-0.0324386597931457,-0.00984397948118707,0.00024555975158107
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0199490853304255,0.00544072750362393,-0.0306129112375284,-0.00928525942332264,0.000246572667777586
NMR metabolomics,X23408.Triglycerides in VLDL,S100G,Protein S100-G,37411,-0.0160430034165053,0.0043842512156813,-0.0246361357992406,-0.00744987103376991,0.000253929824911094
NMR metabolomics,X23408.Triglycerides in VLDL,STX3,Syntaxin-3,37388,0.0135391709410533,0.00370950059894746,0.00626854976711624,0.0208097921149903,0.000263367596802696
NMR metabolomics,X23408.Triglycerides in VLDL,CST6,Cystatin-M,39524,0.0166587829016726,0.004566629203232,0.0077081896633379,0.0256093761400073,0.000265210577017094
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.00833152548420643,0.00228624035417649,-0.0128125565783924,-0.00385049439002051,0.000269059657156027
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0206405115442845,0.00568757849526761,0.00949285769356003,0.0317881653950091,0.000285366822806713
NMR metabolomics,X23408.Triglycerides in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0114052590422716,0.0031470404381812,-0.0175734583011067,-0.00523705978343642,0.000290865280780757
NMR metabolomics,X23408.Triglycerides in VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.00990173313707732,0.00274076337639337,0.00452983691934631,0.0152736293548083,0.000303873519627262
NMR metabolomics,X23408.Triglycerides in VLDL,ERC2,ERC protein 2,37039,0.0264081076752689,0.00731583696117086,0.012069067231374,0.0407471481191637,0.00030766679697105
NMR metabolomics,X23408.Triglycerides in VLDL,GNLY,Granulysin,39858,0.0178839582007645,0.00496151677722841,0.00815938531739686,0.0276085310841322,0.00031366284534741
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0226907025570909,0.00633910305699264,0.0102660605653853,0.0351153445487965,0.000345511910914465
NMR metabolomics,X23408.Triglycerides in VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.0101889024387545,0.00285310963819894,-0.0157809973296244,-0.00459680754788456,0.000356672029117157
NMR metabolomics,X23408.Triglycerides in VLDL,TFF2,Trefoil factor 2,39908,0.0198129063737524,0.00555255182763152,0.0089299047915946,0.0306959079559102,0.000360417995156049
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0257098816642463,0.00722301465432088,0.0115527729417774,0.0398669903867152,0.000372962769556681
NMR metabolomics,X23408.Triglycerides in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00665019846732736,0.00186956265560079,-0.0103145412723049,-0.00298585566234981,0.00037626480747857
NMR metabolomics,X23408.Triglycerides in VLDL,GBP2,Guanylate-binding protein 2,39587,0.0205153775908034,0.00577195021291254,0.00920235517349482,0.031828400008112,0.000380063992288523
NMR metabolomics,X23408.Triglycerides in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0113282676941762,0.00318985881401899,0.005076144418699,0.0175803909696534,0.000384579950984663
NMR metabolomics,X23408.Triglycerides in VLDL,SSB,Lupus La protein,39489,0.0209814157961562,0.00591291186200663,0.00939210854662319,0.0325707230456892,0.000388705684047594
NMR metabolomics,X23408.Triglycerides in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0180337438828944,0.0050899126546966,0.00805751507968902,0.0280099726860997,0.000396702739342173
NMR metabolomics,X23408.Triglycerides in VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00974838482704172,0.00275947559372093,0.00433981266334869,0.0151569569907347,0.000412517660499791
NMR metabolomics,X23408.Triglycerides in VLDL,ACHE,Acetylcholinesterase,37124,0.0112298296189939,0.00319294365684582,0.00497166005157607,0.0174879991864117,0.000437785197432743
NMR metabolomics,X23408.Triglycerides in VLDL,ELAVL4,ELAV-like protein 4,36991,0.028862459899522,0.00824747563714701,0.0126974076507138,0.0450275121483301,0.000467587326958261
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00632237918957241,0.00181775269003993,0.00275958391709415,0.00988517446205068,0.0005065058210158
NMR metabolomics,X23408.Triglycerides in VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0212683098550146,0.00611626670701009,-0.0332561926007544,-0.00928042710927483,0.00050806308652706
NMR metabolomics,X23408.Triglycerides in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0237174223923899,0.00682244968474196,0.0103454210102957,0.0370894237744842,0.000509590716406058
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0122454355796627,0.00352600392345233,0.00533446788969614,0.0191564032696293,0.000516531727930896
NMR metabolomics,X23408.Triglycerides in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0237178251429639,0.00685771647621392,0.0102767008495846,0.0371589494363432,0.000544770268503614
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0303540996344623,0.00877688725448002,0.0131514006156814,0.0475567986532431,0.000545082612187624
NMR metabolomics,X23408.Triglycerides in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0184057187280328,0.00532476782047398,0.00796917379990377,0.0288422636561617,0.000548443450585543
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0170466651835998,0.00493442299285138,0.00737519611761111,0.0267181342495885,0.000552760131252689
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0193857380076677,0.00562356161291743,-0.0304079187689858,-0.00836355724634951,0.000568126240326089
NMR metabolomics,X23408.Triglycerides in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0200921122825998,0.00584838671572211,0.00862927431978442,0.0315549502454151,0.000593289713229869
NMR metabolomics,X23408.Triglycerides in VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0232275370446397,0.00676192574284546,-0.0364809115006168,-0.00997416258866257,0.000593998013259973
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.0147863580391749,0.00430923144235127,0.00634026441216646,0.0232324516661834,0.000602168657864556
NMR metabolomics,X23408.Triglycerides in VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.0203784648250364,0.00594376148710617,-0.0320282373397646,-0.00872869231030835,0.00060862252396265
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0200998634021,0.00586281651990042,0.00860874302309519,0.0315909837811049,0.000608773043451987
NMR metabolomics,X23408.Triglycerides in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0195711357869033,0.0057140560841808,0.00837158586190892,0.0307706857118976,0.000616160011630346
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0204422632651817,0.00598430951414731,0.00871301661745298,0.0321715099129104,0.000637178625229194
NMR metabolomics,X23408.Triglycerides in VLDL,RCC1,Regulator of chromosome condensation,37368,0.0168131285332142,0.00494317680713671,0.00712450199122623,0.0265017550752021,0.000672653957408655
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0130639747882414,0.00385736141128026,0.00550354642213211,0.0206244031543507,0.000708963292289706
NMR metabolomics,X23408.Triglycerides in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.0114107646894963,0.00337169384420496,-0.0180192846241381,-0.0048022447548546,0.000715732838190398
NMR metabolomics,X23408.Triglycerides in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0279868802178697,0.00828104491937938,-0.0442177282598533,-0.0117560321758861,0.000727621174845564
NMR metabolomics,X23408.Triglycerides in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00925755329851098,0.00274119112816977,0.00388481868729822,0.0146302879097237,0.000734018553008863
NMR metabolomics,X23408.Triglycerides in VLDL,TYMP,Thymidine phosphorylase,39764,0.0222317318296757,0.00659553085974305,0.00930449134457934,0.0351589723147721,0.000751485650724487
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0104604746951894,0.0031104334958477,-0.0165569243470509,-0.00436402504332794,0.000773106588924912
NMR metabolomics,X23408.Triglycerides in VLDL,IDS,Iduronate 2-sulfatase,40058,0.00294234177656969,0.000876399063409073,0.0012245996122879,0.00466008394085147,0.000788864713893452
NMR metabolomics,X23408.Triglycerides in VLDL,SAG,S-arrestin,36991,-0.01737729132857,0.00518730564963529,-0.0275444104018552,-0.00721017225528481,0.000810494779300527
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.01420609650212,0.00424327805933474,0.00588927150582394,0.0225229214984161,0.000816168176882283
NMR metabolomics,X23408.Triglycerides in VLDL,VIM,Vimentin,39585,0.0381529623974131,0.0114135466160594,0.0157824110299366,0.0605235137648895,0.000831374789094577
NMR metabolomics,X23408.Triglycerides in VLDL,MYH4,Myosin-4,37021,-0.0155867336524675,0.00466325226405317,-0.0247267080900117,-0.00644675921492327,0.000832707803905769
NMR metabolomics,X23408.Triglycerides in VLDL,GFAP,Glial fibrillary acidic protein,39453,0.0142175125935777,0.0042565691630296,0.00587463703403971,0.0225603881531157,0.000839343291079322
NMR metabolomics,X23408.Triglycerides in VLDL,MYO6,Unconventional myosin-VI,37411,0.0124154020399349,0.00372395635023941,0.00511644759346568,0.0197143564864042,0.000858584259802724
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO4,Roundabout homolog 4,37043,-0.00579706271439867,0.00174223810339762,-0.00921184939705801,-0.00238227603173932,0.000879112082202413
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00653776046003691,0.00196505357942836,0.00268625544435732,0.0103892654757165,0.000879789149346262
NMR metabolomics,X23408.Triglycerides in VLDL,LY6D,Lymphocyte antigen 6D,39761,0.0117104336760609,0.00352006968216754,0.00481109709901252,0.0186097702531093,0.000880605472748374
NMR metabolomics,X23408.Triglycerides in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0121674232994246,0.0036575163048412,-0.0193361552569134,-0.00499869134193586,0.000881243887266817
NMR metabolomics,X23408.Triglycerides in VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.011008376980538,0.00330993533810958,0.00452090371784324,0.0174958502432328,0.000883448693521839
NMR metabolomics,X23408.Triglycerides in VLDL,NINJ1,Ninjurin-1,39477,0.0182673555132723,0.00549568034636734,0.00749582203439235,0.0290388889921523,0.000889569257092286
NMR metabolomics,X23408.Triglycerides in VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0193866693282872,0.00583655420449761,-0.0308263155691026,-0.00794702308747193,0.00089702837098998
NMR metabolomics,X23408.Triglycerides in VLDL,PRKCQ,Protein kinase C theta type,39587,0.0139908251599097,0.00422248476982764,0.00571475501104756,0.0222668953087719,0.000923736915567472
NMR metabolomics,X23408.Triglycerides in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0192656992783756,0.00581664968578384,0.00786506589423928,0.0306663326625119,0.000928277313092521
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0154279181571577,0.00466925153918348,0.00627618514035809,0.0245796511739573,0.000954769209945598
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN1,Nectin-1,37056,0.0103466374063818,0.00313326315845173,0.00420544161581638,0.0164878331969472,0.000961872136429819
NMR metabolomics,X23408.Triglycerides in VLDL,LHB,Lutropin subunit beta,39477,0.0283694667752747,0.00861660143170154,0.0114809279691397,0.0452580055814098,0.000995498960161522
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0156736521558166,0.00477848454222531,-0.0250394818585783,-0.00630782245305504,0.00104011055033987
NMR metabolomics,X23408.Triglycerides in VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0095322844840268,0.00292543556922122,-0.0152661381997004,-0.0037984307683532,0.0011232166171562
NMR metabolomics,X23408.Triglycerides in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0175835509479821,0.00539701114160809,0.00700540911043026,0.028161692785534,0.00112470591020821
NMR metabolomics,X23408.Triglycerides in VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0206928220765916,0.00636389527909914,0.00821958732955726,0.0331660568236259,0.00114996437928452
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0124243248628621,0.00382817417340021,-0.0199275462427265,-0.0049211034829977,0.00117530137658945
NMR metabolomics,X23408.Triglycerides in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0221343689595172,0.00682336165545394,0.00876058011482751,0.035508157804207,0.00118148762614414
NMR metabolomics,X23408.Triglycerides in VLDL,CHGA,Chromogranin-A,37437,-0.024787166446707,0.00764996146136173,-0.039781090910976,-0.00979324198243804,0.00119746590547482
NMR metabolomics,X23408.Triglycerides in VLDL,CLPS,Colipase,39836,0.0218281596353243,0.00674192720441406,0.00861398231467276,0.0350423369559759,0.00120754462984343
NMR metabolomics,X23408.Triglycerides in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.0108602809436184,0.00336438083915791,0.00426609449886889,0.0174544673883679,0.00124901571091984
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00956898087702998,0.00296924119672814,0.00374926813144282,0.0153886936226171,0.00127247733116252
NMR metabolomics,X23408.Triglycerides in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0153013138977693,0.00477271534669198,0.00594679181825303,0.0246558359772856,0.00134865812274937
NMR metabolomics,X23408.Triglycerides in VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0135455786671877,0.00422867290949778,-0.0218337775698033,-0.00525737976457203,0.00136199889312574
NMR metabolomics,X23408.Triglycerides in VLDL,CAPS,Calcyphosin,37388,0.0271830928432312,0.00849117773244576,0.0105403844876375,0.0438258011988249,0.00137109214812252
NMR metabolomics,X23408.Triglycerides in VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.00801176486442042,0.00250420026070745,-0.012919997375407,-0.00310353235343383,0.00138015484086634
NMR metabolomics,X23408.Triglycerides in VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0111224436269658,0.00348153043730575,0.00429864396984658,0.0179462432840851,0.00140297010316543
NMR metabolomics,X23408.Triglycerides in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00703450481203233,0.00220323802265986,0.002716158287619,0.0113528513364457,0.00141168458380918
NMR metabolomics,X23408.Triglycerides in VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.00994610682391282,0.00311879426210252,0.00383327007019187,0.0160589435776338,0.00143056259819006
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0227876846006415,0.00716279854049295,0.00874859946127533,0.0368267697400077,0.00146897981539602
NMR metabolomics,X23408.Triglycerides in VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.0112169690616089,0.00353307968215805,0.00429213288457914,0.0181418052386387,0.00150265199416027
NMR metabolomics,X23408.Triglycerides in VLDL,GAL,Galanin peptides,39931,-0.0197928029507587,0.00626518412584837,-0.0320725638374215,-0.00751304206409587,0.00158510451259793
NMR metabolomics,X23408.Triglycerides in VLDL,INHBB,Inhibin beta B chain,37124,0.0151971556193783,0.00483293253655944,0.00572460784772174,0.0246697033910348,0.00166738150477575
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD9,COMM domain-containing protein 9,37368,0.0120281952814934,0.0038313228741668,0.00451880244812651,0.0195375881148604,0.00169637671965207
NMR metabolomics,X23408.Triglycerides in VLDL,AMBN,Ameloblastin,39587,-0.00872007701340808,0.00277827425336853,-0.0141654945500104,-0.00327465947680577,0.00170032044509068
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0312339393379012,0.00995505170104385,0.0117220380038553,0.0507458406719472,0.00170708656760238
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00862407135738663,0.00274955042264675,0.00323495252899899,0.0140131901857743,0.00171328629387617
NMR metabolomics,X23408.Triglycerides in VLDL,TNR,Tenascin-R,39749,-0.0127636796545723,0.00408402259992569,-0.0207683639504266,-0.00475899535871794,0.00177960915994242
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0130327134283463,0.00418020934509912,-0.0212259237447406,-0.00483950311195201,0.00182650883255815
NMR metabolomics,X23408.Triglycerides in VLDL,RYR1,Ryanodine receptor 1,37021,-0.0102833469230846,0.00330352286058933,-0.0167582517298397,-0.00380844211632955,0.00185691836112669
NMR metabolomics,X23408.Triglycerides in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0107433845420092,0.00345764481528631,-0.0175203683799704,-0.00396640070404807,0.00189234510589686
NMR metabolomics,X23408.Triglycerides in VLDL,F3,Tissue factor,39931,-0.00821079045394693,0.0026439700680959,-0.0133929717874149,-0.00302860912047897,0.00190302311715789
NMR metabolomics,X23408.Triglycerides in VLDL,CD109,CD109 antigen,39858,-0.0101927236812086,0.00328531455312885,-0.0166319402053412,-0.00375350715707609,0.00192220722290528
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0119329725354458,0.00387533008841985,-0.0195286195087487,-0.00433732556214286,0.00207961474475152
NMR metabolomics,X23408.Triglycerides in VLDL,BEX3,Protein BEX3,36962,-0.0140494818836342,0.00456802039457035,-0.0230028018569921,-0.00509616191027627,0.00210500038620128
NMR metabolomics,X23408.Triglycerides in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00888930247877734,0.00290323182101133,0.00319896810959514,0.0145796368479595,0.00220405471452172
NMR metabolomics,X23408.Triglycerides in VLDL,MYH7B,Myosin-7B,36962,-0.0131464411447977,0.00429408310087359,-0.0215628440225099,-0.00473003826708546,0.00220658859475474
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.011827991426105,0.00387428510970937,0.00423439261107461,0.0194215902411354,0.00227057311493216
NMR metabolomics,X23408.Triglycerides in VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0118401791110571,0.00387887927489018,-0.0194427824898418,-0.00423757573227233,0.00227404222065439
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB1A1,Uteroglobin,39903,0.0162221800165605,0.00532442930320402,0.00578629858228066,0.0266580614508404,0.00231709487505619
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00769652560365841,0.00253223153692868,0.0027333517912782,0.0126596994160386,0.00237415403441434
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0161358219430335,0.00532927908381695,0.00569043493875226,0.0265812089473147,0.00246768560785276
NMR metabolomics,X23408.Triglycerides in VLDL,DCLRE1C,Protein artemis,36962,-0.00914804538257198,0.00302898264463287,-0.0150848513660524,-0.00321123939909156,0.00253118848071679
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00674690199647355,0.0022395326994476,-0.0111363860873908,-0.00235741790555626,0.00259478859679133
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00787996244679686,0.00261890627396705,0.00274690614982144,0.0130130187437723,0.00262631925430956
NMR metabolomics,X23408.Triglycerides in VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0152211561423349,0.00506557594435061,0.0052926272914077,0.0251496849932621,0.00266230730592504
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00925608475472145,0.00309886637933152,-0.0153298628582112,-0.00318230665123167,0.00282316298163199
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00962622764863913,0.00322709565070548,-0.0159513351240219,-0.0033011201732564,0.00286002767714172
NMR metabolomics,X23408.Triglycerides in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0096083074024054,0.00322281501942647,0.00329158996432953,0.0159250248404813,0.00287421171493022
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB1,Lamin-B1,37348,0.0168666877572957,0.00565926197223632,0.0057745342917125,0.0279588412228789,0.00288414933970493
NMR metabolomics,X23408.Triglycerides in VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.0103266518193694,0.00346730600522628,0.00353073204912594,0.0171225715896129,0.00290304378683036
NMR metabolomics,X23408.Triglycerides in VLDL,RETN,Resistin,39790,0.0118210335385395,0.00397003473047996,0.00403976546679877,0.0196023016102802,0.00290985876649747
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0851839646372752,0.0286221897332714,0.0290844727600632,0.141283456514487,0.00292327337189297
NMR metabolomics,X23408.Triglycerides in VLDL,DRAXIN,Draxin,39749,0.0121684917346432,0.00409297757395166,0.00414625568969797,0.0201907277795885,0.00295330510628112
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC1,Sialoadhesin,39931,0.0120725096881691,0.00406654937317555,0.00410207291674506,0.0200429464595932,0.00299468975735534
NMR metabolomics,X23408.Triglycerides in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0204766102597155,0.00690660771297616,0.00693965914228222,0.0340135613771488,0.0030333661068708
NMR metabolomics,X23408.Triglycerides in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0349565144322434,0.0117977528902487,0.0118329187673559,0.0580801100971309,0.00305131732245115
NMR metabolomics,X23408.Triglycerides in VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00629699702653949,0.00213207168016224,-0.0104758575196575,-0.00211813653342151,0.00314783339510647
NMR metabolomics,X23408.Triglycerides in VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,0.0348174225319962,0.0118121514376628,0.0116656057141772,0.0579692393498153,0.00320818405908357
NMR metabolomics,X23408.Triglycerides in VLDL,GUK1,Guanylate kinase,37021,-0.011918070233812,0.00404384306837514,-0.0198440026478273,-0.00399213781979671,0.00321213974766842
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00817696038181531,0.00277533108407266,0.0027373114570329,0.0136166093065977,0.00322148549205356
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00987208338048084,0.00335184046096054,0.00330247607699819,0.0164416906839635,0.00323131971862912
NMR metabolomics,X23408.Triglycerides in VLDL,TFF1,Trefoil factor 1,39789,0.0215404747396127,0.00732639014979762,0.00718075004600937,0.035900199433216,0.00328555335787569
NMR metabolomics,X23408.Triglycerides in VLDL,KLK15,Kallikrein-15,37351,0.0144316853841973,0.0049186044031144,0.00479122075409309,0.0240721500143016,0.00335077949156865
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00230643898398731,0.000789277623996544,-0.00385342312702054,-0.000759454840954084,0.00348132624476278
NMR metabolomics,X23408.Triglycerides in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00844659000597631,0.00290068797394263,0.00276124157704875,0.0141319384349039,0.00359808834062334
NMR metabolomics,X23408.Triglycerides in VLDL,TMOD4,Tropomodulin-4,36962,-0.0115415862730034,0.0039816201935788,-0.0193455618524178,-0.00373761069358895,0.00375315791265967
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171B,Protein FAM171B,37368,0.0078389854343047,0.00270536262657864,0.00253647468621057,0.0131414961823988,0.0037666667450272
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.00634068847269051,0.00218847920697012,-0.0106301077183519,-0.00205126922702908,0.00376896979140485
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH3,Neurexophilin-3,37056,0.00840889801188808,0.0029022909285736,0.00272040779188382,0.0140973882318923,0.0037697115793005
NMR metabolomics,X23408.Triglycerides in VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0115073005547729,0.0039850712637115,-0.0193180402316475,-0.0036965608778984,0.00388825650795948
NMR metabolomics,X23408.Triglycerides in VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0183372947902827,0.0063606783796032,0.00587036516626041,0.030804224414305,0.00394653311342177
NMR metabolomics,X23408.Triglycerides in VLDL,CENPJ,Centromere protein J,37169,0.0203753938504309,0.00708985126912457,0.00647928536294679,0.0342715023379151,0.00406102726868222
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0162967109032671,0.00569870418779686,0.0051272506951853,0.027466171111349,0.00424671641626187
NMR metabolomics,X23408.Triglycerides in VLDL,EP300,Histone acetyltransferase p300,37056,0.00826250742560016,0.00289015766716765,0.00259779839795157,0.0139272164532488,0.00425855114106201
NMR metabolomics,X23408.Triglycerides in VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0249058651257561,0.00876764708934064,-0.0420904534208637,-0.00772127683064842,0.00450901787420329
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0171362613436531,0.00604347974520427,0.00529104104305273,0.0289814816442535,0.00458119852603039
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0125116209426309,0.00442335828651066,0.00384183870106998,0.0211814031841918,0.00468305398462069
NMR metabolomics,X23408.Triglycerides in VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0207050934326443,0.00734006170027079,0.00631857250011354,0.035091614365175,0.00479701545855874
NMR metabolomics,X23408.Triglycerides in VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0269323312276567,0.00955122236765699,0.008211935387049,0.0456527270682644,0.00481289112888065
NMR metabolomics,X23408.Triglycerides in VLDL,OPTC,Opticin,39788,-0.0120900772785409,0.00428953884559261,-0.0204975734159024,-0.0036825811411794,0.0048307671439421
NMR metabolomics,X23408.Triglycerides in VLDL,TNXB,Tenascin-X,39858,-0.00702577515609653,0.00250443148493141,-0.0119344608665621,-0.00211708944563096,0.00503246056681225
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB5,Integrin beta-5,39913,0.0103092269668818,0.00369353833813922,0.00306989182412891,0.0175485621096346,0.00525828223274308
NMR metabolomics,X23408.Triglycerides in VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0143470858376535,0.00514119105156379,0.00427035137658852,0.0244238202987186,0.00526836031467294
NMR metabolomics,X23408.Triglycerides in VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0143018878680569,0.00514346556221674,-0.0243830803700017,-0.0042206953661121,0.00543368774941687
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN2,Contactin-2,40030,0.0118812488539782,0.00431293635144142,0.00342789360515297,0.0203346041028033,0.00587948717365284
NMR metabolomics,X23408.Triglycerides in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00975384759333792,0.00356710586528918,-0.0167453750893047,-0.00276232009737113,0.00625801652375254
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0113473917689656,0.00416339334207043,0.00318714081850756,0.0195076427194237,0.00642864953486387
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GL3,Endophilin-A3,37083,0.0218798867823139,0.00806179273263471,0.0060787730263499,0.037681000538278,0.00665578154238484
NMR metabolomics,X23408.Triglycerides in VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.00960366549928744,0.003541981981419,0.00266138081570619,0.0165459501828687,0.00670902352259699
NMR metabolomics,X23408.Triglycerides in VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00737149440973067,0.00271877623938813,-0.0127002958389314,-0.00204269298052993,0.00671012432545659
NMR metabolomics,X23408.Triglycerides in VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0159851231321226,0.00589610020012539,0.00442876673987683,0.0275414795243684,0.00671261318226034
NMR metabolomics,X23408.Triglycerides in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00996867320109159,0.00367903189055822,0.00275777069559747,0.0171795757065857,0.00674408988472016
NMR metabolomics,X23408.Triglycerides in VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0110935118316836,0.00410061486626195,0.00305630669381017,0.019130716969557,0.00683235559208903
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA10,Annexin A10,39489,0.020640354810815,0.00763400168375089,0.00567771151066325,0.0356029981109667,0.00686381106502434
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA7A,Semaphorin-7A,40002,0.00707582193489188,0.00262231353780673,0.00193608740079068,0.0122155564689931,0.00697644136116492
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.012146406365257,0.00450402927996116,0.00331850897653315,0.0209743037539809,0.00701002227085255
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0180292646062743,0.00671070334932445,0.0048762860415984,0.0311822431709502,0.00722636629185147
NMR metabolomics,X23408.Triglycerides in VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0109260403855003,0.00407401646388792,0.00294096811627995,0.0189111126547206,0.00733005635944369
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1,Integrin beta-1,39862,0.00565823719201741,0.00211444693372115,0.00151392120192396,0.00980255318211085,0.00745849095975756
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0121633273859209,0.00456093249093043,-0.0211027550681446,-0.00322389970369727,0.00766419523846605
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.00737592441691491,0.00277057538163942,0.00194559666890164,0.0128062521649282,0.00777171414750005
NMR metabolomics,X23408.Triglycerides in VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0147562201493339,0.00554942347000302,0.00387935014812797,0.0256330901505398,0.00784396176742925
NMR metabolomics,X23408.Triglycerides in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.013759998744511,0.00518017224652644,0.00360686114131917,0.0239131363477028,0.00791026299082188
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0131326695476499,0.00495543336312486,-0.0228453189393746,-0.00342002015592517,0.00805509172225601
NMR metabolomics,X23408.Triglycerides in VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0122732913942229,0.00464047797365846,-0.0213686282225935,-0.00317795456585233,0.00818281729831181
NMR metabolomics,X23408.Triglycerides in VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.0101205694929496,0.00384165779849086,0.00259092020790754,0.0176502187779917,0.0084375254665355
NMR metabolomics,X23408.Triglycerides in VLDL,ASPN,Asporin,37437,0.0069345991454281,0.00263407577586568,0.00177181062473137,0.0120973876661248,0.00848175588381136
NMR metabolomics,X23408.Triglycerides in VLDL,GPA33,Cell surface A33 antigen,39788,0.033587579774631,0.0127684328093632,0.00856145146827913,0.0586137080809829,0.00853371323227422
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0125586284539164,0.00478990017802128,-0.0219468328028381,-0.00317042410499471,0.00875243362090282
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0159348638848424,0.00608094895693862,0.00401620392924272,0.0278535238404421,0.00879129326879676
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.014282216196068,0.00545247643445322,0.00359536238453964,0.0249690700075963,0.0088186115155027
NMR metabolomics,X23408.Triglycerides in VLDL,CHGB,Secretogranin-1,39952,0.0100404579975607,0.00384113028243563,0.00251184264398687,0.0175690733511345,0.00895898754335619
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL2,Chordin-like protein 2,39868,0.014277968500503,0.00548315389013276,0.00353098687584283,0.0250249501251632,0.00922358993057038
NMR metabolomics,X23408.Triglycerides in VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0327051570041068,0.0125633848009274,-0.0573293912139245,-0.00808092279428922,0.00924392084246105
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00769306323190497,0.00296721131010699,-0.0135087973997147,-0.00187732906409527,0.00953169291928188
NMR metabolomics,X23408.Triglycerides in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0180472522991822,0.00697029113368007,-0.0317090229211951,-0.00438548167716925,0.00963143725890945
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0175717864268446,0.00679139532250018,0.00426065159474423,0.030882921258945,0.00968007138257411
NMR metabolomics,X23408.Triglycerides in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.018093699154471,0.00699386697423421,-0.03180167842397,-0.00438571988497191,0.00968991102100511
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00726668759509775,0.00281127807906578,-0.0127767926300667,-0.00175658256012881,0.00975326819516594
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00726254843300031,0.00281324495650444,-0.012776508547749,-0.0017485883182516,0.00984631080681322
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.0052062175884986,0.00202439780175914,0.00123839789705069,0.00917403727994652,0.010127973043622
NMR metabolomics,X23408.Triglycerides in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0101690637414806,0.00398449665669178,-0.0179786771885965,-0.00235945029436471,0.0107170010112434
NMR metabolomics,X23408.Triglycerides in VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00858551383436671,0.00337297633822504,0.00197448021144564,0.0151965474572878,0.0109251173722964
NMR metabolomics,X23408.Triglycerides in VLDL,CDH23,Cadherin-23,37388,-0.00667085071757012,0.00262130245738925,-0.0118086035340531,-0.00153309790108718,0.0109431302700672
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF8,SLAM family member 8,39477,0.0128851698640974,0.0050672755732232,0.00295330974057995,0.0228170299876149,0.0110057500916643
NMR metabolomics,X23408.Triglycerides in VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0109695386693693,0.00432186811244191,-0.0194404001697555,-0.0024986771689832,0.0111554025174529
NMR metabolomics,X23408.Triglycerides in VLDL,RALB,Ras-related protein Ral-B,37056,0.00724133370754706,0.00285671974943724,0.00164216299865007,0.0128405044164441,0.0112612531102649
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00726947284786079,0.00287437568837285,0.00163569649865,0.0129032491970716,0.0114483638988345
NMR metabolomics,X23408.Triglycerides in VLDL,MELTF,Melanotransferrin,37437,0.00717091278668282,0.00283662290627946,0.00161113189037509,0.0127306936829906,0.0114834841033953
NMR metabolomics,X23408.Triglycerides in VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0156022769089049,0.00619778102865259,0.00345462609274579,0.0277499277250639,0.0118343218722718
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.00656943564817624,0.00261211025032961,-0.0116891717388223,-0.0014496995575302,0.0119132335961057
NMR metabolomics,X23408.Triglycerides in VLDL,RLN1,Prorelaxin H1,37411,-0.0197757651492855,0.00787268990154296,-0.0352062373563097,-0.00434529294226132,0.0120183027602666
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM1,Myomesin-1,36991,0.0115898610533139,0.0046269412693425,0.00252105616540257,0.0206586659412252,0.0122618470064605
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_DRA,,39799,-0.00864940578689638,0.00345399465945776,-0.0154192353194336,-0.00187957625435916,0.0122836529329582
NMR metabolomics,X23408.Triglycerides in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0363739491722919,0.0145332761640345,0.00788872789078431,0.0648591704537995,0.0123312446498233
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00814067573877925,0.00326217666225801,0.00174680948075354,0.014534541996805,0.012591028412936
NMR metabolomics,X23408.Triglycerides in VLDL,ARG1,Arginase-1,39754,0.0125617481336304,0.00503450997620616,0.00269410858026634,0.0224293876869945,0.0126012253900202
NMR metabolomics,X23408.Triglycerides in VLDL,SCG3,Secretogranin-3,39885,-0.00784717684685949,0.00315537461010093,-0.0140317110826573,-0.00166264261106167,0.0128953897125487
NMR metabolomics,X23408.Triglycerides in VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.0068271787403149,0.00274798196787994,-0.0122132233973596,-0.00144113408327022,0.0129881364020296
NMR metabolomics,X23408.Triglycerides in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0157165934843018,0.00632812803634171,0.00331346253307202,0.0281197244355315,0.0130178619077738
NMR metabolomics,X23408.Triglycerides in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0127809824211914,0.00514710351778279,0.00269265952633714,0.0228693053160457,0.0130351849850878
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.0081997749926233,0.0033086528641545,-0.0146847346063661,-0.00171481537888049,0.0132140768955082
NMR metabolomics,X23408.Triglycerides in VLDL,TEX33,Testis-expressed protein 33,37169,-0.00960729228459957,0.00387696341941514,-0.0172061405866532,-0.00200844398254589,0.0132227337073252
NMR metabolomics,X23408.Triglycerides in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.014895218901346,0.00601353642921358,-0.0266817503026046,-0.00310868750008734,0.0132636038809154
NMR metabolomics,X23408.Triglycerides in VLDL,PRR4,Proline-rich protein 4,37031,-0.0168782970324656,0.00682647487435486,-0.0302581877862011,-0.00349840627873004,0.013430596399814
NMR metabolomics,X23408.Triglycerides in VLDL,GKN1,Gastrokine-1,39123,0.00673089069364249,0.00273826365672133,0.00136389392646868,0.0120978874608163,0.0139789572188389
NMR metabolomics,X23408.Triglycerides in VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.00702869769536707,0.00286108333557597,0.00142097435763818,0.012636421033096,0.0140361620783017
NMR metabolomics,X23408.Triglycerides in VLDL,MYL3,Myosin light chain 3,37043,-0.0174507202697185,0.00711488862414207,-0.031395901973037,-0.00350553856640005,0.014191534217338
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00721447051288088,0.00294301596136528,-0.0129827817971568,-0.00144615922860492,0.014241311880307
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.0136384639870539,0.00557209016619034,0.00271716726132084,0.024559760712787,0.0143901135950078
NMR metabolomics,X23408.Triglycerides in VLDL,NRTN,Neurturin,39587,0.0118033254087787,0.00483396741761954,0.00232874927024438,0.021277901547313,0.0146273275719755
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00772899625354508,0.00318142510334153,0.00149340305099569,0.0139645894560945,0.0151344752809801
NMR metabolomics,X23408.Triglycerides in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0148386753087373,0.00612335167109341,-0.0268404445840804,-0.0028369060333942,0.0153938940894849
NMR metabolomics,X23408.Triglycerides in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0146282148734626,0.00604101428736719,0.00278782687022291,0.0264686028767023,0.0154685523526054
NMR metabolomics,X23408.Triglycerides in VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.00408510320933617,0.00169488796732723,-0.00740708362529754,-0.000763122793374813,0.0159528307911364
NMR metabolomics,X23408.Triglycerides in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.01193002159472,0.00495443734187324,0.0022193244046485,0.0216407187847916,0.0160562453519749
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00778402299792965,0.00323948315832853,-0.0141334099882536,-0.00143463600760573,0.0162787500545239
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00500120973211148,0.00208644753388234,0.00091177256570209,0.00909064689852086,0.0165435199551739
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00621821642375207,0.00259548107007557,-0.0113053593211002,-0.00113107352640395,0.0165986399195729
NMR metabolomics,X23408.Triglycerides in VLDL,NXPE4,NXPE family member 4,37021,-0.00814881257111614,0.0034111728739124,-0.0148347114039844,-0.00146291373824784,0.0169147675519764
NMR metabolomics,X23408.Triglycerides in VLDL,ESPL1,Separin,36962,-0.0125332715127309,0.00525199769436107,-0.0228271869936786,-0.00223935603178321,0.0170291858838896
NMR metabolomics,X23408.Triglycerides in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.01362383509189,0.00571245209369466,-0.0248202411955315,-0.00242742898824848,0.0170935091021615
NMR metabolomics,X23408.Triglycerides in VLDL,RBP7,Retinoid-binding protein 7,37382,0.0139962832552612,0.00588392607955467,0.00246378813933408,0.0255287783711884,0.0173861021566748
NMR metabolomics,X23408.Triglycerides in VLDL,STX5,Syntaxin-5,37056,0.00945870702838531,0.00397712039744862,0.00166355104938602,0.0172538630073846,0.0174077492005001
NMR metabolomics,X23408.Triglycerides in VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0205635672355812,0.00866049258626687,0.00358900176649818,0.0375381327046643,0.0175912378809899
NMR metabolomics,X23408.Triglycerides in VLDL,IL36A,Interleukin-36 alpha,37056,-0.0136448596794137,0.00574737948748266,-0.0249097234748797,-0.00237999588394765,0.0176059588025902
NMR metabolomics,X23408.Triglycerides in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0200307749761249,0.00843962184535111,0.00348911615923676,0.0365724337930131,0.0176385045696188
NMR metabolomics,X23408.Triglycerides in VLDL,NDRG1,Protein NDRG1,39489,0.0159760441499118,0.00674865939864284,0.00274867172857185,0.0292034165712518,0.0179309226616528
NMR metabolomics,X23408.Triglycerides in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0115431278856397,0.00488615277459419,0.00196626844743503,0.0211199873238443,0.0181703128503254
NMR metabolomics,X23408.Triglycerides in VLDL,PXDNL,Peroxidasin-like protein,37368,0.013689128277484,0.00580975827509281,0.00230200205830212,0.0250762544966659,0.018475672254774
NMR metabolomics,X23408.Triglycerides in VLDL,TNN,Tenascin-N,37437,0.00987938011231892,0.00419570247216486,0.0016558032668758,0.018102956957762,0.0185546817879859
NMR metabolomics,X23408.Triglycerides in VLDL,CD48,CD48 antigen,39908,0.00663030196272964,0.00281769422692877,0.00110762127794925,0.01215298264751,0.0186298806917098
NMR metabolomics,X23408.Triglycerides in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00757175177794985,0.00321794378509092,-0.0138789215967281,-0.00126458195917164,0.0186358145521318
NMR metabolomics,X23408.Triglycerides in VLDL,IL19,Interleukin-19,39419,0.0156980645463548,0.00667741485081796,0.00261033143875159,0.028785797653958,0.0187394960068932
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0133392322541478,0.00570132741524296,0.00216463052027161,0.024513833988024,0.0193156206329382
NMR metabolomics,X23408.Triglycerides in VLDL,TSC1,Hamartin,37056,0.0174599423900663,0.00746384478077494,0.00283080661974746,0.0320890781603852,0.019336341658491
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.00863586214138881,0.00370359236388346,-0.0158949031746004,-0.00137682110817723,0.0197261922927768
NMR metabolomics,X23408.Triglycerides in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00852733803128742,0.00366067513358144,0.0013524147694678,0.015702261293107,0.0198505625037795
NMR metabolomics,X23408.Triglycerides in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00748101530086608,0.00321260720524652,-0.0137777254231493,-0.0011843051785829,0.0198903223018666
NMR metabolomics,X23408.Triglycerides in VLDL,CD160,CD160 antigen,40058,0.0101555633309302,0.004365224331371,0.00159972364144308,0.0187114030204174,0.0200057635891891
NMR metabolomics,X23408.Triglycerides in VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.0177512917092263,0.00763985880414742,0.00277716845309735,0.0327254149653552,0.0201641721398537
NMR metabolomics,X23408.Triglycerides in VLDL,KEL,Kell blood group glycoprotein,39489,0.00802583567654149,0.0034571617633047,0.00124979862046428,0.0148018727326187,0.0202721255902548
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN15,Tetraspanin-15,37021,-0.0110473343220286,0.00481973435122818,-0.0204940136504358,-0.00160065499362134,0.0219153294783729
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00917741158352013,0.00401843351012004,-0.0170535412633554,-0.00130128190368485,0.022397488262322
NMR metabolomics,X23408.Triglycerides in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0153448145645578,0.006720231056003,0.0021731616947919,0.0285164674343236,0.022421586012683
NMR metabolomics,X23408.Triglycerides in VLDL,REST,RE1-silencing transcription factor,36962,-0.00793938076585233,0.00348397686771363,-0.014767975426571,-0.00111078610513361,0.022693363333197
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0168188967760493,0.00744927570839761,-0.0314194771645087,-0.00221831638759002,0.0239746274868273
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0100142706767136,0.00443829132030556,0.00131521968891474,0.0187133216645125,0.0240633511543601
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00588876294802314,0.00261690949684282,0.000759620334211207,0.0110179055618351,0.024447567089534
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00813883044864922,0.0036257363585852,-0.0152452737114762,-0.00103238718582224,0.0248015330423305
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM25,Transmembrane protein 25,37411,-0.00977576305767543,0.00436830291511481,-0.0183376367713005,-0.0012138893440504,0.0252446850049837
NMR metabolomics,X23408.Triglycerides in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.00789385636321317,0.00354415119183384,0.000947320027218847,0.0148403926992075,0.0259421179638555
NMR metabolomics,X23408.Triglycerides in VLDL,COL5A1,Collagen alpha-1(V) chain,37124,0.0085982338938126,0.00386449232422839,0.00102382893832497,0.0161726388493002,0.0261025368452754
NMR metabolomics,X23408.Triglycerides in VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.00798396358589901,0.00359208960761824,0.000943467954967265,0.0150244592168308,0.0262560420349141
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0173828406161814,0.00784943287753378,-0.0327677290561476,-0.00199795217621515,0.0268091693038477
NMR metabolomics,X23408.Triglycerides in VLDL,IL36G,Interleukin-36 gamma,37021,0.0145759893502921,0.00658733081739325,0.00166482094820135,0.0274871577523829,0.026933312832142
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.0063132034225864,0.00285426613531225,0.000718841797374392,0.0119075650477984,0.0269910644568821
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00764372809764454,0.00347642054447177,0.000829943830479868,0.0144575123648092,0.0279135663040572
NMR metabolomics,X23408.Triglycerides in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00432706705120002,0.00196880163289413,-0.00818591825167252,-0.000468215850727524,0.027979454825424
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00695067141314633,0.00316464970715719,-0.0131533848391744,-0.000747957987118242,0.0280844782957442
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00431557695348202,0.00196757853771573,0.000459123019559183,0.00817203088740486,0.0282999748550589
NMR metabolomics,X23408.Triglycerides in VLDL,IL11,Interleukin-11,39587,0.013273018492104,0.0060593226006146,0.00139674619489938,0.0251492907893086,0.0285017573160048
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00541306229089064,0.0024744425873331,-0.0102629697620635,-0.000563154819717773,0.0287166398728554
NMR metabolomics,X23408.Triglycerides in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00783046576529527,0.00358020603438886,-0.0148476695926974,-0.000813261937893112,0.0287487426731658
NMR metabolomics,X23408.Triglycerides in VLDL,IL17C,Interleukin-17C,39587,-0.0140731481636369,0.00646880364351823,-0.0267520033049326,-0.00139429302234113,0.0296044327718612
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.011863318029883,0.00545690361960596,-0.0225588491243107,-0.00116778693545534,0.0297194589989123
NMR metabolomics,X23408.Triglycerides in VLDL,EPN1,Epsin-1,37169,0.00912697287066219,0.00420525598553345,0.000884671139016621,0.0173692746023078,0.0299962455222544
NMR metabolomics,X23408.Triglycerides in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.0111327326880084,0.00514409455162515,-0.0212151580091937,-0.00105030736682313,0.0304687943746108
NMR metabolomics,X23408.Triglycerides in VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00569066763457092,0.00262992417275575,0.000536016255969652,0.0108453190131722,0.0304932157597691
NMR metabolomics,X23408.Triglycerides in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00760759007764323,0.00352512168584173,0.000698351573393436,0.014516828581893,0.0309370468566201
NMR metabolomics,X23408.Triglycerides in VLDL,FBLN2,Fibulin-2,37437,-0.00636338961256617,0.0029551481518157,-0.0121554799901249,-0.000571299235007407,0.0313108265099477
NMR metabolomics,X23408.Triglycerides in VLDL,MN1,Transcriptional activator MN1,37039,-0.0124244520632845,0.00577588678780372,-0.0237451901673798,-0.00110371395918922,0.0314872216132056
NMR metabolomics,X23408.Triglycerides in VLDL,REG1B,Lithostathine-1-beta,40052,0.011365259428243,0.00528895981288182,0.000998898194994673,0.0217316206614914,0.0316599005382488
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00666167196293473,0.00311114148205937,0.000563834658098374,0.0127595092677711,0.0322732141192478
NMR metabolomics,X23408.Triglycerides in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0142815097156206,0.00668036490147676,0.00118799450872613,0.027375024922515,0.0325485550408574
NMR metabolomics,X23408.Triglycerides in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.00869520728268012,0.00407422612910062,0.00070972406964291,0.0166806904957173,0.0328415077326595
NMR metabolomics,X23408.Triglycerides in VLDL,HCG22,Protein PBMUCL2,37021,-0.0112624875992223,0.00528936665710325,-0.0216296462471447,-0.000895328951299929,0.0332504703856229
NMR metabolomics,X23408.Triglycerides in VLDL,POF1B,Protein POF1B,37056,0.00940453540905371,0.00441888568856782,0.00074351945946079,0.0180655513586466,0.033334050744679
NMR metabolomics,X23408.Triglycerides in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00824889592142707,0.00387665708999786,-0.0158471438178229,-0.000650648025031262,0.0333690998683921
NMR metabolomics,X23408.Triglycerides in VLDL,LEG1,Protein LEG1 homolog,36703,-0.0144259113653715,0.00683274849820098,-0.0278180984218454,-0.00103372430889755,0.0347666890648466
NMR metabolomics,X23408.Triglycerides in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.00997576870332767,0.00473359135621847,-0.0192536077615159,-0.000697929645139463,0.0350948250307552
NMR metabolomics,X23408.Triglycerides in VLDL,PGM2,Phosphoglucomutase-2,37039,0.0124505143479827,0.0059093666878091,0.000868155639876859,0.0240328730560886,0.0351440742289022
NMR metabolomics,X23408.Triglycerides in VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0180492737769454,0.00856976103067947,0.00125254215681363,0.0348460053970772,0.0352065150157748
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00558639143784944,0.00266617279738161,0.000360692754981479,0.0108120901207174,0.0361611720853609
NMR metabolomics,X23408.Triglycerides in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.0062440116915114,0.00298605270202258,0.000391348395547154,0.0120966749874757,0.0365388032537879
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX2,Peroxiredoxin-2,37249,0.0124128921255693,0.00593988472557909,0.000770718063434249,0.0240550661877043,0.0366588133559933
NMR metabolomics,X23408.Triglycerides in VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00629830841757219,0.00301524388855305,-0.0122081864391362,-0.000388430396008213,0.0367393478943428
NMR metabolomics,X23408.Triglycerides in VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0123027728174928,0.00589562119619687,-0.0238581903620387,-0.000747355272946936,0.0369254951450535
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00678925683844123,0.00326585250599711,-0.0131903277501956,-0.000388185926686898,0.0376493534696272
NMR metabolomics,X23408.Triglycerides in VLDL,COPE,Coatomer subunit epsilon,39489,0.00957369913793138,0.00460973034003005,0.000538627671472482,0.0186087706043903,0.0378320900137806
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM132A,Transmembrane protein 132A,37043,0.0127080077605322,0.00612620372325284,0.000700648462956683,0.0247153670581078,0.0380644041385929
NMR metabolomics,X23408.Triglycerides in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0130325398434224,0.00629387907818513,-0.0253685428366652,-0.000696536850179539,0.0384090235836057
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0151427194293808,0.00731999547083638,-0.0294899105522201,-0.000795528306541476,0.0385957642883515
NMR metabolomics,X23408.Triglycerides in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0123507312900024,0.00597869461547736,-0.0240689727363381,-0.000632489843666805,0.0388678249502202
NMR metabolomics,X23408.Triglycerides in VLDL,SELENOP,Selenoprotein P,37453,0.00447515737027132,0.00216904947632522,0.000223820396673894,0.00872649434386875,0.0391136923216153
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT2,Angiopoietin-2,40030,-0.00762739241864983,0.00370832617979826,-0.0148957117310544,-0.000359073106245238,0.039718694024223
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00632725545498463,0.00307670138601776,-0.0123575901715795,-0.000296920738389813,0.0397497381542409
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00601744807033365,0.002934674213245,0.000265486612373449,0.0117694095282938,0.040335570955657
NMR metabolomics,X23408.Triglycerides in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.0103391012401242,0.0050586317463394,0.00042418301729902,0.0202540194629495,0.0409888389119923
NMR metabolomics,X23408.Triglycerides in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.0050752539675217,0.00249169237079175,-0.00995897101427353,-0.000191536920769865,0.0416824078161685
NMR metabolomics,X23408.Triglycerides in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00523901643487028,0.00257688093446463,-0.0102897030664209,-0.000188329803319612,0.042060544091788
NMR metabolomics,X23408.Triglycerides in VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00481132336936987,0.00237511642695329,-0.00946655156619832,-0.000156095172541421,0.042809934469432
NMR metabolomics,X23408.Triglycerides in VLDL,TAGLN3,Transgelin-3,36962,-0.0118162276128086,0.00583789719343179,-0.0232585061119349,-0.000373949113682347,0.0429846992042648
NMR metabolomics,X23408.Triglycerides in VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.00980580823168398,0.00484898692383782,-0.0193098226024061,-0.000301793860961864,0.0431719029351293
NMR metabolomics,X23408.Triglycerides in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.011115599502143,0.00550132756492512,0.00033299747488978,0.0218982015293963,0.0433486152062698
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0164122595815762,0.0081738463274939,-0.0324329983834642,-0.00039152077968814,0.0446738776008283
NMR metabolomics,X23408.Triglycerides in VLDL,IL31,Interleukin-31,37056,-0.0112167114891706,0.00561165450185641,-0.0222155543128092,-0.000217868665532047,0.0456478404036268
NMR metabolomics,X23408.Triglycerides in VLDL,RTKN2,Rhotekin-2,37021,-0.0100589804598578,0.00507306661593974,-0.0200021910270997,-0.000115769892615927,0.0474082398414775
NMR metabolomics,X23408.Triglycerides in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00710544479476053,0.0035960496579831,-0.0141537021244074,-5.71874651136639e-05,0.0481866327905178
NMR metabolomics,X23408.Triglycerides in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00893661891960829,0.00452699736440646,6.37040853716225e-05,0.017809533753845,0.0483905667028186
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00725562584519168,0.00367914656653141,4.44985747901222e-05,0.0144667531155932,0.0486191522571335
NMR metabolomics,X23408.Triglycerides in VLDL,STX1B,Syntaxin-1B,37039,0.00816614946703629,0.00414808519070689,3.59024932507761e-05,0.0162963964408218,0.0490136229053663
NMR metabolomics,X23408.Triglycerides in VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.0130741999860769,0.00664124981270293,-0.0260910496189746,-5.73503531791156e-05,0.0490158624010712
NMR metabolomics,X23408.Triglycerides in VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00623152200568573,0.00318111525055122,-3.46388539466426e-06,0.0124665078967661,0.0501409524551686
NMR metabolomics,X23408.Triglycerides in VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00436832530374662,0.002249349299017,-4.03993223267018e-05,0.00877704992981993,0.0521499552570153
NMR metabolomics,X23408.Triglycerides in VLDL,MUCL3,Mucin-like protein 3,36962,-0.00850960494438616,0.00439057239301679,-0.0171151268346991,9.59169459267377e-05,0.0526259056237723
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN2,Neuroligin-2,36991,-0.00891772202780492,0.00460207643347978,-0.0179377918374253,0.00010234778181544,0.052673858827965
NMR metabolomics,X23408.Triglycerides in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00933721050064339,0.00482155930121266,-0.00011304572973342,0.0187874667310202,0.0528178748017098
NMR metabolomics,X23408.Triglycerides in VLDL,CTNNA1,Catenin alpha-1,36991,-0.00662869574136692,0.00342934416013196,-0.0133502102952256,9.28188124917186e-05,0.0532658102427393
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0091758042040912,0.0047551771722355,-0.0184959514616728,0.000144343053490367,0.0536684654788323
NMR metabolomics,X23408.Triglycerides in VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00644229482945368,0.00336009806510416,-0.0130280870370578,0.000143497378150476,0.0552221969815408
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.00928282442974412,0.00487476694744482,-0.000271718787247726,0.018837367646736,0.0568980655444372
NMR metabolomics,X23408.Triglycerides in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0111812726077495,0.00587557434054067,-0.0226973983152092,0.00033485309971025,0.0570610727960979
NMR metabolomics,X23408.Triglycerides in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00876062213643395,0.00460720640012245,-0.0177907466806739,0.000269502407806044,0.0572577952290869
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00962743618452156,0.00508471259518273,-0.000338600502036587,0.0195934728710797,0.0583252843836563
NMR metabolomics,X23408.Triglycerides in VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00852095129112685,0.00450818674596178,-0.0173569973132119,0.000315094730958233,0.0587657231061201
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00861001731365518,0.00455855049352401,-0.000324741653651886,0.0175447762809622,0.0589456839956719
NMR metabolomics,X23408.Triglycerides in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.010280798744497,0.00550755754988306,-0.0210756115422678,0.000514014053273759,0.0619697962651232
NMR metabolomics,X23408.Triglycerides in VLDL,FZD8,Frizzled-8,36991,0.0077562395007324,0.0041560897435272,-0.000389696396580904,0.0159021753980457,0.0620307910174412
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0120919297035415,0.00648621707555085,-0.0248049151716211,0.000621055764538195,0.0623088310192959
NMR metabolomics,X23408.Triglycerides in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00699395483939052,0.00375909561510736,-0.000373872566219906,0.0143617822450009,0.062830580579481
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB116,Beta-defensin 116,36991,-0.0140009368590734,0.00755632233497714,-0.0288113286356286,0.000809454917481817,0.0639223920744621
NMR metabolomics,X23408.Triglycerides in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00712883747271469,0.00385152615740089,-0.00042015379579105,0.0146778287412204,0.0642039044717131
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00546725522962317,0.00295756452555918,-0.000329571240472813,0.0112640816997192,0.0645422151518683
NMR metabolomics,X23408.Triglycerides in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0116549075811905,0.00631371728861076,-0.0240297934668676,0.000719978304486569,0.0649156831286069
NMR metabolomics,X23408.Triglycerides in VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00728691037479129,0.00394896020212607,-0.0150268723709584,0.000453051621375801,0.0650202587665092
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00391614351512548,0.00212423153603282,-0.00807963732574981,0.000247350295498849,0.0652693971573177
NMR metabolomics,X23408.Triglycerides in VLDL,GSN,Gelsolin,37383,-0.00334222571509967,0.00182033313790375,-0.00691007866539102,0.000225627235191672,0.0663719551576609
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00793801394556187,0.0043361314607839,-0.0164368316086983,0.000560803717574578,0.0671686388376658
NMR metabolomics,X23408.Triglycerides in VLDL,MSMB,Beta-microseminoprotein,39780,0.0119362220262577,0.00653181814910726,-0.000866141545992547,0.0247385855985079,0.0676588755527851
NMR metabolomics,X23408.Triglycerides in VLDL,KLHL41,Kelch-like protein 41,37411,0.00911451983048502,0.00498920437389611,-0.000664320742351357,0.0188933604033214,0.0677445580415859
NMR metabolomics,X23408.Triglycerides in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.015561846003157,0.00857561468689374,-0.0012463587831547,0.0323700507894688,0.069598710313713
NMR metabolomics,X23408.Triglycerides in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00953545639617292,0.00525913981404643,-0.000772457639358079,0.0198433704317039,0.0698323482840645
NMR metabolomics,X23408.Triglycerides in VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00768285191324589,0.00424268307112576,-0.0159985107326524,0.000632806906160592,0.0701873091736775
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00835408812629625,0.00461836047859197,-0.0174060746643365,0.000697898411744009,0.0704915084575874
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0111862978960081,0.00625007960921682,-0.00106385813805683,0.0234364539300731,0.0735078561664524
NMR metabolomics,X23408.Triglycerides in VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00809906951534208,0.00453132665514744,-0.000782330728746903,0.0169804697594311,0.0739038404557948
NMR metabolomics,X23408.Triglycerides in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.0108789899849654,0.00610078687916366,-0.0228365322681261,0.00107855229819541,0.074574752890625
NMR metabolomics,X23408.Triglycerides in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00830891556807916,0.00466342674819561,-0.0174492319945426,0.000831400858384231,0.0748181350692178
NMR metabolomics,X23408.Triglycerides in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0114679180384878,0.00644375065613103,-0.0240976693245046,0.00116183324752907,0.0751488271708575
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00650999286903983,0.0036659453108205,-0.000675259940168347,0.013695245678248,0.0757884861453268
NMR metabolomics,X23408.Triglycerides in VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00681134192678379,0.00383814403922434,-0.00071142039009591,0.0143341042436635,0.0759796230067836
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA5,Annexin A5,39415,0.0052232845496964,0.00294763842273045,-0.000554086758855273,0.0110006558582481,0.0764102284716749
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00982059756462352,0.00555235374322992,-0.00106201577210713,0.0207032109013542,0.076958958263191
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00746288850854987,0.00421994041457333,-0.0157339717211136,0.000808194704013854,0.0770034640745378
NMR metabolomics,X23408.Triglycerides in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00994907213056599,0.00563312765223612,-0.0010918580678168,0.0209900023289488,0.0773902349839148
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0206862686376077,0.0117217163324602,-0.00228829537401423,0.0436608326492296,0.0776200307861041
NMR metabolomics,X23408.Triglycerides in VLDL,CD99,CD99 antigen,39858,-0.00328904881669736,0.00186456864596578,-0.00694360336279029,0.000365505729395559,0.0777556017143773
NMR metabolomics,X23408.Triglycerides in VLDL,MYOC,Myocilin,39858,-0.00787161174201335,0.00447491705037063,-0.0166424491607398,0.000899225676713099,0.0785877927415251
NMR metabolomics,X23408.Triglycerides in VLDL,NOP56,Nucleolar protein 56,37021,0.0189159354427011,0.0107728882527354,-0.00219892553266017,0.0400307964180625,0.0791315821453714
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5A,Cytochrome b5,36962,0.0122592314678873,0.00699625228047438,-0.00145342300184246,0.0259718859376171,0.0797530312210655
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.0083414754314024,0.00476915816985109,-0.00100607458150572,0.0176890254443105,0.0803058370360708
NMR metabolomics,X23408.Triglycerides in VLDL,SOX9,Transcription factor SOX-9,37039,0.0045999279361725,0.00263738391748263,-0.000569344542093461,0.00976920041443846,0.081160562405235
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.0050734626587192,0.00290902612414919,-0.0107751538620516,0.000628228544613218,0.0811751156008632
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.00834178440541428,0.00479343151521093,-0.0177369101752277,0.00105334136439915,0.0818378185737949
NMR metabolomics,X23408.Triglycerides in VLDL,WNT9A,Protein Wnt-9a,39587,0.00476419173752512,0.0027389721091506,-0.000604193596410053,0.0101325770714603,0.0819824751090891
NMR metabolomics,X23408.Triglycerides in VLDL,MAPT,Microtubule-associated protein tau,39489,0.00890941334846704,0.00513023870237922,-0.00114585450819624,0.0189646812051303,0.0824692121136478
NMR metabolomics,X23408.Triglycerides in VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0114689036194414,0.00661805683678137,-0.0244402950195329,0.00150248778065012,0.0831241332372093
NMR metabolomics,X23408.Triglycerides in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0110371216364208,0.00638465853408273,-0.023551052363223,0.00147680909038132,0.0838832078486006
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_A,,37411,0.00544572869178834,0.00315184646497022,-0.000731890379553287,0.01162334776313,0.0840486704826928
NMR metabolomics,X23408.Triglycerides in VLDL,ERVV_1,,37021,-0.00810223873031867,0.0046964460726394,-0.0173072730326919,0.00110279557205456,0.0845175976811666
NMR metabolomics,X23408.Triglycerides in VLDL,CPLX2,Complexin-2,36962,-0.00505077365400946,0.0029284509372592,-0.0107905374910375,0.000688990183018576,0.0846005592130361
NMR metabolomics,X23408.Triglycerides in VLDL,ADA2,Adenosine deaminase 2,39782,-0.00688228044685983,0.0040159906705377,-0.0147536221611137,0.000989061267394067,0.086599767616452
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00903992069110731,0.0052932482270734,-0.0194146872161712,0.00133484583395656,0.0876931371659516
NMR metabolomics,X23408.Triglycerides in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00676702817271645,0.00397519349317298,-0.0145584074193355,0.0010243510739026,0.0887201609470634
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00964634459554255,0.00570352889705034,-0.00153257204267612,0.0208252612337612,0.0908001857184522
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB2,Integrin beta-2,39731,-0.00472793590931117,0.00279887537375422,-0.0102137316418694,0.000757859823247102,0.0911955748494561
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.011274617375481,0.00667800177700631,-0.00181426610745139,0.0243635008584133,0.0913730611822789
NMR metabolomics,X23408.Triglycerides in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00761492161637745,0.00452128827945891,-0.00124680341136202,0.0164766466441169,0.092159561577374
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP2,Dipeptidase 2,39788,-0.00475098535456113,0.00282828051335204,-0.0102944151607311,0.000792444451608864,0.0930131110458117
NMR metabolomics,X23408.Triglycerides in VLDL,FGF12,Fibroblast growth factor 12,37056,0.00768027680856362,0.00457716213178069,-0.00129096096972653,0.0166515145868538,0.0933793629472869
NMR metabolomics,X23408.Triglycerides in VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00649769450016241,0.00387867860699589,-0.00110451556954953,0.0140999045698743,0.0939120739730278
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3G,Semaphorin-3G,37124,0.00715043288141411,0.00428027472419271,-0.0012389055780036,0.0155397713408318,0.0948332677654883
NMR metabolomics,X23408.Triglycerides in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00780902262541375,0.00467908344097429,-0.0169800261697233,0.00136198091889585,0.095156674053669
NMR metabolomics,X23408.Triglycerides in VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00653097617297633,0.00391449962557139,-0.0011414430931436,0.0142033954390963,0.0952544903895114
NMR metabolomics,X23408.Triglycerides in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0150845556470883,0.00905007696131074,-0.00265359519708077,0.0328227064912573,0.0955805574995906
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0112564069394467,0.00676931228315984,-0.0245242590144399,0.00201144513554662,0.0963646743837566
NMR metabolomics,X23408.Triglycerides in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0109633365304861,0.00659405692363929,-0.0238876881008191,0.00196101503984695,0.0964145973623148
NMR metabolomics,X23408.Triglycerides in VLDL,ENO1,Alpha-enolase,39830,0.0127881584413817,0.0076974976542435,-0.00229893696093553,0.027875253843699,0.0966648695538736
NMR metabolomics,X23408.Triglycerides in VLDL,KLK12,Kallikrein-12,39477,-0.0221993717676143,0.0134159052976531,-0.0484945461510144,0.00409580261578583,0.0980043535807189
NMR metabolomics,X23408.Triglycerides in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00446850855908118,0.00271351155680502,-0.000849974092256661,0.00978699121041901,0.0996307227008693
NMR metabolomics,X23408.Triglycerides in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00697740307330045,0.0042465288649666,-0.00134579350203408,0.015300599648635,0.100389204426349
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00974451964964543,0.00594055498091804,-0.00189896811295392,0.0213880074122448,0.100958718469565
NMR metabolomics,X23408.Triglycerides in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0136071898338879,0.00830048875444268,-0.0298761477925956,0.00266176812481973,0.101169715989287
NMR metabolomics,X23408.Triglycerides in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00410031125214609,0.00250199292900104,-0.00900421739298812,0.000803594888695942,0.101275162436788
NMR metabolomics,X23408.Triglycerides in VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00578659490478285,0.00353387232796697,-0.0127129846675981,0.00113979485803241,0.101557204192062
NMR metabolomics,X23408.Triglycerides in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00897673590711587,0.00548388496805487,-0.0197251504445034,0.00177167863027168,0.101669109794104
NMR metabolomics,X23408.Triglycerides in VLDL,OGN,Mimecan,39858,0.00629329289002643,0.00384577587219046,-0.00124442781946687,0.0138310135995197,0.101772020774391
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.00751872148349595,0.00461027633771678,-0.0165548631054208,0.00151742013842894,0.102939308094609
NMR metabolomics,X23408.Triglycerides in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00478014905312027,0.00293159545803704,-0.0105260761508729,0.000965778044632319,0.103006691421653
NMR metabolomics,X23408.Triglycerides in VLDL,HSP90B1,Endoplasmin,39405,0.0107110136632208,0.00656951521092834,-0.00216523615019876,0.0235872634766403,0.103034798614958
NMR metabolomics,X23408.Triglycerides in VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.00923942636563798,0.00570696159554678,-0.0019462183616337,0.0204250710929097,0.105472211732716
NMR metabolomics,X23408.Triglycerides in VLDL,IL9,Interleukin-9,37169,-0.00905134028592294,0.00559202802809632,-0.0200117152209917,0.00190903464914586,0.105553827326333
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00534341462972244,0.0033082937714229,-0.00114084116226645,0.0118276704217113,0.106296213983658
NMR metabolomics,X23408.Triglycerides in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00503185698663604,0.00311566391832199,-0.00107484429327505,0.0111385582665471,0.106330567001469
NMR metabolomics,X23408.Triglycerides in VLDL,CD82,CD82 antigen,37169,-0.00663063519281311,0.00411502853182572,-0.0146960911151915,0.0014348207295653,0.10713331389387
NMR metabolomics,X23408.Triglycerides in VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00640653196917872,0.00397634835278066,-0.0142001747406288,0.00138711080227138,0.107164592552305
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00768625043957825,0.00477425119381288,-0.0170437827794515,0.001671281900295,0.107435337138359
NMR metabolomics,X23408.Triglycerides in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00766854289718658,0.00476964602987393,-0.00167996332136632,0.0170170491157395,0.10790794068429
NMR metabolomics,X23408.Triglycerides in VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00407055814913966,0.00253183115913956,-0.00903294722105321,0.000891830922773879,0.10791346703992
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00746621861377599,0.00464672870834133,-0.00164136965457302,0.016573806882125,0.108128398433776
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1B,Protein phosphatase 1B,37056,0.0100018827428782,0.00622723785506791,-0.00220350345305491,0.0222072689388113,0.10826471882816
NMR metabolomics,X23408.Triglycerides in VLDL,DAND5,DAN domain family member 5,37056,-0.00842072799814752,0.00524490198724331,-0.0187007358931444,0.00185927989684937,0.108406154400543
NMR metabolomics,X23408.Triglycerides in VLDL,HEBP1,Heme-binding protein 1,39585,-0.0083937619336639,0.00523157512825374,-0.0186476491850412,0.00186012531771344,0.108636612015159
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0122354341773225,0.00763629388587116,-0.002731701838985,0.0272025701936299,0.109115146100489
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00607875051539942,0.0038030347381371,-0.0013751975713493,0.0135326986021481,0.10997917031411
NMR metabolomics,X23408.Triglycerides in VLDL,LAYN,Layilin,39713,0.0049899390509075,0.00314102920754517,-0.00116647819588103,0.011146356297696,0.112163474367949
NMR metabolomics,X23408.Triglycerides in VLDL,SHPK,Sedoheptulokinase,37169,-0.00648851031558278,0.00408941822650574,-0.014503770039534,0.00152674940836847,0.112613759668442
NMR metabolomics,X23408.Triglycerides in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0130569812286447,0.00826384102958019,-0.00314014718933243,0.0292541096466219,0.114127750110746
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0131179726322162,0.00831909198032657,-0.0294233929136563,0.00318744764922385,0.114853693729804
NMR metabolomics,X23408.Triglycerides in VLDL,JUN,Transcription factor AP-1,39587,0.00794058374075572,0.00505493948800049,-0.00196709765572524,0.0178482651372367,0.116236139029315
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN4,Alpha-actinin-4,39587,0.00478242523355297,0.00305763672131177,-0.0012105427402181,0.010775393207324,0.117816076958619
NMR metabolomics,X23408.Triglycerides in VLDL,BSND,Barttin,36962,-0.00513176784870211,0.0032918599865798,-0.0115838134223985,0.00132027772499431,0.119037924270587
NMR metabolomics,X23408.Triglycerides in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00763064707328359,0.00489614387035614,-0.00196579491261445,0.0172270890591816,0.119138481080034
NMR metabolomics,X23408.Triglycerides in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00398534118656518,0.00256200329378742,-0.00103618526925815,0.00900686764238852,0.119837713879991
NMR metabolomics,X23408.Triglycerides in VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.0114671011452382,0.00740008384392715,-0.00303706318885907,0.0259712654793354,0.12126382981701
NMR metabolomics,X23408.Triglycerides in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00996328170019497,0.00643268929981084,-0.0225713527278242,0.00264478932743427,0.121441528945548
NMR metabolomics,X23408.Triglycerides in VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00387462353858562,0.00250347039207511,-0.00878142550705283,0.00103217842988159,0.121717603759253
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.00469483261370426,0.00303472943981182,-0.0106429023157354,0.00125323708832691,0.121878820948968
NMR metabolomics,X23408.Triglycerides in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.0083224382056356,0.00538554366588195,-0.0188781037907642,0.00223322737949302,0.122290621319581
NMR metabolomics,X23408.Triglycerides in VLDL,BCAN,Brevican core protein,39749,-0.00500521641188493,0.00324144137988315,-0.0113584415164559,0.00134800869268605,0.122576045245875
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00688948746981209,0.00448283459917877,-0.0156758432842025,0.00189686834457829,0.124351665691868
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00962462698986276,0.00629096355481027,-0.0219549155572909,0.00270566157756536,0.12606226329862
NMR metabolomics,X23408.Triglycerides in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00697558917784265,0.00456679856841869,-0.00197533601625798,0.0159265143719433,0.126667608206451
NMR metabolomics,X23408.Triglycerides in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.0064365565858082,0.00424813814908511,-0.014762907358015,0.00188979418639863,0.129759137049916
NMR metabolomics,X23408.Triglycerides in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00847100663743201,0.00560977008984256,-0.00252414273865942,0.0194661560135234,0.13105523560296
NMR metabolomics,X23408.Triglycerides in VLDL,TEF,Thyrotroph embryonic factor,37021,0.0062493196308555,0.00414068493002394,-0.00186642283199141,0.0143650620937024,0.131259473706175
NMR metabolomics,X23408.Triglycerides in VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0122339576350564,0.00811925970278283,-0.00367979138239795,0.0281477066525108,0.13189047734744
NMR metabolomics,X23408.Triglycerides in VLDL,PRG3,Proteoglycan 3,37437,-0.00732341629760015,0.00487795334882913,-0.0168842048613052,0.00223737226610496,0.133293558545721
NMR metabolomics,X23408.Triglycerides in VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.0158833974701808,0.0106356513317276,-0.036729274080367,0.00496247914000537,0.135352914891505
NMR metabolomics,X23408.Triglycerides in VLDL,MSLNL,Mesothelin-like protein,37039,-0.00525509908516193,0.00354151592804021,-0.0121964703041207,0.00168627213379689,0.13787108430051
NMR metabolomics,X23408.Triglycerides in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0374174175942031,0.0252287084767181,-0.0868656862085706,0.0120308510201645,0.138064167443402
NMR metabolomics,X23408.Triglycerides in VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00765447538951684,0.00516445194471303,-0.00246785042212069,0.0177768012011544,0.138325316068373
NMR metabolomics,X23408.Triglycerides in VLDL,NRXN3,Neurexin-3,37039,0.00507372838147734,0.00342453184556039,-0.00163835403582103,0.0117858107987757,0.13847517629868
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B4,Protein ATP1B4,36962,-0.0060524608026174,0.00408866140084521,-0.014066237148274,0.00196131554303922,0.138816247737374
NMR metabolomics,X23408.Triglycerides in VLDL,CDH22,Cadherin-22,37169,-0.00417098623906878,0.00283030160020815,-0.00971837737547676,0.0013764048973392,0.140588815287232
NMR metabolomics,X23408.Triglycerides in VLDL,TAP1,Antigen peptide transporter 1,37169,-0.00846514855537886,0.00574436783076979,-0.0197241095036877,0.00279381239292992,0.140601335630241
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS2,Podocin,37056,-0.0146048433367101,0.00996755784420686,-0.0341412567113555,0.00493157003793539,0.14287985241406
NMR metabolomics,X23408.Triglycerides in VLDL,MMP13,Collagenase 3,39489,-0.00455314476428899,0.00312659957617633,-0.0106812799335946,0.00157499040501662,0.145340593099744
NMR metabolomics,X23408.Triglycerides in VLDL,TP73,Tumor protein p73,37039,-0.00490763373490314,0.0033788778032955,-0.0115302342293623,0.00171496675955604,0.146401754265061
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN5,Contactin-5,39897,-0.00506312785319063,0.00350502468763135,-0.0119329762409481,0.00180672053456683,0.148608317939765
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00606357598908971,0.00423611685919184,-0.0143663650331057,0.00223921305492629,0.152339404358878
NMR metabolomics,X23408.Triglycerides in VLDL,PTTG1,Securin,37169,0.00582391399957157,0.00407521981218609,-0.00216351683231317,0.0138113448314563,0.152997738754553
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1,DNA topoisomerase 1,37382,0.0158273854472341,0.0111110658130197,-0.00595030354628453,0.0376050744407526,0.154333396704251
NMR metabolomics,X23408.Triglycerides in VLDL,COL3A1,Collagen alpha-1(III) chain,37437,0.00323181217267583,0.00227049533026025,-0.00121835867463427,0.00768198301998593,0.154644599238065
NMR metabolomics,X23408.Triglycerides in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00667626656715952,0.00471717475369987,-0.0159219290844113,0.00256939595009222,0.157001131010771
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN1,Cerebellin-1,36991,-0.0131142999943919,0.00938844677732773,-0.0315156556779542,0.00528705568917045,0.162480747744687
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00438823258512174,0.00314551433246045,-0.0105534406767442,0.00177697550650075,0.16301641866362
NMR metabolomics,X23408.Triglycerides in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.0064744194807253,0.00468738933622186,-0.00271286361826955,0.0156617025797202,0.167227382366823
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA6C,Semaphorin-6C,37056,0.0035159285286722,0.00255709557980993,-0.00149597880775526,0.00852783586509966,0.169164232826307
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00821181802336714,0.00601722259910199,-0.00358193827087275,0.020005574317607,0.172360909368633
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00446773485390988,0.0032746564107741,-0.00195059171120736,0.0108860614190271,0.172484859077338
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00858419547841469,0.00629576802122064,-0.00375550984317777,0.0209239008000071,0.172748836728869
NMR metabolomics,X23408.Triglycerides in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00475541401582618,0.00349973359749681,-0.00210406383526756,0.0116148918669199,0.174235173827423
NMR metabolomics,X23408.Triglycerides in VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.0061866074761654,0.00455508565406994,-0.00274136040581168,0.0151145753581425,0.174431162846744
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.005613427898419,0.00415308183591323,-0.00252661249997092,0.0137534682968089,0.176512893975604
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.00772626689162062,0.00572827709670408,-0.00350115621791937,0.0189536900011606,0.177426248185417
NMR metabolomics,X23408.Triglycerides in VLDL,IL1A,Interleukin-1 alpha,39587,0.00699403861732727,0.00519979725534003,-0.00319756400313917,0.0171856412377937,0.178625296393243
NMR metabolomics,X23408.Triglycerides in VLDL,TCN1,Transcobalamin-1,37235,0.00449079058112187,0.00333902144151919,-0.00205369144425573,0.0110352726064995,0.178666730896286
NMR metabolomics,X23408.Triglycerides in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.0083386954758679,0.00621515209933459,-0.0205203935905637,0.00384300263882789,0.179725521484129
NMR metabolomics,X23408.Triglycerides in VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00653012340560804,0.00489086594453359,-0.0161162206568939,0.00305597384567778,0.181844851907699
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171A2,Protein FAM171A2,37411,0.0204689182975294,0.0153384128645574,-0.00959437091700305,0.0505322075120618,0.182066604766625
NMR metabolomics,X23408.Triglycerides in VLDL,UNG,Uracil-DNA glycosylase,37368,0.00451605442498198,0.00338638810690825,-0.00212126626455818,0.0111533751145222,0.182360640961047
NMR metabolomics,X23408.Triglycerides in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00949665131583311,0.00715754276904961,-0.0235254351431703,0.00453213251150412,0.18459683291734
NMR metabolomics,X23408.Triglycerides in VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00542027885527181,0.00408956736876991,-0.00259527318751721,0.0134358308980608,0.185064258386811
NMR metabolomics,X23408.Triglycerides in VLDL,CD70,CD70 antigen,39866,-0.00543969330567698,0.00411352561085517,-0.0135022035029531,0.00262281689159915,0.186056550969455
NMR metabolomics,X23408.Triglycerides in VLDL,PROK1,Prokineticin-1,39866,0.00829638845472327,0.00630537900837778,-0.00406215440169718,0.0206549313111437,0.188272230525949
NMR metabolomics,X23408.Triglycerides in VLDL,CTRC,Chymotrypsin-C,39856,0.00786373293720536,0.0060125226360973,-0.00392081142954535,0.0196482773039561,0.190928587294111
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL1,Interferon lambda-1,39489,0.00570972059954237,0.0043743660371328,-0.00286403683323792,0.0142834780323227,0.191820775634443
NMR metabolomics,X23408.Triglycerides in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.0109138597428082,0.00836264689209858,-0.0273046476513214,0.00547692816570502,0.191890754867551
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR1B,Cornifin-B,37169,0.0111545083552108,0.00855999812538123,-0.00562308797053642,0.027932104680958,0.192564172347847
NMR metabolomics,X23408.Triglycerides in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00918623103119711,0.00706534232065732,-0.0230343019796855,0.00466183991729125,0.193561107741483
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00664226562740831,0.00511695976617295,-0.0166715067691073,0.00338697551429066,0.194279524636018
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD7,FERM domain-containing protein 7,37039,0.0042491563354505,0.00328126399456551,-0.00218212109389791,0.0106804337647989,0.195351382064257
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00548974182621498,0.00423937949034246,-0.0137989256272862,0.00281944197485623,0.195363664781938
NMR metabolomics,X23408.Triglycerides in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00439751479289494,0.00339804608199715,-0.00226265552781947,0.0110576851136093,0.195642375754502
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00505855547657977,0.00393862868021828,-0.0127782676898076,0.00266115673664806,0.19904385228406
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00587630183483106,0.0045825722621638,-0.00310553979900999,0.0148581434686721,0.19975113485238
NMR metabolomics,X23408.Triglycerides in VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00364523353763749,0.00284907385384111,-0.00193895121589108,0.00922941829116607,0.200762230208232
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00576716386489101,0.00450911022499111,-0.0146050199058736,0.00307069217609157,0.200918779502927
NMR metabolomics,X23408.Triglycerides in VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00472676560142276,0.00369786785673428,-0.011974586600622,0.00252105539777643,0.201187073329008
NMR metabolomics,X23408.Triglycerides in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00369211145750139,0.00289102791666893,-0.00935852617417249,0.00197430325916971,0.201591262593485
NMR metabolomics,X23408.Triglycerides in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00251070333105487,0.00196657552662572,-0.00636519136324127,0.00134378470113154,0.201730854025432
NMR metabolomics,X23408.Triglycerides in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00416119496873875,0.0032621232775175,-0.00223256665519555,0.010554956592673,0.202112488695255
NMR metabolomics,X23408.Triglycerides in VLDL,RELB,Transcription factor RelB,37056,0.00612427965804308,0.00480459903550387,-0.00329273445154452,0.0155412937676307,0.202448410134028
NMR metabolomics,X23408.Triglycerides in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00769327405725324,0.00603971791803502,-0.0195311211766019,0.0041445730620954,0.202763762030447
NMR metabolomics,X23408.Triglycerides in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00970777668894512,0.00762649805822369,-0.00524015950517331,0.0246557128830635,0.203075642980693
NMR metabolomics,X23408.Triglycerides in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00307486197457239,0.00242088245010102,-0.0016700676276256,0.00781979157677038,0.204056174974224
NMR metabolomics,X23408.Triglycerides in VLDL,NPTN,Neuroplastin,39477,0.010369964576164,0.00817805987311489,-0.00565903277514114,0.0263989619274692,0.204808790753632
NMR metabolomics,X23408.Triglycerides in VLDL,EDNRB,Endothelin receptor type B,37056,0.00576562504852425,0.00455598149052856,-0.00316409867291172,0.0146953487699602,0.205712096035538
NMR metabolomics,X23408.Triglycerides in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0119688933452221,0.00950836369215527,-0.0306052861818465,0.00666749949140219,0.208133832156971
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00599248007312531,0.00478105510936825,-0.00337838794123645,0.0153633480874871,0.210089619093847
NMR metabolomics,X23408.Triglycerides in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00422767712363768,0.00337384283762278,-0.0108404090853783,0.00238505483810297,0.210200860038467
NMR metabolomics,X23408.Triglycerides in VLDL,IL17F,Interleukin-17F,39587,-0.00937091166500179,0.00754723132791721,-0.0241634850677195,0.00542166173771595,0.214389529953985
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00615025442737345,0.00495977161793389,-0.0158714067985239,0.00357089794377698,0.214987239173709
NMR metabolomics,X23408.Triglycerides in VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00720796914283425,0.00581509459112413,-0.0186055545414375,0.00418961625576904,0.21517210018544
NMR metabolomics,X23408.Triglycerides in VLDL,CYTH3,Cytohesin-3,36962,0.00873722024815781,0.00706032203697445,-0.00510101094431212,0.0225754514406277,0.215919922044894
NMR metabolomics,X23408.Triglycerides in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00691440195476042,0.00562287698089963,-0.00410643692780285,0.0179352408373237,0.21883487009441
NMR metabolomics,X23408.Triglycerides in VLDL,EVPL,Envoplakin,37169,-0.00393694316087352,0.00321434860983561,-0.0102370664361513,0.00236318011440427,0.220671208992326
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC8,Histone deacetylase 8,37056,0.00755292917166424,0.00617248284464472,-0.0045451372038394,0.0196509955471679,0.221107938825863
NMR metabolomics,X23408.Triglycerides in VLDL,CDH17,Cadherin-17,39868,-0.00784803641052585,0.00646809098225041,-0.0205254947357367,0.00482942191468496,0.225015223822461
NMR metabolomics,X23408.Triglycerides in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.0034298452986065,0.0028271221842269,-0.00211131418247823,0.00897100477969123,0.22507482607267
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00987486286090408,0.00815006007490706,-0.0258489806077219,0.00609925488591376,0.225675634792952
NMR metabolomics,X23408.Triglycerides in VLDL,IL33,Interleukin-33,39587,0.00460149785358512,0.00381190445735915,-0.00286983488283881,0.0120728305900091,0.227396841500936
NMR metabolomics,X23408.Triglycerides in VLDL,CLINT1,Clathrin interactor 1,36962,-0.00572714976710773,0.00477608569737458,-0.0150882777339619,0.00363397819974646,0.230498913604469
NMR metabolomics,X23408.Triglycerides in VLDL,AOC3,Membrane primary amine oxidase,39931,-0.0035055774673806,0.00292426613321931,-0.00923713908849044,0.00222598415372925,0.230627757471993
NMR metabolomics,X23408.Triglycerides in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00663344127496105,0.00554249318915499,-0.00422984537578272,0.0174967279257048,0.231393130586513
NMR metabolomics,X23408.Triglycerides in VLDL,OTOA,Otoancorin,36991,-0.00619026054580442,0.00517327018432762,-0.0163298701070866,0.00394934901547772,0.231489724506564
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB2,Beta-crystallin B2,37388,0.00662583987423809,0.00554330713663782,-0.00423904211357203,0.0174907218620482,0.231996087343616
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0106616898383367,0.00892220040541136,-0.028149202632943,0.00682582295626953,0.232123533411636
NMR metabolomics,X23408.Triglycerides in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00636483350310525,0.00534095114317525,-0.00410343073751824,0.0168330977437287,0.23339881831096
NMR metabolomics,X23408.Triglycerides in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00599757570168125,0.00506022128376112,-0.0159156094178531,0.00392045801449055,0.235944045063249
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB5,Serpin B5,39585,0.00560732556231761,0.00473731084507082,-0.0036778036940212,0.0148924548186564,0.236568898019709
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00542127485125692,0.00458027172558426,-0.0143986074334021,0.00355605773088823,0.236587141830817
NMR metabolomics,X23408.Triglycerides in VLDL,GH2,Growth hormone variant,39477,0.0189348518230987,0.0160089640425255,-0.0124427177002512,0.0503124213464487,0.236920066887983
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.00346508586366085,0.00293055215885509,-0.00227879636769513,0.00920896809501684,0.237064251568199
NMR metabolomics,X23408.Triglycerides in VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.00979619736639117,0.00832690402038886,-0.0261169292463533,0.00652453451357099,0.239435894126898
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00392600257914056,0.00335181544238801,-0.00264355568793994,0.0104955608462211,0.24149354626311
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4C,Semaphorin-4C,39788,0.00320685305086858,0.00275554113071804,-0.00219400756533879,0.00860771366707595,0.244529229866016
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.00431129609011268,0.00371046878869045,-0.011583814915946,0.00296122273572061,0.245282238886565
NMR metabolomics,X23408.Triglycerides in VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00674936128982491,0.00584783702955982,-0.00471239928811233,0.0182111218677621,0.248450597239172
NMR metabolomics,X23408.Triglycerides in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00564770387135266,0.0048937935962747,-0.0152395393200511,0.00394413157734575,0.248498930319006
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L,Seizure 6-like protein,39913,0.00301951357913178,0.00262152628313444,-0.00211867793581173,0.00815770509407528,0.249414211665262
NMR metabolomics,X23408.Triglycerides in VLDL,TTN,Titin,37021,-0.00767239568587333,0.00667767603790543,-0.020760640720168,0.00541584934842131,0.250592550909817
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00287736051216647,0.00250577322678669,-0.00778867603666837,0.00203395501233544,0.250868118958853
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00608731493407824,0.00530264583666938,-0.0164805007739502,0.00430587090579375,0.250998764479382
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00713616333756795,0.00621896488978946,-0.0193253345215553,0.00505300784641938,0.251202552561642
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.0028340891633317,0.00247094605262934,-0.0020089650998218,0.00767714342648521,0.251416975392029
NMR metabolomics,X23408.Triglycerides in VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.0117676648485976,0.0102681338384877,-0.00835787747483841,0.0318932071720335,0.25180058435079
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.0016185234444996,0.00141250326464943,-0.00114998295421329,0.00438702984321249,0.251875535612076
NMR metabolomics,X23408.Triglycerides in VLDL,DCC,Netrin receptor DCC,37039,0.00251487082720787,0.00220748613715781,-0.00181180200162144,0.00684154365603718,0.25462106746635
NMR metabolomics,X23408.Triglycerides in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0108373344717787,0.0095284249911801,-0.00783837851093433,0.0295130474544917,0.255404267266519
NMR metabolomics,X23408.Triglycerides in VLDL,CHIT1,Chitotriosidase-1,39906,0.0166808620301171,0.0146826686226951,-0.0120971684703652,0.0454588925305994,0.25593503965471
NMR metabolomics,X23408.Triglycerides in VLDL,ANK2,Ankyrin-2,37021,-0.00787736848888112,0.00693476397847071,-0.0214695058866837,0.00571476890892148,0.25600883672241
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00649666339210728,0.005740387443517,-0.0177478227814006,0.00475449599718604,0.257761693775769
NMR metabolomics,X23408.Triglycerides in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00478579467176688,0.00422977630528659,-0.0130761562301286,0.00350456688659484,0.257884340007049
NMR metabolomics,X23408.Triglycerides in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.00540626029217741,0.00478700077228587,-0.0147887818058577,0.00397626122150289,0.258761726320263
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00285203905315849,0.00253186729354908,-0.0021104208421977,0.00781449894851469,0.259989193489222
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0186867383872363,0.0166223318259799,-0.0512665087661568,0.0138930319916843,0.260950366938478
NMR metabolomics,X23408.Triglycerides in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00531427315949582,0.00473985564949596,-0.0146043902325079,0.00397584391351626,0.262228046762318
NMR metabolomics,X23408.Triglycerides in VLDL,AKAP12,A-kinase anchor protein 12,37124,-0.00230576246615764,0.00205999975761543,-0.00634336199108388,0.0017318370587686,0.263031463663915
NMR metabolomics,X23408.Triglycerides in VLDL,CDSN,Corneodesmosin,39992,0.00459430563858436,0.00411997239737192,-0.0034808402602646,0.0126694515374333,0.264811243873338
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG4,Proteasome assembly chaperone 4,37056,0.00603330222487476,0.00541558726685724,-0.00458124881816544,0.016647853267915,0.265272702370279
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA11,Serpin A11,40052,-0.00443576185829566,0.00398259940600853,-0.0122416566940724,0.00337013297748106,0.265387710055406
NMR metabolomics,X23408.Triglycerides in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00588027972916536,0.00532666881124658,-0.00455999114087793,0.0163205505992087,0.26963956105036
NMR metabolomics,X23408.Triglycerides in VLDL,CASP4,Caspase-4,37169,-0.0176746799427112,0.01609856576029,-0.0492278688328797,0.0138785089474573,0.272266267965037
NMR metabolomics,X23408.Triglycerides in VLDL,PALM3,Paralemmin-3,37021,0.0080937698511433,0.00738665995114616,-0.00638408365310318,0.0225716233553898,0.273217892480535
NMR metabolomics,X23408.Triglycerides in VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.00894495034846841,0.008193894582097,-0.00711508303244171,0.0250049837293785,0.274999116522095
NMR metabolomics,X23408.Triglycerides in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00514189485153432,0.00471302642562535,-0.01437942664576,0.00409563694269136,0.275294413334242
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00571306013485635,0.00526436580654251,-0.0160312171156797,0.00460509684596698,0.277838677889615
NMR metabolomics,X23408.Triglycerides in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00296107389715767,0.00273177790553961,-0.00239321079769996,0.0083153585920153,0.278412253609459
NMR metabolomics,X23408.Triglycerides in VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0101205097380957,0.00934469418392893,-0.00819509086240506,0.0284361103385964,0.27881842987101
NMR metabolomics,X23408.Triglycerides in VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00553595673631256,0.0051216590582304,-0.0155744084904441,0.00450249501781903,0.279764703154838
NMR metabolomics,X23408.Triglycerides in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.0057611709386458,0.00534302530432417,-0.0162335005351212,0.00471115865782958,0.280937553645848
NMR metabolomics,X23408.Triglycerides in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00395474726078824,0.00367372148747898,-0.00324574685467057,0.0111552413762471,0.281721907450493
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00282292066416965,0.00262404498892004,-0.00796604884245292,0.00232020751411363,0.282037332945129
NMR metabolomics,X23408.Triglycerides in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00901862956257551,0.0084495511108841,-0.0255797497399083,0.00754249061475733,0.285833114613228
NMR metabolomics,X23408.Triglycerides in VLDL,BMP10,Bone morphogenetic protein 10,37124,-0.00294835931503319,0.00276234229030715,-0.0083625502040352,0.00246583157396882,0.285837611151895
NMR metabolomics,X23408.Triglycerides in VLDL,FBN2,Fibrillin-2,37039,0.00625983054034519,0.00586673542876255,-0.00523897090002941,0.0177586319807198,0.285989546432672
NMR metabolomics,X23408.Triglycerides in VLDL,ISM2,Isthmin-2,37437,-0.00462915174425355,0.00434434832911572,-0.0131440744693204,0.00388577098081327,0.286642793305964
NMR metabolomics,X23408.Triglycerides in VLDL,IL20,Interleukin-20,39587,0.00506481019701669,0.00475504473784739,-0.0042550774891642,0.0143846978831976,0.28682685407377
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00788115378435521,0.00741735660154591,-0.0224191727233852,0.00665686515467476,0.288015305879746
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00340526281055355,0.00320744842107801,-0.00288133609475935,0.00969186171586645,0.288403407908414
NMR metabolomics,X23408.Triglycerides in VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.0109366172016361,0.010301323990265,-0.0311272122225556,0.00925397781928331,0.288403941788039
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00370590486004603,0.00353527792656505,-0.0106350495961135,0.00322323987602147,0.294533063522976
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00603506331580217,0.00578074286348818,-0.00529519269663466,0.017365319328239,0.296506931321545
NMR metabolomics,X23408.Triglycerides in VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,0.00363123017455013,0.0034812679029959,-0.00319205491532184,0.0104545152644221,0.296928426384498
NMR metabolomics,X23408.Triglycerides in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00408779534660604,0.0039341594369384,-0.00362315714979323,0.0117987478430053,0.298799745783569
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.00547361459856224,0.00528887172649851,-0.00489257398537484,0.0158398031824993,0.300717087269892
NMR metabolomics,X23408.Triglycerides in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00520104899097763,0.00503913011713885,-0.0150777440205698,0.00467564603861452,0.302029081352917
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00319977894441338,0.00310726338383997,-0.00289045728791297,0.00929001517673972,0.30313196201875
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00748363211527455,0.00729723603014002,-0.00681895050379988,0.021786214734349,0.305125758469074
NMR metabolomics,X23408.Triglycerides in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00646660162111331,0.00630776814277807,-0.0188298271809583,0.0058966239387317,0.305296815407674
NMR metabolomics,X23408.Triglycerides in VLDL,RLN2,Prorelaxin H2,37095,0.0140642687473558,0.0138693923337034,-0.0131197402267028,0.0412482777214144,0.310577037939924
NMR metabolomics,X23408.Triglycerides in VLDL,C9orf40,Uncharacterized protein C9orf40,37382,0.0078341674334771,0.00774283745223913,-0.00734179397291159,0.0230101288398658,0.311653986738311
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0116519188821181,0.0115548720168688,-0.0109956302709447,0.0342994680351809,0.313278308161358
NMR metabolomics,X23408.Triglycerides in VLDL,CRNN,Cornulin,39397,0.0063373484459367,0.00630073808626731,-0.00601209820314723,0.0186867950950206,0.314522405264158
NMR metabolomics,X23408.Triglycerides in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00337812829093216,0.00337403634273009,-0.00999123952268313,0.00323498294081881,0.316742358855266
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.00326943728039951,0.00327631818636491,-0.00315214636487572,0.00969102092567474,0.318343039425311
NMR metabolomics,X23408.Triglycerides in VLDL,IL10,Interleukin-10,39587,0.00769022659639495,0.00770899829050942,-0.00741941005300351,0.0227998632457934,0.318505705749955
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,-0.00276349540160105,0.00278521201604819,-0.0082225109530555,0.00269552014985341,0.32111339141369
NMR metabolomics,X23408.Triglycerides in VLDL,ACTA2,"Actin, aortic smooth muscle",39585,0.0041416954147286,0.00420644682184981,-0.00410294035609703,0.0123863311855542,0.324832482234771
NMR metabolomics,X23408.Triglycerides in VLDL,TLR2,Toll-like receptor 2,37169,-0.00215592257223606,0.00221646139440883,-0.00650018690527738,0.00218834176080525,0.330726703088551
NMR metabolomics,X23408.Triglycerides in VLDL,FGF7,Fibroblast growth factor 7,36962,-0.007547511851318,0.00777002203260737,-0.0227767550352284,0.00768173133259245,0.331385482277044
NMR metabolomics,X23408.Triglycerides in VLDL,TLR4,Toll-like receptor 4,37056,0.00261357745799656,0.00269325110813955,-0.00266519471395696,0.00789234962995008,0.331856316973087
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00724476338234936,0.00749487202527033,-0.0219347125518792,0.00744518578718048,0.333747152057172
NMR metabolomics,X23408.Triglycerides in VLDL,WIF1,Wnt inhibitory factor 1,40030,-0.00315372120262725,0.00326298705432065,-0.00954917582909573,0.00324173342384122,0.33380172464275
NMR metabolomics,X23408.Triglycerides in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.005285959395422,0.00549529385040923,-0.0160567353422241,0.00548481655138009,0.336114197611759
NMR metabolomics,X23408.Triglycerides in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00461318004477131,0.00479773836289847,-0.00479038714650969,0.0140167472360523,0.336302335750674
NMR metabolomics,X23408.Triglycerides in VLDL,S100A3,Protein S100-A3,37368,0.00421470647391839,0.00440671438916099,-0.00442245372883714,0.0128518666766739,0.338872994965465
NMR metabolomics,X23408.Triglycerides in VLDL,PLAU,Urokinase-type plasminogen activator,39858,-0.00266418616207003,0.0027863754397777,-0.00812548202403431,0.00279710969989426,0.339012121977296
NMR metabolomics,X23408.Triglycerides in VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00329963490879725,0.00345838082350684,-0.00347879150527615,0.0100780613228706,0.3400483542166
NMR metabolomics,X23408.Triglycerides in VLDL,ENG,Endoglin,40052,-0.00156477608450753,0.00164944273872132,-0.00479768385240131,0.00166813168338625,0.342802868783517
NMR metabolomics,X23408.Triglycerides in VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00860126349397616,0.00909540433047935,-0.0264282559817157,0.00922572899376336,0.344333543472746
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00576111964274992,0.00609541919054835,-0.00618590197072485,0.0177081412562247,0.344596789338358
NMR metabolomics,X23408.Triglycerides in VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.00429207247888577,0.00455482840059659,-0.0132195361440551,0.00463539118628355,0.346049353291477
NMR metabolomics,X23408.Triglycerides in VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00733224802095886,0.00778655689398,-0.00792940349124194,0.0225938995331597,0.346386807898434
NMR metabolomics,X23408.Triglycerides in VLDL,SELL,L-selectin,37453,-0.00207954245097306,0.00220913258669591,-0.00640944232089704,0.00225035741895093,0.346547939677742
NMR metabolomics,X23408.Triglycerides in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00473274996668428,0.00505220896438046,-0.01463507953687,0.00516957960350143,0.348894865901908
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00564194993062571,0.00605427750078423,-0.00622443397091138,0.0175083338321628,0.351404825124051
NMR metabolomics,X23408.Triglycerides in VLDL,IGLON5,IgLON family member 5,36962,0.00836779986264491,0.00900375109697743,-0.00927955228743085,0.0260151520127207,0.352715428864566
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00377878551937356,0.0040761596017789,-0.00421048730011309,0.0117680583388602,0.353919460792714
NMR metabolomics,X23408.Triglycerides in VLDL,ACRV1,Acrosomal protein SP-10,37056,0.0065953687661542,0.00712765076579962,-0.00737482673481304,0.0205655642671214,0.354815599822935
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.00358594251533349,0.00388250479056783,-0.00402376687417946,0.0111956519048464,0.355700588497365
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00375099099871071,0.00406919462872145,-0.0117266124710048,0.00422463047358334,0.356648812306487
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00228831657301593,0.0024899741533481,-0.0071686659135782,0.00259203276754634,0.358105528183506
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0130598519978156,0.0142246287976973,-0.0148204204456711,0.0409401244413023,0.358574783256278
NMR metabolomics,X23408.Triglycerides in VLDL,PAPPA,Pappalysin-1,39587,0.00421502330951219,0.00462150774535019,-0.00484313187137417,0.0132731784903986,0.361758977422606
NMR metabolomics,X23408.Triglycerides in VLDL,TPSD1,Tryptase delta,37411,0.00325173683649368,0.00357097795325292,-0.00374737995188204,0.0102508536248694,0.362521730922591
NMR metabolomics,X23408.Triglycerides in VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00411424651213756,0.00454214806920301,-0.0130168567277755,0.00478836370350033,0.365061497640161
NMR metabolomics,X23408.Triglycerides in VLDL,CTSV,Cathepsin L2,39967,0.00359774996860614,0.00398763162855112,-0.00421800802335406,0.0114135079605663,0.366949646715947
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00674611938523269,0.00748765258585562,-0.0214219184535097,0.00792967968304432,0.367622532215925
NMR metabolomics,X23408.Triglycerides in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00548994343720464,0.00611102011336674,-0.0174675428594034,0.00648765598499417,0.369005991939276
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB118,Beta-defensin 118,36991,0.00508484775827635,0.00567280035508402,-0.00603384093768833,0.016203536454241,0.370079173715924
NMR metabolomics,X23408.Triglycerides in VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00457031837314376,0.00511235180984855,-0.0054498911741594,0.0145905279204469,0.371348649763602
NMR metabolomics,X23408.Triglycerides in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00491520421062476,0.00550540328337162,-0.00587538622478362,0.0157057946460331,0.371982613906885
NMR metabolomics,X23408.Triglycerides in VLDL,FGF9,Fibroblast growth factor 9,36931,0.00351617866170608,0.00395588343210846,-0.0042373528652265,0.0112697101886387,0.374101188321856
NMR metabolomics,X23408.Triglycerides in VLDL,SCGN,Secretagogin,39587,-0.00371363842974783,0.0041973454632616,-0.0119404355377406,0.0045131586782449,0.376300248690718
NMR metabolomics,X23408.Triglycerides in VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00625248211352118,0.00708683662747671,-0.00763771767633317,0.0201426819033755,0.377648585965969
NMR metabolomics,X23408.Triglycerides in VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00646534572679642,0.00733809029289389,-0.0208480027008684,0.0079173112472756,0.378297939446051
NMR metabolomics,X23408.Triglycerides in VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00331812469820516,0.00380252296613347,-0.0107710697118268,0.00413482031541643,0.382887999562968
NMR metabolomics,X23408.Triglycerides in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00346184737184613,0.003986000796079,-0.011274408932161,0.00435071418846871,0.385135702724689
NMR metabolomics,X23408.Triglycerides in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00457659826627076,0.00527530254260534,-0.0149161912497772,0.0057629947172357,0.385655379194929
NMR metabolomics,X23408.Triglycerides in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00251823519945714,0.00290562380900065,-0.00821325786509841,0.00317678746618413,0.386134757131167
NMR metabolomics,X23408.Triglycerides in VLDL,IL21R,Interleukin-21 receptor,37056,-0.00459773825785424,0.00531028584761744,-0.0150058985191844,0.00581042200347593,0.386606007885383
NMR metabolomics,X23408.Triglycerides in VLDL,CASQ2,Calsequestrin-2,37021,0.0041035024972932,0.00476082644531559,-0.00522771733552536,0.0134347223301118,0.388741354864765
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.00182366536979854,0.00212716280949248,-0.00234557373680672,0.0059929044764038,0.391282030296089
NMR metabolomics,X23408.Triglycerides in VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00411477865719774,0.00482290661366815,-0.0135676756199873,0.00533811830559184,0.393575889409152
NMR metabolomics,X23408.Triglycerides in VLDL,EXOSC10,Exosome component 10,37021,-0.00505640099906324,0.00595174191541172,-0.0167218151532702,0.00660901315514373,0.395581554854764
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00543051105769688,0.00639766454609004,-0.0179699335680333,0.00710891145263959,0.395992773733011
NMR metabolomics,X23408.Triglycerides in VLDL,FZD10,Frizzled-10,37039,0.00487957963258214,0.00584614885413353,-0.00657887212151958,0.0163380313866839,0.403921116647353
NMR metabolomics,X23408.Triglycerides in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00578535378339256,0.00693250000766329,-0.0078023462316275,0.0193730537984126,0.403999583452986
NMR metabolomics,X23408.Triglycerides in VLDL,CORO6,Coronin-6,36991,-0.00308674801523841,0.00370116391659464,-0.0103410292917639,0.00416753326128709,0.404299609550996
NMR metabolomics,X23408.Triglycerides in VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0094440288842273,0.0113760653839127,-0.0128530592682415,0.0317411170366961,0.406459720565962
NMR metabolomics,X23408.Triglycerides in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00453236365751623,0.00548152618989388,-0.0152761549897082,0.00621142767467578,0.408340861695273
NMR metabolomics,X23408.Triglycerides in VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00637579112547001,0.00772208310950614,-0.0215110740201021,0.00875949176916203,0.409013822447876
NMR metabolomics,X23408.Triglycerides in VLDL,LTO1,Protein LTO1 homolog,39587,0.00324351659094552,0.00392962179875852,-0.00445854213462117,0.0109455753165122,0.409156078603961
NMR metabolomics,X23408.Triglycerides in VLDL,CDAN1,Codanin-1,37388,0.0018115112991918,0.0022004008092728,-0.00250127428698288,0.00612429688536648,0.41037225699143
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.00277989467440577,0.00339136490157009,-0.00386718053267161,0.00942696988148314,0.412400561320956
NMR metabolomics,X23408.Triglycerides in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00267896061072152,0.00327973646539328,-0.00910724408289235,0.00374932286144931,0.414045059601642
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00309430988169682,0.00380062917045697,-0.0105435430557925,0.00435492329239885,0.41556947486563
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00391304393997723,0.00481529195052477,-0.0133510161630058,0.00552492828305132,0.416443206071573
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00208969742569116,0.00261017383109184,-0.00302624328324886,0.00720563813463117,0.423376746376108
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00469361519526187,0.00588155451801454,-0.0162214620505704,0.00683423166004662,0.424871632329541
NMR metabolomics,X23408.Triglycerides in VLDL,HMCN2,Hemicentin-2,37100,0.00440271887907114,0.00554886800604416,-0.00647306241277542,0.0152785001709177,0.42753310335716
NMR metabolomics,X23408.Triglycerides in VLDL,NCAN,Neurocan core protein,40009,0.00283291585743472,0.00357532367755989,-0.00417471855058266,0.00984055026545211,0.428166936816616
NMR metabolomics,X23408.Triglycerides in VLDL,YY1,Transcriptional repressor protein YY1,37056,-0.00214569176331889,0.00271222026440219,-0.00746164348154719,0.0031702599549094,0.428888173187788
NMR metabolomics,X23408.Triglycerides in VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.00462014078671885,0.00584428352230207,-0.0068346549169932,0.0160749364904309,0.429226240430737
NMR metabolomics,X23408.Triglycerides in VLDL,ESR1,Estrogen receptor,37056,0.00458380133106383,0.00580693154643311,-0.00679778449994506,0.0159653871620727,0.429911599523255
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.0038629024461298,0.00497016863701481,-0.0136044329746788,0.00587862808241924,0.437044225318991
NMR metabolomics,X23408.Triglycerides in VLDL,EPGN,Epigen,37368,-0.00377963815472132,0.00487267514351407,-0.0133300814360089,0.00577080512656625,0.43795134950828
NMR metabolomics,X23408.Triglycerides in VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00178258057684283,0.00232012616339861,-0.00276486670341844,0.0063300278571041,0.442313218981999
NMR metabolomics,X23408.Triglycerides in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.0046463402596541,0.00617479182617133,-0.00745625171964171,0.0167489322389499,0.451782292948355
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00354513551624566,0.00473970320109538,-0.00574468275790129,0.0128349537903926,0.454494229987137
NMR metabolomics,X23408.Triglycerides in VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00335149772899176,0.00450568867118402,-0.0121826475245124,0.00547965206652892,0.456988059781179
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00976293819680749,0.0131323940122925,-0.0355024304609009,0.0159765540672859,0.457237822009034
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00564022398497866,0.00774678281706543,-0.00954347033646958,0.0208239183064269,0.466579762587681
NMR metabolomics,X23408.Triglycerides in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00477607677769284,0.00663879204379316,-0.0177881091835274,0.00823595562814176,0.47189508734506
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00196260027954827,0.00273147476691948,-0.00731629082271046,0.00339109026361392,0.472451446891841
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH17,Protocadherin-17,39868,0.00244540659775534,0.0034050197907142,-0.00422843219204449,0.00911924538755516,0.472658693040176
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00504844769351197,0.00704883625002606,-0.00876727135653911,0.018864166743563,0.473874366111149
NMR metabolomics,X23408.Triglycerides in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00323035763817034,0.00452679717884347,-0.0121028801087036,0.00564216483236287,0.475482434576464
NMR metabolomics,X23408.Triglycerides in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0118956717431636,0.016712515454559,-0.020860858547772,0.0446522020340992,0.476610152849288
NMR metabolomics,X23408.Triglycerides in VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.00323828157899399,0.0045506349960139,-0.0121575261711812,0.00568096301319325,0.476718319054804
NMR metabolomics,X23408.Triglycerides in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00255143949576796,0.00359446086578009,-0.00449370380116101,0.00959658279269693,0.47782499619663
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.0018872526008425,0.00267491656770504,-0.00335558387185938,0.00713008907354438,0.48048635435219
NMR metabolomics,X23408.Triglycerides in VLDL,IFNW1,Interferon omega-1,37021,-0.00243826099333348,0.00345736307591636,-0.00921469262212955,0.00433817063546259,0.480675126652078
NMR metabolomics,X23408.Triglycerides in VLDL,RRP15,RRP15-like protein,36991,0.00621943418509246,0.0088284706324642,-0.0110843682545374,0.0235232366247223,0.48114969510471
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00570938572359798,0.00813226589889346,-0.0102298554382332,0.0216486268854292,0.482648341110738
NMR metabolomics,X23408.Triglycerides in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00266960909835472,0.00380763334370384,-0.0047933522553048,0.0101325704520142,0.483240327749877
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.00294935823600387,0.00424013208712271,-0.00536130065475665,0.0112600171267644,0.486703146857463
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR3,Folate receptor gamma,39858,-0.0127751900052062,0.0184099918114547,-0.0488587739556573,0.0233083939452449,0.487738078839084
NMR metabolomics,X23408.Triglycerides in VLDL,IL13,Interleukin-13,39587,0.00329078891457228,0.00474726136794502,-0.00601384336659996,0.0125954211957445,0.4881959589094
NMR metabolomics,X23408.Triglycerides in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00315549704038539,0.00456473422381006,-0.00579138203828232,0.0121023761190531,0.489403121626789
NMR metabolomics,X23408.Triglycerides in VLDL,SHH,Sonic hedgehog protein,37056,-0.00294632322161927,0.00426332938760505,-0.0113024488213252,0.00540980237808663,0.489524248516882
NMR metabolomics,X23408.Triglycerides in VLDL,FGF5,Fibroblast growth factor 5,39587,-0.00222576280618592,0.00322509859579469,-0.0085469560539435,0.00409543044157166,0.490117648435374
NMR metabolomics,X23408.Triglycerides in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00672207644184001,0.00977767317409322,-0.0124421629793827,0.0258863158630627,0.491784574538032
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00518190368887657,0.00754412748024968,-0.0199683935501659,0.00960458617241281,0.492170655979365
NMR metabolomics,X23408.Triglycerides in VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00344152916498714,0.00503418632464918,-0.0133085343612995,0.00642547603132526,0.494219821294728
NMR metabolomics,X23408.Triglycerides in VLDL,PRTN3,Myeloblastin,39421,0.00307497050286132,0.00450345883189994,-0.00575180880766256,0.0119017498133852,0.494742157678996
NMR metabolomics,X23408.Triglycerides in VLDL,KLK1,Kallikrein-1,39720,-0.00829059390273328,0.0122284401944141,-0.0322583366837849,0.0156771488783184,0.497796545265264
NMR metabolomics,X23408.Triglycerides in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00226585382358354,0.00334643447998227,-0.00429315775718171,0.00882486540434879,0.498357493260406
NMR metabolomics,X23408.Triglycerides in VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00422059900722076,0.00624163183134397,-0.00801299938221342,0.0164541973966549,0.498924839286426
NMR metabolomics,X23408.Triglycerides in VLDL,LY96,Lymphocyte antigen 96,39749,-0.00232226881828874,0.00343936796038282,-0.00906343002063906,0.00441889238406158,0.49955713351952
NMR metabolomics,X23408.Triglycerides in VLDL,NGF,Beta-nerve growth factor,39749,0.000806003979918157,0.00119688716753158,-0.00153989486844373,0.00315190282828005,0.500691929977837
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00301461343889546,0.00447912970089736,-0.00576448077486336,0.0117937076526543,0.500934403226364
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.00450903523889381,0.00680331006903179,-0.0088254524964085,0.0178435229741961,0.50748865101948
NMR metabolomics,X23408.Triglycerides in VLDL,IL3,Interleukin-3,36962,-0.00377152664344291,0.00582137569261925,-0.0151814230009766,0.00763836971409082,0.517076835505712
NMR metabolomics,X23408.Triglycerides in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.00162636633733792,0.00253050539924546,-0.00658615691985901,0.00333342424518318,0.520427279670578
NMR metabolomics,X23408.Triglycerides in VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00471275007659367,0.00733436032414585,-0.00966259615873221,0.0190880963119195,0.520522323243931
NMR metabolomics,X23408.Triglycerides in VLDL,TNPO1,Transportin-1,37169,-0.002217439862661,0.00345818658227977,-0.00899548556392936,0.00456060583860735,0.521394280948584
NMR metabolomics,X23408.Triglycerides in VLDL,UBQLN3,Ubiquilin-3,37021,-0.00293945917163121,0.00458792066679865,-0.0119317836785566,0.00605286533529414,0.521731828562065
NMR metabolomics,X23408.Triglycerides in VLDL,DKKL1,Dickkopf-like protein 1,39788,0.00522207859926882,0.00818580965541137,-0.0108221083253375,0.0212662655238751,0.523520065001622
NMR metabolomics,X23408.Triglycerides in VLDL,STC2,Stanniocalcin-2,39831,0.00163411858729796,0.00257806479323446,-0.00341888840744158,0.0066871255820375,0.526184703189353
NMR metabolomics,X23408.Triglycerides in VLDL,PRND,Prion-like protein doppel,37388,-0.0031261646866831,0.00495881703875215,-0.0128454460826373,0.0065931167092711,0.52842688349409
NMR metabolomics,X23408.Triglycerides in VLDL,PMCH,Pro-MCH,37021,-0.00509454548829298,0.00809150383159348,-0.0209538929982162,0.0107648020216303,0.528956360607594
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00295447804123173,0.00470536631866205,-0.0121769960258093,0.00626803994334589,0.530083359607876
NMR metabolomics,X23408.Triglycerides in VLDL,IL4,Interleukin-4,39587,0.00551834914333737,0.00879140628130933,-0.0117128071680289,0.0227495054547037,0.530210834552682
NMR metabolomics,X23408.Triglycerides in VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.0017418184582653,0.00278307471173309,-0.00371300797673156,0.00719664489326215,0.531414888515149
NMR metabolomics,X23408.Triglycerides in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00373925834609253,0.00597725720437893,-0.00797616577449016,0.0154546824666752,0.531600394223966
NMR metabolomics,X23408.Triglycerides in VLDL,PI16,Peptidase inhibitor 16,37445,-0.00145602432022941,0.00233078018143256,-0.00602435347583723,0.00311230483537842,0.532182424156112
NMR metabolomics,X23408.Triglycerides in VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00450802606363816,0.00724599343749354,-0.0187101732011255,0.00969412107384917,0.533860136299758
NMR metabolomics,X23408.Triglycerides in VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00583027070568471,0.00937761301212174,-0.0125498507980739,0.0242103922094433,0.53413530907407
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00700626469194842,0.0112913266554027,-0.0151247355526409,0.0291372649365377,0.534939292943658
NMR metabolomics,X23408.Triglycerides in VLDL,FGF20,Fibroblast growth factor 20,37056,-0.00259843487490278,0.00419788165590252,-0.0108262829204717,0.00562941317066615,0.535935497981296
NMR metabolomics,X23408.Triglycerides in VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00597449827463249,0.00965562025175876,-0.0248995139680796,0.0129505174188147,0.536085981510856
NMR metabolomics,X23408.Triglycerides in VLDL,NENF,Neudesin,37368,0.00662006759381085,0.0107203242922024,-0.0143917680189058,0.0276319032065276,0.536898947141864
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00162764989467948,0.00264233433766886,-0.00680662519651044,0.00355132540715149,0.537910261682385
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00238800858393986,0.00387693772786828,-0.00521078936268196,0.00998680653056168,0.537936723774872
NMR metabolomics,X23408.Triglycerides in VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00201885299795679,0.00330571871005089,-0.00849806166965655,0.00446035567374296,0.541398644697421
NMR metabolomics,X23408.Triglycerides in VLDL,SCIN,Adseverin,36991,0.00440394755636457,0.00721875087506919,-0.00974480415877104,0.0185526992715002,0.541825609427508
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00357666360890391,0.00587245634850552,-0.00793335083416691,0.0150866780519747,0.542496808500792
NMR metabolomics,X23408.Triglycerides in VLDL,CA3,Carbonic anhydrase 3,40017,0.00357311761688392,0.0058668791243125,-0.00792596546676859,0.0150722007005364,0.54251173601457
NMR metabolomics,X23408.Triglycerides in VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00155164510908299,0.00254803786063642,-0.00344250909776439,0.00654579931593037,0.542563523383926
NMR metabolomics,X23408.Triglycerides in VLDL,VASN,Vasorin,39642,-0.0016087138779222,0.00266282961058108,-0.00682785991466112,0.00361043215881671,0.545761249639309
NMR metabolomics,X23408.Triglycerides in VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.00197997955808581,0.00328763254707719,-0.00842373935035711,0.00446378023418549,0.54701752069586
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00291703423340801,0.00498391021217034,-0.0126854982492619,0.00685142978244585,0.55836256644098
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00274710504642843,0.00476329749364872,-0.0120831681339799,0.00658895804112306,0.564136241541213
NMR metabolomics,X23408.Triglycerides in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00709018931756538,0.0123653703313533,-0.0171459365318871,0.0313263151670179,0.566388389169876
NMR metabolomics,X23408.Triglycerides in VLDL,EFNB2,Ephrin-B2,37039,-0.00335177021118572,0.00588002141360654,-0.0148766121818545,0.00817307175948309,0.568669189414658
NMR metabolomics,X23408.Triglycerides in VLDL,MTR,Methionine synthase,37021,0.00357826033782738,0.00628789868096199,-0.00874602107685812,0.0159025417525129,0.569317717726038
NMR metabolomics,X23408.Triglycerides in VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00255056254571893,0.00450411389580541,-0.0113786257814975,0.00627750069005967,0.571217181436003
NMR metabolomics,X23408.Triglycerides in VLDL,TBR1,T-box brain protein 1,37039,-0.00264865145837106,0.00470543381953744,-0.0118713017446644,0.00657399882792232,0.573517944746526
NMR metabolomics,X23408.Triglycerides in VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00134037694714413,0.00238201339644163,-0.00600912320416973,0.00332836930988147,0.57364333648979
NMR metabolomics,X23408.Triglycerides in VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00289856736243529,0.00518555926899579,-0.013062263529667,0.00726512880479645,0.57619236685188
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00426443209908202,0.00764989277370209,-0.0192582219355381,0.0107293577373741,0.577229442963417
NMR metabolomics,X23408.Triglycerides in VLDL,IL25,Interleukin-25,36903,-0.00186514230026308,0.00335199134385172,-0.00843504533421245,0.00470476073368629,0.577927754031652
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN1,Neuroligin-1,37039,-0.0036358117654514,0.00656727256900308,-0.0165076660006974,0.00923604246979464,0.579844332916111
NMR metabolomics,X23408.Triglycerides in VLDL,PKLR,Pyruvate kinase PKLR,39881,0.0034300413504896,0.00622386025077626,-0.00876872474103187,0.0156288074420111,0.58156488461816
NMR metabolomics,X23408.Triglycerides in VLDL,SKIV2L,Helicase SKI2W,37021,0.00216556293722011,0.00393063035953013,-0.00553847256745894,0.00986959844189916,0.58168041738238
NMR metabolomics,X23408.Triglycerides in VLDL,NRN1,Neuritin,37411,-0.00188888076370516,0.00343702317131485,-0.00862544617948228,0.00484768465207195,0.582624207187626
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.00217250540129225,0.00398948316211692,-0.00564688159645691,0.0099918923990414,0.586065059880289
NMR metabolomics,X23408.Triglycerides in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00216656213089853,0.00400414598255373,-0.00568156399490678,0.0100146882567039,0.588461581330999
NMR metabolomics,X23408.Triglycerides in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.0034281183538933,0.00640760853687112,-0.0159870310861607,0.0091307943783741,0.592653638571396
NMR metabolomics,X23408.Triglycerides in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.00292607056214081,0.00547598503772945,-0.0136590012360905,0.00780686011180891,0.593111236083146
NMR metabolomics,X23408.Triglycerides in VLDL,NOS1,"Nitric oxide synthase, brain",39489,0.00278845871252128,0.00525972748867321,-0.00752060716527821,0.0130975245903208,0.59601359651383
NMR metabolomics,X23408.Triglycerides in VLDL,SPRING1,SREBP regulating gene protein,36962,0.00309671673196749,0.00584630467867732,-0.00836204043824005,0.014555473902175,0.596337327460716
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00241816754606212,0.00458186238522947,-0.00656228272898764,0.0113986178211119,0.597666889988237
NMR metabolomics,X23408.Triglycerides in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00376398245173048,0.00713271710075972,-0.0102161430657586,0.0177441079692195,0.597711734197062
NMR metabolomics,X23408.Triglycerides in VLDL,NEB,Nebulin,37021,-0.00193117577915601,0.00366544003797153,-0.0091154382535802,0.00525308669526818,0.598299306004657
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2B,Alpha-amylase 2B,38832,0.00245852268801878,0.00468226328338102,-0.00671871334740802,0.0116357587234456,0.599541309517739
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3A,Uroplakin-3a,36991,-0.00242065622306153,0.00466089726020993,-0.011556014853073,0.00671470240694994,0.603522568635908
NMR metabolomics,X23408.Triglycerides in VLDL,CD177,CD177 antigen,39844,-0.00628568196290053,0.0121581738738031,-0.0301157027555545,0.0175443388297535,0.605168705208006
NMR metabolomics,X23408.Triglycerides in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.00297243435355758,0.00575282147007088,-0.00830309572778133,0.0142479644348965,0.605378707548511
NMR metabolomics,X23408.Triglycerides in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00199696509335594,0.00388781679364243,-0.0096170860088951,0.00562315582218323,0.607507516702679
NMR metabolomics,X23408.Triglycerides in VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00176522152848808,0.00345045125488737,-0.00852810598806731,0.00499766293109116,0.608945578677756
NMR metabolomics,X23408.Triglycerides in VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.00315463244011219,0.00626907850327677,-0.00913276142631028,0.0154420263065347,0.614828470670658
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN4,Prefoldin subunit 4,36962,0.00265838766594715,0.00531233816182886,-0.00775379513123741,0.0130705704631317,0.616789448161728
NMR metabolomics,X23408.Triglycerides in VLDL,REN,Renin,39868,0.00318557679956522,0.00641882235054853,-0.0093953150075099,0.0157664686066403,0.619698892631041
NMR metabolomics,X23408.Triglycerides in VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00175307210257723,0.00354714380268354,-0.00519932975068251,0.00870547395583697,0.621158517832656
NMR metabolomics,X23408.Triglycerides in VLDL,NMI,N-myc-interactor,37311,0.00343292176380886,0.00704542580570681,-0.0103761128153765,0.0172419563429942,0.626085290668425
NMR metabolomics,X23408.Triglycerides in VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00235304150603685,0.00483735113276644,-0.00712816671418537,0.0118342497262591,0.626668887307211
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM2,Intercellular adhesion molecule 2,40052,0.00147819254840807,0.00304876679378758,-0.00449739036741559,0.00745377546423172,0.627789783738693
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00209241256354151,0.00433541135712552,-0.00640499369642451,0.0105898188235075,0.629364168718597
NMR metabolomics,X23408.Triglycerides in VLDL,RUVBL1,RuvB-like 1,39477,0.00475220985860934,0.0098930087094043,-0.0146380872118231,0.0241425069290418,0.630977858612222
NMR metabolomics,X23408.Triglycerides in VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00185242878160053,0.00386322433149869,-0.0057194909081369,0.00942434847133796,0.631588595015654
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM1,Neural cell adhesion molecule 1,39931,-0.00139801682909706,0.00291611793327553,-0.00711360797831709,0.00431757432012298,0.631653326053418
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00177547357400486,0.00374545014820182,-0.00911655586448043,0.00556560871647071,0.635482970793977
NMR metabolomics,X23408.Triglycerides in VLDL,CGN,Cingulin,37039,0.0017819252875335,0.00379399280246057,-0.00565430060528922,0.00921815118035623,0.638598445588904
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA3,GDNF family receptor alpha-3,39709,-0.00125091278234437,0.0026915566668312,-0.00652636384933352,0.00402453828464477,0.642113736552848
NMR metabolomics,X23408.Triglycerides in VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.00288433136430047,0.006212018438889,-0.00929122477592197,0.0150598875045229,0.64243002144417
NMR metabolomics,X23408.Triglycerides in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.00328675641819527,0.00708625185052263,-0.0106022972088291,0.0171758100452196,0.64278191181262
NMR metabolomics,X23408.Triglycerides in VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00399214822032028,0.00895168717102259,-0.013553158634884,0.0215374550755246,0.655629150978467
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00234190426835622,0.00530725919211959,-0.0127441322849106,0.00806032374819817,0.659028914496737
NMR metabolomics,X23408.Triglycerides in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.00619673168215384,0.0140575457433175,-0.033749521339056,0.0213560579747484,0.659356541773719
NMR metabolomics,X23408.Triglycerides in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.0035833687686498,0.0081938929171044,-0.0124766613488748,0.0196433988861744,0.661885085418467
NMR metabolomics,X23408.Triglycerides in VLDL,MLLT1,Protein ENL,36962,-0.00304223857244023,0.00696866083025769,-0.0167008137997453,0.0106163366548648,0.66243767063858
NMR metabolomics,X23408.Triglycerides in VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00197429334630206,0.00452323291224895,-0.01083982985431,0.00689124316170589,0.662495596732041
NMR metabolomics,X23408.Triglycerides in VLDL,TEX101,Testis-expressed protein 101,37039,0.00200564377734467,0.0047467266706939,-0.00729794049721538,0.0113092280519047,0.672643662901941
NMR metabolomics,X23408.Triglycerides in VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00344762836841688,0.00818071002447926,-0.0125865632795625,0.0194818200163962,0.673445089589936
NMR metabolomics,X23408.Triglycerides in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00184846041641277,0.00446312458766861,-0.00689926377541771,0.0105961846082432,0.678761575418914
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00118570039937713,0.00287917706150638,-0.00682888743992964,0.00445748664117537,0.680478473642043
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00126495762841499,0.00309201036256372,-0.00479538268220991,0.00732529793903989,0.682469091190455
NMR metabolomics,X23408.Triglycerides in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00204746228782578,0.00502710787846318,-0.00780566915396205,0.0119005937296136,0.683805620794814
NMR metabolomics,X23408.Triglycerides in VLDL,IL17A,Interleukin-17A,39558,0.00165710260895353,0.00412333809120127,-0.00642464004980095,0.00973884526770802,0.687775047524979
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2BP,LRP2-binding protein,37039,-0.00310681150082968,0.00778373219877861,-0.0183629266104357,0.0121493036087764,0.689795322027912
NMR metabolomics,X23408.Triglycerides in VLDL,THBS2,Thrombospondin-2,39858,0.00138641557217827,0.00350989511843023,-0.00549297885994498,0.00826581000430153,0.692846682233798
NMR metabolomics,X23408.Triglycerides in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00313851043656643,0.00794959134234642,-0.0124426885944326,0.0187197094675654,0.692995828293579
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,0.00262380814225648,0.00666872166912973,-0.0104468863292378,0.0156945026137508,0.693993368671245
NMR metabolomics,X23408.Triglycerides in VLDL,HRAS,GTPase Hras,37161,0.00369230123373057,0.00954327809122795,-0.0150125238250762,0.0223971262925373,0.698835892411336
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,0.00119905453870515,0.00311998521469194,-0.00491611648209105,0.00731422555950135,0.700750800992103
NMR metabolomics,X23408.Triglycerides in VLDL,CD2,T-cell surface antigen CD2,37021,0.00142749042520114,0.00374729194839684,-0.00591720179365667,0.00877218264405894,0.703254507267717
NMR metabolomics,X23408.Triglycerides in VLDL,DLL1,Delta-like protein 1,39913,0.00104675943144449,0.00276645739013252,-0.00437549705321524,0.00646901591610423,0.705156740870144
NMR metabolomics,X23408.Triglycerides in VLDL,SHC1,SHC-transforming protein 1,36962,-0.00414288223683205,0.0112848860894417,-0.0262612589721377,0.0179754944984736,0.713537100501203
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00241649957751013,0.00663509280724059,-0.0105882823246814,0.0154212814797017,0.715714590355221
NMR metabolomics,X23408.Triglycerides in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00177836234632369,0.00496000114573816,-0.0114999645919705,0.0079432398993231,0.719944456638647
NMR metabolomics,X23408.Triglycerides in VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00186281451228343,0.005219539068531,-0.0120931110866042,0.00836748206203733,0.721177835681056
NMR metabolomics,X23408.Triglycerides in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00109449916938572,0.00309903189630411,-0.00497960334737034,0.00716860168614177,0.723962326636804
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC9,Histone deacetylase 9,36991,-0.00220179853898201,0.00627195419518131,-0.0144948287615374,0.0100912316835734,0.725552998850009
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.0019392261832648,0.00556752675713866,-0.00897312626072698,0.0128515786272566,0.727611835707905
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.0011970559777344,0.00351941900390074,-0.00809511722537986,0.00570100526991105,0.733764759949252
NMR metabolomics,X23408.Triglycerides in VLDL,CDC25A,M-phase inducer phosphatase 1,36962,-0.00137589772533384,0.00406875251095384,-0.00935065264680336,0.00659885719613568,0.735246484314955
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN4,Nectin-4,39913,0.000963418148063164,0.00286308282168865,-0.0046482241824466,0.00657506047857292,0.736500678392559
NMR metabolomics,X23408.Triglycerides in VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,-0.00235148002830401,0.00699244582474401,-0.0160566738448023,0.0113537137881943,0.736658584273654
NMR metabolomics,X23408.Triglycerides in VLDL,TCN2,Transcobalamin-2,40012,0.000955484853757744,0.00284783561426085,-0.00462627295019352,0.00653724265770901,0.737242766682596
NMR metabolomics,X23408.Triglycerides in VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00210972345474995,0.00635419800362253,-0.0103445046323502,0.0145639515418501,0.739878268663467
NMR metabolomics,X23408.Triglycerides in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00248924782131379,0.00750561196419027,-0.0122217516284991,0.0172002472711267,0.740157664958582
NMR metabolomics,X23408.Triglycerides in VLDL,CAPN3,Calpain-3,37368,0.00121337718502005,0.0036757850870279,-0.00599116158555463,0.00841791595559473,0.741329413761169
NMR metabolomics,X23408.Triglycerides in VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00128720910499837,0.00395724989624011,-0.00646900069163225,0.00904341890162899,0.74497531302345
NMR metabolomics,X23408.Triglycerides in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00111362079201705,0.00343519996295663,-0.00561937113537796,0.00784661271941205,0.745807421424345
NMR metabolomics,X23408.Triglycerides in VLDL,EVI2B,Protein EVI2B,36962,-0.00130289775752091,0.00402601427151036,-0.00919388572968121,0.00658809021463939,0.746231094052843
NMR metabolomics,X23408.Triglycerides in VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.00124311175551174,0.00385440584911944,-0.00879774721978583,0.00631152370876236,0.747066139558528
NMR metabolomics,X23408.Triglycerides in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.0035938701324962,0.0113102084454567,-0.0257618786855913,0.0185741384205989,0.750676174333036
NMR metabolomics,X23408.Triglycerides in VLDL,OSTN,Osteocrin,37039,-0.00129586844956323,0.00408247130769401,-0.0092975122126435,0.00670577531351703,0.75092802798333
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.0010175978072306,0.00321563829578092,-0.0073202488669612,0.00528505325250001,0.751662995232023
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00125659192077357,0.00405291648469675,-0.0092003082307792,0.00668712438923207,0.756530572034857
NMR metabolomics,X23408.Triglycerides in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00204842214326522,0.00664991009392714,-0.010985401640832,0.0150822459273624,0.758058613078045
NMR metabolomics,X23408.Triglycerides in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00078188337970298,0.00260694867210545,-0.0043277360176237,0.00589150277702966,0.764239946784914
NMR metabolomics,X23408.Triglycerides in VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.0013891870396927,0.00463736661869909,-0.0104784256123429,0.00770005153295752,0.764514680058158
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00125078703829461,0.00417643443568277,-0.00943659853223284,0.00693502445564361,0.764573355164681
NMR metabolomics,X23408.Triglycerides in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.000655956331877436,0.00220082794730986,-0.00365766644484988,0.00496957910860476,0.765669846528663
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0015481702020159,0.00524066665298527,-0.011819876841867,0.00872353643783523,0.767681606719107
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00297909901423301,0.0100954949330662,-0.0168080710545767,0.0227662690830427,0.767928307990183
NMR metabolomics,X23408.Triglycerides in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.000878949637472738,0.00299270984851296,-0.00498676166561267,0.00674466094055815,0.768993322587777
NMR metabolomics,X23408.Triglycerides in VLDL,PRR5,Proline-rich protein 5,37056,-0.00131904685999099,0.0046506708395659,-0.0104343617055402,0.00779626798555819,0.776702169272063
NMR metabolomics,X23408.Triglycerides in VLDL,PSMA1,Proteasome subunit alpha type-1,39477,0.00126956734460213,0.00452698627026718,-0.00760332574512153,0.0101424604343258,0.779140393878762
NMR metabolomics,X23408.Triglycerides in VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00121244281075945,0.00437398523703858,-0.00736056825383617,0.00978545387535507,0.781635390653939
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.00119829536724579,0.00441940948130771,-0.00746374721611732,0.00986033795060889,0.786283941369906
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,-0.000828666871605923,0.00312030007851592,-0.00694445502549713,0.00528712128228528,0.790572373987022
NMR metabolomics,X23408.Triglycerides in VLDL,GJA8,Gap junction alpha-8 protein,36962,0.00153259495039647,0.00583228181375504,-0.0098986774045634,0.0129638673053563,0.792725877834691
NMR metabolomics,X23408.Triglycerides in VLDL,FGF6,Fibroblast growth factor 6,37056,0.00105058379650159,0.004003581346279,-0.00679643564220524,0.00889760323520842,0.793008686916877
NMR metabolomics,X23408.Triglycerides in VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.002117779227044,0.00807681749820525,-0.0137127830694383,0.0179483415235263,0.793167770038901
NMR metabolomics,X23408.Triglycerides in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00103240041243782,0.00399886592542199,-0.00680537680138929,0.00887017762626492,0.796276444288364
NMR metabolomics,X23408.Triglycerides in VLDL,PSCA,Prostate stem cell antigen,37382,0.00635824858619085,0.0247731774982062,-0.0421971793102933,0.054913676482675,0.797446252863356
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00136276702002284,0.00540782781360412,-0.0119621095346869,0.00923657549464124,0.801045792182346
NMR metabolomics,X23408.Triglycerides in VLDL,LPO,Lactoperoxidase,39344,-0.0014610342753854,0.00582168122980492,-0.012871529485803,0.00994946093503225,0.801845024550115
NMR metabolomics,X23408.Triglycerides in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00189970759103664,0.00760688634732052,-0.0168092048317849,0.0130097896497116,0.802795995848334
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00117498726162395,0.0047765609717599,-0.00818707224302546,0.0105370467662734,0.805693017465511
NMR metabolomics,X23408.Triglycerides in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00120756729590724,0.00491879868428503,-0.00843327812529141,0.0108484127171059,0.806072776738643
NMR metabolomics,X23408.Triglycerides in VLDL,ARG2,"Arginase-2, mitochondrial",37368,-0.00105102881692448,0.00428248489111023,-0.00944469920350053,0.00734264156965157,0.806131108824687
NMR metabolomics,X23408.Triglycerides in VLDL,MB,Myoglobin,40052,-0.00122862740086539,0.00504799631835332,-0.0111227001848379,0.00866544538310712,0.807707051726235
NMR metabolomics,X23408.Triglycerides in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00119771956875743,0.00494927758169071,-0.0108983036288712,0.00850286449135636,0.808784779039545
NMR metabolomics,X23408.Triglycerides in VLDL,CDH4,Cadherin-4,36991,-0.00110542079749975,0.00457035377715178,-0.0100633142007172,0.00785247260571775,0.808886482691037
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.000976347279962573,0.00408500526130148,-0.00898295759211347,0.00703026303218833,0.811103410465396
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3B,Sodium channel subunit beta-3,36991,-0.00101719557389555,0.00434344417498206,-0.00953034615686038,0.00749595500906927,0.814840345866943
NMR metabolomics,X23408.Triglycerides in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00111205406615429,0.0047942407539677,-0.00828465781162241,0.010508765943931,0.816575607484305
NMR metabolomics,X23408.Triglycerides in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00133265751710857,0.00574736803356775,-0.00993218382868421,0.0125974988629014,0.816640524590313
NMR metabolomics,X23408.Triglycerides in VLDL,GAGE2A,G antigen 2A,36962,-0.00137278446223758,0.00595556948385443,-0.0130457006505923,0.0103001317261171,0.81770350998346
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN6,Prefoldin subunit 6,37039,-0.00148485448968503,0.00644211994218579,-0.0141114095763692,0.0111417005969991,0.817713372836789
NMR metabolomics,X23408.Triglycerides in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.00153214740890534,0.00688171706724461,-0.0150203128607048,0.0119560180428941,0.823818304962634
NMR metabolomics,X23408.Triglycerides in VLDL,RBP1,Retinol-binding protein 1,37039,0.00148185318190785,0.00685628487468059,-0.0119564651724661,0.0149201715362818,0.828889268184746
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN7,Tetraspanin-7,36991,0.00193797584306517,0.00920091339493941,-0.0160958144110161,0.0199717660971464,0.833180333103571
NMR metabolomics,X23408.Triglycerides in VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,0.000947085133393833,0.00449721935525938,-0.00786746480291456,0.00976163506970223,0.833207184045204
NMR metabolomics,X23408.Triglycerides in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00184184439710468,0.00888727320028137,-0.0155772110754468,0.0192608998696562,0.835821594485668
NMR metabolomics,X23408.Triglycerides in VLDL,PALLD,Palladin,37056,-0.000823921289098772,0.00397911814035707,-0.00862299284419863,0.00697515026600108,0.835965196949943
NMR metabolomics,X23408.Triglycerides in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000482331166671858,0.00233175961374931,-0.00408791767627679,0.00505258000962051,0.836127873130827
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO1,R-spondin-1,39749,0.00070678062381839,0.00343528981387215,-0.00602638741137103,0.00743994865900781,0.836995715472652
NMR metabolomics,X23408.Triglycerides in VLDL,RBM25,RNA-binding protein 25,36962,-0.000915760929252609,0.00445913881461806,-0.009655673005904,0.00782415114739879,0.837288421749333
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD2,Leiomodin-2,36991,-0.00127169413965817,0.00626292916962211,-0.0135470353121175,0.0110036470328012,0.839098302715784
NMR metabolomics,X23408.Triglycerides in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00121937540107756,0.00619691870152838,-0.0133653360560732,0.0109265852539181,0.844009607249496
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000684610677083213,0.00349511432394809,-0.00753503475202148,0.00616581339785505,0.844709869923962
NMR metabolomics,X23408.Triglycerides in VLDL,TLR1,Toll-like receptor 1,37056,0.000496803858643908,0.00254916895785003,-0.00449956729874214,0.00549317501602996,0.845483193240916
NMR metabolomics,X23408.Triglycerides in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.000565596360172059,0.0029142519858515,-0.00514633753209688,0.006277530252441,0.846116592532938
NMR metabolomics,X23408.Triglycerides in VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.000931186613199139,0.00485541799364051,-0.00858543265433626,0.0104478058807345,0.847915070059535
NMR metabolomics,X23408.Triglycerides in VLDL,RGS8,Regulator of G-protein signaling 8,39587,0.00119997902938995,0.00640632144347972,-0.0113564109998303,0.0137563690586102,0.851418657925995
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00135117383541505,0.00727011765348909,-0.0128982567654236,0.0156006044362537,0.852562383183073
NMR metabolomics,X23408.Triglycerides in VLDL,LCN15,Lipocalin-15,37411,0.00110975445318749,0.00605252741298363,-0.0107531992762604,0.0129727081826354,0.854523095103733
NMR metabolomics,X23408.Triglycerides in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.000730896607217831,0.00404777782077206,-0.00866454113593107,0.00720274792149541,0.856709940360232
NMR metabolomics,X23408.Triglycerides in VLDL,UNC5D,Netrin receptor UNC5D,37056,0.000465759573015216,0.00259955611974097,-0.00462937042167708,0.00556088956770751,0.857807844800169
NMR metabolomics,X23408.Triglycerides in VLDL,KLK3,Prostate-specific antigen,37437,-0.00136757753931777,0.00768481568410913,-0.0164298162801717,0.0136946612015361,0.858758297445011
NMR metabolomics,X23408.Triglycerides in VLDL,GUCA2A,Guanylin,39796,-0.000540549495330268,0.00314216104723558,-0.00669918514791201,0.00561808615725148,0.863415245150772
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.000942850736634195,0.00570414612315125,-0.0121229771380106,0.0102372756647423,0.868716139647535
NMR metabolomics,X23408.Triglycerides in VLDL,CD27,CD27 antigen,39913,0.000608311244570305,0.00378786871260868,-0.0068159114321427,0.00803253392128331,0.87241473237062
NMR metabolomics,X23408.Triglycerides in VLDL,CD5L,CD5 antigen-like,37380,0.000717845726821379,0.0045611557259519,-0.00822201949604434,0.0096577109496871,0.874945817675948
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAX,Integrin alpha-X,37169,0.000790801386277585,0.00516314907329306,-0.00932897079737681,0.010910573569932,0.878272364845358
NMR metabolomics,X23408.Triglycerides in VLDL,SOX2,Transcription factor SOX-2,37391,0.000351130640612359,0.0023196931714519,-0.00419546797543337,0.00489772925665808,0.879686556917707
NMR metabolomics,X23408.Triglycerides in VLDL,NCLN,Nicalin,39587,-0.000773936323971301,0.00513356154516623,-0.0108357169524971,0.0092878443045545,0.880166884440197
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF830,Zinc finger protein 830,37368,-0.00109732497218267,0.00786862789729727,-0.0165198356508853,0.01432518570652,0.889092143063399
NMR metabolomics,X23408.Triglycerides in VLDL,MYL4,Myosin light chain 4,37043,-0.000703402582784756,0.00507201616862849,-0.0106445542732966,0.00923774910772708,0.88970274495652
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB7,Integrin beta-7,40030,-0.000603360389240857,0.00442938340783864,-0.00928495186860459,0.00807823109012288,0.891650884269332
NMR metabolomics,X23408.Triglycerides in VLDL,IL2,Interleukin-2,39587,0.000412277813285264,0.0030347023487183,-0.00553573879020261,0.00636029441677314,0.89193808527871
NMR metabolomics,X23408.Triglycerides in VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.000993982164026211,0.0074921836808182,-0.0136906978503775,0.0156786621784299,0.894456992279967
NMR metabolomics,X23408.Triglycerides in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.000745153527605579,0.00573484916953654,-0.0119854578998972,0.010495150844686,0.896620408787948
NMR metabolomics,X23408.Triglycerides in VLDL,DUOX2,Dual oxidase 2,39585,0.000880334943779688,0.0069428101625971,-0.0127275729749106,0.01448824286247,0.899101842831543
NMR metabolomics,X23408.Triglycerides in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.000429979776992027,0.00339801403528356,-0.0070900872861478,0.00623012773216375,0.899307262917301
NMR metabolomics,X23408.Triglycerides in VLDL,CA11,Carbonic anhydrase-related protein 11,39477,0.000373612076962002,0.00305580699248421,-0.00561576962830705,0.00636299378223105,0.902692320820292
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,-0.000640006451694689,0.00559627602887462,-0.0116087074682889,0.0103286945648996,0.908951808635758
NMR metabolomics,X23408.Triglycerides in VLDL,IKZF2,Zinc finger protein Helios,39477,-0.00104632391365399,0.00916003039756437,-0.0189999834928802,0.0169073356655722,0.909059220434496
NMR metabolomics,X23408.Triglycerides in VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.000854881498220923,0.00750602051670585,-0.0155666817109644,0.0138569187145225,0.909324526467757
NMR metabolomics,X23408.Triglycerides in VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.000613967397764847,0.00544847507586054,-0.0100650437509218,0.0112929785464515,0.910281097497181
NMR metabolomics,X23408.Triglycerides in VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,0.000650525075501025,0.0057900973561324,-0.0106980657425185,0.0119991158935205,0.910546569977922
NMR metabolomics,X23408.Triglycerides in VLDL,CRX,Cone-rod homeobox protein,39585,0.00114925415549175,0.0105355996995266,-0.0195005212555804,0.0217990295665639,0.91313810049538
NMR metabolomics,X23408.Triglycerides in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000413671621773766,0.00398869321795566,-0.00823151032896686,0.00740416708541932,0.917400223455757
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,-0.000374649001674707,0.00364320382234428,-0.0075153284934695,0.00676603049012008,0.918095463518609
NMR metabolomics,X23408.Triglycerides in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.00029968206254028,0.00319625439085362,-0.00656434066861337,0.00596497654353281,0.925300923396827
NMR metabolomics,X23408.Triglycerides in VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.0002933597901224,0.00321126589545183,-0.00600072136496319,0.006587440945208,0.927213251073062
NMR metabolomics,X23408.Triglycerides in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000272653800066629,0.00326883469225697,-0.00613426219675704,0.00667956979689029,0.933526696828391
NMR metabolomics,X23408.Triglycerides in VLDL,HK2,Hexokinase-2,39585,-0.00021702478893955,0.0026624011483456,-0.00543533103969692,0.00500128146181782,0.935033684823237
NMR metabolomics,X23408.Triglycerides in VLDL,IL24,Interleukin-24,39587,-0.000369950353916229,0.00459842750001108,-0.00938286825393795,0.00864296754610549,0.935879198447994
NMR metabolomics,X23408.Triglycerides in VLDL,IL5,Interleukin-5,39587,0.00102762470492738,0.0140517451651326,-0.0265137958187326,0.0285690452285873,0.941702433526001
NMR metabolomics,X23408.Triglycerides in VLDL,FGF3,Fibroblast growth factor 3,37056,0.000212018107696911,0.00300691143758106,-0.00568152830996197,0.00610556452535579,0.943788602927075
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.000203220275727298,0.00289836814913819,-0.00547758129658356,0.00588402184803816,0.944102670922019
NMR metabolomics,X23408.Triglycerides in VLDL,MYL6B,Myosin light chain 6B,37039,-0.000615500552481995,0.00902545625357026,-0.0183053948094797,0.0170743937045157,0.945630598229231
NMR metabolomics,X23408.Triglycerides in VLDL,CNTF,Ciliary neurotrophic factor,36991,-0.000224399184865226,0.00331363900969278,-0.00671913164386307,0.00627033327413261,0.946009667059009
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.000416774343688654,0.00626576353874978,-0.0126976708796382,0.0118641221922609,0.946967744858587
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.000244246170013026,0.00382659119649092,-0.00774436491513522,0.00725587257510917,0.949107465025583
NMR metabolomics,X23408.Triglycerides in VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.000532575296002878,0.00846906421533124,-0.0160667905660464,0.0171319411580521,0.949859208655359
NMR metabolomics,X23408.Triglycerides in VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00024732496646035,0.00403521735890484,-0.00815635098991383,0.00766170105699313,0.951127902046723
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL6,Fc receptor-like protein 6,39866,0.000393300100751388,0.00642243539382533,-0.0121946732711463,0.012981273472649,0.951170059210245
NMR metabolomics,X23408.Triglycerides in VLDL,ABO,Histo-blood group ABO system transferase,37445,-0.000843915819784488,0.0140055906214855,-0.028294873437896,0.0266070417983271,0.951952918583408
NMR metabolomics,X23408.Triglycerides in VLDL,IL22,Interleukin-22,37368,-0.000352346177709584,0.00639173539204649,-0.0128801475461207,0.0121754551907015,0.956039474663397
NMR metabolomics,X23408.Triglycerides in VLDL,OMP,Olfactory marker protein,36991,0.000255218138937655,0.00474712294810731,-0.00904914283935267,0.00955957911722798,0.957125046816888
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,-0.000204283382169063,0.00425692572912017,-0.00854785781124459,0.00813929104690646,0.961726024828845
NMR metabolomics,X23408.Triglycerides in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.00014939160508404,0.00345978066941842,-0.00693056171714414,0.00663177850697606,0.96555909847327
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN7,Septin-7,37169,0.000205806191544295,0.00501149895601303,-0.00961673176224123,0.0100283441453298,0.967243263409401
NMR metabolomics,X23408.Triglycerides in VLDL,TP53BP1,TP53-binding protein 1,37056,0.000348449504313536,0.00859295694802041,-0.0164937461138065,0.0171906451224335,0.967654785852306
NMR metabolomics,X23408.Triglycerides in VLDL,TG,Thyroglobulin,37368,0.000425066978549436,0.0106098779149074,-0.0203702937346692,0.021220427691768,0.968043233446221
NMR metabolomics,X23408.Triglycerides in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.000151503587044059,0.00422163014245151,-0.00842589866624902,0.00812289149216091,0.971372623843104
NMR metabolomics,X23408.Triglycerides in VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,-9.42073875469023e-05,0.00265291424154153,-0.0052939193009683,0.0051055045258745,0.971672791375191
NMR metabolomics,X23408.Triglycerides in VLDL,KHDC3L,KH domain-containing protein 3,36962,-0.000224927706436275,0.0064910518893947,-0.0129473894096499,0.0124975339967773,0.972357791711412
NMR metabolomics,X23408.Triglycerides in VLDL,TPSG1,Tryptase gamma,37056,8.76297137978557e-05,0.00262787305840739,-0.00506300148068063,0.00523826090827634,0.973398975867794
NMR metabolomics,X23408.Triglycerides in VLDL,PGR,Progesterone receptor,37056,-0.000340849261381077,0.0102606655276365,-0.0204517536955485,0.0197700551727864,0.973500432515194
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAV,Integrin alpha-V,40030,4.70947588828339e-05,0.00161005684530556,-0.00310861665791607,0.00320280617568174,0.976665269713167
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF174,Zinc finger protein 174,37056,7.87055037574377e-05,0.003730242017599,-0.0072325688507366,0.00738997985825148,0.983166760509437
NMR metabolomics,X23408.Triglycerides in VLDL,SLC1A4,Neutral amino acid transporter A,37039,-9.91388187469151e-05,0.00501092140199573,-0.00992054476665854,0.00972226712916472,0.984215543291018
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL2,Interferon lambda-2,36991,-0.000110061966237398,0.00605051963048638,-0.0119690804419907,0.0117489565095159,0.985487159121789
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.000111529141699394,0.00628943594939878,-0.012438823602521,0.0122157653191222,0.98585230426581
NMR metabolomics,X23408.Triglycerides in VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,5.42359937136271e-05,0.00314296230931912,-0.00610597013255185,0.0062144421199791,0.986232387049823
NMR metabolomics,X23408.Triglycerides in VLDL,S100A16,Protein S100-A16,39456,4.07884527622961e-05,0.00605387350654564,-0.0118248036200672,0.0119063805255917,0.994624316353639
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,2.2204391027629e-05,0.00384147297473714,-0.00750708263945717,0.00755149142151243,0.99538819888825
NMR metabolomics,X23408.Triglycerides in VLDL,AREG,Amphiregulin,39788,1.89227417416956e-05,0.00454855060376705,-0.00889623644164172,0.00893408192512511,0.996680726615352
